0001201800-15-000011.txt : 20150514 0001201800-15-000011.hdr.sgml : 20150514 20150514160315 ACCESSION NUMBER: 0001201800-15-000011 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20150331 FILED AS OF DATE: 20150514 DATE AS OF CHANGE: 20150514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VASOMEDICAL, INC CENTRAL INDEX KEY: 0000839087 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 112871434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-18105 FILM NUMBER: 15862769 BUSINESS ADDRESS: STREET 1: 180 LINDEN AVENUE CITY: WESTBURY STATE: NY ZIP: 11590 BUSINESS PHONE: 516-997-4600 MAIL ADDRESS: STREET 1: 180 LINDEN AVENUE CITY: WESTBURY STATE: NY ZIP: 11590 FORMER COMPANY: FORMER CONFORMED NAME: VASOMEDICAL INC DATE OF NAME CHANGE: 19950517 FORMER COMPANY: FORMER CONFORMED NAME: FUTURE MEDICAL PRODUCTS INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FUTURE MEDICAL PRODUCTS INC /NY/ DATE OF NAME CHANGE: 19920506 10-Q 1 vaso-10qmarch2015.htm vaso-10qmarch2015.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549


FORM 10-Q


[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended March 31, 2015

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from _______________ to ______________

Commission File Number: 0-18105


VASOMEDICAL, INC.

(Exact name of registrant as specified in its charter)
 
Delaware
11-2871434
(State or other jurisdiction of
(IRS Employer Identification Number)
incorporation or organization)
  

180 Linden Ave., Westbury, New York 11590
(Address of principal executive offices)

Registrant’s Telephone Number
(516) 997-4600

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.
 
 
Large Accelerated Filer o
Accelerated Filer o
Non-Accelerated Filer o
Smaller Reporting Company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso No x
 
Number of Shares Outstanding of Common Stock, $.001 Par Value, at  May 8, 2015 – 166,450,370
 
 
Page 1
 
Vasomedical, Inc. and Subsidiaries

INDEX
3
   
3
   
3
   
4
   
5
   
6
   
7
   
16
   
20
   
21
   
21
 
 
 
Page 2
 
ITEM 1 - FINANCIAL STATEMENTS
Vasomedical, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
                                                   
   
March 31, 2015
    
December 31, 2014
  
     (unaudited)        
ASSETS
            
CURRENT ASSETS
            
Cash and cash equivalents
   $ 15,269     $ 9,128  
Short-term investments
     109       111  
Accounts and other receivables, net of an allowance for doubtful
                
accounts and commission adjustments of $4,361 at March 31,
                
2015 and $4,571 at December 31, 2014
     5,025       15,273  
Receivables due from related parties
     76       21  
Inventories, net
     2,129       1,898  
Deferred commission expense
     2,416       2,200  
Prepaid expenses and other current assets
     440       363  
 Total current assets
     25,464       28,994  
                 
PROPERTY AND EQUIPMENT, net of accumulated depreciation of
                
$1,443 at March 31, 2015 and $1,397 at December 31, 2014
     242       266  
GOODWILL
     3,304       3,288  
INTANGIBLES, net
     2,668       2,826  
OTHER ASSETS
     4,620       5,617  
    $ 36,298     $ 40,991  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY
                
CURRENT LIABILITIES
                
Accounts payable
   $ 567     $ 462  
Accrued commissions
     1,151       2,247  
Accrued expenses and other liabilities
     3,366       5,627  
Sales tax payable
     199       247  
Deferred revenue - current portion
     11,400       9,882  
Notes payable
     164       163  
Deferred tax liability, net
     112       112  
Notes payable due to related party
     1,056       1,039  
Total current liabilities
     18,015       19,779  
                 
LONG-TERM LIABILITIES
                
Deferred revenue
     10,053       12,650  
Other long-term liabilities
     705       811  
Total long-term liabilities
     10,758       13,461  
                 
COMMITMENTS AND CONTINGENCIES (NOTE N)
                
                 
STOCKHOLDERS' EQUITY
                
Preferred stock, $.01 par value; 1,000,000 shares authorized; nil shares
                
 issued and outstanding at March 31, 2015, and December 31, 2014
     -       -  
Common stock, $.001 par value; 250,000,000 shares authorized;
                
166,450,370 and 166,435,370 shares issued at March 31, 2015
               
and December 31, 2014, respectively; 156,142,283 and
                
156,127,283 shares outstanding at March 31, 2015 and
                
December 31, 2014, respectively
     166       166  
Additional paid-in capital
     61,943       61,924  
Accumulated deficit
     (52,685 )     (52,433 )
Accumulated other comprehensive income
     101       94  
Treasury stock, at cost, 10,308,087 shares at March 31, 2015 and December 31, 2014
     (2,000 )     (2,000 )
Total stockholders’ equity
     7,525       7,751  
    $ 36,298     $ 40,991  
 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
Page 3
 

Vasomedical, Inc. and Subsidiaries
 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)
(in thousands, except per share data)
 
      Three months ended  
      March 31,  
   
2015
    
2014
  
Revenues
            
Commissions
   $ 6,390     $ 6,241  
Equipment sales
     719       483  
Equipment rentals and services
     344       367  
Total revenues
     7,453       7,091  
                 
Cost of revenues
                
Cost of commissions
     1,523       1,602  
Cost of equipment sales
     175       144  
Cost of equipment rentals and services
     188       181  
Total cost of revenues
     1,886       1,927  
Gross profit
     5,567       5,164  
                 
Operating expenses
                
Selling, general and administrative
     5,719       6,041  
Research and development
     134       213  
Total operating expenses
     5,853       6,254  
Operating loss
     (286 )     (1,090 )
                 
Other income (expense)
                
Interest and other income, net
     40       56  
Total other income, net
     40       56  
                 
Loss before income taxes
     (246 )     (1,034 )
Income tax benefit (expense)
     (6 )     (10 )
Net loss
     (252 )     (1,044 )
                 
Other comprehensive income
                
Foreign currency translation gain (loss)
     7       (39 )
Comprehensive loss
   $ (245 )   $ (1,083 )
                 
Loss per common share
                
- basic and diluted
   $ (0.00 )   $ (0.01 )
                 
Weighted average common shares outstanding
  
- basic and diluted
     155,945       155,454  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
Page 4
 
 
Vasomedical, Inc. and Subsidiaries
 
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
 
 
(in thousands)
       
                               
                        Accumulated      
      Common Stock     Treasury Stock   Additional Paid-in  
Accumulated
  
Other Comprehensive
  
Total Stockholders'
  
   
Shares
  
Amount
  
Shares
  
Amount
  
Capital
  
Deficit
  
Income
  
Equity
  
Balance at December 31, 2013
     164,705    $ 165     (9,481)    $ (1,755)    $ 61,508    $ (53,561 )  $ 108    $ 6,465  
Repurchase of
shares
     -     -     (827 )   (245 )   -     -     -     (245 )
Share-based
compensation
     1,280     1     -     -     389     -     -     390  
Shares not issued
for employee tax
liability
     -     -     -     -     (9 )   -     -     (9 )
Exercise of stock options     450     -     -     -     36     -     -     36  
Foreign currency
translation loss
     -     -     -     -     -     -     (14)     (14 )
Net income
     -     -     -     -     -     1,128     -     1,128  
Balance at December 31, 2014
     166,435     166     (10,308 )   (2,000 )   61,924     (52,433 )   94     7,751  
Share-based
compensation
     15     -      -     -     19     -     -     19  
Foreign currency
translation gain
    -     -     -     -     -     -       7     7  
Net loss     -     -     -     -      -     (252)     -     (252 )
Balance at March 31, 2015 
(unaudited)
     166,450    $ 166     (10,308)    $ (2,000 )  $ 61,943    $ (52,685 )  $ 101    $ 7,525  
                                                   


The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
Page 5
 
Vasomedical, Inc. and Subsidiaries 
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands)

     Three months ended  
     March 31,  
   
2015
    
2014
  
Cash flows from operating activities
            
Net loss
   $ (252 )   $ (1,044 )
Adjustments to reconcile net loss to net cash
                
  provided by operating activities
                
Depreciation and amortization
     212       99  
Loss from interest in joint venture
     2       -  
Provision for doubtful accounts and commission adjustments
     9       (8 )
Share-based compensation and arrangements
     19       153  
Changes in operating assets and liabilities:
                
Accounts and other receivables
     10,240       8,194  
Receivables due from related parties
     (55 )     -  
Inventories, net
     (227 )     (225 )
Deferred commission expense
     (211 )     (7 )
Other current assets
     (76 )     3  
Other assets
     1,070       (184 )
Accounts payable
     105       147  
Accrued commissions
     (1,095 )     (461 )
Accrued expenses and other  liabilities
     (2,267 )     (1,449 )
Sales tax payable
     (48 )     (33 )
Deferred revenue
     (1,078 )     (1,014 )
Notes payable due to related party
     18       -  
Other long-term liabilities
     (107 )     25  
Net cash provided by operating activities
     6,259       4,196  
                 
Cash flows from investing activities
                
Purchases of equipment and software
     (45 )     (136 )
Purchases of short-term investments
     (38 )     (40 )
Redemption of short-term investments
     40       40  
Net cash used in investing activities
     (43 )     (136 )
                 
Cash flows from financing activities
                
Debt issuance costs
     (60 )     -  
Net cash used in financing activities
     (60 )     -  
Effect of exchange rate differences on cash and cash equivalents
     (15 )     (12 )
                 
NET INCREASE IN CASH AND CASH EQUIVALENTS
     6,141       4,048  
Cash and cash equivalents - beginning of period
     9,128       7,961  
Cash and cash equivalents - end of period
   $ 15,269     $ 12,009  
                 
SUPPLEMENTAL DISCLOSURE OF CASH INFORMATION
                
Interest paid
   $ 3     $ -  
Income taxes paid
   $ 65     $ 13  
                 
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
          
Common shares issued for prepaid directors' fees
   $ -     $ 175  

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
 
 
Page 6
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
NOTE A - ORGANIZATION AND PLAN OF OPERATIONS

Vasomedical, Inc. was incorporated in Delaware in July 1987.  Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Vasomedical” or “management” refer to Vasomedical, Inc. and its subsidiaries.  Until 2010, we were primarily engaged in designing, manufacturing, marketing and supporting Enhanced External Counterpulsation (EECP®) systems, based on our proprietary technology, to physicians and hospitals throughout the United States and in select international markets. Beginning in July 2010 the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. (Vaso Diagnostics), began its sales representation business via its agreement (the “GEHC Agreement”) with GE Healthcare (“GEHC”), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC’s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.   In June 2012, the GEHC Agreement was amended and extended through June 30, 2015 and again, in December 2014, the GEHC Agreement was further amended and extended through December 31, 2018, subject to earlier termination under certain circumstances and termination without cause on or after July 1, 2017.

In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company, which owns or controls two Chinese operating companies - Life Enhancement Technology Ltd. and Biox Instruments Co. Ltd. (Biox), respectively - to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.  Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy, and started to operate through three wholly-owned subsidiaries.  Vaso Diagnostics continues as the operating subsidiary for the sales representation of GE diagnostic imaging products; Vasomedical Global Corp. operates the Company’s Chinese companies; and Vasomedical Solutions, Inc. was formed to manage and coordinate our EECP® therapy business as well as other medical equipment operations.

In April 2014, the Company entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. (PSK) of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited (VSK), for the global marketing, sale and advancement of ECP therapy technology.  The Company owns 49.9% of the joint venture, which began operations in January 2015.

In June 2014, the Company entered into a Value Added Reseller Agreement (VAR Agreement) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.  This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.  A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.

In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (Genwell), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (Gentone).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.

We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.  Vaso Diagnostics activities are included under our Sales Representation segment.  VasoHealthcare IT operations report under the IT segment.

NOTE B - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES

Basis of Presentation and Use of Estimates

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the unaudited condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the SEC on March 30, 2015. These unaudited condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.
 
Page 7
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the unaudited condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.
 
Significant Accounting Policies
 
Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2014, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.

Revenue and Expense Recognition for the Sales Representation Segment

The Company recognizes commission revenue in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.  These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.  Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.  Commission expense is recognized when the corresponding commission revenue is recognized.
 
Variable Interest Entities

The Company follows the guidance of accounting for variable interest entities, which requires certain variable interest entities to be consolidated by the primary beneficiary of the entities.  Biox is a Variable Interest Entity (VIE).

Liabilities recognized as a result of consolidating this VIE do not represent additional claims on the Company’s general assets. The financial information of Biox, which was included in the accompanying condensed consolidated financial statements, is presented as follows:
 
     (in thousands)  
   
As of March 31, 2015
    
As of December 31, 2014
  
     (unaudited)        
Cash and cash equivalents
   $ 117     $ 159  
Total assets
   $ 1,083     $ 1,047  
Total liabilities
   $ 1,047     $ 878  

    (in thousands)  
      Three months ended March 31,  
   
2015
    
2014
  
    (unaudited)       (unaudited)  
Total net revenue
   $ 371     $ 329  
                 
Net loss
   $ (135 )   $ (148 )
 
Reclassifications
 
Certain reclassifications have been made to prior period amounts to conform with the current period presentation.
 
 
Page 8
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
NOTE C – SEGMENT REPORTING AND CONCENTRATIONS
 
The Company views its business in three segments – the Sales Representation segment, the Equipment segment, and the IT segment. The Sales Representation segment operates through the Vaso Diagnostics subsidiary and is currently engaged solely in the fulfillment of the Company’s responsibilities under our agreement with GEHC. The Equipment segment is engaged in designing, manufacturing, marketing and supporting EECP® enhanced external counterpulsation systems both domestically and internationally, as well as the development, production, marketing and supporting of other medical devices. The Company’s new subsidiary, VasoHealthcare IT Corp., formed to conduct its healthcare IT operations, reports through the IT segment. Operations in the IT segment began in the third quarter of 2014.
 
The chief operating decision maker is the Company’s Chief Executive Officer, who in conjunction with upper management, evaluates segment performance based on operating income. Administrative functions such as finance, human resources, and information technology are centralized and related expenses allocated to each segment. Other costs not directly attributable to operating segments, such as audit, legal, director fees, investor relations, and others, as well as certain assets – primarily cash balances – are reported in the Corporate entity below. There are no intersegment revenues. Summary financial information for the segments is set forth below:
                 
     (in thousands)  
      As of or for the three months ended March 31, 2015 (unaudited)  
   
Sales Representation Segment
  
Equipment Segment
  
IT Segment
    
Corporate
    
Consolidated
  
                               
Revenues from external customers
   $ 6,390     $ 1,063     $ -     $ -     $ 7,453  
Operating income (loss)
   $ 1,087     $ (635 )   $ (355 )   $ (383 )   $ (286 )
Total assets
   $ 11,142     $ 9,592     $ 159     $ 15,405     $ 36,298  
Accounts and other receivables, net
   $ 4,363     $ 576     $ 86     $ -     $ 5,025  
Deferred commission expense
   $ 2,412     $ -     $ 4     $ -     $ 2,416  
Other assets
   $ 3,832     $ 715     $ -     $ 73     $ 4,620  
                                         
        As of or for the three months ended March 31, 2014 (unaudited)  
   
Sales Representation Segment
  
Equipment Segment
  
IT Segment
    
Corporate
    
Consolidated
  
                                         
Revenues from external customers
   $ 6,241     $ 850     $ -     $ -     $ 7,091  
Operating income (loss)
   $ 523     $ (1,082 )   $ -     $ (531 )   $ (1,090 )
Total assets
   $ 10,209     $ 7,728     $ -     $ 11,986     $ 29,923  
Accounts and other receivables, net
   $ 4,535     $ 846     $ -     $ -     $ 5,381  
Deferred commission expense
   $ 2,319     $ -     $ -     $ -     $ 2,319  
Other assets
   $ 2,836     $ 432     $ -     $ 13     $ 3,281  
 
For the three months ended March 31, 2015 and 2014, GE Healthcare accounted for 86% and 88% of revenue, respectively, and $4.2 million or 85%, and $14.2 million or 93%, of accounts and other receivables at March 31, 2015 and December 31, 2014, respectively.

NOTE D – LOSS PER COMMON SHARE

 Basic loss per common share is computed as earnings applicable to common stockholders divided by the weighted-average number of common shares outstanding for the period.  Diluted loss per common share reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted to common stock.

The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three months ended March 31, 2015 and 2014, because the effect of their inclusion would be anti-dilutive.
 
 
Page 9
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
    (in thousands)  
    For the three months ended  
   
March 31, 2015
    
March 31, 2014
  
    (unaudited)       (unaudited)  
Stock options
     952       1,754  
Common stock grants
     390       875  
      1,342       2,629  
 
NOTE E – FAIR VALUE MEASUREMENTS

The Company complies with the provisions of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).  Under ASC 820, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The following tables present information about the Company’s assets measured at fair value as of March 31, 2015 and December 31, 2014:
         
      (in thousands)
   
 
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
  
 
Significant
Other
Observable
Inputs
(Level 2)
    
 
 
Significant
Unobservable
Inputs
(Level 3)
    
 
 
Balance
as of
March 31,
2015
  
                     (unaudited)  
Assets
                        
Cash equivalents invested in money market funds (included in cash and cash equivalents)
   $ 14,666     $ -     $ -     $ 14,666  
                                 
   
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
    
Significant
Other
Observable
Inputs
(Level 2)
    
Significant
Unobservable
Inputs
(Level 3)
    
Balance
as of
December 31,
2014
  
Assets
                                
Cash equivalents invested in money market funds (included in cash and cash equivalents)
   $ 8,149     $ -     $ -     $ 8,149  
                                 

The fair values of the Company’s cash equivalents invested in money market funds are determined through market, observable and corroborated sources.

NOTE F – ACCOUNTS AND OTHER RECEIVABLES, NET

The following table presents information regarding the Company’s accounts and other receivables as of March 31, 2015 and December 31, 2014:
 
 
Page 10
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
    (in thousands)  
   
March 31, 2015
    
December 31, 2014
  
     (unaudited)        
             
Trade receivables
   $ 9,270     $ 19,734  
Due from employees
     116       110  
Allowance for doubtful accounts and
                
commission adjustments
     (4,361 )     (4,571 )
Accounts and other receivables, net
   $ 5,025     $ 15,273  
 
Trade receivables include amounts due for shipped products and services rendered. Amounts currently due under the GEHC Agreement are subject to adjustment in subsequent periods should the underlying sales order amount, upon which the receivable is based, change.
 
Allowance for doubtful accounts and commission adjustments include estimated losses resulting from the inability of our customers to make required payments, and adjustments arising from subsequent changes in sales order amounts that may reduce the amount the Company will ultimately receive under the GEHC Agreement. Due from employees is primarily commission advances made to sales personnel.
 
NOTE G – INVENTORIES, NET

Inventories, net of reserves, consist of the following:
                            
    (in thousands)  
   
March 31, 2015
    
December 31, 2014
  
     (unaudited)        
             
Raw materials
   $ 592     $ 583  
Work in process
     691       679  
Finished goods
     846       636  
    $ 2,129     $ 1,898  
                 
 
 
At March 31, 2015 and December 31, 2014, the Company maintained reserves for excess and obsolete inventory of $783,000 and $815,000, respectively.

NOTE H – GOODWILL AND OTHER INTANGIBLES

Goodwill aggregating $3,304,000 and $3,288,000 was recorded on the Company’s condensed consolidated balance sheets at March 31, 2015 and December 31, 2014, respectively, pursuant to the acquisition of FGE in September 2011.  All of the goodwill was allocated to the Company’s Equipment segment.  The components of the change in goodwill are as follows:
       
 
    (in thousands)  
   
Carrying Amount
  
       
Balance at December 31, 2014
   $ 3,288  
Foreign currency translation
     16  
Balance at March 31, 2015 (unaudited)
   $ 3,304  
 
 
 
Page 11
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
 
The Company’s other intangible assets consist of capitalized patent costs, customer lists and software costs, as follows:
 
      (in thousands)  
   
March 31, 2015
    
December 31, 2014
  
     (unaudited)        
Patents and Technology
            
Costs
   $ 2,478     $ 2,489  
Accumulated amortization
     (613 )     (549 )
      1,865       1,940  
                 
Customer lists
                
Costs
     800       800  
Accumulated amortization
     (410 )     (381 )
      390       419  
                 
Software
                
Costs
     986       962  
Accumulated amortization
     (573 )     (495 )
      413       467  
                 
    $ 2,668     $ 2,826  
                 

Patents, customer lists, and software are included in other assets in the accompanying condensed consolidated balance sheets and are amortized on a straight line basis over their estimated useful lives of ten, seven, and five years, respectively.  Amortization expense amounted to $171,000 and $46,000 for the three months ended March 31, 2015 and 2014, respectively.
 
NOTE I – OTHER ASSETS
 
Other assets consist of the following at March 31, 2015 and December 31, 2014:

 
    (in thousands)  
   
March 31, 2015
    
December 31, 2014
  
    (unaudited)        
             
Deferred commission expense - noncurrent
   $ 2,493     $ 2,988  
Trade receivables - noncurrent
     1,612       2,171  
Other
     515       458  
    $ 4,620     $ 5,617  
                 
 

 
Page 12
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
 
NOTE J – ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities consist of the following at March 31, 2015 and December 31, 2014:

 
    (in thousands)  
   
 March 31, 2015
    
December 31, 2014
  
    (unaudited)         
             
Accrued compensation
   $ 433     $ 2,917  
Accrued expenses - other
     1,090       1,098  
Other liabilities
     1,843       1,612  
    $ 3,366     $ 5,627  

 
NOTE K- DEFERRED REVENUE

The changes in the Company’s deferred revenues are as follows:
 

    (in thousands)  
      For the three months ended  
   
March 31, 2015
    
March 31, 2014
  
     (unaudited)      (unaudited)  
Deferred revenue at beginning of period
   $ 22,532     $ 18,019  
Additions:
                
Deferred extended service contracts
     211       237  
Deferred in-service and training
     3       3  
Deferred service arrangements
     10       5  
Deferred commission revenues
     1,849       1,770  
Recognized as revenue:
                
Deferred extended service contracts
     (231 )     (227 )
Deferred in-service and training
     (8 )     (8 )
Deferred service arrangements
     (23 )     (24 )
Deferred commission revenues
     (2,890 )     (2,771 )
Deferred revenue at end of period
     21,453       17,004  
Less: current portion
     11,400       10,294  
Long-term deferred revenue at end of period
   $ 10,053     $ 6,710  

 
 
Page 13
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)
NOTE L – RELATED-PARTY TRANSACTIONS

David Lieberman, the Vice Chairman of the Company’s Board of Directors, is a practicing attorney in the State of New York and a senior partner at the law firm of Beckman, Lieberman & Barandes, LLP, which performs certain legal services for the Company.  Fees of approximately $60,000 were billed by the firm through each of the three month periods ended March 31, 2015 and 2014, at which dates no amounts were outstanding.
 
In January 2015, operations began under the VSK joint venture.  The Company accounts for its investment in VSK using the equity method.  At March 31, 2015, approximately $55,000 was due from VSK for equipment the Company sold to it, and the Company’s minority interest in VSK’s loss from operations for the three months ended March 31, 2015 approximated $2,000 and is recorded in Interest and Other Income, net on the Company’s condensed consolidated statement of operations and comprehensive loss.
 
NOTE M – BUSINESS COMBINATION

On August 6, 2014 the Company acquired Genwell Instruments Co. Ltd (Genwell).  The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013.
                                                                                                    
    (in thousands)  
      Three months ended  
   
March 31, 2015
    
March 31, 2014
  
Revenue
   $ 7,453     $ 7,091  
                 
Net loss
     (252 )     (1,173 )
                 
Basic and diluted loss per share
   $ (0.00 )   $ (0.01 )
                 

NOTE N – COMMITMENTS AND CONTINGENCIES

Sales representation agreement

In June 2012, the Company concluded an amendment of the GEHC Agreement with GEHC, originally signed on May 19, 2010.  The amendment, effective July 1, 2012, extended the initial term of three years commencing July 1, 2010 to five years through June 30, 2015.  In December 2014, the Company concluded an additional amendment, effective January 1, 2015, extending the term through December 31, 2018, subject to earlier termination under certain circumstances and termination without cause on or after July 1, 2017.  These circumstances include not materially achieving certain sales goals, not maintaining a minimum number of sales representatives, and various legal and GEHC policy requirements.  Under the terms of the agreement, the Company is required to lease dedicated computer equipment from GEHC for connectivity to their network.

NOTE O - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In May 2014, the FASB issued ASU 2014-09 “Revenue from contracts with customers”, a comprehensive new revenue recognition standard which will supersede previous existing revenue recognition guidance. The standard creates a five-step model for revenue recognition that requires companies to exercise judgment when considering contract terms and relevant facts and circumstances. The five-step model includes (1) identifying the contract, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations and (5) recognizing revenue when each performance obligation has been satisfied. The standard also requires expanded disclosures surrounding revenue recognition. The standard is effective for fiscal periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption.  In April 2015 the FASB issued a proposal to defer the effective date for one year.  The Company is currently evaluating the impact of the adoption of this standard on its Consolidated Financial Statements.
 
 
Page 14
 
Vasomedical, Inc. and Subsidiaries
 
Notes to Condensed Consolidated Financial Statements (unaudited)

 
In April 2015, the FASB issued ASU 2015-03 “Simplifying the Presentation of Debt Issuance Costs”, which changes the presentation of debt issuance costs in financial statements. An entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense.  The standard is effective for fiscal periods beginning after December 31, 2015 and allows for early adoption.  The adoption of this statement will impact future presentation and disclosure of the Consolidated Financial Statements.
 
 
Page 15
 
Vasomedical, Inc. and Subsidiaries

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 

Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the effect of the dramatic changes taking place in the healthcare environment; the impact of competitive procedures and products and their pricing; medical insurance reimbursement policies; unexpected manufacturing or supplier problems; unforeseen difficulties and delays in the conduct of clinical trials and other product development programs; the actions of regulatory authorities and third-party payers in the United States and overseas; uncertainties about the acceptance of a novel therapeutic modality by the medical community; continuation of the GEHC Agreement and the risk factors reported from time to time in the Company’s SEC reports, including its recent report on Form 10-K.  The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

General Overview

Vasomedical, Inc. was incorporated in Delaware in July 1987.  Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Vasomedical” or “management” refer to Vasomedical, Inc. and its subsidiaries.  Until 2010, we were primarily engaged in designing, manufacturing, marketing and supporting Enhanced External Counterpulsation (EECP®) systems, based on our proprietary technology, to physicians and hospitals throughout the United States and in select international markets. Beginning in July 2010 the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. d/b/a VasoHealthcare, began its sales representation business via its agreement (GEHC Agreement) with GE Healthcare (GEHC), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC’s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.   In June 2012, the GEHC Agreement was amended and extended through June 30, 2015 and again, in December 2014, the GEHC Agreement was further amended and extended through December 31, 2018, subject to earlier termination under certain circumstances and termination without cause on or after July 1, 2017.

In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company, which owns or controls two Chinese operating companies - Life Enhancement Technology Ltd. and Biox Instruments Co. Ltd., respectively - to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.  Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy, and started to operate through three wholly-owned subsidiaries.  Vaso Diagnostics d/b/a VasoHealthcare continues as the operating subsidiary for the sales representation of GE diagnostic imaging products; Vasomedical Global Corp. operates the Company’s Chinese companies; and Vasomedical Solutions, Inc. was formed to manage and coordinate our EECP® therapy business as well as other medical equipment operations.
 
In April 2014, the Company entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. (PSK) of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited (VSK), for the global marketing, sale and advancement of ECP therapy technology.  The Company owns 49.9% of the shares of VSK.  VSK began operations in January 2015.
 
In June 2014, the Company entered into a Value Added Reseller Agreement (VAR Agreement) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.  This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.  A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.
 
 
Page 16
 
Vasomedical, Inc. and Subsidiaries

In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (Genwell), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (Gentone).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.

We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.  Vaso Diagnostics activities are included under our Sales Representation segment.  VasoHealthcare IT operations report under the IT segment.

The Company continues to pursue acquisitions or partnership opportunities in the international and domestic markets and to seek expansion of its sales representation business.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

Certain of our accounting policies are deemed “critical”, as they are both most important to the financial statement presentation and require management’s most difficult, subjective or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our critical accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2014.

Results of Operations – For the Three Months Ended March 31, 2015 and 2014

Total revenue for the three months ended March 31, 2015 and 2014 was $7,453,000 and $7,091,000, respectively, an increase of $362,000, or 5% year-over-year. Net loss for the three months ended March 31, 2015 and 2014 was $252,000 and $1,044,000, respectively, a decrease of $792,000, or 76%.  Our total net loss was $(0.00) and $(0.01) per basic and diluted common share for the three months ended March 31, 2015 and 2014, respectively.

Revenues

Commission revenues in the Sales Representation segment were $6,390,000 in the first quarter of 2015, as compared to $6,241,000 in the first quarter of 2014, an increase of 2%.  The increase in commission revenue in the first quarter of 2015 is due primarily to an increase in volume of equipment delivered by GEHC.  The Company recognizes commission revenue when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the agreement with GE Healthcare prior to customer acceptance of the equipment are recorded as deferred revenue in the condensed consolidated balance sheet.  As of March 31, 2015, $20,114,000 in deferred commission revenue was recorded in the Company’s condensed consolidated balance sheet, of which $9,420,000 is long-term.  At March 31, 2014, $15,665,000 in deferred commission revenue was recorded in the Company’s condensed consolidated balance sheet, of which $6,112,000 was long-term.
 
Revenue in our Equipment segment increased by $213,000, or 25%, to $1,063,000 for the three-month period ended March 31, 2015 from $850,000 for the same period of the prior year.  Equipment segment revenue from equipment sales increased by $236,000, or 49%, to $719,000 for the three-month period ended March 31, 2015 as compared to $483,000 for the same period in the prior year, resulting from increases in EECP® revenues as a result of higher sales volume, and in international sales by our China operations.
 
 
Page 17
 
Vasomedical, Inc. and Subsidiaries

Equipment segment revenue from equipment rental and services decreased 6% to $344,000 in the first quarter of 2015 from $367,000 in the first quarter of 2014. Revenue from equipment rental and services represented 32% and 43% of total Equipment segment revenue in the first quarters of fiscal 2015 and fiscal 2014, respectively.  The decrease in revenue generated from equipment rentals and services is due primarily to lower field service and accessory part revenues, partially offset by increased service contract revenue..

Gross Profit

The Company had a gross profit of $5,567,000, or 75% of revenue, in the first quarter of 2015 compared to $5,164,000, or 73% of revenue, in the first quarter of the prior year, an increase of 8%.  The increase is principally due to higher gross profit margin in both our Sales Representation segment and our Equipment segment.

Sales Representation segment gross profit was $4,867,000, or 76% of the segment revenue, for the three months ended March 31, 2015 as compared to $4,639,000, or 74% of the segment revenue, for the three months ended March 31, 2014.  The increase in absolute dollars and margin percentage was due to higher equipment deliveries by GEHC during the first quarter of 2015 than in the same period last year, as well as lower commission expense in the first quarter of 2015.  Cost of commissions of $1,523,000 and $1,602,000, for the three months ended March 31, 2015 and 2014, respectively, reflects commission expense associated with recognized commission revenues.  Commission expense associated with deferred revenue is recorded as deferred commission expense until the related commission revenue is earned.

Equipment segment gross profit increased to $700,000, or 66% of Equipment segment revenues, for the first quarter of 2015 compared to $525,000, or 62% of Equipment segment revenues, for the same quarter of 2014.  Gross profit margin in the Equipment segment improved due to higher margin on EECP® equipment as a result of higher shipment volume during the quarter.

Operating Loss

Operating loss was $286,000 for the three months ended March 31, 2015 as compared to $1,090,000 for the three months ended March 31, 2014, a decrease of $804,000.  Included in this loss was a $355,000 operating loss in our IT segment which began operations in the third quarter of 2014.  During this period, there was also a $403,000 increase in gross profit and a $322,000 decrease in selling, general, and administrative costs.  Operating income in the Sales Representation segment increased by $564,000 to $1,087,000 as compared to $523,000 in the first quarter of the prior year, due mainly to higher gross margin combined with lower SG&A costs.  In addition, operating loss in the Equipment segment decreased by $447,000, or 41%, to $635,000 compared to $1,082,000 in the same quarter of the prior year, due primarily to $175,000 higher gross profit and $193,000 lower SG&A costs in the current year quarter.  

SG&A expenses for the first quarter of 2015 and 2014 were $5,719,000, or 77% of revenues, and $6,041,000, or 85% of revenues, respectively, reflecting a decrease of $322,000 or approximately 5%. The decrease in SG&A expenditures in the first quarter of 2015 resulted primarily from having the annual national sales meeting of the Sales Representation segment in the second quarter of 2015 instead of the first quarter last year, a reduction in personnel and other costs in the Equipment segment, and lower corporate expenses, primarily accounting and directors’ fees, partially offset by costs incurred in the IT segment,
 
Research and development (“R&D”) expenses were $134,000, or 2% of revenues (13% of Equipment segment revenues), for the first quarter of 2015, a decrease of $79,000, or 37%, from $213,000, or 3% of revenues (25% of Equipment segment revenues), for the first quarter of 2014. The decrease is primarily attributable to the elimination of non-recurring costs in the first quarter of 2014 associated with the reclassification by FDA of our EECP® therapy system, as well as lower clinical grants in the first quarter of 2015.
 
 
Page 18
 
Vasomedical, Inc. and Subsidiaries

Interest and Other Income, Net

Interest and other income, net for the first quarter of 2015 was $40,000 as compared to $56,000 for the first quarter of 2014. The decrease was due primarily to lower government grants received by our Chinese subsidiaries.

Income Tax Expense

During the first quarter of 2015 we recorded income tax expense of $6,000 as compared to income tax expense of $10,000 for the first quarter of 2014.  The decrease arose from lower tax expense at our Chinese subsidiaries.

Liquidity and Capital Resources

Cash and Cash Flow

We have financed our operations from working capital.  At March 31, 2015, we had cash and cash equivalents of $15,269,000, short-term investments of $109,000 and working capital of $7,449,000 compared to cash and cash equivalents of $9,128,000, short-term investments of $111,000 and working capital of $9,215,000 at December 31, 2014.

Cash provided by operating activities was $6,259,000 during the first three months of 2015, which consisted of a net loss after adjustments to reconcile net loss to net cash of $10,000, offset by cash provided by operating assets and liabilities of $6,269,000. The changes in the account balances primarily reflect a decrease in accounts and other receivables of $10,240,000, partially offset by decreases in deferred revenue of $1,078,000, accrued commissions of $1,095,000, and accrued expenses of $2,267,000.  Significantly higher commission billings and recognized revenue were generated in the fourth quarter of 2014 resulting in significant cash inflows early in 2015.
 
Cash used in investing activities during the three-month period ended March 31, 2015 was $43,000, primarily for the purchase of equipment and software.

Cash used in financing activities during the three-month period ended March 31, 2015 was $60,000 for expenses incurred in debt issuance activities.
 
Liquidity
 
The Company expects to be profitable for the year ended December 31, 2015 and continue to generate positive cash flow through its existing sales representation operations, improved operating efficiency and growth in its China operations and by expanding its market presence and product portfolio.  The Company has reorganized its EECP® business model, both domestically and internationally, including the start of operations of the joint venture VSK Medical, to reduce costs and achieve profitability in this business.  The Company will continue to pursue acquisitions and partnership opportunities in the international and domestic markets and to expand its sales representation business.
 
 
 
Page 19
 
Vasomedical, Inc. and Subsidiaries

ITEM 4 - CONTROLS AND PROCEDURES
 
Evaluation of Disclosure Controls and Procedures
 
Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.  Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2015 and have concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2015.

Changes in Internal Control Over Financial Reporting

There was no change in the Company’s internal control over financial reporting during the Company’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
 
 
Page 20
 
Vasomedical, Inc. and Subsidiaries



PART II - OTHER INFORMATION



 

 
Exhibits

31
Certifications of the Chief Executive Officer and the Chief Financial Officer pursuant to Rules 13a-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32
Certifications of the Chief Executive Officer and the Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.


 
Page 21
 
Vasomedical, Inc. and Subsidiaries


In accordance with the requirements of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


VASOMEDICAL, INC.

By:           /s/ Jun Ma                                           
Jun Ma
 
President and Chief Executive Officer
 
(Principal Executive Officer)

/s/ Michael J. Beecher   .
Michael J. Beecher
 
Chief Financial Officer and Principal Accounting Officer

Date:  May 14, 2015
 
 
Page 22
 
 
 GRAPHIC 2 vasojune2014.jpg begin 644 vasojune2014.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4` M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@`` M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`"L! M$`,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/[^**_FM_X+3?\`!4[]J7_@G[\9_AKX3^$EEX'N/"7CKP3>^(U? MQ'HLVI7AN["_@TVXC25;B!(D68RN`!*7!`(3;D]I_P`$2_\`@J+^T!_P4!\8 M?&7P[\:K+P?;V_@3PUH^M:+-X8TR3397GO\`5([2:&YC>:?>B0OE)`Z[FS^[ M&*_1*GAAQ/3X,CQVUE\LAE0AB%*&-C+%J$\7]2L\-R74XU[QG'FTBN;8_/X> M)7#<^,)<#IX^.>1KSP[C+!M85SAA/KMXXCGLX2H:QERZO2U]OZ'JHZCJFFZ1 M:R7VK:A9:99PJSRW5_=06EO&B`LS/-(XO@!\0--URW\+>'K>^EM;6?4/"NJ6VE:I?7,5ML\_P"W MS/YT<,C,HCW*Z.#Q^/\`%>;8GAGAK%\3?V9B+QRJO# M0K5Y*2ASJC4=HPG*R^%73/ZO^CAX.4OI!^,&1^$E/B[+>$L?G&59SG<,7CL- M6Q^(K8#(:-*OCZ>7X"A.D\5C'3JITH5<1AJ/NSXL?$_QS\(/JUN7232=*N9-1O1)'D,F((S#G*D9$I''N*^+?%O\`P7B_8X\. MRR0:78^/O%$JLRQOIVE6T%M*1T*W-S`_B5\1K];?POX M:\4>*;^>98FCT;2=2U.?S9`"%E^QV\@0D$-F9T4`Y+`&OOCX:_\`!(_]M[XD MI9WMC\*-2TG2[E8Y#?\`B2]L]'2-'SC]S/<-<%Q_%&T2<=&R<5^%KQ0XZSB; MCDF34.6]DL+@,7CY+;XJLI*E?S<8Q[KM_K;6_9Z_1`\+<)"MXM>+.;*O&,95 M9<0<8\-<&4JDK)OV&6TJ%7,N23ORQAB,1/5+G;U?[A:Q_P`'"7P93=_8/PF\ M57)`R/[0U#3(AR>.8+L@G&O'^KN#^ M)XKY<\&?\&^G[0NK1V\WB3XB^`_"H?!N()8=1U.>(-C*J;6?RV9>%W*A5SQ9]6I74OJ.<>(. M=*JM[E6W5:,J+_P<):C(^(O@3HI7N7\1W(YSQTE/YX]/6NFT MO_@OXEPR_P!H_!.QA4XW?9==FD89]/,F"GCU(]`2>OI^D?\`!`/X%6RK_:?Q M1\9SO@;S:6.CH"V.2HEM#WY'L:[NR_X(/_LO6P7[1XV^)%R5ZE;C3;:<3_LLZ2G3PO"7%>(TLJF# MPO&Z;VUC+%YU2\]91_R.5T#_`(+M?"R[V_VW\+?$5L2,G^S]0T^49XR%\^Z7 MGTSCT([U[CX:_P""SW[+^NE$O=&\>:)*Q4-]ITVUN8%SU/GV]QM(!XX!/?IS M7/6W_!#W]E2W`'_"0_$:0C`W-JMIG`X_Y]C_`)]3DG6A_P""*O[+]NH$/B+X MC(0W_D(!_GVXKJI4O'VA_R_X7Q2O\.(]BM/\5&G2?X[GY;G6,_9NYAS M?V?EWB[E$G\,\#]=E&-^U/'XO&Q:7FKGTQX:_P""D7[(_B)(F?XG6&B/*0!' MK,,UNRLW16*)(`>N1VQ7T+X;_:+^!OB_RQX;^*/A'53*`4$&IHA(.,<3K%CK MT./T-?GC%_P1O_9[M_\`CU\9?$.+C@27EC<`'CD+-"R@X&.`./>M*V_X)+?" MK3\?V;\1?&L)4D@O#I).<="PM"Q'8@D\5[.&S7QIP[BL;PMPGCXJW-+"YQ5P ME1][>T=6"^<.NETC\=SWAGZ'&,YY<-^)?BID\VWR4\XX3PV94(;6YGAJ>%K. MW;VE]]=%?]4[76M'OD62RU73;M'^X]M>VTZMGT,4K`]:T@P)V9QTZUZ;I/[.?[1_AV96 MT?\`:4U">U7&++5;.>X@.WINVQEC[\\^W2OH\+Q)Q>K+,N`<;2?6>79WE&.C MTUY:U7!2[Z:O3K<_*,TX'\-DY/(/&#+<9%*\89SPKQ%E%26ND>;#T,TIIVZR M<5Z'W=17SUH6C_M%:*BQ:KXG\$>)HU(4R_V=?6MR5Y^8LS+EOKQSSP*]9T:] M\4L`FMZ7;HW`,EG,#&.<$A7._'!(!YP17U&$S5XCE57+Q^>YADD<$Y.AG&39G33TJ8#%SO)=U2Q=#"UEZ.G?NCK**!GN,?K1 M7JGAA1110`45\^?M5?&^S_9Q_9Z^*_QJO3;@>`?".IZS:+=_\>TFI)%Y6FQS M#(W1/>R0B11RR;@.37\D7[)?_!=__@H!^TO^TC\)_@M8:)\+Y+;QSXWTG2M4 M%IX:N8;BUT&:[1]5F2X%Y*4>TT_SF24Q,&D1-R1*2R?><+>'7$?%^5YOG65K M`T\NR12>.KXW%QPR7L\//%5/9)PE[3V=&'-/:W-!:N1\1Q-X@\/<*9IE.3YI M+&3S#.7%8*A@\++$M\^(IX:G[5J453]I5J';+4=8^'7B#5;J_P!4LX$75KQ;VW"1 M2VQNRZ6ZH"-J;E?YL#^B3]@SXE_&;XQ?LK_"KXG?'W3+'1OB=XRT>36=;TG3 M["?3+>PBGN)%L(38W&9;>8VJI++&Q;:9``S8W&.(/#WB#AG(= M>P>"HTL;"MC;8C#?6XNMAHQ4J7)2Y?::2YI=%=] M#CS#'8;+,#C,QQDW3PN!PU;%XB:7,XT:%.52HU'[4N6+Y8KXG9=3[6HK^/#_ M`()U?\%JOV[OVR/VMOA9\$=4TKX;?\(?KFM2R>-;[3/#=U:7ECX:M;>5[J[A MG%W<".43>0BAEVD2'YU(57_K`T?XM^$];\;:A\/[4ZDOB+39)UFCFTZYCM'B M@BFE:>.\9!"R,L+A/FR6VCJ0*^FXOX#S_@K,(99G$<)/%2P*S&<$9+B[_9K\:B/]W9:1XF\/O+CO/?/? M+'G'JN['X_3Q+_@UMU;ROV@OV@=()(-U\,-'N-N>HBUX\D9R?]4,9'T)QQ^E MO_!RY\.=0\6?LI_#'Q#I-FMS=Z#\3([2X6>EZ#X=^"%Y-!#-,BR:EJT>HRR:;I\0+[W:ZN%6' M"!F7S-V,#!_IGAK"8[/_`*-N-PN!P>(Q5:E];R^E"A2G4E4Q"SW#5:5**BG[ M\Y8B"4=_>3ZW/YJXES+*^'_I&X*MF&88/!1K+"9A5>(KPI1XB%:M)3:M M",,-4RN#'>Z-X M*W+);6!,;;E;7RLT4J$H?LZENH`;X/\`^"=_@[]G3XC_`/!.VW^+/[:-QKWA MCX1?LM^//$7_``CTEHTUK-\1)/$EW-JEUX=T5U*OJ4XOU@T][*$,Q,N"-B.X M_*9?AG^T=_P5,_;HNKV^MKBY\0?%GQK)>7$?#NDV=SI7PY7 M3X-5USQ3K5G`!J/B1=,)11=7=X9KC[1(W$7C]P7QU1X%P_"F4YQPWPYQ1+'+"X?!?VM@YX#V7UI3A[*53#X MF6)Q;H3ABO;8FA1HN,^5P_GB'_!<;XB:;XIB^&W_``3T_9)\!>`-.CEGT[0H MX/"+^+/&/B"S@/_!,PZW\0==@;36US68GE*QI<+)%Y#Z2EVFCRRS^4 M[".6&=ES&Q=!)7Y%_P#!6'XZ?MU?M*_$?PIH/[4WPTT;X7:CX4T[^T=`\"V- MO`MWI5MK8<+]MO!)-*ACQ]UPSX>Y&\WP7#L/!K(>'\HC@9 MU9T?L$?L^QZM'9/4NU6)E#*?$_V7_P#@G-\;OBK_ M`,$6_BI:_"VQN9?B;\3_`(K:?XI_X16.1H)?%'AGP'?_`+JQMOF7SKB]B"]?\`>*=2TUM!\06WB/PDUW M;7NEK.MTUE7OA35_AXVB:G M>::\O^ML)X!<2/!,JLJ3V_FB,D;MK8`_IU_9X_X*0?"+XJ_L7VO[8WQ*$OP? M\+Z7%>V/C/3_`!$&ADT[Q%I:HMWIVD"X\F35/MDKA=*5`'NB<#`5F'\UGPI_ MX+K?%K4O&FAG]J/]EGX)?$^VBEM]-U/QC=>'[2?QAI&EB=#<'3EO;":V<1J9 M)5MVD"EP%1CZ):P:% M::GXG\3QRRR-JNF:<+>SDN-)2U$<8DB8QRN)%^;FN?.O"/'\19OP[PYBO#+# M\%8BK.KB\PXCR#&O%X#$X+!4X_7<+0P2I?N\16G5PZPOUJ2JTI2E+][34T;9 M-XQY+P_E/$7$.%\4O]5"G&EB'B? MJT94JBC&*]E4<&_IS]H[_@Y<^)/B#Q?>^%?V0OA/91:9#?/:Z/XB\6V,VN:O MK\(;"7"^'8K9S:!NJPDF4<[P%PS?,_@O_@Y)_;B\#^,(K7XN^#_`?B'2[2]7 M^UO#I\+'PMJPB+*9+=;E4:>V8ICRRZ)@,&Q@@U^J_P#P;Y?\$^OAOX)_9Z/[ M2OQ&\(:'XG^)?Q%U74;30)M>TVTU./PUX:TN:6T5;&WO(IX$GU-F6X>XV^:A M1A&5!!K\K_\`@XZ^'W@JY_:T\$0?"SPSX=TK5[;X>HGCP:':6FGBXUF?4`^G M->6]FD,8NTL<*S%=[(5+9+"NCAW*_#',^.L=X899X=T\>LLH8VEC,\Q%2MB, M:\7ET;8MS=U6ITXU7*@J].K2_?6<*,:=D\^(\Y\1,JX#P/B?FGB+_9T,SKX" MM@\GHPP^&P/U3,9)X-4Y-.C4G.C;$.C4I5?W'-SU934F?THM_P`%4_ACXM_X M)V>,?VYOA];*?^$8T62UO_"NI.K2Z)XZ;R8$T&[?Y5N%2XN8620!%FB)P.#G M\)/V>/\`@Y1^*FM_$FTA^/.A^#]&^&MAIFJ:EK,OA_1S)K-]-9HKV6F:>@5) M#<7SL85,6YE*Y"GDU^;8N?B?\+/^"3,?PR-K/:Q_';XZW.HRV$K%%ET+PQIE MG<0:DB%AO@N;FU:.-P-KX7DD`5]*?\$"?^"=7A/]H7XV>+OB?\<_"]IXD\$? M"6PLY=/\.:BGF:7JOB?5'D-A)=QG*W*:8+=;DV[9C?S/FZ4UX7<#\(<+%674 MJ.*]E2G!RA5E3C)*:DNN^.G_```O!<5W*NFV?B+1X MO$VKW%I%*RP37=S*(5BEN(0DDL<6](W'?"_A:V:S\/>+HI+*.==6O;I1Y>@6UO'/!\GAOP3:6_C6'P[9VVF6-]K&H2V]U82 MFSM4A@BEALQ)$X5>2Q)QTK]/?^"`_P#P37^$L7P.US]I+X]?#[0_%WBOQ3J5 M[IWA2#Q/:1:GHVE>$K."(W%]%972R6YNKJY24O.4.R--N6VJ5.(^'/"[!>&. M1\9YAP)B.>75\!A,)6E1S7&U*\I^RPE?,Y/,'FF.P"S&EF%?$TH5LNP-.@J4:V+HY9#E="OA:] M6%"E14U35>].K*I!._YMZK_P$;K3 M;J/7;.]E22X;Q'I;FUO=*T2$NCZC<7=W&XL;>$EG!QNPN:_@8_;U^&>FZI^V MA\>8O@]X4L])\#3?$S6[3POI&F!?LR6\=X;58K**/$:QR7`80QQJ$`*X`SS] M%_\`!0#5_B7X=^&?[.7[&OAT7%I\/O@]\/M-\4:CIZ3O%#JGC7QU;V^LZE/? MPJZK-/I;--#;M,C%%N#@[AQ[O$O@MPYQ-1X*PV3<-2X9K9E*.:8Z>$H3CBZ> M14\!2KXNC5A*4Z=;%?6,5@L/2K33<*M:'?&_-N&ZO&F)SGBS#\2 M4,KOE>$CBL52>$EGE7'5*&%J4Y14)T'?VAOAGX51K:2&[U+PIK/@F?P9K4UC,V0 M(IWA-Q$CH&"3*C@'T^[7G7_!*_\`:=\9_L'>`=?U71OV+=0^*GC?QIJ:7VO[*.O_``XO?"_AYM'O;BWT+6)[S5U-Q+,KW<[VH>40&4K&TC%E154< M5M@O#C(%J3 MITW&JVW4I2C^[!_`_AZWO+7QKI M>I2QR:AHOB;3@J7&@6B;D;4+B[N&$6EE`#=Y)7(1FK^:?]HK_@YC_:!\0^-+ MVR_9F\"^%_!_@ZVNY+;3Y_%FE)XDUO5K:.1EAO9[>1(TLI+I0'^RQ.[1A@C# M=N%?D1\2O#O[0OPL_90\"_`?69-3\/:5XM\6ZYXS\2>!KX36#_`()T?#V]\#^+OVG?C5X)T?Q7XCGUQ_#G MP\L])\->!/#3)>(> M-^(#\3>,?$K/,@X(X=SO#9!F4,GH8[B'&X91^M^UCAZ5?$UW27[W#T(PK8 M>,,/3=&<\37<*E2%-1BOSF_:F_X+J?$7]K+]BGQ=^SM\4O!MEI7Q*\1ZY8KJ MOB?P]"=/T?4_#]H\=PUE+I8P+2']OA'2?^$XL=`@MK"Q'BJ66X:9_L%HL5O;3-;-!YL<:* MN[!VKD`>J_!+P=K7[,'_``1+^-OC"WA_LCXH?M1_$33O`^E`MY4UWX-TNY6. M[E0G:TD+PF20;205)/3`K[:668"/AGEM#A?A_$Y!0\3,RRO"X?+;5*CI3S^M M1IX_V4GJZ4,JPF)G3Y;1C2M.,8)\J^+CG=9^)>9U.)N)<%GE?PSRS-,7B\>Y MTJ=Z>0TJD\%+$0O:-5YIC,-"HY^\ZUX2E*6K]%^$7_!>']H3X]_'SP5\,M%^ M!?P9O+SXC^/],\/6#77A.SN-4>#5M1CA5KBXDA_>745L6GFE9V.49OFQ@_NG M_P`%"O\`@L5\#OV`-+L?``L;/XB?'C^R+*2?X=^'[F.VTCPY))`HD_MV_MA* MFFJLVY[>Q6/SI(`"OS';7\C/_!)WX:ZWX(^-GCC]I#Q%H4=S8?L[?"OQC\2= M%:4!K=_&5E:QQ^'(=QROF&0W3`<'N.E>$?!_X)_%C]O']M[PQH_CR^O+S5/C M1\4Y+KQ-JUU)K3J5)TL/A,MPT:]54G"I4>(A M"$HJ3D=^2^,_$.$X>P=*EQ#ALUXGXUSIX'(ZF*GA)QP>$P]6E@IU,)1A"$*] M?%YEB)8>G[55*=/V$YRC-I1?Z?:__P`'$7_!1/Q;_:OB3X?^"?!NE>#M/N'E MD>W\!S:]#80`EA#>ZJ85C&Q/ON[*<#+**^M?V%O^#D#QWXU^*OA3X;?M5>$/ M#9T;QAK%CH,7CGPG:_V0=!OM2N8+*QFO=+6,PS63W,ZKOA1\)].^$'ACX5^![+P5I_A_^P;JVG\/Z3<37]L]F;6\N=1OKFT> MXN+FY5I))+B:0LC/E-FT`?`GAK_@B)_P3<\.^(KKQQ_PK)=4NX=4F\01->^* M[W^R-*=)S>!HK:"Y2WAM[67,B'*)&JKP`BX_&Y<<>#&9X+-L!C/#BIE4%&5' M*,;E"A5S";DI0IUZ]6=;#^PK0E&G4Y)3Q<*G-*G-2LW+]FAP7XPY9C,JQN$\ M0Z6:2YU5S7!YMSTL#%1<)5*%&C&AB%7I3BZE-3C'"SIM*<7&Z4(O@+:?M'^.= M/MK3PU^%_V(/\`@GAHOPL^#_AC0]1\KQ7J-O$` MR2&ZD:XFF#*66<,9=B:GA'+%9ABY498C/?$',\)D^4UH5K2 M3P%"O7I5TFI0C0HPPLZTU+GE4J2<8+Y7B7CJGF?$^886CXO4*&"P<:T:&0^' M^`Q.<9M1G1?+-8ZOAZ-:CHX5'7K3Q,*5-QY5"FDYGR?\#/\`@Y0_:C\/_$O2 M=`_:*\!^#]?\-G6K71_$-MH^B'PMKFE)+>Q6=[=;%C8FXT]7>8VTFWS#$8R, ML,_7_P#PWFTPW,0.=K MRWVW:<@2@@C%?R^_#WX5_%;]IK]JGPK'XEL8+KQ!\5?BOHK^('L8$@B#:[X@ MM)=4EBM[?]W#%';23N%4;55/7K^BW_!=._U_QK^UUIGPM\*2IJ/@?X"?#GPC M\,?#ZB7>(KO3-.A.M`8.%_TF&,$+SN5L]./U"MX79'@O$O@>>3\.0RK'8/+< MUS[-<%@:=9X5QP:PN%P-6-.>D91S+%N-.HH0]K3HMR@Y1LOS*EXL9CC/#7C9 MYMQ53S3+\3F>59!E>.QM>@L2IXQ8C%XVE.K"S?/EN%4YTY3J>RG45I.,_>^U MO^#7OX%2:M\3?C5\?;VV$MCX5T.W\#:9)+&"(M5UC[)J<\L3$'Y_L8V<8*E< MYR,5_:2MC9)=/>I:6Z7CIY;W*PQB=DSG:TH7>1GL37XP?\$%_P!GM_@7^P;X M1U+4;`Z?XC^*FJWWC/6H73;-L$LUEIAE[[OLB\`G@$`<8K]JJ_D_QASN6=^( MG$==2DZ.#Q2RF@KO2EEL8X62WM9UZ=6>FCYK[ZG]6^$63PR?P^X7=Z7K.GVFJ M:==)_)X:JYTJF;5\RHUX9A#"PIJ MO2P\?92IRPU9MQJ4'/G4E\2LDXW/R#QH^C=6\5N+0E;KPSX1DC\VRLU251-:WVH&:22_0A&VJB%=I7'\\/_!6VR^- M6K?MG_%&_P#B#HVOK##J5O9^'7:TU!]+?P[#;QC2_P"S9Q$;5HGB4/,+=L^< M#Y@)"FO[W(HHX(XX88TAAB18XHHD6...-`%1(T0!415`"JH"J```!7G_`(U^ M$?PH^)+P2?$7X8?#SQ]):KLM7\:^"O#?BI[9#_#`VNZ;?M"O^S&5'M7E<&>/ M>.R+Q)X@\0L_RB.>5\_PE7!.A3Q'L*N5X9UJ-3#8?+JM2G5A&A1I4*>&E2<8 M^TIWESJ3ES^MQQ]'?`<0>%_#GAMPYG+R##\.XNACO;U,,\11S;%*A6I8O$9E M2IU*4Y5\16KU,5&JI2]E4:@HN"CR_P`OW["7_!2BP^#W[.W@?X$_"#]CSQCX ML^-<2S:5_P`)!I&GVHT/7M?NGN);;7-:N4M6U&&)=Z).))52..+(`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`L?)]Q_X*R_\`!/+Q MQ^SYX^\*^)?AQX9USQ#\)9O!WA[0;/6=/LKO49;/7-'AG74H=46SCG:T2X>= M);:615B*@J6!Q7]K>@^&_#OA73X])\+Z!HOAO2H3F+3-!TJQT?3XC@#,=EIT M%O;(<`#Y8QP`.U6-7T?2-?T^YTG7=*TW6]*O$\N[TS5[&UU+3[J/.?+N;*\B MFMITR`=LL;+D9Q7O?\32Y]0XIR/,(<5B^+>(, MSHYS7XHA@,/AJ&%QE"=>JL+A_MXH\W4 M5O*28%5"Q&$==N17G'P-_8T_:T_X*6_M":G\2_B+I^NZ/H^O^(8]4\<^/O$N MF7NF6-EI[2IFUT:VNU@FNVCMHUMK"*U22*$@.6)!4_V@1_LM_LR0W0OH?V=/ M@3%?!_-%Y'\(OA^ET),Y\P7"^'A-OSSOW[L\YKVC3=,TW1K*WTW1].L=*TZT M01VNGZ;:6]C96T8Z1V]K:QQ00H.RQQJOM5XSZ1>0934SW-O#_P`.L%P[Q7Q) M[1YCQ%C<8\=6A4K3]K5JX?#*"I*2,%G@OHS<1YQ3 MX>R?Q'\3&XN9"(MTZL/WW_P"")'P>;X._L7IXQ\2:9<:/KOCC7=<\ M1:HMU;2072Z+IY)TUI(Y%64XMFD*C;_"0`2:_5G5_@W\(?$&H76KZ_\`"KX; MZWJM\Y>]U/5_`WAC4M0O'889[J]O=+FN;AV`P6FEWKXFK."H4W"IB\PQ-3&3(KA=;\=ZGIU@Z:3J3L] MGIMV='L-F+9E_>+:*T85L%75N]?V7:+9VG[&O_!-NTLOL=P;CP'\$WB\BRMI M9KR36=0S6DL:%5*I)$RK@8`P*T\0O&O`<;Y;P+D-#ANM ME>0<(8G"UL3@?K\*T\QHX.AA<)1I0G'#TH4''"T<1!2<*EI8ERM:-GGX;>!. M8:'X4UK4OAGXO MTS2KCPUJ^FV-Y?V=FVGV$-K>Z5>O:PR+9RVLBL8?.")+&#M(VJ&_LVT/X1?" M?PQJ4&L^&_AA\//#VL6JNEMJNA^"O#>DZE;K(,.L%]8:9;W42N``ZQRJ&`Y! MKJ/$/AGPWXMTR;1?%?A_1/$VCW!!GTGQ#I-AK6F3E<[3-8:E;W-K(5R<%XFQ MDXZU]OC?I48RIQQDO$V"X9]AD^79)B\DQ61U/P6!^B+@:7`.>\*X_BEXC.LSS_!9]A<^I9;R0PU3 M`8.MA*>%Q&$GB9SQ%&NL7C)UG&O3DIU*4X>]2M/^1K]DK_@LK)^S_P#LX^%O M@MXB_9WO/%OBGP1I-QH_AOQ!9QV-K:7,1EGFMI-3:5H>A>'Y)T M-PT.L7!MI+V>*T^6%88+AYIV4N(@Q8?O^G[*O[+\4PN8_P!F_P"`L=P&W"=/ M@_\`#U)@P.0PE7PZ'#9YR&SGFO8]$T#0?#.GQ:3X;T32/#^E0$F#3-$TVSTK M3X20`3%96$-O;1DA0#LC&0`.PKY#/O%CPTQ,,\Q>2>$>">>Y]6KXBMF'$6;8 MK,\-@L5B)2J5<3@L#!TXTYNK.=54XU*5-U&G-2IKV1]KP[X/>*6%GD&#S[QD MQW]@G?M'Z!\5/["OM1\*>*/`/A_2UU31]-N6T>VU?P]"+?4;9(RQ9FKR#]@#]O#]MOX/^![C]G;X#_#B'QT?$>I74GAR7 M4=`U:]N/#6H7\#/!_CK2GT+ MQOX4\->,M$EUO+1W&>&:$D=C7/>"_@]\(_AO- M/OEGTA,G7A MQEG`W$O`&"XFJ9+0HT<#/&8R5/+*E3!2F\OQ.)PU.FL0JF'A-TZD*-:,:\%* M+E"-6:/%S/Z-V=?\10S7Q`X6\1<=PK3SS$5JV80P6"C5S6G3QL:2S'"87%5: MCPSI8B=)5*4Z]"<\/-PDHSE1A)_YVWQF\'?'GQK\>?%4GQ'@\0^*/B#K/B[R MM>UEK#4+F.[UNZDMHGCBE6W\LPV\LB6<04J@2#`/!:OU+_X*L66M^`O@Y^Q[ M^R3X?T#699_A;\*=,\5>)_L&FWK)YHNS=G23.;H2_O!<>9YHD^ MUF_%M",16XO-1TZYN! M!$`!'")/+0#"J*]S%_2?P6,S?@G'5.#9T\%P?3Q]6&7X?,*5"CB,RQ.6PRO" MXFC"&%5/"X?!8>>,]CAE"HHNO34)15*[\#`_10QV`R;CO+Z?&\:N/XUJY=1J M9GB,MK5Z^'RO"YI/-L9AJ\YXSVN+Q./Q-/!>VQ4IP:WNK M68O;JES:3QNRB:%Y$92DR[@NT_Z-&@>&_#OA/38M&\+:!HOAK2(&=X=*T#2K M'1M-A>0YD:*QTZ"VM8V<\NR1`L>6)-^(5T+WQ]\*/AKXXO0JH+O MQAX$\+^);H(@PBBXUK2KV7:HX5=^`.`!7!D?TFZN#SOCFOG?"\,XX>XTQOUF M>5O&\E?`T5@*65?4G6E1E2Q6&K8"C2IU8.%%J<93IM>TDCT,^^BI2QF0<`8? M(.+*F2<2\"X+ZM#-XX#GPV/KRS&IF[QJH0KQJX7$T77@6;78(;;Q!K'A2PUG4?$=T`4$UII M;VL,S6EM=L661EC,VTA`.04[KX.?LJ?\%`-#_9&^+_QR\7>/OBEI/E^";^U\ M)_"E]2O9]6U_1]0B=-4UB[L7:2ZMS9PD&QM5"W3,LCYYV1?U,^&_V?/@)X,O MXM4\'_!#X0^%-3@=7AU'PW\-?!FA7\+JBVMQ&ZD`JR2`@C(->N.B2 M(\RO+&C7A25"5=5:E6E1E*-!4FW)^Y@/H^ M<29KFN)S_P`1O%+/N)(H5*5/%U,-AJ].GBI8>I5>( MAAG2I4JM91EB)5E%17^;E^SCXIA^#/[0_P`/_B'\3OAIK'Q`T'PCXKM]5USP M??6=PEQK$<,CDP2)?PJGG^:PE(N!AFSO#$XK]Y?VRO\`@HI^T!^TQ^S?X[T' M]G']FOQS\*_A!;VMCIGC_P`9:W8+:7UQIUTUN;?3O#L>G0VL7V21S&ES+;1R MM'"IB*$,0O\`1W>?LR_LVZCJ,NKZA^SY\$+_`%:>8W$VJ7GPG\!W6HS3LVYI MI;V?0'N9)F;YC(\IE2PU;&J7-]6Q.)BXTY*E.K1K*E""\#@_P"C9QGP MGP]Q)PK@_$ZC@9XBO4POU6E'$9IB*U3%4,"X*/UK"X22 ME4BZL*->@ZTZC_AZ_P""/WPWO;/]K*W^(WC7P_JL>C?"OP3XN\?O'>:7>*MQ MJ&BZ7,]A&AG@0-*'4O'&NYG;9@9Q7QOXR\.?$7]I/]IO6]9A\.^)'N?BG\3; MVXM9+G2]2#+#XAUZ5;?)>`*GDV,\;!=V$5/FZ&O]#32/A'\*/#TES+H'PQ^' MNARWEM)9W"_#>FR75G,GERVER]EIL+3VTJ?))!*6B=/E92.*IV'P4^#6 ME7MKJ>E_"3X8Z;J-C,MQ9:A8>`O"MG>V=PA)6>UNK?2HY[>9225EBD1P2<-7 MJ4_I3X6EQ-GW$ZX0Q,L9F619;DF74YYM3<,MI8&>.Q-2;?U/]\L3CL73KU$H MTWRT(PN])1\FK]$?%5>%.'>$Y<9X:."RKB'-,_S.I#)ZBGFE7,(9?A:=.SQG M[IX7`8.KAZ;E*HN:O*:4=8NQ\(/!EI\._A;\/_!%C;K;0>&O".@Z4854*%N+ M;3K=+HD``!FN?-8^YKT:BBOY`Q%>IBL17Q-:3G5Q%:I7JR;; EX-31 3 vaso-10qmarch2015ex31.htm CERTIFICATION vaso-10qmarch2015ex31.htm
EXHIBIT 31.1
 
CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jun Ma, certify that:

1.  
I have reviewed this quarterly report on Form 10-Q of Vasomedical, Inc. and subsidiaries (the “registrant”);

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.  
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.  
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.  
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a.  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b.  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Jun Ma                         .
Jun Ma
President and Chief Executive Officer

Date: May 14, 2015

 
 
 
EXHIBIT 31.2
 
CERTIFICATION PURSUANT TO RULE 13a/15d OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael J. Beecher, certify that:

1.  
I have reviewed this quarterly report on Form 10-Q of Vasomedical, Inc. and subsidiaries (the “registrant”);

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.  
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.  
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.  
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a.  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
b.  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
/s/ Michael J. Beecher           .
Michael J. Beecher
Chief Financial Officer

Date: May 14, 2015


 EX-32 4 vaso-10qmarch2015ex32.htm CERTIFICATION vaso-10qmarch2015ex32.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Vasomedical, Inc. and subsidiaries (the “Company”) on Form 10-Q for the period ending March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jun Ma, as President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Jun Ma                          .
Jun Ma
President and Chief Executive Officer

Dated: May 14, 2015


 
 
 



 



EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Vasomedical, Inc. and subsidiaries (the “Company”) on Form 10-Q for the period ending March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael J. Beecher, as Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Michael J. Beecher             .
                Michael J. Beecher
                Chief Financial Officer
Dated: May 14, 2015
 EX-101.INS 5 vaso-20150331.xml INSTANCE DOCUMENT 0000839087 2015-01-01 2015-03-31 0000839087 2015-05-08 0000839087 2014-12-31 0000839087 2015-03-31 0000839087 2014-01-01 2014-03-31 0000839087 us-gaap:TreasuryStockMember 2013-12-31 0000839087 us-gaap:CommonStockMember 2013-12-31 0000839087 us-gaap:RetainedEarningsMember 2013-12-31 0000839087 2013-12-31 0000839087 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000839087 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0000839087 us-gaap:TreasuryStockMember 2014-12-31 0000839087 us-gaap:CommonStockMember 2014-12-31 0000839087 us-gaap:RetainedEarningsMember 2014-12-31 0000839087 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000839087 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000839087 2014-01-01 2014-12-31 0000839087 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000839087 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0000839087 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000839087 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0000839087 us-gaap:TreasuryStockMember 2014-01-01 2014-12-31 0000839087 us-gaap:RetainedEarningsMember 2015-01-01 2015-03-31 0000839087 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-03-31 0000839087 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-03-31 0000839087 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0000839087 us-gaap:CommonStockMember 2015-03-31 0000839087 us-gaap:RetainedEarningsMember 2015-03-31 0000839087 us-gaap:AdditionalPaidInCapitalMember 2015-03-31 0000839087 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-03-31 0000839087 us-gaap:TreasuryStockMember 2015-03-31 0000839087 2014-03-31 0000839087 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2014-12-31 0000839087 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2015-03-31 0000839087 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2014-01-01 2014-03-31 0000839087 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2015-01-01 2015-03-31 0000839087 vaso:EquipmentSegmentMember us-gaap:OperatingSegmentsMember 2015-01-01 2015-03-31 0000839087 us-gaap:CorporateNonSegmentMember 2014-01-01 2014-03-31 0000839087 us-gaap:CorporateNonSegmentMember 2015-01-01 2015-03-31 0000839087 vaso:SalesRepresentationSegmentMember us-gaap:OperatingSegmentsMember 2014-01-01 2014-03-31 0000839087 vaso:InformationTechnologySegmentMember us-gaap:OperatingSegmentsMember 2014-01-01 2014-03-31 0000839087 vaso:EquipmentSegmentMember us-gaap:OperatingSegmentsMember 2014-01-01 2014-03-31 0000839087 vaso:InformationTechnologySegmentMember us-gaap:OperatingSegmentsMember 2015-01-01 2015-03-31 0000839087 vaso:SalesRepresentationSegmentMember us-gaap:OperatingSegmentsMember 2015-01-01 2015-03-31 0000839087 us-gaap:CorporateNonSegmentMember 2014-03-31 0000839087 us-gaap:CorporateNonSegmentMember 2015-03-31 0000839087 us-gaap:OperatingSegmentsMember vaso:InformationTechnologySegmentMember 2015-03-31 0000839087 us-gaap:OperatingSegmentsMember vaso:EquipmentSegmentMember 2014-03-31 0000839087 us-gaap:OperatingSegmentsMember vaso:SalesRepresentationSegmentMember 2015-03-31 0000839087 us-gaap:OperatingSegmentsMember vaso:InformationTechnologySegmentMember 2014-03-31 0000839087 vaso:SalesRepresentationSegmentMember us-gaap:OperatingSegmentsMember 2014-03-31 0000839087 vaso:EquipmentSegmentMember us-gaap:OperatingSegmentsMember 2015-03-31 0000839087 vaso:GeHealthcareMember us-gaap:SalesRevenueNetMember 2015-01-01 2015-03-31 0000839087 us-gaap:SalesRevenueNetMember vaso:GeHealthcareMember 2014-01-01 2014-03-31 0000839087 us-gaap:CreditConcentrationRiskMember us-gaap:AccountsReceivableMember vaso:GeHealthcareMember 2015-03-31 0000839087 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember vaso:GeHealthcareMember 2014-12-31 0000839087 us-gaap:AccountsReceivableMember vaso:GeHealthcareMember us-gaap:CreditConcentrationRiskMember 2015-01-01 2015-03-31 0000839087 us-gaap:CreditConcentrationRiskMember us-gaap:AccountsReceivableMember vaso:GeHealthcareMember 2014-01-01 2014-12-31 0000839087 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0000839087 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-03-31 0000839087 us-gaap:CommonStockMember 2014-01-01 2014-03-31 0000839087 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-03-31 0000839087 us-gaap:FairValueInputsLevel1Member 2014-12-31 0000839087 us-gaap:FairValueInputsLevel2Member 2015-03-31 0000839087 us-gaap:FairValueInputsLevel3Member 2014-12-31 0000839087 us-gaap:FairValueInputsLevel3Member 2015-03-31 0000839087 us-gaap:FairValueInputsLevel2Member 2014-12-31 0000839087 us-gaap:FairValueInputsLevel1Member 2015-03-31 0000839087 vaso:PatentsAndTechnologyMember 2014-12-31 0000839087 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-12-31 0000839087 us-gaap:ComputerSoftwareIntangibleAssetMember 2015-03-31 0000839087 vaso:PatentsAndTechnologyMember 2015-03-31 0000839087 us-gaap:CustomerListsMember 2015-03-31 0000839087 us-gaap:CustomerListsMember 2014-12-31 0000839087 us-gaap:CustomerListsMember 2015-01-01 2015-03-31 0000839087 us-gaap:PatentsMember 2015-01-01 2015-03-31 0000839087 us-gaap:ComputerSoftwareIntangibleAssetMember 2015-01-01 2015-03-31 0000839087 vaso:CommissionRevenuesMember 2015-01-01 2015-03-31 0000839087 vaso:InServiceAndTrainingMember 2015-01-01 2015-03-31 0000839087 vaso:ServiceArrangementsMember 2015-01-01 2015-03-31 0000839087 vaso:ServiceArrangementsMember 2014-01-01 2014-03-31 0000839087 vaso:InServiceAndTrainingMember 2014-01-01 2014-03-31 0000839087 vaso:ExtendedServiceContractsMember 2014-01-01 2014-03-31 0000839087 vaso:CommissionRevenuesMember 2014-01-01 2014-03-31 0000839087 vaso:ExtendedServiceContractsMember 2015-01-01 2015-03-31 0000839087 vaso:DirectorDavidLiebermanMember 2015-01-01 2015-03-31 0000839087 vaso:DirectorDavidLiebermanMember 2014-01-01 2014-03-31 0000839087 us-gaap:CorporateJointVentureMember 2015-03-31 0000839087 us-gaap:CorporateJointVentureMember 2015-01-01 2015-03-31 0000839087 vaso:GenwellInstrumentsCoLtdMember 2015-01-01 2015-03-31 0000839087 vaso:GenwellInstrumentsCoLtdMember 2014-01-01 2014-03-31 0000839087 2012-06-01 2012-06-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares vaso:State vaso:Company vaso:Subsidiary xbrli:pure vaso:Segment false --12-31 2015-03-31 No No Yes Smaller Reporting Company VASOMEDICAL, INC 0000839087 166450370 2015 Q1 10-Q 21000 76000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE J &#8211; ACCRUED EXPENSES AND OTHER LIABILITIES</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">Accrued expenses and other liabilities consist of the following at March 31, 2015 and December 31, 2014:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; font-weight: normal; font-style: italic; text-align: center;">(in thousands)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid; font-weight: normal;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">March </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">31,</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"></font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid; font-weight: normal;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">December </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">31,</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"></font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accrued compensation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">433</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accrued expenses - other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,090</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,098</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,843</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,612</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,366</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: left; text-indent: 324pt;">&#160;</div></div> 5025000 15273000 0 576000 5381000 86000 4363000 846000 0 0 4535000 4200000 14200000 19734000 9270000 1612000 2171000 567000 462000 2247000 1151000 1090000 1098000 1443000 1397000 94000 101000 61924000 61943000 4571000 4361000 171000 46000 390000 952000 2629000 875000 1342000 1754000 40991000 36298000 11986000 15405000 159000 7728000 11142000 0 29923000 10209000 9592000 25464000 28994000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE B - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Basis of Presentation and Use of Estimates</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the unaudited&#160;condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the SEC on March 30, 2015. These unaudited&#160;condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the unaudited&#160;condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Significant Accounting Policies</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2014, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: justify;">Revenue and Expense Recognition for the Sales Representation Segment</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The Company recognizes commission revenue in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.&#160; These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.&#160; Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated&#160;balance sheets.&#160; Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.&#160; Commission expense is recognized when the corresponding commission revenue is recognized</div><div>&#160;</div><div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; font-style: italic; text-align: justify;">Variable Interest Entities</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The Company follows the guidance of accounting for variable interest entities, which requires certain variable interest entities to be consolidated by the primary beneficiary of the entities.&#160; Biox is a Variable Interest Entity (VIE).</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Liabilities recognized as a result of consolidating this VIE do not represent additional claims on the Company&#8217;s general assets. The financial information of Biox, which was included in the accompanying condensed consolidated financial statements, is presented as follow. </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div></div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="vertical-align: top; text-align: center;"><em>&#160;(in thousands)</em></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">As of March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2015</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">As of December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">159</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,083</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">878</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="7" style="vertical-align: bottom; text-align: center;"><em>(in thousands)</em></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" style="vertical-align: bottom; border-bottom: #646464 2px solid; text-align: center;"><div>&#160;&#160;(unaudited)</div><div>Three months ended March 31,</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total net revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">371</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">329</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">(135</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">(148</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">)</div></td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: justify;">Reclassifications</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Certain reclassifications have been made to prior period amounts to conform with the current period presentation.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013.</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center;">&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">(in thousands)</font></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center;">&#160;&#160; Three months ended</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Revenue</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,091</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Net loss</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(252</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(1,173</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Basic and diluted loss per share</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div>$&#160;</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(0.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div>$&#160;</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(0.01</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr></table></div><div><br /></div></div> 7453000 7091000 -252000 -1173000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">NOTE&#160;M &#8211; BUSINESS COMBINATION</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 35.4pt;">On August 6, 2014 the Company acquired Genwell Instruments Co. Ltd (Genwell).&#160; The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 35.4pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center;">&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">(in thousands)</font></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid; text-align: center;">&#160;&#160; Three months ended</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Revenue</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,091</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Net loss</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(252</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(1,173</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 75.99%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Basic and diluted loss per share</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div>$&#160;</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(0.00</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div>$&#160;</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(0.01</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr></table></div><div><br /></div></div> 6141000 4048000 9128000 15269000 7961000 12009000 159000 117000 8149000 0 14666000 0 0 0 14666000 8149000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">NOTE&#160;N &#8211; COMMITMENTS AND CONTINGENCIES</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: justify;">Sales representation agreement</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">In June 2012, the Company concluded an amendment of the GEHC Agreement with GEHC, originally signed on May 19, 2010.&#160; The amendment, effective July 1, 2012, extended the initial term of three years commencing July 1, 2010 to five years through June 30, 2015.&#160; In December 2014, the Company concluded an additional amendment, effective January 1, 2015, extending the term through December 31, 2018, subject to earlier termination under certain circumstances and termination without cause on or after July 1, 2017.&#160; These circumstances include not materially achieving certain sales goals, not maintaining a minimum number of sales representatives, and various legal and GEHC policy requirements.&#160; Under the terms of the agreement, the Company is required to lease dedicated computer equipment from GEHC for connectivity to their network.</div></div> 0.001 0.001 166000 166000 166435370 166450370 250000000 250000000 156127283 156142283 -245000 -1083000 0.86 0.88 0.85 0.93 144000 175000 1886000 1927000 188000 181000 4000 2319000 2319000 0 0 0 0 0 2416000 2412000 2200000 2416000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The changes in the Company&#8217;s deferred revenues are as follows:</div><div style="text-align: center;">&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="width: 601px; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 5px; vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="width: 176px; vertical-align: top; font-style: italic; text-align: center;">(in thousands)</td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; text-align: left;"></td></tr><tr><td valign="bottom" style="width: 601px; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 5px; vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="width: 176px; vertical-align: top; text-align: center;">&#160;&#160; For the three months ended</td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 601px; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5px; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="width: 76px; vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11px; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="width: 82px; vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 76.37%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</div></td><td style="width: 9.4%; vertical-align: bottom; text-align: center; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</div></td><td style="width: 9.4%; vertical-align: bottom; text-align: center; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 76.37%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Deferred revenue&#160;at beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">$</td><td style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;">22,532</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">$</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">18,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Additions:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred extended service contracts</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">211</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">237</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr style="height: 18px;"><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred in-service and training</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr style="height: 19px;"><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred service arrangements</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,849</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,770</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr style="height: 18px;"><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Recognized as revenue:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred extended service contracts</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(231</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(227</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred in-service and training</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred service arrangements</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(23</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(2,890</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(2,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred revenue at end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">21,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">17,004</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Less: current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">11,400</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10,294</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Long-term deferred revenue at end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10,053</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">6,710</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table><br /></div></div> 1849000 3000 10000 5000 3000 237000 1770000 211000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE K- DEFERRED REVENUE</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The changes in the Company&#8217;s deferred revenues are as follows:</div><div style="text-align: center;">&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="width: 601px; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 5px; vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="width: 176px; vertical-align: top; font-style: italic; text-align: center;">(in thousands)</td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; text-align: left;"></td></tr><tr><td valign="bottom" style="width: 601px; vertical-align: top;">&#160;</td><td valign="bottom" style="width: 5px; vertical-align: bottom;">&#160;</td><td colspan="6" valign="bottom" style="width: 176px; vertical-align: top; text-align: center;">&#160;&#160; For the three months ended</td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 601px; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 5px; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="width: 76px; vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 11px; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="width: 82px; vertical-align: top; border-bottom: #000000 2px solid; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="width: 5px; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 76.37%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</div></td><td style="width: 9.4%; vertical-align: bottom; text-align: center; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</div></td><td style="width: 9.4%; vertical-align: bottom; text-align: center; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td style="width: 76.37%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Deferred revenue&#160;at beginning of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">$</td><td style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;">22,532</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;"></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">$</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">18,019</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Additions:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred extended service contracts</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">211</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">237</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr style="height: 18px;"><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred in-service and training</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr style="height: 19px;"><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred service arrangements</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,849</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,770</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr style="height: 18px;"><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Recognized as revenue:</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred extended service contracts</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(231</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(227</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred in-service and training</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(8</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred service arrangements</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(23</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(24</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission revenues</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(2,890</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(2,771</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred revenue at end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">21,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">17,004</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Less: current portion</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">11,400</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10,294</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76.37%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Long-term deferred revenue at end of period</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10,053</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1.4%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9.4%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">6,710</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table><br /></div></div> 22532000 18019000 17004000 21453000 11400000 9882000 10294000 10053000 12650000 6710000 231000 227000 23000 8000 24000 2771000 8000 2890000 112000 112000 212000 99000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE&#160;O - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">In May 2014, the FASB issued ASU 2014-09 &#8220;Revenue from contracts with customers&#8221;, a comprehensive new revenue recognition standard which will supersede previous existing revenue recognition guidance. The standard creates a five-step model for revenue recognition that requires companies to exercise judgment when considering contract terms and relevant facts and circumstances. The five-step model includes (1) identifying the contract, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations and (5) recognizing revenue when each performance obligation has been satisfied. The standard also requires expanded disclosures surrounding revenue recognition. The standard is effective for fiscal periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption.&#160; In April 2015 the FASB issued a proposal to defer the effective date for one year.&#160; The Company is currently evaluating the impact of the adoption of this standard on its Consolidated Financial Statements.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">In April 2015, the FASB issued ASU 2015-03 &#8220;Simplifying the Presentation of Debt Issuance Costs&#8221;, which changes the presentation of debt issuance costs in financial statements. An entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense.&#160; The standard is effective for fiscal periods beginning after December 31, 2015 and allows for early adoption.&#160; The adoption&#160;of this statement will impact future presentation and disclosure of the&#160;Consolidated Financial Statements.</div></div> 110000 116000 55000 0 -0.01 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE D &#8211; LOSS PER COMMON SHARE</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;Basic loss per common share is computed as earnings applicable to common stockholders divided by the weighted-average number of common shares outstanding for the period.&#160; Diluted loss per common share reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted to common stock.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three months ended March 31, 2015 and 2014, because the effect of their inclusion would be anti-dilutive.</div><div style="text-align: center; margin-left: 180pt;">&#160;</div><div style="text-align: center;"><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td colspan="7" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><em>(in thousands)</em></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">For the three months ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Stock options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">952</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,754</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Common stock grants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">390</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">875</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,342</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,629</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> -15000 -12000 2917000 433000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The following tables present information about the Company&#8217;s assets measured at fair value as of <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">March 31, 2015 and December 31, 2014:</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 288pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><em>(in thousands)</em></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Quoted Prices</div>in Active</div>Markets for <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Identical Assets <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 1)</div></div></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div>Other</div>Observable</div>Inputs <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 2)</div></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div>Unobservable</div>Inputs</div>(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Balance</div>as of</div>March 31,</div>2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Assets</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">14,666</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">14,666</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Quoted Prices</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">in Active</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Other</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Balance</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Markets for</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Observable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Unobservable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">as of</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Identical Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Assets</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">8,149</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">8,149</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE E &#8211; FAIR VALUE MEASUREMENTS</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The Company complies with the provisions of ASC 820 &#8220;Fair Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;).&#160; Under ASC 820, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the &#8220;exit price&#8221;) in an orderly transaction between market participants at the measurement date.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The following tables present information about the Company&#8217;s assets measured at fair value as of <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">March 31, 2015 and December 31, 2014:</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 288pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="14" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><em>(in thousands)</em></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Quoted Prices</div>in Active</div>Markets for <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Identical Assets <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 1)</div></div></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div>Other</div>Observable</div>Inputs <div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 2)</div></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div>Unobservable</div>Inputs</div>(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Balance</div>as of</div>March 31,</div>2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Assets</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">14,666</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">14,666</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Quoted Prices</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">in Active</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Other</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Significant</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Balance</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Markets for</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Observable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Unobservable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">as of</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Identical Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; background-color: #ffffff;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31,</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Assets</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 51.98%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Cash equivalents invested in money market funds (included in cash and cash equivalents)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">8,149</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">8,149</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The fair values of the Company&#8217;s cash equivalents invested in money market funds are determined through market, observable and corroborated sources.</div></div> P7Y P10Y P5Y 2489000 962000 986000 2478000 800000 800000 613000 549000 381000 573000 410000 495000 2668000 2826000 467000 1940000 390000 413000 419000 1865000 3304000 3288000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE H &#8211; GOODWILL AND OTHER INTANGIBLES</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Goodwill aggregating $3,304,000 and $3,288,000 was recorded on the Company&#8217;s condensed consolidated balance sheets at March 31, 2015 and December 31, 2014, respectively, pursuant to the acquisition of FGE in September 2011.&#160; All of the goodwill was allocated to the Company&#8217;s Equipment segment.&#160; The components of the change in goodwill are as follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td colspan="3" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: center;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td colspan="3" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Carrying Amount</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td colspan="3" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Balance at December 31, 2014</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,288</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Foreign currency translation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Balance at March 31, 2015 (unaudited)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,304</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="text-align: center; text-indent: 36pt;"></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The Company&#8217;s other intangible assets consist of capitalized patent costs, customer lists and software costs, as follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: center;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31,</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31,</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Patents and Technology</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,478</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,489</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accumulated amortization</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(613</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(549</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,865</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,940</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Customer lists</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">800</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">800</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accumulated amortization</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(410</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(381</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">390</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">419</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Software</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">986</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">962</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accumulated amortization</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(573</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(495</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">413</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">467</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,668</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,826</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Patents, customer lists, and software are included in other assets in the accompanying condensed consolidated balance sheets and are amortized on a straight line basis over their estimated useful lives of ten, seven, and five years, respectively.&#160; Amortization expense amounted to $171,000 and $46,000 for the three months ended March 31, 2015 and 2014, respectively.</div></div> -16000 5567000 5164000 0 -2000 -2000 -246000 -1034000 6000 10000 13000 65000 105000 147000 76000 -3000 55000 0 25000 -107000 -2267000 -1449000 7000 211000 -1070000 184000 -10240000 -8194000 -1078000 -1014000 -461000 -1095000 227000 225000 0 18000 -48000 -33000 40000 56000 3000 0 2129000 1898000 636000 846000 592000 583000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE G &#8211; INVENTORIES, NET</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Inventories, net of reserves, consist of the following:<font style="font-size: 6pt;">&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div><div style="text-align: center;"><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; border-top: medium none; font-family: 'Times New Roman', Times, serif; border-right: medium none; width: 100%; border-bottom: medium none; border-left: medium none;"><tr><td valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: top; padding-bottom: 2px; border-left: medium none;">&#160;</td><td valign="bottom" style="border-top: medium none; vertical-align: bottom; padding-bottom: 2px; border-left: medium none;"></td><td colspan="6" style="border-top: medium none; vertical-align: bottom; border-bottom: #000000 2px solid; font-style: italic; text-align: center;">&#160;(in thousands)</td><td nowrap="nowrap" valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: top; padding-bottom: 2px; border-left: medium none;">&#160;</td><td valign="bottom" style="border-top: medium none; vertical-align: bottom; padding-bottom: 2px; border-left: medium none;">&#160;</td><td colspan="2" valign="bottom" style="border-top: medium none; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="border-top: medium none; vertical-align: bottom; padding-bottom: 2px; border-left: medium none;">&#160;</td><td colspan="2" valign="bottom" style="border-top: medium none; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; vertical-align: top; border-left: medium none;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-left: medium none;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-left: medium none;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; border-left: medium none; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Raw materials</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">592</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">583</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; border-left: medium none; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Work in process</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">679</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; padding-bottom: 2px; border-left: medium none; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Finished goods</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">846</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">636</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; padding-bottom: 4px; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,129</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,898</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">At March 31, 2015 and December 31, 2014, the Company maintained reserves for excess and obsolete inventory of $783,000 and $815,000, respectively.</div></div> 815000 783000 679000 691000 60000 60000 19779000 18015000 40991000 36298000 13461000 10758000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE F &#8211; ACCOUNTS AND OTHER RECEIVABLES, NET</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The following table presents information regarding the Company&#8217;s accounts and other receivables as of March 31, 2015 and December 31, 2014:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; font-style: italic; text-align: center;">(in thousands)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Trade receivables</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">9,270</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">19,734</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Due from employees</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">116</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">110</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Allowance for doubtful accounts and</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">commission adjustments</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(4,361</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(4,571</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accounts and other receivables, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,025</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">15,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Trade receivables include amounts due for shipped products and services rendered.&#160; Amounts currently due under the GEHC Agreement are subject to adjustment in subsequent periods should the underlying sales order amount, upon which the receivable is based, change.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Allowance for doubtful accounts and commission adjustments include estimated losses resulting from the inability of our customers to make required payments, and adjustments arising from subsequent changes in sales order amounts that may reduce the amount the Company will ultimately receive under the GEHC Agreement.&#160; Due from employees is primarily commission advances made to sales personnel.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div></div> 0.499 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE A - ORGANIZATION AND PLAN OF OPERATIONS</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Vasomedical, Inc. was incorporated in Delaware in July 1987.&#160; Unless the context requires otherwise, all references to &#8220;we&#8221;, &#8220;our&#8221;, &#8220;us&#8221;, &#8220;Company&#8221;, &#8220;registrant&#8221;, &#8220;Vasomedical&#8221; or &#8220;management&#8221; refer to Vasomedical, Inc. and its subsidiaries.&#160; Until 2010, we were primarily engaged in designing, manufacturing, marketing and supporting Enhanced External Counterpulsation (EECP</font><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">&#174;</sup><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">) systems, based on our proprietary technology, to physicians and hospitals throughout the United States and in select international markets. Beginning in July 2010 the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. (Vaso Diagnostics), began its sales representation business via its agreement (the &#8220;GEHC Agreement&#8221;) with GE Healthcare (&#8220;GEHC&#8221;), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC&#8217;s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.&#160;&#160; In June 2012, the GEHC Agreement was amended and extended through June 30, 2015 and again, in December 2014, the GEHC Agreement was further amended and extended through December 31, 2018, subject to earlier termination under certain circumstances </font>and termination without cause on or after July 1, 2017.</div><div>&#160;</div><div>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company, which owns or controls two Chinese operating companies - Life Enhancement Technology Ltd. and Biox Instruments Co. Ltd. (Biox), respectively - to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.&#160; Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy, and started to operate through three wholly-owned subsidiaries.&#160; Vaso Diagnostics continues as the operating subsidiary for the sales representation of GE diagnostic imaging products; Vasomedical Global Corp. operates the Company&#8217;s Chinese companies; and Vasomedical Solutions, Inc. was formed to manage and coordinate our EECP<sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">&#174; </sup>therapy business as well as other medical equipment operations.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">In April 2014, the Company entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. (PSK) of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited (VSK), for the global marketing, sale and advancement of ECP therapy technology.&#160; The Company owns 49.9% of the joint venture, which began operations in January 2015.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">In June 2014, the Company entered into a Value Added Reseller Agreement (VAR Agreement) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.&#160; This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.&#160; A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (Genwell), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (Gentone).&#160; Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCare<sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">TM</sup> wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.&#160; Vaso Diagnostics activities are included under our Sales Representation segment.&#160; VasoHealthcare IT operations report under the IT segment.</div></div> -252000 -1044000 1128000 0 0 0 0 0 -252000 0 1128000 -148000 -135000 4196000 6259000 0 -60000 -136000 -43000 56000 40000 1056000 1039000 164000 163000 48 3 2 5853000 6254000 -286000 -1090000 -1082000 0 -531000 -635000 523000 -383000 1087000 -355000 -39000 7000 0 0 -14000 0 0 0 -14000 0 7000 5617000 4620000 2836000 13000 73000 0 715000 432000 3281000 0 3832000 458000 515000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE I &#8211; OTHER ASSETS</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">Other assets consist of the following at March 31, 2015 and December 31, 2014:<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 324pt;">&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><em>(in thousands)</em></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td style="width: 76%; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission expense - noncurrent</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,493</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,988</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td style="width: 76%; vertical-align: top; white-space: nowrap; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Trade receivables - noncurrent</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,612</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,171</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">458</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,620</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,617</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> 811000 705000 1843000 1612000 136000 45000 60000 0 40000 38000 0.01 0.01 0 0 0 0 1000000 1000000 0 0 363000 440000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: justify;">Reclassifications</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Certain reclassifications have been made to prior period amounts to conform with the current period presentation.</div></div> 40000 40000 266000 242000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; margin-right: 41.4pt;">NOTE&#160;L &#8211; RELATED-PARTY TRANSACTIONS</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">David Lieberman, the Vice Chairman of the Company&#8217;s Board of Directors, is a practicing attorney in the State of New York and a senior partner at the law firm of Beckman, Lieberman &amp; Barandes, LLP, which performs certain legal services for the Company.<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160; Fees of approximately $60,000 were billed by the firm through each of the three month periods ended March 31, 2015 and 2014, at which dates no amounts were outstanding.</font></div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: justify; text-indent: 36pt;">In January 2015, operations began under the VSK joint venture.&#160; The Company accounts for its investment in VSK using the equity method.&#160; At March 31, 2015, approximately $55,000 was due from VSK for equipment the Company sold to it, and the Company&#8217;s minority interest in VSK&#8217;s loss from operations for the three months ended March 31, 2015 approximated $2,000 and is recorded in Interest and Other Income, net on the Company&#8217;s condensed consolidated statement of operations and comprehensive loss.</div><div><br /></div></div> 213000 134000 -52433000 -52685000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: justify;">Revenue and Expense Recognition for the Sales Representation Segment</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The Company recognizes commission revenue in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.&#160; These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.&#160; Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated&#160;balance sheets.&#160; Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.&#160; Commission expense is recognized when the corresponding commission revenue is recognized</div><div>&#160;</div><div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; font-style: italic; text-align: justify;">Variable Interest Entities</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The Company follows the guidance of accounting for variable interest entities, which requires certain variable interest entities to be consolidated by the primary beneficiary of the entities.&#160; Biox is a Variable Interest Entity (VIE).</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Liabilities recognized as a result of consolidating this VIE do not represent additional claims on the Company&#8217;s general assets. The financial information of Biox, which was included in the accompanying condensed consolidated financial statements, is presented as follow. </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div></div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="vertical-align: top; text-align: center;"><em>&#160;(in thousands)</em></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">As of March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2015</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">As of December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">159</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,083</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">878</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="7" style="vertical-align: bottom; text-align: center;"><em>(in thousands)</em></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" style="vertical-align: bottom; border-bottom: #646464 2px solid; text-align: center;"><div>&#160;&#160;(unaudited)</div><div>Three months ended March 31,</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total net revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">371</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">329</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">(135</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">(148</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">)</div></td></tr></table></div></div> 1063000 7453000 0 0 6241000 7091000 0 850000 0 6390000 483000 719000 7091000 7453000 329000 371000 367000 344000 199000 247000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">Other assets consist of the following at March 31, 2015 and December 31, 2014:<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 324pt;">&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; text-align: center;"><em>(in thousands)</em></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td style="width: 76%; vertical-align: top; white-space: nowrap; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission expense - noncurrent</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,493</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,988</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td style="width: 76%; vertical-align: top; white-space: nowrap; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Trade receivables - noncurrent</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,612</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,171</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">515</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">458</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,620</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,617</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three months ended March 31, 2015 and 2014, because the effect of their inclusion would be anti-dilutive.</div><div style="text-align: center; margin-left: 180pt;">&#160;</div><div style="text-align: center;"><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td colspan="7" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><em>(in thousands)</em></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">For the three months ended</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; margin-left: 9pt; text-indent: -9pt;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td colspan="3" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Stock options</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">952</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,754</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Common stock grants</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">390</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">875</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; margin-left: 9pt; background-color: #cceeff; text-indent: -9pt;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,342</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,629</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div>&#160;</div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">Accrued expenses and other liabilities consist of the following at March 31, 2015 and December 31, 2014:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; font-weight: normal; font-style: italic; text-align: center;">(in thousands)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid; font-weight: normal;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">March </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">31,</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"></font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid; font-weight: normal;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">December </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">31,</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"></font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accrued compensation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">433</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,917</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accrued expenses - other</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,090</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,098</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Other liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,843</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,612</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,366</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,627</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: left; text-indent: 324pt;">&#160;</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Inventories, net of reserves, consist of the following:<font style="font-size: 6pt;">&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div><div style="text-align: center;"><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; border-top: medium none; font-family: 'Times New Roman', Times, serif; border-right: medium none; width: 100%; border-bottom: medium none; border-left: medium none;"><tr><td valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: top; padding-bottom: 2px; border-left: medium none;">&#160;</td><td valign="bottom" style="border-top: medium none; vertical-align: bottom; padding-bottom: 2px; border-left: medium none;"></td><td colspan="6" style="border-top: medium none; vertical-align: bottom; border-bottom: #000000 2px solid; font-style: italic; text-align: center;">&#160;(in thousands)</td><td nowrap="nowrap" valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: top; padding-bottom: 2px; border-left: medium none;">&#160;</td><td valign="bottom" style="border-top: medium none; vertical-align: bottom; padding-bottom: 2px; border-left: medium none;">&#160;</td><td colspan="2" valign="bottom" style="border-top: medium none; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="border-top: medium none; vertical-align: bottom; padding-bottom: 2px; border-left: medium none;">&#160;</td><td colspan="2" valign="bottom" style="border-top: medium none; vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="border-top: medium none; border-right: medium none; vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; vertical-align: top; border-left: medium none;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-left: medium none;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-left: medium none;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; border-left: medium none; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Raw materials</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">592</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">583</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; border-left: medium none; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Work in process</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: medium none; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: medium none; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">679</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; padding-bottom: 2px; border-left: medium none; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Finished goods</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">846</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: right; border-left: medium none; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">636</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="border-right: medium none; width: 76%; vertical-align: top; padding-bottom: 4px; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,129</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: right; border-left: medium none; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,898</div></td><td nowrap="nowrap" valign="bottom" style="border-right: medium none; width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div><br /></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The Company&#8217;s other intangible assets consist of capitalized patent costs, customer lists and software costs, as follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: center;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31,</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31,</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Patents and Technology</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,478</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,489</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accumulated amortization</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(613</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(549</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,865</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,940</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Customer lists</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">800</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">800</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accumulated amortization</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(410</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(381</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">390</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">419</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Software</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Costs</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">986</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">962</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accumulated amortization</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(573</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(495</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">413</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">467</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,668</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,826</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">&#160;</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>The components of the change in goodwill are as follows:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td colspan="3" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic; text-align: center;">(in thousands)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td colspan="3" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Carrying Amount</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td colspan="3" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Balance at December 31, 2014</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,288</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Foreign currency translation</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">16</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 88%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Balance at March 31, 2015 (unaudited)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,304</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div style="text-align: center; text-indent: 36pt;"></div><div><br /></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div>Summary financial information for the segments is set forth below:<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">&#160;&#160;&#160;&#160;&#160;&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="18" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: normal; font-style: italic; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(in</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> thousand</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">s)</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: normal; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">As of or for the&#160;thee months&#160;March </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">31, </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2015</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> (unaudited)</font></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Sales</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Representation</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Equipment</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Revenues from external customers</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">6,390</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,063</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: bold; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Operating income (loss)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(635</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(355</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(383</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(286</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">11,142</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">9,592</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">159</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">15,405</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">36,298</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,363</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">576</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">86</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,025</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred commission expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,412</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: bold; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: bold; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,416</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,832</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">715</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,620</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;&#160;&#160;&#160;&#160;&#160; </td><td colspan="20" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div>&#160;&#160;&#160;&#160;<em>(in thousands)</em></div><div>As of or for the&#160;three months&#160;March 31, 2014&#160;(unaudited)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Sales</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">&#160;Representation </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Equipment </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Revenues from external customers</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">6,241</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">850</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,091</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Operating income (loss)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">523</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(1,082</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(531</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(1,090</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Total assets</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10,209</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,728</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">11,986</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">29,923</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accounts and other receivables, net</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,535</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">846</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,381</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission expense</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,319</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,319</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Other assets</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,836</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">432</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">13</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,281</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Liabilities recognized as a result of consolidating this VIE do not represent additional claims on the Company&#8217;s general assets. The financial information of Biox, which was included in the accompanying condensed consolidated financial statements, is presented as follow. </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="6" valign="bottom" style="vertical-align: top; text-align: center;"><em>&#160;(in thousands)</em></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">As of March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2015</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">(unaudited)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">As of December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Cash and cash equivalents</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">117</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">159</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,083</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total liabilities</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">1,047</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">878</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div><div>&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;"></td><td colspan="7" style="vertical-align: bottom; text-align: center;"><em>(in thousands)</em></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="6" style="vertical-align: bottom; border-bottom: #646464 2px solid; text-align: center;"><div>&#160;&#160;(unaudited)</div><div>Three months ended March 31,</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #646464 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Total net revenue</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">371</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">329</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000; text-align: left;">Net loss</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">(135</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">(148</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">)</div></td></tr></table></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">The following table presents information regarding the Company&#8217;s accounts and other receivables as of March 31, 2015 and December 31, 2014:</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; text-indent: 36pt;">&#160;</div><div style="text-align: center;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;"></td><td colspan="6" style="vertical-align: bottom; white-space: nowrap; border-bottom: #000000 2px solid; font-style: italic; text-align: center;">(in thousands)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;"></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">March 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2015</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">December 31, </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; text-align: center;">(unaudited)</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Trade receivables</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">9,270</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">19,734</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Due from employees</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">116</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">110</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Allowance for doubtful accounts and</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 2px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">commission adjustments</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(4,361</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(4,571</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 2px; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 76%; vertical-align: top; padding-bottom: 4px; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accounts and other receivables, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,025</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">15,273</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #cceeff;">&#160;</td></tr></table></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">NOTE C &#8211; SEGMENT REPORTING AND CONCENTRATIONS</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The Company views its business in three segments &#8211; the Sales Representation segment, the Equipment segment, and the IT segment.&#160; The Sales Representation segment operates through the Vaso Diagnostics subsidiary and is currently engaged solely in the fulfillment of the Company&#8217;s responsibilities under our agreement with GEHC.&#160; The Equipment segment is engaged in designing, manufacturing, marketing and supporting EECP<sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">&#174;</sup> enhanced external counterpulsation systems both domestically and internationally, as well as the development, production, marketing and supporting of other medical devices.&#160; The Company&#8217;s new subsidiary, VasoHealthcare IT Corp., formed to conduct its healthcare IT operations, reports through the IT segment.&#160; Operations in the IT segment began in the third quarter of 2014.&#160; </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The chief operating decision maker is the Company&#8217;s Chief Executive Officer, who in conjunction with upper management, evaluates segment performance based on operating income.&#160; Administrative functions such as finance, human resources, and information technology are centralized and related expenses allocated to each segment.&#160; Other costs not directly attributable to operating segments, such as audit, legal, director fees, investor relations, and others, as well as certain assets &#8211; primarily cash balances &#8211; are reported in the Corporate entity below.&#160; There are no intersegment revenues.&#160; Summary financial information for the segments is set forth below:<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;&#160;&#160;</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">&#160;&#160;&#160;&#160;&#160;&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="18" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: normal; font-style: italic; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(in</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> thousand</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">s)</font></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: normal; text-align: center;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">As of or for the&#160;thee months&#160;March </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">31, </font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2015</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> (unaudited)</font></div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Sales</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Representation</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Equipment</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div></td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Revenues from external customers</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">6,390</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,063</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: bold; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,453</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Operating income (loss)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">1,087</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(635</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(355</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(383</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(286</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Total assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">11,142</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">9,592</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">159</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">15,405</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">36,298</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Accounts and other receivables, net</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,363</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">576</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">86</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,025</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Deferred commission expense</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,412</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: bold; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: bold; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,416</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 40%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left; margin-left: 9pt; text-indent: -9pt;">Other assets</div></td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,832</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">715</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; text-align: right; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 1%; vertical-align: bottom; font-weight: normal; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 9%; vertical-align: bottom; font-weight: normal; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,620</div></td><td nowrap="nowrap" valign="bottom" style="width: 1%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">&#160;</div><div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;&#160;&#160;&#160;&#160;&#160; </td><td colspan="20" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div>&#160;&#160;&#160;&#160;<em>(in thousands)</em></div><div>As of or for the&#160;three months&#160;March 31, 2014&#160;(unaudited)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: top; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Sales</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">&#160;Representation </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Equipment </div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">IT Segment</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Corporate</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: center;">Consolidated</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Revenues from external customers</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">6,241</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">850</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,091</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Operating income (loss)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">523</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(1,082</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(531</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(1,090</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Total assets</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">10,209</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">7,728</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">11,986</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">29,923</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Accounts and other receivables, net</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">4,535</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">846</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">5,381</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Deferred commission expense</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,319</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #cceeff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #cceeff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,319</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="width: 39.98%; vertical-align: top; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: left;">Other assets</div></td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">2,836</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">432</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">13</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; background-color: #ffffff;">&#160;</td><td valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">$</div></td><td valign="bottom" style="width: 8.98%; vertical-align: bottom; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">3,281</div></td><td nowrap="nowrap" valign="bottom" style="width: 0.99%; vertical-align: bottom; text-align: left; background-color: #ffffff;">&#160;</td></tr></table></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">For the three months ended March 31, 2015 and 2014, GE Healthcare accounted for 86% and 88% of revenue, respectively, and $4.2 million or 85%, and $14.2 million or 93%, of accounts and other receivables at March 31, 2015 and December 31, 2014, respectively.</div></div> 6041000 5719000 -10308000 -9481000 164705000 166435000 166450000 -10308000 111000 109000 245000 0 0 0 0 245000 0 36000 0 0 36000 0 175000 1280000 15000 450000 0 1000 19000 0 0 389000 19000 390000 0 0 827000 0 7751000 7525000 -1755000 165000 -53561000 6465000 108000 61924000 -2000000 166000 -52433000 94000 61508000 166000 -52685000 61943000 101000 -2000000 10308087 10308087 2000000 2000000 1047000 1083000 878000 1047000 155454000 155945000 0 -0.01 2988000 2493000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Basis of Presentation and Use of Estimates</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the unaudited&#160;condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the SEC on March 30, 2015. These unaudited&#160;condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the unaudited&#160;condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold; text-align: left;">Significant Accounting Policies</div><div><br /></div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; text-align: justify; text-indent: 36pt;">Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2014, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.</div></div> P5Y P3Y 3 9000 -8000 19000 153000 9000 0 0 0 9000 3366000 5627000 6390000 6241000 1523000 1602000 EX-101.SCH 6 vaso-20150331.xsd XBRL TAXONOMY EXTENSION SCHEME DOCUMENT 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - LOSS PER COMMON SHARE link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - INVENTORIES, NET link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - GOODWILL AND OTHER INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - OTHER ASSETS link:presentationLink link:calculationLink link:definitionLink 061000 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES link:presentationLink link:calculationLink link:definitionLink 061100 - Disclosure - DEFERRED REVENUE link:presentationLink link:calculationLink link:definitionLink 061200 - Disclosure - RELATED-PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 061300 - Disclosure - BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 061400 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 061500 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 080300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 080400 - Disclosure - LOSS PER COMMON SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 080500 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 080700 - Disclosure - INVENTORIES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 080900 - Disclosure - OTHER ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 081000 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 081100 - Disclosure - DEFERRED REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 081300 - Disclosure - BUSINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 090202 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 090302 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - LOSS PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - INVENTORIES, NET (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 090900 - Disclosure - OTHER ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 091000 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 091100 - Disclosure - DEFERRED REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 091200 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 091300 - Disclosure - BUSINESS COMBINATION (Details) link:presentationLink link:calculationLink link:definitionLink 091400 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 vaso-20150331_cal.xml XBRL EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 vaso-20150331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 vaso-20150331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES [Abstract] Receivables due from related parties Accounts Receivable, Related Parties ACCRUED EXPENSES AND OTHER LIABILITIES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accounts and other receivables, net Accounts and other receivables, net of an allowance for doubtful accounts and commission adjustments of $4,361 at March 31, 2015 and $4,571 at December 31, 2014 Accounts and other receivables, net Accounts and other receivables Trade receivables Accounts Receivable, Net, Current Trade receivables - noncurrent Accounts payable Accounts Payable, Current Accounts and Other Receivables [Member] Accrued commissions Accrued Sales Commission, Current Accrued expenses - other PROPERTY AND EQUIPMENT, accumulated depreciation Accumulated other comprehensive income Accumulated Other Comprehensive Income [Member] Additional paid-in capital Additional Paid-in Capital [Member] Adjustments to reconcile net loss to net cash provided by operating activities Accounts and other receivables, allowance for doubtful accounts and commission adjustments Allowance for doubtful accounts and commission adjustments Amortization expense Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities, Name [Domain] Antidilutive securities excluded from computation of diluted earnings per share (in shares) Total assets Total Assets CURRENT ASSETS ASSETS Assets [Abstract] Total current assets Assets, Current BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] Business Acquisition [Axis] Business acquisition proforma information [Abstract] Business Acquisition Proforma Information Business Acquisition [Line Items] Revenue Business Acquisition, Acquiree [Domain] Net loss Business Acquisition, Pro Forma Net Income (Loss) BUSINESS COMBINATION [Abstract] BUSINESS COMBINATION Business Combination Disclosure [Text Block] NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents - end of period Cash and cash equivalents - beginning of period Cash and cash equivalents Cash equivalents invested in money market funds (included in cash and cash equivalents) Variable Interest Entity, Classification [Domain] COMMITMENTS AND CONTINGENCIES [Abstract] COMMITMENTS AND CONTINGENCIES (NOTE N) COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Common stock, par value (in dollars per share) Common Stock [Member] Common Stock Grants [Member] Common stock, $.001 par value; 250,000,000 shares authorized; 166,450,370 and 166,435,370 shares issued at March 31, 2015 and December 31, 2014, respectively; 156,142,283 and 156,127,283 shares outstanding at March 31, 2015 and December 31, 2014, respectively Common Stock, Value, Issued Common stock, shares issued (in shares) Common stock, shares authorized (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Software [Member] Concentration Risk Type [Domain] Concentration Risk [Line Items] Concentration Risk Benchmark [Domain] Concentration Risk Type [Axis] Concentration Risk [Table] Concentration Risk Benchmark [Axis] Percentage of revenue (in hundredths) Percentage of accounts and other receivables (in hundredths) Consolidation Items [Domain] Consolidation Items [Axis] VSK Medical Limited [Member] Corporate [Member] Cost of equipment sales Total cost of revenues Cost of Goods and Services Sold Cost of equipment rentals and services Cost of revenues Credit Concentration Risk [Member] Customer Lists [Member] Deferred commission expense DEFERRED REVENUE [Abstract] Deferred commission expense Deferred Costs, Current Changes in Deferred Revenues Deferred Revenue [Domain] Deferred Revenue Arrangement, by Type [Table] Additions: DEFERRED REVENUE Deferred Revenue Disclosure [Text Block] Deferred revenue at end of year Deferred revenue at the beginning of the year Deferred Revenue Less: current portion Deferred revenue - current portion Deferred Revenue Arrangement [Line Items] Long-term deferred revenue at end of year Deferred revenue Deferred Revenue, Noncurrent Deferred Revenue Arrangement Type [Axis] Recognized as revenue: Deferred Revenue, Revenue Recognized Deferred tax liability, net Deferred Tax Liabilities, Net, Current Depreciation and amortization Depreciation, Depletion and Amortization RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Description of New Accounting Pronouncements Not yet Adopted [Text Block] Due from employees Receivables due from related parties Weighted average common shares outstanding - basic and diluted (in dollars per share) Earnings Per Share, Basic and Diluted LOSS PER COMMON SHARE Loss per common share LOSS PER COMMON SHARE [Abstract] Effect of exchange rate differences on cash and cash equivalents Accrued compensation Employee-related Liabilities, Current Stock Options [Member] Revenue, Major Customer [Line Items] Investment, Name [Domain] Equity Component [Domain] Assets Measured at Fair Value Fair Value, Hierarchy [Axis] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] FAIR VALUE MEASUREMENTS [Abstract] Fair Value, Measurements, Fair Value Hierarchy [Domain] FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Significant Other Observable Inputs (Level 2) [Member] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Significant Unobservable Inputs (Level 3) [Member] Useful life of intangible assets Finite-Lived Intangible Asset, Useful Life Costs Finite-Lived Intangible Assets [Line Items] Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization INTANGIBLES, net Intangible assets, net Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets by Major Class [Axis] Other intangible assets, net [Abstract] GOODWILL Goodwill, Ending Balance Goodwill, Beginning Balance GOODWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] Foreign currency translation Goodwill, Translation Adjustments Change in carrying amount of goodwill [Roll Forward] Goodwill [Roll Forward] GOODWILL AND OTHER INTANGIBLES [Abstract] Gross profit Gross Profit Loss from joint venture Loss from interest in joint venture Income (Loss) from Equity Method Investments CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) [Abstract] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax benefit (expense) Income Tax Expense (Benefit) Income taxes paid Accounts payable Other current assets Increase (Decrease) in Other Current Assets Receivables due from related parties Increase (Decrease) in Due from Related Parties, Current Other long-term liabilities Accrued expenses and other liabilities Deferred commission expense Increase (Decrease) in Deferred Charges Other assets Increase (Decrease) in Other Noncurrent Assets Accounts and other receivables Increase (Decrease) in Accounts and Other Receivables Deferred revenue Increase (Decrease) in Deferred Revenue Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accrued commissions Inventories, net Increase (Decrease) in Inventories Notes payable due to related party Increase (Decrease) in Notes Payable, Related Parties Increase (Decrease) in Stockholders' Equity [Roll Forward] Sales tax payable Interest and other income, net Interest paid Inventories, net Inventories, net Inventory, Net Finished goods Inventory, Finished Goods, Net of Reserves Raw materials INVENTORIES, NET Inventory Disclosure [Text Block] Reserves for excess and obsolete inventory INVENTORIES, NET [Abstract] Work in process Fees for legal services Total current liabilities Liabilities, Current Total liabilities and stockholders' equity Liabilities and Equity Total long-term liabilities Liabilities, Noncurrent CURRENT LIABILITIES LONG-TERM LIABILITIES LIABILITIES AND STOCKHOLDERS' EQUITY ACCOUNTS AND OTHER RECEIVABLES, NET Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Major Customers [Axis] Noncontrolling interest (in hundredths) Changes in deferred revenue [Roll Forward] Name of Major Customer [Domain] ORGANIZATION AND PLAN OF OPERATIONS Nature of Operations [Text Block] Cash flows from financing activities Net loss Net income (loss) Net loss Net (loss) income Cash flows from operating activities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash flows from investing activities RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS [Abstract] SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES Total other income, net Nonoperating Income (Expense) Other income (expense) Notes payable due to related party Notes payable Notes Payable, Current Number of contiguous states in which VasoHealthcare has been appointed exclusive representative for GE Healthcare Diagnostic Imaging products Number of segments Number of Chinese operating companies acquired Number of Businesses Acquired Operating expenses Operating Expenses [Abstract] Total operating expenses Operating Expenses Operating loss Operating income (loss) Operating Segments [Member] ORGANIZATION AND PLAN OF OPERATIONS [Abstract] Foreign currency translation gain (loss) Foreign currency translation gain (loss) Other assets OTHER ASSETS Total Other OTHER ASSETS Other Assets Disclosure [Text Block] Other comprehensive income OTHER ASSETS [Abstract] Other long-term liabilities Other Liabilities, Noncurrent Other liabilities Patents [Member] Patents [Member] ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract] Purchases of equipment and software Payments to Acquire Property, Plant, and Equipment Debt issuance costs Payments of Debt Issuance Costs Purchases of short-term investments Payments to Acquire Short-term Investments Preferred stock, par value (in dollars per share) Preferred stock, $.01 par value; 1,000,000 shares authorized; nil shares issued and outstanding at March 31, 2015, and December 31, 2014 Preferred Stock, Value, Issued Preferred stock, shares issued (in shares) Preferred stock, shares authorized (in shares) Preferred stock, shares outstanding (in shares) Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Reclassifications Redemption of short-term investments Proceeds from Sale of Short-term Investments PROPERTY AND EQUIPMENT, net of accumulated depreciation of $1,443 at March 31, 2015 and $1,397 at December 31, 2014 Property, Plant and Equipment, Net ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract] RELATED-PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Related Party Transaction [Line Items] Related Party [Axis] Related Party [Domain] RELATED-PARTY TRANSACTIONS [Abstract] Research and development Accumulated deficit Accumulated Deficit [Member] Retained Earnings [Member] Revenue and Expense Recognition for the Sales Representation Segment Revenue Recognition, Policy [Policy Text Block] Revenues from external customers Equipment sales Total revenues Total net revenue Revenue, Net Revenues Revenue, Net [Abstract] Sales Revenue, Net [Member] Equipment rentals and services Sales tax payable Sales and Excise Tax Payable, Current Schedule of Other Assets Schedule of Other Assets [Table Text Block] Antidilutive Common Stock Equivalents Excluded from Computation of Diluted Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Schedule of Finite-Lived Intangible Assets [Table] Inventories, Net of Reserves Schedule of Other Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Investment, Name [Axis] Schedule of Changes in Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Summary Financial Information for Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Variable Interest Entities Schedule of Variable Interest Entities [Table Text Block] Accounts and Other Receivables Schedule of Variable Interest Entities [Table] SEGMENT REPORTING AND CONCENTRATIONS [Abstract] Segment Reporting Information [Line Items] Segment [Domain] SEGMENT REPORTING AND CONCENTRATIONS Segment Reporting Disclosure [Text Block] Selling, general and administrative Balance (in shares) Balance (in shares) Shares, Outstanding Short-term investments Statement [Table] Statement [Line Items] CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) [Abstract] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) [Abstract] Equity Components [Axis] CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) [Abstract] Segments [Axis] Repurchase of shares Stock Repurchased During Period, Value Exercise of stock options Common shares issued for prepaid directors' fees Stock Issued Share-based compensation (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Exercise of stock options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Share-based compensation Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Repurchase of shares (in shares) Stock Repurchased During Period, Shares STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY Balance Balance Total stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest SUPPLEMENTAL DISCLOSURE OF CASH INFORMATION Treasury stock, at cost (in shares) Treasury Stock [Member] Treasury stock, at cost, 10,308,087 shares at March 31, 2015 and December 31, 2014 Treasury Stock, Value Total assets Variable Interest Entity, Consolidated, Carrying Amount, Assets Variable Interest Entities [Axis] Biox [Member] Total liabilities Variable Interest Entity [Line Items] - basic and diluted (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Name of the acquired entity. Genwell Instruments Co. Ltd. [Member] The pro forma of Basic and diluted loss per share for the period as if the business combination or combinations had been completed at the beginning of a period. Business Acquisitions ProForma Basic and diluted loss per share (in dollars per share) Basic and diluted loss per share (in dollars per share) Noncurrent carrying amount of advanced commission payments. Deferred Sales Commission Noncurrent Deferred commission expense - noncurrent Exclusive legal right granted by the government to the owner of the patents and technology to exploit an invention or a process for a period of time specified by law. Patents and Technology [Member] Patents and Technology [Member] Disclosure of accounting policy for Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). and for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles. Basis of Presentation and Use of Estimates [Policy Text Block] Basis of Presentation and Use of Estimates Disclosure of accounting policy for all significant accounting policies of the reporting entity. Significant Accounting Policies [Policy Text Block] Significant Accounting Policies Document and Entity Information [Abstract] Refers to the extended term of sales representation agreement into an amendment entered by entity. Amended Term of Sales Representation Agreement Amended term of sales representation agreement Refers to the initial term of sales representation agreement into an amendment entered by entity. Initial Term of Sales Representation Agreement Initial term of sales representation agreement Sales Representation Agreement [Abstract] Sales Representation Agreement [Abstract] David Lieberman who serves on the board of directors (who collectively have responsibility for governing the entity). Director David Lieberman [Member] Director - David Lieberman [Member] The number of wholly-owned subsidiaries owned by the entity. Number Of Wholly Owned Subsidiaries Number of wholly-owned subsidiaries A type of deferred revenue by arrangement relating to service arrangements. Service Arrangements [Member] A type of deferred revenue by arrangement relating to extended service contracts. Extended Service Contracts [Member] A type of deferred revenue by arrangement relating to commission revenues. Commission Revenues [Member] A type of deferred revenue by arrangement relating to in-service and training. In Service and Training [Member] In-Service and Training [Member] Amount of the current period expense charged against operations, the offset which is generally to the allowance for doubtful accounts and commission adjustments for the purpose of reducing receivables, including notes receivable, to an amount that approximates their net realizable value (the amount expected to be collected). Provision for doubtful accounts and commission adjustments Provision for doubtful accounts and commission adjustments The aggregate amount of noncash, equity-based Employee and Non Employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Share based compensation and arrangements Share-based compensation and arrangements Major external customer that accounts for 10 percent or more of the entity's revenues. GE Healthcare [Member] Refers to component of an entity for which there is an accounting requirement to report separate financial information for this particular segment on that component in the entity's financial statements. Information Technology Segment [Member] IT Segment [Member] Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Equipment Segment [Member] Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. Sales Representation Segment [Member] Refers to amount of increase (decrease) in additional paid in capital (APIC) resulting from common stock that is not issued for employee tax liability. Shares not issued for employee tax liability Shares not issued for employee tax liability Amount of expenses as of balance sheet date incurred and payable, pertaining to costs that are statutory in nature, incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include, but not limited to, taxes, interest, rent and utilities. Also includes the aggregate carrying amount of liabilities not separately disclosed. Accrued Expenses and Other Liabilities, Current Accrued expenses and other liabilities Accrued expenses and other liabilities Aggregate revenue during the period from commissions earned from the sales representative agreement with GE Healthcare. Commissions Revenue Net Commissions Total costs related to commissions earned under the sales representative agreement with GE Healthcare. Cost Of Commissions Revenue Cost of commissions EX-101.PRE 10 vaso-20150331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
FAIR VALUE MEASUREMENTS (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) $ 14,666us-gaap_CashAndCashEquivalentsFairValueDisclosure $ 8,149us-gaap_CashAndCashEquivalentsFairValueDisclosure
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) 14,666us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member		 8,149us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel1Member
Significant Other Observable Inputs (Level 2) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) 0us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member		 0us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel2Member
Significant Unobservable Inputs (Level 3) [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents invested in money market funds (included in cash and cash equivalents) $ 0us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member		 $ 0us-gaap_CashAndCashEquivalentsFairValueDisclosure
/ us-gaap_FairValueByFairValueHierarchyLevelAxis
= us-gaap_FairValueInputsLevel3Member
XML 12 R48.htm IDEA: XBRL DOCUMENT v2.4.1.9
COMMITMENTS AND CONTINGENCIES (Details)
 1 Months Ended 3 Months Ended
Jun. 30, 2012
Mar. 31, 2015
Sales Representation Agreement [Abstract]    
Initial term of sales representation agreement 3 years  
Amended term of sales representation agreement   5 years
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#A_+]<%@(``"\>```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F4]OTS`8QN](?(?(5]2X M_L,8J.T.`XXPB?$!3/*VB9K8ENV-]MOCI%LU3:55126>2Z,F]OO\XL/OD&=V ML^F[XI%";)V=,U%.64&V/MF=K_U M%(N\V\8Y:U+RGSB/54.]B:7S9/.3I0N]2?EO6'%OJK59$9?3Z16OG$UDTR0- M,]AB]IF6YJ%+Q9=-OKTC"=1%5MSN%@Y9.: MV+0^OLL8C!],&)[\/>!IW_=\-*&MJ;@S(7TS?<;@FX[_=F']R[EU>7S(`4JW M7+85U:YZZ/,)E-$',G5LB%+?E>.U[$UKG[F/Y(^+(Q\OXL(@P_N-@\_DD"`< M"H1#@W"\!^&X`N'X`,)Q#<+Q$81#3%%`4(PJ4)0J4)PJ4*0J4*PJ4+0J4+PJ M4,0J4,PJ4P3')7I MJMLF-V@7/H3]W&/YN=:["\['7'`&.A_@N<$<=D]\'D0AM;3O,`]U@?O$7(Z> M'_BJC*2A?JVI/I#-Q[IW\0<``/__`P!02P,$%``&``@````A`+55,"/U```` M3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ? M>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSB MIX3A363X8<'%#U1?````__\#`%!+`P04``8`"````"$`S4_#WD4"``!T'0`` M&@`(`7AL+U]R96QS+W=O=^5WP/ M0]SV765D-C=%Z.J^V7:;RGQ]^71S9XJ8?-?X7=^%RAQ#-(^K]^\>/H>=3_E+ ML=T>8I%7Z6)EVI0.'\HRUFW8^SCK#Z'+3];]L/?#UJ]^$4N?S93E< MKF%6;]8LGIO*#,^-6%.\'`]YZ_\OWJ_7VSI\[.MO^]"EO^Q1_NB'U]B&D/*B M?MB$5)EQ*I:G)V)G6;,I_R$GGP=7SAV2HTNR'%TB.?:>+,?>(SDJ9#DJ2(YU M9#G6(3E.R7*<0CFW;#FW2,XBDW"Z0H_IN,OD'*'S>XSV9Y\&/`RV4Z!1A,T\ M@X5]M$(M(M.:I+FT;:!MA$U`@ M`85-0($$5#9R%"+'TJT#O6/916YAE3OV7`54P-; M#13#-L[HF_+-?Z6K7P```/__`P!02P,$%``&``@````A`&.!,!<[!```Y`X` M``\```!X;"]W;W)K8F]O:RYX;6R4EU]SFD`4Q=\[T^_`\-XJ?R0F$]-!W9B= M07!VT;1]8:BND2F"`Z0FW[X7K.3"&B9]T@4YG'OW=RYR^^UE'RM_1)9':3)2 MM:]]51').MU$R=-(7?KW7X:JDA=AL@GC-!$C]57DZK>[SY]NCVGV^U>:_E9` M(,E'ZJXH#C>]7K[>B7V8?TT/(H$SVS3;AP4LLZ=>?LA$N,EW0A3[N*?W^U9O M'T:)>E*XR3ZBD6ZWT5I,T_7S7B3%2203<5B`_7P7'7+U[G8;Q6)UJD@)#PX M\*&\LSKT2S=UW2I_6;9B%8EC_G91N51>'J-DDQ[+GT)K7^N5`0:.U:G':%/L MX'R_WZ^//8CH:5><#X)\#^E7'83[5)]*4I5W[D@`.Q60I(B*UX`FI^Y'*6QA MV74*E6FJDMU$\"6C&ZTTCE4FGCLE+B?3`+YQSZ%3VX?%V'9L=T*0BGF-9/3_ MDP$'M9L!]*2V4W7\`W:X#Z[F#3M(Q?R@FW\J#3>X.8/_T]%151:R4\&!B_+8 MS';I3]NGGAO8[C180',#[S[P%H392&4`DG5OKMINQC:GO+QLP0@G+K3DK#=A MU,0#^@9OY'.KB M#S;#&S0`LNM:M'[[\GN;LF!E.TL2S(G-EPRVU_4YOCWNJ2:!:T\FWA*NJ-Q[ M_@,X861"Z,H>.Z2A=[TD3H.,D!A M4]P9;1O`R=$D6$_>;00O3J$DX,N*4HV)A,_]'X#/;Y?:D)!+WWL(D:A**XR6G+@&. M@*$Q=2N@$0$6!E"3""S!HWZ%S1GA$F?B3F`OL0PF$49R:P*6U+B^\R.@G)<= M_0=6&8P%\[`.!E*7@.R.)^Q"/0(M3*0N$=DMU)@ZF%!=(K0[Z0U'&%%=0O1B MU@,__!7#7X.WNJXPLKJ$[#N1OZ"#D3T]:_$X[4X^+NL*$ZQ+!+>B?\$(QE>7 M\.V>``TCF&1=(AF/@`LN,+^&Q&_W)&BXP``;$L#M47#!"0;7D,&]$.<+(AA: M0X*V^V'9*`=#:TC0=L<(=K;.8_G'K![TL&@-B.X8X3P.<0`,:=9V"S4<-1HM M@7LYCU-1A%&,`VDT6BWQ^UX@3T*H04-H^UN#)'R[`]EH$`ZD*:'<#J1'N2&(;0SP83(EA*9*R%1/#"XM61]Y] M2@>E%-IC$P\'6+1T+CVJ*XDF<28&%Q8MEE5=X"5J'\1K> MSLJ/ZO7&'%BGIW'O_()Z]Q<``/__`P!02P,$%``&``@````A`"?:L=PZ!0`` M)Q4``!@```!X;"]W;W)KG>D76FUVH\S39P$->`(Z$[/O]^RRP&[F/2&2\^$>I2?7U4] MP-LO'U7IO/.F+42]<]G<=QU>Y^)0U*>=^_=?S[.UZ[1=5A^R4M1\YW[GK?ME M__-/VZMH7MLSYYT#&>IVYYZ[[K+QO#8_\RIKY^+":X@<15-E'?QL3EY[:7AV M4#=5I1?X_M*KLJ)V,<.F>22'.!Z+G#^)_*WB=8=)&EYF'?!OS\6EO66K\D?2 M55GS^G:9Y:*Z0(J7HBRZ[RJIZU3YYMNI%DWV4L*^/UB8Y;?[$'F?;;0P$[D+([#3_NW*]LDRZ8Z^VW2J!_"GYMC?\[[5E< M?VF*PV]%S4%MJ).LP(L0KQ+Z[2`OPZ.YG58$_&N?`C]E;V?TIKK_RXG3N MH-P1[$AN;'/X_L3;'!2%-/,@DIER40(!^.M4A6P-4"3[4/]>BT-WWKF+Y3Q: M^0L&<.>%M]US(5.Z3O[6=J+Z%T%J1WV20"=9`'L=#QY-XB$AM;^GK,OVVT9< M'6@:6+*]9+(%V082WS:&-/JMWMLI;%$F^2JSJ%RPB1;*\[Y?K;?>.RB::TB" M$!B('L)L1'I#R$(`NYXB[)M27$`%?ZS]C9&\B3"*[?62,22P$>D8L?9[B,41 MI#,Y?LY-@G=N:$BQ)EHD",%6D@JGQ@5K8ARU=]K45I-H23!A%+4IT65$+)$E<)H$`)+9X7]^$[IY!/+ M\(//&UF"22,O"2F$&(UL7+#4B*XX--,FN%)N4:Y-:JF(;,%B2-O$)IDV0P>VYH[,5:(Q*,@L&,\=YD#B M,^8;@VLSF^3J#$W9ZN]AHG4E$6/VMW'%6CR89-X*3=J(V&"B,2A+2-^-K&@T M2&J3FF3=P=BZ8VK=&G./%&;`Z%U2DXP[&!LW\XD8B0;=.B@F=7-N M^?DT"R+B[*E.TBMV[^5`?E%.H(:V;LX<\P<#U-009`R=6D2^QHP^UB9Y=X"^ M;`LSN)Q>W31OX@>ISJ#+M1B&PR[7).L.QM;-?.K=&H1?2K,@)/'4CC/_WH=) M,,F\%=I^Y68^:>%$@\QRH5__H%S$H.7W_P,?UVBY=ME(99(`02C0,$:JIJD. MPNNNZG9_;DRI53E)QNSFQPBJNZA,U,TUR)#)O&*SF.3:>\K)LG5R\R;,H!MKV5_&<+(%S,G6HY/4! M.*:Z9"?^>]:1$='%"I_Y[A0)+#X80_ M!_!1B.[V0YI"?\2Y_P\``/__`P!02P,$%``&``@````A`&L,/.'U`@``Z0@` M`!D```!X;"]W;W)K&ULE%9=;YLP%'V?M/]@\5Z^ M`H%$2:HFJ%NE39JF?3P[8()5P,AVFO;?[QJ'UH:N35]";)][./?>8YO5]6-3 MHP?"!67MV@E?/ZU.C-^+ MBA")@*$5:Z>2LEMZGL@KTF#ALHZTL%(RWF`)0W[P1,<)+OJ@IO9"WY][#::M MHQF6_!(.5I8T)QG+CPUII2;AI,82](N*=F)@:_)+Z!K,[X_=5*@G=CB$AE=>R>,J(R*&@0..&L6+*60T" MX!)%K):.[.Y&R?^+``XVA,A;ZFB=%!^%)(U?S4H.%-IDO!, M`L\S21"[41@GZ4=89F<6>`XL\X^S1&<6>`XLX:4)>;HX?:TS+/%FQ=D)@7\A M?=%AM1N")1"K(D?_+3)45\7RZ4H,.PG0TH0O:38 MFV2K,8O>'K$?CHJT,Y>#.$QF=B:9N1[/TA?S6*K!JJ;JR^RK@FSU49#8K]]J MC%'(\41F3%B2YK:DMWNJP._U5&,,*>.)S)BPI"0?D:+`=E6F/=48W=,(KD.[ M:#MS.9BN9WJ]S\32J6[LT2'T_FY60;;>*$AM05N-2>:]"7TW'9MPM+X8FU"O M&X+U;:5/T`X?R'?,#[05J"8E[$K?3<`57-]5>B!9UQ\Y>R;ACNG_5O!)06!O M^BZ`2\;D,%"'W/-'RN8?````__\#`%!+`P04``8`"````"$`7U69HPL#```` M"0``&0```'AL+W=OGATP8!4PLIVF_?L=VX%BTDMV7Y)@GSD^,V?P9'/U MU#;6(V:S+=SEM"!=E=B_?MY>7-H6%Z@K4$,[G-C/F-M7V\^?-@?* M'GB-L;"`H>.)70O1KUV7YS5N$7=HCSO8*2EKD8!'5KF\9Q@5*JAMW,#S%FZ+ M2&=KAC4[AX.6)Z$)F&X00+T\YKT?&!K\W/H6L0>]OU%3ML>*':D M(>)9D=I6FZ_OJHXRM&L@[R<_0OG`K1Y.Z%N2,\II*1R@<[70TYQ7[LH%INVF M()"!++O%<)G8U_XZ\SW;W6Y4@7X3?."3WQ:OZ>$+(\4WTF&H-O@D'=A1^B"A M=X5<@F#W)/I6.?"=604NT;X1/^CA*R95+<#N&#*2B:V+YQO,U/>!%*).['#AQ$LO]`%N[3`7MT12VE:^YX*V?S3(/U)I MDN!($H+ZXWYP+HFK!:G\;I!`VPVC!PN:!H[D/9(MZ*^!>$A,RQA3?2M32%&2 M7$L6Q05)<+#G<1OYJXW[""7-CYA48^"-&#&^B<@&A'0"Y(T:(?&YQA`L?+WX M@R099$H*(O.\]!6(B"#$T0NWF&J,W&V30*(,2.YJ4)`I>^%5I4XW1 M325KG4T6#`5`\^\*9!`THZ%@9DNJ,0MEJQ]&P5@`)3";;@>+X,5V0QW48JKN M?>\D>*YJ=FRJ,9.Z3!:,DQ?FR;+#/W9&!GWDC,9,%$P6#`7+_U$@@^8UF#NC M,;%R9A7/*I3IW:-OR_BE^PUQ853C#3<.MG.[ED/'!\'%5#\!4#D`UPL8-F#\]JO`]8A7IN-7@$D(] M9PGO"=,33#\(VJM[PD)"33.,1J M$D>V*>W?[]@#J4U`0%\:,CYS>GS&&<_L_K4JO14WG_AN5_OWB\Z?9CHMG65"J/&"HY=POE&JF02#3@E9$ M]GA#:UC)N:B(@E>Q"60C*,E,4E4&4;\_#"K":A\9IN(:#I[G+*6//-U6M%9( M(FA)%.B7!6OD@:U*KZ&KB'C>-G?^0SA=A0,_6,R, M07\9W4GKMR<+OOLB6/:=U13Q(;VR:O3U2F8*C0-.+$LV4\A($P%^O8OIH@"/DU3QW+%/% MW!\,>\FH/P@![JVI5$],4_I>NI6*5_\0%.ZID"3:D\!S3Q)&-Y,,]B3P?">) MQDF8#"]+"7!;QJ5'HLAB)OC.@Z,'PF5#]$$.I\"L[1F`R:?M`5]TSH-.,JF` MEE#3ET4J0[C%+Q,!GU&(B%[$Z@4A:2`#Z6I'@V^TB=9(KLJ,1(6-3 M*[VQE15P!(`SQP+BLX?HX)).FONQY4`6#&L;S+QT@GN?+BZ.C?+Q%C M&60%'`7#KH++)=))ETJ$&$N!%7`4C#ZB0">Y'G1+A)CAV1+9Z^=+I&^TF[]T MG>3*BZ-1>P3P!"'&,L@*.`9-N@HNET@G72H18BP%5L!1$$)K.S;AL@23Y;K0 M+=(>E)@J]5V+5F<676T?:\781>UO/(Z.O_$0099!=L15<:+77N$0-D[H%6VW M[_:Z$$&V"BOBJM!M\.BP7J$"FZ?MQ8DZ(0@;7J=.IQ=1&\X8>'M65&SHBI:E M]%*^U?-#!(5OHSC;+,/I,M*7RU%\!3./B0?M`HP<#=G0'T1L6"V]DN9`V>^- MH-L)'%KP1?'&W&EKKF#8,#\+&"XI7%[]'H!SSM7A18]%[;BZ^`\``/__`P!0 M2P,$%``&``@````A`$+3,082`P``O@@``!D```!X;"]W;W)K&ULE%;;;J,P$'U?:?\!\=Z`(4""DE0-J+N5MM)JM9=G!TRP"AC9 M3M/^_8[MA,2DJI*7$,^<.9RYV&9Q_]8VSBOA@K)NZ:*)[SJD*UA)N^W2_?/[ M\6[F.D+BKL0-Z\C2?2?"O5]]_;+8,_XB:D*D`PR=6+JUE'WJ>:*H28O%A/6D M`T_%>(LE+/G6$STGN-1!;>,%OA][+::=:QA2?@T'JRI:D)P5NY9TTI!PTF`) M^D5->W%D:XMKZ%K,7W;]7<':'B@VM*'R79.Z3END3]N.<;QI(.\W-,7%D5LO M+NA;6G`F6"4G0.<9H96*Y,A_/U$:7.L<2KQ:<[1T87\A>]%AM!I0"L:IQ")WZN,907!7SH()T M**`%S,7K:AK,%]XK-+,X8-8&`UMQP`0V(OL`$=F0_!(R\P>(!RD,>4!_;L]# M!=EY!-.!7J>Z-I"9G@F5>S8VY&<&2Q$T^W9%*FCI0B-.58M'=5L;C)EX+6EL MR,\,EB3@/9?T>9,5&(;!DC+JS]I@YGH$YD%RZHTN7G;N1O,D'!4W-WZ=B:43 MMN?U.A5XK#,>==%@(JT3H9$WL[VC)/*C5QU5YQ,7VR*OVSDJR!8[#43<,8VP[7E[9[0P!<'SW>DF?,M[033D,J>)4_26`&N+F`S$*R7I\;&R;A MXM!_:_A.('!`^!,`5XS)XT+-S?#EL?H/``#__P,`4$L#!!0`!@`(````(0!` MH$3R<`<``#(B```9````>&PO=V]R:W-H965TU45Y6H_5)!B/\M.FW!:GM_7XG[\_/2W&H[K) M3MOL4)[R]?A;7H]_>OGQA^>/LOI<[_.\&8&'4[T>[YOFO)I.Z\T^/V;UI#SG M)[#LRNJ8-?"V>IO6YRK/MNVDXV&J@V`V/6;%:8P>5M40'^5N5VQR4V[>C_FI M02=5?L@:X%_OBW-]\7;<#'%WS*K/[^>G37D\@XO7XE`TWUJGX]%QL_KM[516 MV>L!UOU51=GFXKM](]P?BTU5UN6NF8"[*1*5:UY.EU/P]/*\+6`%-NRC*M^M MQS^KE8GFX^G+T0 M3)Z*V9_:'?BS&FWS7?9^:/XJ/W[-B[=]`]L=PXKLPE;;;R:O-Q!1<#/1L?6T M*0]``%Y'Q\*F!D0D^]K^_2BVS7X]#F>3>!Z$"N"CU[QN/A76Y7BT>:^;\O@? M@I1SA4ZTV?7#SN)G!/X>W6B%[&*9_>I3'%9;91,UF0OSU7Y,8+4`^+U M.;.)K%;@^1(>7$P7L._%"P)EG?QLO;2^(!0U;/*7ERB(GZ=?8&,V#I,@!NJJ MPRB*2"\(NPO6K;FXM1L,?#O2$$]..H3,N+VG%XYV$N6H(TH@N0&AB!01_B(6 M`848"='74)!E0#KXR^BG;\&6_B4XR67@&D\=+"B7%#&+;I+Q!@@5V'J?BDV# M^Q&UD]9C>.UV%)H;99`@!BO+[FG*!XPW0"A!>?F4^J-CP4#9HQ(%,T8%,7&; MGB&UI1?;);K&&R"L9I35L$#9231043"G#!+$>('B`\8;()3FE%)_H"R8!DHK M%HP$,RI;]?+I6;Q-KX] M"I9>P$E\%73`X0%NT92YUBQ$B0,A]3CP^EB[`RFUAPN>"L2N8CV_+HU2MXU^ M<&XHE`6_V$/-JLEAD+F.%$\.:@_5DLXWSBZS6-GV/IPJBH%/546"*X*0:S3C MNY"V'[D>NP32,LK^_'BFKIV%!MGV?H_YL-:E["R:)Q&7F<2!O.8E1HP_0GE9 M`?!X]3<&A7(!KYWH0$W0W4L81S@1CY:51C.%C6$LF55FRA/:%R=\Q'C8VCT;/OW^`S, M,A0-NJO7/,9^KSQE<;SXB/$QE)=M]QZO.UF&XN#'2^R+4_[C*8S M_SV@ZHXCI0^JBI;H( M(728[Y!$!S>-IILI2$+"#4]2;=$TE%("'0B)>*<$3%%BY:=5TUD%3]OAO6*R MK2B"1MM?^AIUP2^J2'')=B!/8,2(\4=(*[)/ZYS7_8>M=M:]AP@'\GFALEQ' MC(^AO!Z2$BVE1+9(!\*"GH7\#)Y2.YS3J)`;9[]1SDQF[NPIZH2_IUKQ1JD1 MY)I/L&#RDSH[YF@L3NF=6:3A0\JCI?+;FL1?,3DG&`&X%] M2('T#07BY]?$@9!,%,ZX`E%['+*-,G3A0^YG8V\6(\4=(?PJ9[@SDA?K3?[1L7=M#$A2OXX73KB/&QU!>3&?N MI*'4%]DW0P3AWJE`E(RS8R]:Q.SP83HS[T4ADYX[5%$[^MMFZ[([7\YX]:;. MCDN![V$6+$]-YT"0?4B/0JE'LG$Z$))9QDO&)27V^5SSQS!GOU$S#^E1>$./ M1-MT(*F,@NA#VA-)[9$]TH&0J(K9=VLI,0N>^`&R/]KG MKN%'M19-RT,^?CL0\N1?!*3$*FAZ#T4T.Q^2G$A*#F\.7#B*1]1GMW;]U[+/$J'B^9CWGUEJ?YX5"/-N6[O68/ MX3ZF&\6?`"1J!5>_D-EL/-4KN,"4XT:OX![35D(W`6[LS]E;_D=6O16G>G3( M=_!1P60.^USAG3^^:P7\6C9P5]_^NX??9N1P,1E,`+PKR^;RQGY`]VN/ ME_\!``#__P,`4$L#!!0`!@`(````(0"F,W=P``0``(4-```9````>&PO=V]R M:W-H965TP"PA1$E:S5(S+?5( MH]$LSP2WPX=[.=W:?WIC;><$\KTNY-9#FF M@=N"E%5[WIO__/VRVI@&97E;YC5I\=[\P-3\=/CUE]V-]*_T@C$S@*&E>_/" M6+>U;5I<<)-3BW2X!<^)]$W.X+$_V[3K<5X.BYK:=AUG;3=YU9J"8=L_PD%. MIZK`*2FN#6Z9(.EQG3/03R]51R>VIGB$KLG[UVNW*DC3`<6QJBOV,9":1E-L MOYQ;TN?'&N)^1WY>3-S#PX*^J8J>4')B%M#90N@RYLB.;&`Z[,H*(N!I-WI\ MVIN?T39#GFD?=D."_JWPC4J_#7HAM]_ZJOQ:M1BR#77B%3@2\LJA7TIN@L7V M8O7+4($_>Z/$I_Q:L[_([7=.F+*7BE.:1G&EC#3_"1`:J02).Y)X MH'[TNT^3^",)?$\D:\MW@W#SC!00/<0#WQ.+:[F;``7KGP=DB^0,N4YSEA]V M/;D9T,`0/NUR/@YH"\Q3DD5*YK1_+^N0;D[RF;,,7)!0"JWR=O"B:&>_07F+ M$1,+#$SGC$$J(ID0O):<-EW2^HZC+LHF#&\EB&D.#"JG!^9!#WZ[>Z8X^"(U M#M=7WQ=_`Z(BDB5BHXE.EQ`W4%FR)<1W[@E30H7FE$/]<8@A%>U<3",J:3-#35I`A(-/88"=ZUU6:+X8DSV1U&Z^\D'`;E\:`X6`T*19[ZVEA@UD-4H1]H[D1Q.]%=E1@3 MX;Z7*Y,,2C'6S^CF8%6W[VC"8H$)!MTK-]#Z*!%N$=8*.;XV2ZGL1\MB3.SZ M:(?/A,'!>AB:CEA@[@E,=$.J&S+)H*28WSZD_?3'L\C!/YM%@9&TZ894-V22 M0=$6/:.-@]6\+6910$3U$=(F-9F\\VX^&?CQ@`)M,+/)JQ<;P:;]>$8'M"H; M;;0ACT>0Z$OD;+2N3D;_/>>IML+78LWD%4K*$3^>'NZ'`:VKUQ(5CZ!)O:XE M&?VR>G%&BD)M0BT=F;Q`%<_/H,?%BQ-+WKV7&QT2("'%"[6=+%'=KA9Z.KNG MGLIDBZJ='TB/:Q?'EZQ]N=G!99>/A#A[5LC33NQ$\_M:GM/1?R\,OSYSQL$B MU(O;L+BA-;@_XP37-34*'>Q(=F=L`EN,O/^(^\/U^`OF/U"' M_P$``/__`P!02P,$%``&``@````A`/N!C37-`@``X@<``!D```!X;"]W;W)K M&ULG)5=;YLP%(;O)^T_6+XO'R&0$(54[:INE39I MFO9Q[1@#5C%&MM.T_W['=DI"TG;I;D(P[WD?G^/#87GY*%KTP)3FLBMP'$08 ML8[*DG=U@7_]O+V88Z0-Z4K2RHX5^(EI?+GZ^&&YE>I>-XP9!`Z=+G!C3+\( M0TT;)H@.9,\Z>%)))8B!6U6'NE>,E"Y(M.$DBK)0$-YA[[!0YWC(JN*4W4BZ M$:PSWD2QEAC8OVYXKY_=!#W'3A!UO^DOJ!0]6*QYR\V3,\5(T,5=W4E%UBWD M_1A/"7WV=C*506^BA?7<83# MU=(5Z#=G6WWP'^E&;C\K7G[E'8-JPSG9$UA+>6^E=Z5=@N#P)/K6G6&-&--E+\\:)X9^5-)CL3N.Y,XC283M+9_`R7 MT._()7A##%DME=PBZ!I@ZI[8'HP7X/QR1I"*U5Y9<8&AJV&S&H[A897D\3)\ M@-+1G>;::^!WT.P5(4`',M#.)UNQ)=O:VJU<^X5#S&38R`B3O`=CQ2.,7SC$ M)/DKH.E[0%8\`OF%,2AY.2-HF?,+9\4CD%\8@Z8O@[(QR'9]`N_.VSUB@PH, MZ>S//]M7S!^>U[@W9716LU-@]D^@#8*-'0"3/!T2\D"O25W+3N?#PQ'<#NN# M-^&\;&W0,3P;_#W<:SQ\7XD1.Q^SWZZP%1\S9T=,K_',5]H(!N9_).RBCNG[ MBOJ,=Z)9Y@H>!=,\'_;G\_:CUD\BP53-/K&VU8C*C1VC,<0-J\.(O_(-,SR` M"=N3FGTCJN:=1BVK(#0*9M#ARL]H?V-D[^;<6AJ8K>YO`]]2!F,D"D!<26F> M;^Q78/@ZK_X"``#__P,`4$L#!!0`!@`(````(0"M;UR&PO=V]R:W-H965T=^4)G]'*_(DZ\_OZUU\>WW'[ MTAT1Z@U0.'HN+2IWM%%SLISY M_,%JROIL,H6PO4<#[_=UA6)M+)]2:ZAZYIFQ?7B_? M*MQ<0.*Y/M7]3RIJ&DT5YHTUH_4H+]K]-Y-_C>Z(WY/VWKW6WU& MX#;,$YF!9XQ?"#7?$0@:6UKKA,[`'ZVQ0_OR]=3_B=\S5!^./4RW#Q&1P,+= MSQAU%3@*,C/')TH5/L$`X*_1U"0UP)'R@S[?ZUU_7)GNP\P/YJX-=.,9=7U2 M$TG3J%Z['C?_,)+-I9B(PT7@>47D1D.7-X0G;V@O9@O?]QX6`71_HZ7'6\*3 MM[S-A[(KC[&@:\(3Q%EW<&!XN3#A:>=P6W MY'QXBIZ<^VRT(>'8_)/,XPEP,SR+)1#-Q[CLR_5CB]\-6.20(MVE)"7##HFL MR$1F[9";GZ4FY"11>2(R*Q,BAZSK8#V]K=W%XM%Z@S50<4ZD*-B"H2P&B6HQ@A&*))K`); M%4A4(%6!3`5R%2@F@&0$+'3)B.ME2N0"8:],6.)C+GA*@!'C\-I&IGJC(;&& M;#4DT9!40S(-R36DF")2Z!"&%#I9'RZLDR^N#R(#2PPR;31EL91G/6(D4L%' MTG(NDS8#:<@-#=EJ2*(AJ89D&I)K2#%%))]@T)I/MC\C^T%_K*N7"$-,$/Z5 MU'&A7K`J0D2H2R*VB"%T)Z:4#0/8GDA+!`,"&-A@FKUP9=.V`TD()QJ2:DBF M(;F&%`RQ';K=3XL';#RZ(;!)1)%PC8E!FFHVM"(G!%!5;,^']T*U MF*I*WL"IZ:8W]Z4049'-X0AL"$,]<;U`CG[#2=XP]3%'R/(6*\U>*,VVC.20 M@O>V#CQ?*5,)%QDS*M4ZRN[I*)<[FB^5@U8Q[4ARE1P!)5MOKT!*E_T3T)@' M&P$M1[LXY-#/)%K9MP(:68F`:'6EK%37R@1KU,H%-&H5`M(K-=F5OQ(S.RY" M*Y&D$54`&Z9)8\^5,\]&L"99(Z"Q9&\%!+5SR"374\[2B6!!Z1A8]E)9I*E@ MC3UF`AI[S`4D]Z@<3@K!^JQ'.8W(27+Z6?$?:<0.GM#%:"F'IFG$H7%28]A: MR/J5THA#(RL1K&D::5J98$W32-,J!.M*&I$SY!=B9D=.*68.3=/(]=4#(,DR M4K/&28T%-*T^KJ\L^JU@2?/L*UF:"-9G\\R7H3:(3#2\.8A8W>L400@["B29@L-]SQ.= M406/R#W0%7[DA/"QI.M$;@B?$CK^Y(5/$)/^(O)".%/K>.R'<-B\@C^$<,[2 M\2@(HVN!;8(0-G>='P?AEFXS2L#Q(MQ>XR=!"!N\KI,&87H-SX(0#CHZ/UN$ ML,D#;@T=P[W6I3R@W\OV4)\[XX3V,'ES^N70LILQ]J/G)^9GW,.-%LPO7%;` M#2:"C\[%#]+!<">Z_A<``/__`P!02P,$%``&``@````A`)4UM"DI M"```?R(``!D```!X;"]W;W)K&ULK%K;CJ-&$'V/ ME'^P_+YC&GS!:#S1FHL!)5(4;9)GQL9CM+:Q@-G9_?M47XJ^,5X[FI=E?:@^ M39\^75W0\_C;]]-Q]*ULVJH^K\;DP1F/RO.VWE7GE]7X[R_))W\\:KOBO"N. M];E7RKFZ_MH2R[$3"NX\PGIZ(ZCSE#T-S"4>_WU;:,ZNWKJ3QWG*0I MCT4'S]\>JDN+;*?M+72GHOGZ>OFTK4\7H'BNCE7W@Y&.1Z=MD+V'G<5C(#*/FK*_6K\F02Y M.QU/GAZ90/]4Y5NK_'_4'NJW35/M?J_.):@-\T1GX+FNO]+0;$N[_JM[2L7@X=3/<,1D0'%NQ^1&6[!46!YL&=4:9M?80'@']' MIXI:`Q0IOK/K6[7K#JNQZS\LB+/T%L#R7+9=4E'*\6C[VG;UZ5\>1`05)W$% M"5P%B3=_F"T[![$4;>&*_=\_"`(.XA-*K20FZ]9A3+@YF->BHBN>'IOZ;00+&*:_O10T M'9"`]H`NXY[H??>>[(#-]@&L>(_(6G>K0 M0B(+B2TDL9"-A:06DEE(KB+:T&$8'^$!2@-+#)PF1?$7AB@\B"96&42,H+`/ MZKUA(;&%)!:RL9#40C(+R55$TPD>6M/IND5H-),#!['FB,=W'V8("XDL)+:0 MQ$(V%I):2&8AN8IH`X4]1!OH_TR8E$97@"->GR9"#O"MG65##D#-(?U!EHYN MHK@/0FD3"]E82&HAF87D'"$N?4)-DL7'2$)I=$DXHDC"`442#BQ@XU*6C&]( MT@?UDEC(QD)2"\DL).?(@"2T"/^`;972Z))P9#:7-N'(0JZU!"E M#^I%$412[HU%G?:MKE!G?1!2YRJU9AVHB`9T>J`5:G>HME_7-P%A&D88M2R-U9D1\4"FL,S]^N- M^,;FGF!#EBD8_<:F3S%*/D1V$WV.#>U$1/=72S$/9!RPCZH0+P"A-4[*FC&! M:-2'?45+EOH:"C&*O06*BE5PJ0V)N=/'HJ%+/0PV<6>>40$F2+WHGVF#D.PM M1>AJ;YG>&_$==!/2FE#-9#^1DI>0P">E%!#D`"FE:VQ;(>10MHA5 M_W%(<6DLHEP9E2"DFLWB2C%*-9N@EUPY1@TXBQ:(=\C`ZTE-!@'!19'!>@,2 M47*.(R(@N>O%",VY?8C!DN!]U3P6<8I1DCA#2!![1O&9X_T!G]#*\`Z!>"&I M"20@W2?&N@B)B)*S%@E(\PF/`I^P5U%]V2;80+6,19MBE&J9:[0Y-AAP#ZS/ M>\2AX4;&%I#N'D\?6$C3%6VHND=`L0PO+.ZPCZE`UQ0A(MXZQ]89$1*G6X9!F'0$19AWB3XVDGP@:5W6/ MQ9QBE.H>G7FQ,)3/L8=$HBY5)1*0;B!CDD(BHE0#"4A.=(Q1L@A- M$%)-8W&E&"6Y,H0D5X[0@%-H'7F'##3<6$<"TIUBY,^0B"C5*1S2G"(@M1CR M7..K5R*XP"XR[Y.E(?S&[C'%AJJ#!GNTDK2(>J]'?7^GY><=DO)J55M$:4Z2T#2#3$1$*P499,TWN<2C`*#]5$#DEH]IMA0]I@A=+7''*/>ZU&3 M%#QRCZ0L7'/3/98=1[/>J2#A7V9';G>Z)KU_D(Z>8U=PZ,4LPKH+D<=XP0 M]"*5]HSU822HM'E3VF2"][S!#2>S267OZS'G6E83ZT?,"_;TFE;WOI MI.G.2+T(::;V+%.+AM)BD6@(AD'7Q0CQ3=HETYG!DV"$LDOC`TCJ%*,D=8:0 MV/\7CF.X(<<(>YN&][GKXMWT.8.Q&`F!$@.DV=3\I!-B0VF:2$":33G7W.<% M#IDZQM),D$?9S!&2U*E-G2$DJ!UW:6DG!F+O[?2SIF4\#X[)8#71+T'HN]L_ M"S%&0T=1YNL>-#;C$!M*HT0"FFO9RGJMQRC^6D\(-0;2F>2?:6(L_5 MWC*,XKW-X6A7?QV@I]/4->!76#A\E?/39GX">"J;ES(LC\=VM*U?Z4DRE!Q/ MCSW,C[ES/X!/5$!@X'#\_9D1&_@:CL59W6GB+AR7#_"LO0!.7P;XI\#/[&82 M30,XAK`;K&P,?L`7P1P!==&U_[P7IHP*$?A$-XY`9/_`"^)-KXQ@\V0WCJ!_!%U8Y/EP%\301\TG<,Q_^7XJ7\HVA>JG,[ M.I9[F%2'Y>Z&_P$!_]&)#X?/=0<'_S#O<.X+?^A1PCF<0Q?JTUVGJZN+7OWRM;YH7\JVJYKK M6C=GPT8KMU:/_?]+3",KCB7==[-FEMYA3?'IJWS'GZV)Z.[M65^H$[UQ;#F<]>H M\^JJ,X:@?8:C.1ZKHMPWQ7M=7GM&TI:7O(?Y=^?JU@FVNGB&KL[;M_?;IZ*I M;T#Q6EVJ_ALEU;6Z"-+3M6GSUPO$_=5;VR:8:Z]EUT<5 MH=2UXKWKF_IO9F1R*D9B<1)X"A((Y(&#S1W@R1U,<[:P',^GPS[P7'!/>')/ M:^8[SL+U/9CO`T=X2P.%)W?TGQO1Y8[>X/CL7&&/T2'A*6296;YC.B[1]L%< ME]P1GMQQ.?/,^=+^08PFJ,Y6D^017ZG'PAHL'VAZ[?,^WZS:YD.#/0LKWMUR M4@',@/"*Q&+3'E+M>YD&*4987@C-6@<%((DZV!Y?-K:_6!E?(*4+;K/%-J9L ML1,6)'\)[5X%0A6(5"!6@40%4A7()H`!L@S:0)[_']H0&J*-B&HK@%$L2Q%" M6`B7O0J$*A"I0*P"B0JD*I!-`$D(V+]("!N2Y7[U$3E!O-8Z[.`Q)^:^'.B6 MV?"2199\AY`]0D*$1`B)$9(@)$5(-D4D"2`,)`$IP/]RGQ`:V&J0<:,HOJ.( MPHQ(\1B-S+ELM!N,AAQ!2(B0""$Q0A*$I`C)IHBD$TQ:TNEQBA!K*H<(8LN0 M:4(@9(^0$"$10F*$)`A)$9)-$2E0."^D0%GAG)'2W9^KXFW;P.+!.M\1P(8" MR4-(9)40LF/(5"6&.$MZ M/EMS4ZD[X?!>1!%QCHE`B#49O,BI#ZR*[.GP7K!F4U9)&VB$'FKS7`H1%ED< MADPV%0,FFXH#9/.*!L94ZW(X&(E((H:PS4!W=*PR)PRPET-&I0C)IC22(*0C MDQ2Y4TTFFX>:RZ$+"`ZV(3+;1(T7&0<CI5R*XN43\BTI:E,)A,T=#!91]+B3=O<'^C(.D(XIL5* M;\F1312"W)WHJ/9MPFI<[3V'+/I]1Z4-!6320*#A5ZIW)`QHD65YA9D3834R MIP(:F)5^*Q,&N'Q#$LL2_:<#C;(H&EYB*,10A*$80PF&4@R1*Z1Q$DP+=B7$OMGKLCV5N_)RZ;2B>2?7/5!6 M-JL!9G=16W,A+J.4-YD7P.$+*BCX?AG`X8;Q9!G`:85QN.UZH;FA\&S)+=@= M^ZT5P+K?\ M5/Z6MZ?JVFF7\@AI,*=[HF7W@NQ'S]OMUZ:'^SPHR7"W`_>W)7QCSTEI.C9- M+WZ0`88;XA,?\O#R?B_P>7'[TG?HF0K) M^%#BT`LPHD/%:S9L2_SSQ\--CI%49*A)QP=:XEWRXX?%GHLGV5*J$"@, MLL2M4N/<]V75TIY(CX]T@'\:+GJBX%%L?3D*2FHSJ._\*`A2OR=LP%9A+J[1 MX$W#*GK/JUU/!V5%!.V(`O^R9:,\JO75-7(]$4^[\:;B_0@2&]8Q]6I$,>JK M^>-VX()L.JC[)9R1ZJAM'B[D>U8)+GFC/)#SK='+F@N_\$%IN:@95*!C1X(V M);X+Y^L,^\N%R><7HWLYN4>RY?M/@M5?V$`A;%@FO0`;SI\T^ECK5S#8OQC] M8!;@FT`U;4UE!H"#C18E6JG@'!N`7]4SO M#`B$O)CKGM6J+7&<>DD6Q"'@:$.E>F!:$J-J)Q7O?ULH/$A9D>@@`M>#2!B] M6R0^B,#UKTB4)V&2_M^*;\LR*=T3198+P?<(=AX8ER/1^SB<@_+;L4`>FKW3 ML!D"%4M8RN?E+`X7_C/D7QV8U243N<3Z#2(Y(3[X.IF#O*XWI^$2SS`ZF8NR MV4G7%+"RC%UG7=%Z\L*9&:*X?F8-P[YP9L[.9K9,84)+"N@!@0NL'2"/IX#C M#`J\WIF&SYWE[L0KRZ3&65J$TXE-:&L'R(HIX#B#\W"],PV?.RO.G%G&.LMG MZ71BZVP*I+$#.,[2]SC3L.OL8H];Q!J+PLB)Q#J;$F%>Y%/OCK7,M:;;4PQ- M[M_G4`]R+<[BLU.VLHS=<)F[GZS%*9"'R:5#VU-MMQC)EGXE8LL&B3K:@,O` MRR!^83NJ?5!\--UAPQ5T0G/;PH>/PD$+/(`;SM7Q0??LTZ=T^0<``/__`P!0 M2P,$%``&``@````A`"1_"+QK!0``#18``!D```!X;"]W;W)K&ULE)A=CZI($(;O-]G_0+@?D081C'HR0F;W)'N2S68_KA%;)2.T M`6:<^?=;1372W3@>O!G'\NWRH;H^VEY^^RA.UCNOZER4*]N=3&V+EYG8Y>5A M9?_S]\M3:%MUDY:[]"1*OK(_>6U_6__ZR_(BJM?ZR'EC@8>R7MG'ICDO'*?. MCKQ(ZXDX\Q(^V8NJ2!MX6QV<^ESQ=-BFR,NR*M7M_.3YDHSN!BFY_RYK-U:EM%MOA^ M*$65;D_PW!^NGV:=[_;-P'V19Y6HQ;Z9@#N'0(?/'#F1`Y[6RUT.3X!AMRJ^ M7]G/[B)AD>VLEVV`_LWYI5;^M^JCN/Q6Y;L_\I)#M&&?<`>V0KRB]/L.3;#8 M&:Q^:7?@S\K:\7WZ=FK^$I??>7XX-K#=,W@B?+#%[C/A=081!3<3-D-/F3@! M`/RUBAQ3`R*2?K2OEWS7'%>V%TQF\ZGG@MS:\KIYR=&E;65O=2.*_TCD2E?D MA$DG'M#+S]G#3GSI!%Y[)RRPN MP',7'GJ8:\"^BA<$"IT\HY>5#34#H:AAD]_7ON#<4Z&POG1IA($[1L;C`DH\\5 M,L6@D06/D*%8)_.]P"`C#9%YWM0?LI%"85,,&MO\$384F\EE1HTT_3?'IB%1 M#!H*3DZEH]Q/+A2;80J-,)&&PL2"X$9RD:*'3;0E(=-V78.-'H%%L0D;&;"D MD=DV=X=;J@I\#8QZ'GW>/HM&ZD+/&!_75FVP^D9-;J2HCUL\L"2J1>?!YCQZ MGUUJY5#T2D,SST/]6^UJ+#+FT<8EDW^15+B4JL+9KY=XBQ:8\G MIA:O$ON>6=PNB63!A,'L!C%)5&)M482-L\]M/<;8S,<34^O7B/U!5BCS08;4 MM"1XPH16T2+K/-C`Q_-0NX>GO56!+5HO-@AQ[/0_W\)UNH M-'VYA:8E<16+QL,>&@RM6A\,P\8G1524V/64\B(^J5!J\MX:G?>AP<%H`JC[ MR2(SY:1(MCT?IV[?#R3P8)+HB[Q0F]4Z\4.CA0U'R[#M21$1>]AQ!\#D1HVP M.EE\]^LVS2!:XS.T5>L9X?N#"*-+;&AJ41N_`F+I247NED&9ZR'%#CZZB!CU M>S4)?-\\34M1_^WQP)*H%IT'&_9X'FKO]XL:?Y1W,T#FH&E)5(W.@PU[/`^U M=S4^-XJ:1)1R43@\>L9,F1(M<2(MP^6U4$CI]HWNE0I>'7C,3Z?:RL0; MWJPQ^.E]M5YO_9X9WL@8]HV[@%L@;!;7#^`R[IP>^(^T.N1E;9WX'EQ.)W.H MI8JN\^A-(\[M;=96-'`-U_Y[A&M7#AWPX]]QKF]7]2]LXSX0+RKJUBV:^ZY"N8"7M]FOW MS^_'NX7K"(F[$C>L(VOWE0CW?O/YT^K(^).H"9$.,'1B[=92]JGGB:(F+18S MUI,.(A7C+98PY'M/])S@4B]J&R_P_<1K,>U%Y8;\_&,-]KJ'$N\67%V=*!](7O18[494`K$;WL+IBKL@P+K)6"; M@'YXWD318N4]0Q&+$V9K,+`%!TQ@([(W$+$-R:\A"W^`>"!]T`]U&>M7/1)" MI[V?AUIDYQ%$`[U.=6L@"]T+*O=L.I&/)BQ%4.2QHO>5*/#:!>,'MT)_XM?6 M8$R':RG3B7PT84D!WK&4V\Q1B\!$2]*D/EN#6>H6"*)E:)N76>'E8M(BN0GK MA"RYL"O'"7 M_:*MP<1:)IP)=C0;1Z-XZN4YJ@[2\;Z8?T2D`MLB$9IZ:3"FY%$27+:CWB_9 M.!PG:&XG`=>$>H-9'0:+B]5&M+D#S,'4$KXG&6D:X13LH,[W$)P99LW5LT4I M;%%(>C*?H11VZO5\#E>5GO>&!7!5]'A/?F"^IYUP&E+!J_S9',K.S65C!I+U M^JS8,0F7A/Y;PS!ZH*PU?&YC\```#__P,`4$L#!!0`!@`( M````(0",Z2RA20P``#UP```-````>&PO:&.2WL.%EILSEE)TJD7!09,#.^-38Q9F_F3OGOJ6J_5>.W MMFGHNT.W`X:N>NJIZNKJ;K_^/ MUM5$U_:1[:]M+_"=F?[J[/5O[W_[F[M]].HYGYX=)])`A+^?Z<]1M+OM]?:K M9V=K[Z^#G>/#-YL@W-H1?`R?>OM=Z-CK/3;:>CVCW[_I;6W7UV,)M]N5B)"M M'7X^[*Y6P79G1^[2]=SHEWJ]OV3'X3VT@.H+P/37J6RV8>"^*V["H-] ML(FN05POV&SU->R#I_LX_;*UMM-=6P<&/9KJ1'=+B;]ZO9_J-KL4F M+X(U@/C#?P]!],WOXC]O_OCF3?\_7W_SK[\YZW]__U7QN^^_UGNI&B(3?%`O M\[I?*Q:^CB7W$@ON[S:!3PP9`$W(UNUG/_C1M_`["`8P#W]V?[?_2?MB>W!D M@/!6@1>$6@1>!OO8$=_>.O$O%K;G+D,7?[:QMZ[W&A\V\``+C.1W6Q?@!V.+DLNM!U:_KWV,+7)>+D MP@.:5(]!`1>]]=PG/QYN]X<=5'2KT-U%R%Q*[_BZ./ZPGBDK=5;Y\IS4LJ3% M#7.23&*5R1[&?-?SLI)O.,*B"([DH6^'>%+LE`+_EM(XS3IKZ8LD)D\+7)QXM2_'D^GT\G@ M9C*93,WAP#09R21E,1P0@03(>3Z8T!0/KFA*FZ*((A`!B/ M1I/18&J8\#_+6^='()O3D:[:JP2!(J\2!(J\RH;!GH3,G_046,90W%<)`D5> M)0@4>74L.0./E7N5(%#D58)`D5?9BI/$O@K+@XK[*D&@R*L$@2*O2BL^DPP\ M5>Y5@D"15PF"2WLUG58M'AXLMOY0K,RDU<>)+BSBV^MBLT:8IRZ#<`VS_G1S M8G`#<\3XV/V=YVPBF)&&[M,S_HV"'?R[#*((=CWN[]:N_13XM@=O>VF+]&]- M2]@7@BV@F1X]NZO/H(R;A,?B;.)LRQV1^;(^,FGK!)4KUUUNYA M6[0NTUT:ET`CSOM;Q4BZ0`"^) MF,8V13X;FY0PVMA&E-.4/,@OA;XQ-_#%JN,22QM:%.UL:%!B94,+41OYN"FU M.%NZP/1<@N2(;^[GW6"`HK@AP4,R?)*>;DQ\,1=T4R,JO<1F8/\,@,3LQ@V0 M>`M$N-=6>KEH!)%.[`8!)P[21U&2^)!H.X,/B71B2ZW;29,Z0$F9`E7/RO&\ M3UB'_'.3E3ZPFGA_][(A)U#`62UXA@&>GX%O81N7.?$'(+FJD5'92+-W M.^_UXV&[=$*+G>K"5+"CN#60?YJS^BS_S/9KM@Y;#]5C,=^%0>2L(G8J#ML? MJL(SK,`#YW$(XSE%OUFA'WBZB'Y8;RMU(O"B5#\$E[!^F?&`)QTE00TNH$%= MATX$9(11@`CY)>D=<) M`V[$N"`-!(*J#$FBP5"5(BD&53DR=X6A*D42"*HR)/6$JA1),:C*D<05JE(D M@0",*,F0U!.J4B3%H"I'YJX8JDJ1!(*J#$D\,3QSBNS19=-X$96LGX['G=9/ MM9=-XT(J[$IGJP?'KDZ;Q[.G>.8(OF!S*3*5QLO2;#S7'==.M><@='^"229> MGK:"`TZHX^6,D;NB1WX,[=VC\P)3T7B[[65SM-;+9I?)"K$X1G[9-\5Z6>3` M8O/2=N::!C9SYF#!7M<::2/*Q5D3Y.<$+`@K60J$MUQJYX.L,JP:+<<5H<8= MA2/:R\.E.P8:M,(FRP9QSA"0U+DQYZCV%0SORC$05PF'2V5T*NV>-#!P_Y_M M0A>2>KF]P^/:GT\)\:IQFLO/;+X<+(W)ZIQ$%%S1:M0@<2B'"PJ'G>?1;A0[ M*Y[6D7H\0U09J5*P=(U4*TA\CILGFU4MQ^.N``KZ*PVF_J[N%^4<-^2/#CVS0Z:X2`_HF.^YH.CF MD[0/RD!P0EC2,)$*"3J$E)[2/`:2&*9S_*9R#5(+KK8DBSELTSO])-2INH0T M65PZ-SS!`H*0AV_+%B5PQ[BC*Z4$-PS2OT[UM&^U3<'@C'Q0'72GX`RSX!/B M@3(B-=MT#U$Y!/$C9I$A?L@4+AHH7R=UZ`O@ZY`/2<9I2H=B^;G&F1K>M"%. M^2V*+Q[6`&8L?"JZG%]%9C!%?")3F$[1>)JWN>P&'WA2*X=?.>Z57EC6P/IE MA9H2ITG+81V#ANJ72$`QQW?J1R=E=8X128`Z4%39H8J0^,6*3HQ)K1NZ%U8T MK$Z$Q`_.A73(CS%=DF-3%E+BP"90P$/Y=*2[S_A$W1F`K&*S!8"C.J2`@(^1 M3OWJI$QT`7P=$A,)(;Z/%0NERQ%84A8*9ODT6X(),ST)2JKXAQSOIB,(3(0LNM5VVXZEN>MRGY8%N?L?%!F:SB^X+G*J\,>[O,SCP\F9Y?6R^Y$@]V:9']EU.(0O,%D$%Y65^Q''?"(+3&XK*_"L4IEY7[D8Q5-;HLK]R-()7R9\$5;6;D?^3QA"N8):F/N1Y[[D2#WQQF5 MCWA#,.)C*;GOX!WA""?+(AS%4G*O\5$^%(SR6$KN+SZ^3<'XCJ7DG@)YQ"(3 MOA"W*//1D&?7%&1W;J_3K,L'#(XS(C#@(4"K@P M@@$?10#]&1Z$!<_8TH"79!#G",(S+=J(R?H"3P]>%=Y&#+2.T?#QA]?OMA$# MK6,Q?%+%^DE$S'M_=\@\Q.=2'+I%1'QP_<_.FH\"^Q:FG9@3@;!$<#P&<'%6)N(HHPC*^(<=^MA;N*Y[%*,5%N67ND'UOW[) M[Q+&>(_P47'L_F'9?`"(6CL;^^!%C]F7,SU__Q=V1U`(IN17W[E?@HB)F.GY M^P]XJU7HQ;!^`^GFPQYNWPE_M4/HSO2?'^;CZ;L'R[B:].>3*W/HC*ZFH_F[ MJY&YF+][9TW[1G_Q/Z`,GZMW"P]F.^&Y=>SY>G"QV\"\W7OP=+LP,38!_RD_ M-M/)AQ@^NZP"8,/IG*D1O7WVW+_[_P,``/__`P!02P,$%``&``@````A``+L MA51N+P``4YP``!0```!X;"]S:&%R9613=')I;F=S+GAM;.Q]VVX;V;GF_0#S M#@N&,Z$!2M;1EKL[WJ`HRF9:IY"4>WJ"N2B1):FZ*1935;2L8"[R#G.U@0S@ M)YB'\*/D2>;[_G6HXEI5).UD9^\-#'9V8K%6K>-_^/[3JA_^Y=/#5'V,LSQ) M9[][MKN]\TS%LW$Z269WOWMV/3K=.GJF\B*:3:)I.HM_]^PISI_]R]O_^E]^ MR/-"X=U9_KMG]T4Q_^[ERWQ\'S]$^78ZCV=XZ;&Z6)68-R#G3?/U&*6_&D1=_5/!Z]?/7O[0YZ\_:%X M>Y*.%P_QK%"8A^K-BJ1X4OV9'@#S_N%E\?:'EVRJF^^K\W16W.=H.HDG_M/S M*-M6^[MMM;>S>^@_7#.2^F/G)B^R:%S\3_]-,ZU!?)>P!29[$3W$?JL/G>'E M>>^DW^VIB,7=I%BQ^^!!-,;PJ^^^F M#_-H%C0TO>'I0XI5%^GXU[8:WD=9G*O+12%TC>GYRW!$4-W=4]!@,%V_Y56< M)>E$U;;]PV[C.*.G>7!JNSM;?_!?Z(`))L((I].H>=IF%DWTT+V\..E=#'LG M"O\:7I[U3SHC_''<.>M<='MJ^+[7&PU5ZWH6+29)$4]>X-_#$_7\A3^=_DR- M[M-%#J[,V^#>:9SG*BWNX^PQR6.5S^-Q!KE]R(%QOQ'_*=%\C&:QK,B.)GA/4AOJXBS!Y7,/L9YP6T+6G7&(H!R MZ5)FKK)X'*/3&RRFK69QH=);/%6@N/0QFHUC!;&C)NGBIKA=3%54[6`,.DMR M2E(537Y9F#'9P?.#]OZK7145"M)G?._$CXR+AX>OY2$V)GZX`64;\11LSJ"< MG)HL,)A+?QA`F$\AB-_WX$V1X M'M#D51;/HV2BS./JMHV-0(KR/`[W>906D%*KVUP-+J]Z@]'/JG-QHGI_N.Y? MG8,.RC,80P?1$HO2GAN?98NGPZHA3[7;O=2/\$&1+G%!H`B6Z<_V7L,L9Y<7[[9& MO<&Y6G$F_LK],[FD"%3`2W=:`*T83T]LHZ;=R_/S_H@\,106@?`>]2_>]2ZZ M(!O5NK@<]=1%(*._?/[RV9_?<'39_?']Y=E);S#\K;#:Z&>_#5C=B(5S5+IO9G"$32)Y%;6JK< MD%?;TF0MBQI=7DYJ>59[AS*GIGGMOGK5/D"3_=<[,IS\O7\H?YMEV/G6BNI@ M>FW0'?5$<01EBQ_[[V6O\T`*W>A?A.61_&/JC.! MFH8DA(2E=-Y*9FH:[K)F]\`C*Z`)6%JQ$4"&+XA4(H_C>-YH7&HFD1%]#78R>D#82@1 M-$N(Y=MQBK_C3?H8D*=6$0?O^Q+$"0_5`HE.TNDTRJ`.("J%,P+1%8B@0-!( M1_K7C=\V_,TI?.6;5<9=\?JRA/K:12^__54KKGUU_7)K7]MPK0U\O^I<&IAL M.((1HI7;Y:DB$NR,^C!/C*H[OQKTWL-HZ7_HJ;/+X3>8)X;K8!M](^=5_08U MP%PP4("]N+DX`DCGX%$/QLMI;>AVKJ$&($Y`%># M1;G^?@[A_L#SMKJ+9V@+TPWJ.9H\)#/QUU"!^Z\,XAQ^%9AK;#H!RIVFLG2_ MG=Y\N+W63*&*AX2/#H3,>N?QY:ZB?)DK`\_ MF2YH8F^FN'["M._9/()C-;J+EX:!AZ2$P9N.V:"I-I*E=6A_$^\.MM%YS=0? MS\4Q$7@]G0(8TDIH;%:!J%<&HG8U1&U^I0(S8'`1JV[45K/1,@T8NFUUJR`"XVMH?@?S(6".50NX5_[U`L!:.R@=NJ4"@)_[ MCP,`)7@4L\VP+Q:[<"/4'"W6]IVK65HH@TSH3HL?YM/T*8Y%LECD_N2/U_L49V,Z%KE2(;=T3ED02-+& MAJMF1GFE162#6&D@B``*V'8K"*+Q'6T<.<(Y]+>@H>\J-`G>V4A(=#O#]^KT M[/*GC9!5E\[76SA$<^V!+%4?(B/)QUI_4J?B$15WS3B=C1%%$!\KA;3"K_2W MBF<76OYC,@$!WCRI37H_J7H$1;,_,/3PYUK"%?$OKM/$:E-PWR\I_D(H;%8L ML@`*7'$^XMDEO7Z-^]<_PD:ND5EG4'%W<:VONGO/1SD%165'Q*\H.LKR#;Q: MW_F#KK8:_=9:A*[VUNHV]=Y>LM(WG:)/5]IS3U373%=71OY!K]Z*1T"C4^YF MGMX6D)KA859?R3<*%`SB"824]3=O]H[;A@4E*8YMD^7X6W";S*"&5F_!27RC MQ:DH+,+H0"0&<]FDW][M+3Q;LJ^?QD)]"@@W5I,$#X#K88U!]/?VO%_A-B?RAXU_^0>__A\Y9#ZY.GS9E?^H&@_OY M!K'7V8Q[!5(`O$,H[FM>1VRM^<7A]=75F1BHG3-UTA]V885>#WH*QJI,N7]Q M>CDX%YO5']-!=GKGPH?`H*+XQ#4>-E@:>-A]WSNY/I-A+RXOMLS0'WI#NH+% M5C[M7R",)W]U1_T/M4$%`^UR[;BM*&+@9@GP3!(XE1`S@I/M-@[M@,O!N\Y% M_W_(:F70*X0.N16EW>ZO`;V/$$*"K/K[Q?1)[;XY>KW]Y;.ZUI%-6%%`\M`8 MGPJ5DT`#KCF=WZ%Y$UB3.88*)W8Q!%[>0PXO, M_)G]"K]TJ?$\Z' M_[G"?\%8*CI36GR0'[][AB[AY1UGR;QX]A*I'7_6/[_>/N2?XW2*O<"1/"`I M99>_9*Y)/\Q2B?4/,/[3C#^^E`D4;[_\WV!6 M=MQ=&>3?9M@7*G_*B_@A;]/FQ-8QK+G(Z.O`J<22<5'$X_L9%GV'F!C.>G[_ M!.,T@4$L^W^?YN+Q!XJZS]+%'<+R!7<'M,L0OB1@@%J%'F#OQE,*=D$_,X%( M."4\E*O=FD2WX=X89:5-(GHLFESMB[8@V<' MC=W?+C),,E,KAW%=F8R)HS8I\!=2-PX&WKMI@BZ8!@(<);2TP)SA^(&LP734 M.,D0S6`B$,$,V:/:EA1$1AI'@'#"E)C.+5H8_2"K>[WM9(;+01.MPYU<]7_< MY2$B03KE`WN!G#0>BZ6R:"PZ!NE$45XH>#\?0<\]6BP0"CFF>Y8\"'.W3H42 M(W63/T6%`;4[EER&V-H$>PD.C5RTDB=%9-MV;GC)/V$-8&F%IHPN^FV M?MKB(_`*>-K%2M$K3^@39J9UE`@XJFCI;$G;X`#F+E%!'O-5/1V1!Q.AY)N% MG#",R,`P6I3CGW$""&04U>M='`$QH9"S^%ZZ1 M>BEK]+DO4K4D0%(&:)HJH7JN%0E=E4;YDJBB`KJE\%PAE+ZO`@[U;IK>X.RZ M@%3;=@EZ:$//(AXMF3GB^EY6S_D;@*:&D$0\1ZLO"-4P43SFYNC]E9?&:9HA M3Q6;*,KR/RBF8)+L=_D\&@.GB"K(/L;/`#24DQH6__PSD`8E:C1_*ND5F_N( MR`C)1*"LLL=0!GJ,2,")U$BZXBVD6`<"2>"DD>;FQ,&B$%8X-P"-%$>F2K4M MNKE[CQ29/U'/70U_W-)J6@W'R1:E"[2$"[B`JK;;1I2@Z0O2IGNY+;(+0722 M^11IQNRP%!\0UF@-O,GGLG:#M^"98&A:EHV0E4"LX/PQ_5N38@2JF+ M'R'3+`_=:?K7*`I3@"*BCB=O1Y./U"\B.+VYE"**LFA4D?XBI0_>;+_YC57B M2PXJ*\PULV1E>%I@;>3X*GGL06(`LFK.G!TP[EH+`[0V`.`VEAK]:'@9^!HX_+!/XP4D1.P M*9(V?$H8`IPFI)+`^2QG(SVUC821PQ+!K"T;?3Q)KI"#6"1/S+=>V@#0`?*# M(6]+,PHR-/X$Q<09XUF!'4&J@T5MQKT&VX23PA[#TQF(<71Q$]]'TULMC=]W M16/!3?IH]`&5.=XM97I;.EG:4BV303!+@A3:G]!2N*8"@OLC)QL\TA%,0V9? MW&$Q)"Z/?AQ>H2&,HR4_5F)=)CHA*XEG(G3JP0)@-Y^"MZ8ICE?DA_II\2FI M<+K8.!7K(]@'>4&AJP*)[@VHQ#Q]P4TU@U8WRKZ5]DU1;H$GRGZ&8C(/*H8FQ(;7Y;)`J*@+LT#= M&VD;`L"^JPFC5!W'G6%_2#??U:`WA'.V]/]U!_`SHJ9%=;K=RVO)2U57J"Q@ M:NH_II=USL%CV!/_H/DAZB]'?$4]95T0/-9K'7OL0:2CLBETBU)](SM.6ULB M]2%CF4'V^I= MIW/U[(4P$0+)^8)U2Q!>(N3*H;AXF%ACA.FHB+,%!^6/\%2%\OQ&"Y&*1E\3$9KE\M; MV!J5+Y^ISS;=ZU4[[+9%E2=2]@VS.871S1VN[E>^`&"MW99MQ=@;[92[*4P] M;"R(J.QO/5T@UK28`AU0%D5RKGAG!JG&+!BA"3DL7:JS`9WI8]-U%#-)R,?[ M68Q#UY"HW%R(/.O&K6&#A M0N`BUCLI)XS3IT,%D6OLG/43;1,!8W^^\5C-`JK4Z\A2.\B1')ZI6V+^2($1JG@``90%D2ZM,*B=1ME-!I7!%;Z$V\O`G+A')`5ZOY MG)M)]MP]1/N*9V0[Z&!T`0W(\C;J(9".&YX.]F3&\`JSZ+AC=BPQ!>CD M`;UBOK8_;6EZO1K/**JJIHK4Y,'/XBUHP\A&D3@0H=\"2V0F1'I<"B)0VM-K"AZH#@6*M.Q<'FU M$HH7PUIC80I_*R6_C<(U^962D;V1;D$C4%2$I7#@!S/`?G#.:+BQ@*20X#M+ ME"[20GNKFO;`)IBVY@,+'L9ZY?%1!SR]HA+\5F2FIZC>:)B&L4$$F+(-,\< M4@C.$_A*D*%R)UF)UA-38K,APW3(DJ,"I\8Q(.$*H&,,J>>#L`M(?G5LI\J_ M0.3P`E=ARJE./<"&#!E,$)AB#6>0OB&KOULW&*F-XX`9^P#_"3)^-,-(Z-&L MB91H@8]9DUJ8O`HA)@%-3C#PIZ\@^$#6#$Q-&RFPIXLAH?[&*399%"\E&<>H MQ=Y#;>/[>SY">WOTD.WLZ\_8=F@F"XP,^W!KZ52N[=R`<]7*X1268^S"^8+R M'/(3`)S$GF(F3Y$PL9/TNY5I1:!:$#IHV[A"@'*8^HO7D=`A6D4+&:!+O`X@ M?)M\PF%CN1,:8@RCH`I1"'Z,L!_DNG;,0P/0@PP_+AL`B$)Z0D5IMPEU.D]# M]D[SW83Q.P@9B9[!QM-+X):**3)](JF7/D@W2]"!!K@0R'+("^M802B$&T=" MJ2)F-G*A,Z[`08)<[";GD^142?\8%,*48,V*(91(3F75I97DWM+Z!8[RBH7% M66B7GZ5DY_[1T[>>`\ZM7"/%$>DBFU"Q8)LTR7-;;4FR[/O$5N95R$6VHE;` M?_D,M[P,*-[<86:]L@CX1QQV4MS@>36B&?8`H2?IZ M^:ABSNR9J1.>HPL:((DD6),>_ M6\"\LSQ72BM*BH^V`3^5%B5\AYP"F%;D MIT[.QPZ7LM0.R#V50!W8-8*WH7;53_#N]GLO`JEX5I8+"Z7JK11:Q=_4TR3X MKII7_\G/_!UW\H4%A_;,*3O4;K%X'P]HK)CN2 MB"5\=;R$11N%C6O6LT3,%A0D-53!3';W@YSF8'M:NP='_HN#&&0%3RT1A+@H M_`;6]0#YM=RP8OH_1!-$8I%O`\L'MI4Q@`SJQ^\@=EH:I6%+FPW,9IL:8I<) M!.0R[+UCR9L:]*XN!RZ##PG;7?QJ"N#\26_RSCIG61<9,_];;=+3\N@2`JC* MOX])_*C1JPN`"_TS8&V`2BYC43JM@C,:=`0>T=+:J+@E(<$XAU7=50/0.E3` M"02^U3)L(HH53&Y.#P#&)L%!R**RVZ)=6*=P9$S%U6]0:E5::064)U"/(MXK M7MH`,>A@#E<2+)OBQHZ/_9Q\0Q+>_T^PJ^3U-40;3`8)[S,!,&2FHM@8U4Q% M&RN^@C MY)UE_KN$(-0RU3)&^1S6A"3S:5T.]9]-U)\0C\86$QTP;HC5:,$"@>)RIK2# M!R'>V/F@`!\FN.=%ZBYHLF=D#&YLE><0P\<;J/D9(VT$[J?+6PC\.",.D,0> MK/F7Q:SB+T5`%SV51CF<%YL#6.%$MVJH`ILP%$,_$&%HD0R(K+M00Z60A MN('!@&_`GCH^"CT41QC.S)[SNL0V,<4+MI[`+IW13<.L0,X?,J4$[.+%%T!/!:)2A%F1A#`'I)0K_\=\D+%M1J+"(* M04-5>@[%.61L%*TLM"%$&L32#71C7I&D:FOHC`P65.,^&K:`X<1W9CQOD)D] M1`,HM,EC7`OUV)$@G71EMX!T!E\:'9;@>QGJN[I4OF7UB/SA2L*?_TQC/PQD M!OOR&2/&C&@")7WY[`"2I&VH%>A*%)_?^\#":F%+_^FPWB/A%(_?'MS<\(H[ M!_^5;L4>\9\--+(#,_"^JE+:&ML]\$YM^1T8>>,XKZ%$K_4JA(JM_<,`/K;V MC_;](5I[1Z_\WSK6`J>PUW*YM,5!XD"MRZ\(0+)$H!\QU&^B_0DRS?\925YU MV'U9TM;1(C%;+3$>K,3Z7SZO)KT6+@HZVEO>IN)MZW`_N`Z/+=_L^"U/#6OJ M+,AZFT*S#`])9Z4LNV.,'P6RA)QW].HW(DZ/CGY#=61DQ')NJA9DSP^V]Q0< M)4@4A?<5;Q[^QCR`!EMZ\F8?3]"9\]C4T@O+@CTN9[NJ36?F3QC)"!_O%`J, M!KG^`O=CX/:^\_/+"]S7UQGT_%VK;;3.+#@1R5S[JM__E\_'4APOA9M4I]"' M.!N=XT/IB;_G4C(/-8!@#DM(H+'F<[BCK>:QK["4UU0]0\>XLD_*XT=32;]E M*^EG2%+':-AK^[:N8:KF&1GY:BPPJH@34[Y?/UL3E=/(8@Y7.'PST113T1ED M4`PX."!#A!]2%*4#A#!O'__0$!^4H44#@`84-K/UH5:EJ,J;I)39V("C^%3Q M"JM>+#C36\C]"$Y]A-W03@=QJL@>.E>*=B)S^Z4LFBY%(!JL@VO"Y,W`)G-$ MA#!W5Y^1*`SNJ"P84W''Q7.5&C&KLM!;*25\P]YGPIM8I\USI-A5$N(OQ"C% MYR^P[M%&MQ&X2+;TGG^,@^4W2P&?,AV'^0^&JTK&NX9\I8WD<`5*Z;33'R#G M[^RZI\Y1P8CB/[FNQA^FH=DZWNL)[S6\[(]!8L",YXC.RR&BR`%@B^4NW&P8 M&KI669Q-G6%7'>WMH/N_GC(\_$$2,<_EOBX=TQ%Q>.+2.UB;)H4RYDW6RI") MKAD>4.9'Y+VR,^)F<J!ISQZPUIR:U)G_B6&U5X^R5:H. MP39RQ<!-W&%=,>=]MC.>0)!Q1`UR`3B8-&- MK;@R!R,FF@&\9AAL#R!EN6\0C6`[1[`E`P4J(2CHMA@C_%^?5OZP@$2;J"MN M6$#3V#R$7*%G_+"P:^GJ6-79F7]H.7CG74Q!]:SLS_L7XCI%2Y M*HNUQ83#P+9#6<9/EC1A-4YR7DYA)#2>BU5$>"#_J/023+1*+/[$A'P=P0FY MD3VK).KWC\G1KFN<)0TM&PHD,QL?@68RH""WTR)6$,W*TAM38VLLWT"XFZ1! M?=>7ODMUT.OV4`*N;UQ%W;B_L`U>62=Q3T7B;M"1/W:-3(`\DAP&%NJ5,@'9 M<;BS10=!EC=]'5#\=L$PRNBPKE@I_NQ/(+"U&68N70GXJ+/^JF._TW$9PZ[D M*OFM6G(+7^8ZB._#Z!0\=5=T&V@VLH.2CPL!,Z MJDT-UC%N^]+)RS[`>]`W9`NOQI&4#O^:+28L%T;^I>,-7`E1:'`F'`8Z4X\] M29\ZAIU+E%GTDYDZKGM$E!+N*1;CL75Y6D3.XFY"8%8N7`AY9?WA".HTJ9;E MI$F:>@/IPV3^ZD3NYY(]8NB.=.J@("6OCC,VI0G(FQL MFV<49525DJ=I!+KH)`>F3!"C.F8`Y#8ZF?_$! M89O+`7*>VZI&9OG/UPFH=R*@_+>6&44<#GWOAF^B"LHCE)7`20$;@[F%_)$; MZ=",P105_X3U3;RBZQS9'6`NO/&/+;"'@TROH&;@2!P.D(DS&0I#^A#)5$#D0.610\/N7=@_?@P[LTG01/.YMZ"WBJEB?X50T6 M-J-32P%BO/'V2Y15D$&AH1'2*@#;#=D(CS]_?;0OMR:SR?.CW4.YWIF=-'LB M['7I<@6(UMN5F]*7";5XN[KU.F9X+\RPNH]@1&RK"(GH#G5J=P#JD$7/]W$C M\4&YU'W\VU.'D2'@NQ[2-=<\B/( MN:CP)B$M%RF+3H,,-)Q-*I+E2YZ93:B@PU5VM+6&8.Q@<`D"@+!*UQ9\-R9=1% M8(@M1S1-5FS;E?2E7QNA_E7?]>&OLEMWN1/I)\`P M<(>4R`JIJ?P\R!2FM;:ZXAE3+I'@HN=_RT@EL]RAH)=DK(:I[@A=[IS&/Y@' MG"3/=U_+[?M"8L\/7HGT@MDAB_T:%]W2R/XY5S]JL4XZ]T4Z5]\(>L,.P:L3 ML!//QT$2"@6/>W+3TSOR_Q%CG_8$V*YDGOM#<8X'0&/4#RZR`Z MXC]?M^$_;BG_%7].(VI/,=G$K"%95Q6+G^8*.;]:BY+"66;5P-/^\([H33SK MRV>P$A(QUMV'9R_F#=6XZ]%=[6-L:M(&Q"#B'(V32&9;MC'YET*3`:#&]JYQ MF:?>W'F%K6V`W^]X8+/KQ2%M6@4^U-9>30QR;^^UWULKR"S$FT&CO8/PI_91 M&,]L[;5?A^X.M]MFLN0S>"X([6!PUEQD>`8X_YU-5Y,;;>"%]F=PYCY!X]/? MVOX'O3-^%6SKJL-/,B$9\6+8P7V"N)'?'Z2YY1JV^O+Y3`19"&89(P7Z1G(Y[`Y'G@RQ0O'`< MCW^5N;EIJO\6/O](?XY%0'[/S`15,5KC,S/II)4\(;W/:%:C@G%AT METWJE+".K&/!VF_%:`DSBYP[3@:NA&%#]\CRQ21P%6/Q$CQA`0I3QDI/'.]; M6;KNA`NGB#7[4$;:N4',9M->:\G+Q!'R?=X9IPO-Z*B")PM5)O>I5*1T?)@! M4+:\FX=B_XI)Z+ZSQDXY'+O3=?L5*<\+1P2<)85&>)5G8EK(78.2C!4=)F"6-= M&C_<(=A)4J`W>(U`W1[H@]7H"I>\!$[87OV#J^3`L/O!UE>!\W_N?_LG*H!I%.0G^,T,&>X=A MCM)N>S"RG=YDNXK)*BK(^J7X"YYDOS^J%=@]5Z,GD[#S?FO^<]F5J' MHX)ON9[:QJ5FN%+`NM)QI$AH3I#\#AUNL9$.P-RE\+1#8TEK[>UFHPBI>K/D M8?&@RAPQ_4*50"4B0N9E?1WO2=5XB[\(G,_+`10(,G$7>16UX>M M_-35B:Y'?MF%(!GWR_=6?_4=$X1G0*PGX^?1EQ,[88\H'KGGE39>F3D@&5TJ1JH@Y(]< MM8*K?_!=-1/D8RH>2%2^VHTE5)]$$_VU'8I#L*R[\O-0SK/*LS2LTWD*XA<"&\FT_N>M&JP>E!K+A,TC#5.?;8<5\C2(.6!PG)3DO_C?<< M^X%V:!AV*W4)^&R]?$T#,QNZ*RT"@;JT.BW9J\LS(NEP:V>?(@FU]/-IA3^N M-)S78`B3/.''.?JX#4%JB21^@[Q%:_];ER&7,O?>G(2?]:#-6)H(6*JYE@,W MI^"R2?`I%(;IAD2&_!()//$UCK`4Y&`,+P)5@NX*:J>%YC>7`B)E/:1;3L/Z MAJ$:(Z$=B"I@-8H4[=3'#"J1)WLZ9G2:H7-=SD-SQIJAQL]K49H[N6^F=P-N M#@-ZYUT'CE3L>)9TOGP66M*THS<4&@5Q54-IMPNY?G3I>"A!2H8VR_WR^>N) M[=ONK,.EJ.82E"`=\%L['#'1,OR8WA"?2YC@OC&V@!H'_":EQ:K5-*0I MU2J9M5\QERDV3&U2X",>_E.*O&H+)!I7TP%7VK1VRC=62>A4]!XTA$W3QS5Y M^J8"83\"253HB?ZC"#'E"SU;1W$%X3VL,S9/ZW/4FR>GXW$F&QP.S@*7S=LD M<=^`VR!5LGF@:B65=CT-W*TFP3GZ.4^-W2YE/EV@8`^[-3"93_[T5^>.-`Y1 M90!XF>TGN+PL!P[\SN1?^`./!#7]_8D5U9E8[YU+5*A/0:Y&9#=:H>ZWOK,- M@Y>-;%V1)#;25[E0Q-\U/^#6./W*H;@HRL`4'/J=UKD&&SL^ME\=Z?!##,;Q M=H7/SXH+KR*3_%%XX/\9G($;?$R)7ZA$/MDT5`S&V/77/K1?&GH*GA"M^#]> M5.JY("B7OET"T**-,M[;4+E>J;P+"M\<(IA@`3_$I]Q\M6SLBZ6U7`UX4GYE MI>]]9:5YTZH,2"SGN8"_#PHE;X M'Z;R[='B:[##$_4\Z'=W3YUC.KC#I4<+QI\MS`SWI6?5V4%5\N)#[;P)D%-U=5V(!Y3& MU?5OOMZ,+:@G09_(E@DFJDXA%?,/1F,,\$J303ZJNT(Z-V5$D(3P+XLZ\UT M5:#M!RANLDB;%-%->YK51-+L=\]5?/K:75KGRKT.1_!],U M1EF;&(:ZNJ&=EJP,)RUE?NO,B#]V;ICY.RX"Q-*O?<&?Q))KS'B]_#970,=6 MS(]<_GZ_FV;`]ZX MC,/Z]Y;MUG4DM:EANJZ?T.1<]T;%]@PR[%:3L#-5+1HSJ61+.9M0M;(__J'4 MO1Q#2(.#>(A^\XW2`.M>[-FO.@YU.26QA4[];#S0_FS+-J:/=&12/QO;V\:= M2NIG8V.J25/8:"W\QK;-687K(=H`7P*F67F%-+\GKL%%HU;IO#-^Q%Z0PU+J MFG\:3"/SOR76Q%8V8Q'Q52_WL7'=DAY()^ER)J$_BWI/2$GO-KNH)O-IVXW= M5O6&XT8O!S.R[I9JGA,B2=K=4LV8:A;'ZY)S!*M.8%ZC\((A2HW:`M"V,@NF M)!]_!;LKS65\=0WFLOXB:I!K5&M*=6QZP8H`?-]+50E3'@#E7)Z"/^/]>O'; M80X.Z%]22"!4-NWT99X7;_^?`````/__`P!02P,$%``&``@````A`"4U-6Z[ M`P``RPP``!@```!X;"]W;W)KVP%B0Z'3/A1BGWM\ M[H=O+O,OKTWMO1`N*&L7/AJ%OD?:DE6TW2S\7S\?[R:^)R1N*URSEBS\-R+\ M+\L__YCO&7\66T*D!PRM6/A;*;M9$(AR2QHL1JPC+>RL&6^PA$>^"43'":ZT M45,'41BF08-IZQN&&?\(!UNO:4D>6+EK2"L-"2!M,`F);SBH('*NP>)^N%?X]F!4K\8#G7`?J7DKT8?/?$ENV_5`96C#TKZ%.EEL`X.+-^U!GXFWL56>-=+?]A^V^$;K82TIV`1\JQ6?7V M0$0)$06:4:1EE*P&`?#?:Z@J#8@(?M6?>UK)[<*/TU&2A3$"N+E[ MY4Y(UOQG0$B).I)$/0E\]B0H^FV2N">!SQ-)-$E0DMZ6$ABW=)0>L,3+.6=[ M#TH/A(L.JT)&,V!6X1F_&QYP2=G<*R-M"F@!.7U9ILD\>($TE#TD-Q"X14=( M9".*"X@320#RCAHA;*[&&`KA<@H/&I61HS&U%>0&,M&I4GX5@P5+``1F*.#Z MP0H,01QZ[AYL(*;<],&#!>M@8!D>_+'L*",HTX&`-',\-Y"I3MTX3I&]75C; M27;:ML1!F;CB;J=%&3GB)O;IN8$8<6@\CNWMPMJ.IR?7+'&I+>YZRA383EGB MILQ`!BD;+%@'9_;!*F6WHZ*,G*A,;;=S`T&ASEDX"D])T7>R>'_?DJ?>:\Y] MORU/&=GRLM"19R"I5H="_68TPGS'G-9V3N;MK0+7?QV5I'IP,-&D3F7+>\Q($)U>?37G0,HK@!L MB9]JXLAT9$OBV$Y=WF-,Z46)J3VG/(L;(%NJZL:_?4>0LG(2?7J?Z3N:]YC^ MEJ3I.`EC]R859Z`X&8)LJ1=>$!](_/D;(G/['3*87FJ2HG$43DX<3L*)@U&CI>)Y!V,$FMG13$4-X1M2D+H6 M7LEV:BZ,H/*/JV9FS=$,9@<8\)SU`F99O1X<-V"4[/"&_,!\0UOAU60-E.$H M`UG<#*/F0;).#RLK)F&(U%^W\*.!P%02C@"\9DP>'M2X>_P9LOP?``#__P,` M4$L#!!0`!@`(````(0"F@JN%9P8``%D;```8````>&PO=V]R:W-H965T&ULE%G;CIM($'U?:?\!\3Z&;BXVUGBB0)3=2!MIM=K+,X.QC6*, M!4PF^?NMILIT=S'VF)=,3)VN/GVJ^C27QP\_ZJ/SO6R[JCEM7+'P7:<\%P^C[ M\]KSNN)0UGFW:,[E"2*[IJWS'GZV>Z\[MV6^'0;51T_Z?NS5>75R,<.ZO2=' ML]M51?FI*5[J\M1CDK8\YCWP[P[5N;MDJXM[TM5Y^^WE_%`T]1E2/%?'JO\Y M)'6=NEA_V9^:-G\^PKI_B#`O+KF''Y/T=56T3=?L^@6D\Y#H=,V)EWB0Z>EQ M6\$*E.Q.6^XV[D>QSD+?]9X>!X'^KY/1GX<*_-DZVW*7OQS[OYK7W\MJ?^BAW!&L2"ULO?WYJ>P* M4!32+&2D,A7-$0C`OTY=J=8`1?(?P]_7:ML?-FX0+Z*E'PB`.\]EUW^N5$K7 M*5ZZOJG_0Y"@5)A$4A+X2TF$G)TDH"3P5R>1JTA$\?M4/%S6H-*GO,^?'MOF MU8'6`^+=.5>-+-:06M^A#`5!4H3` M+M(0&Y&]@8A&B`?T1HX@VWR.:A#C&([IAV6D"%D-I5+KRHP+%@$0QB1P6QP% MWKBAN?*838P0;+=A8N."-3%DN7]B!8;JF1,OV<0(28:2B4C&B1W/S'@BY&H, M6ZR@\>]GI<",E4Z+=4!(A*Q\SLF*"O$VI=BFI-IX"0-O5TH-8M38Y"E"XH%: MY$O=H`/SS`R#GDN]"RS!EC:[VZP4V&85^..B43"$H&!+UER9&917Y%*GF['K M;Q-28$9(IT5""$&9I)!,QKHW4+,A\\;%*H:AGA];RPH'L1YMTV/^?;N2`CW7M(B` MFR)A2+8HC!D@LP&K)-$`F]H;MAV_?[2@!UL4V:Y+!6)0.1FRNF=V.-9UM^DI MS[U[#PB%9@75B:F@B$'E@L#7NE!%K;A<7=D&8I;I#VA&C+L^8:BD<:PG)F)H M^Q1?2;TP6S'EQ/Q!+P[)(,A,0^DFB'=&F-LOZ!7HWE&/4C/M"2ACCYL&\8D\^ MR^;%U.=#O2IJ<<3@SHMB70]2Q0Q#/:]8ZBRC%U.GYSL^)0SVD1`1HYU9<2E# MS=O22S*OO]U'`]K>>:%V:=2+,$@L"`PO0L&L.-S'7R,VR^7EU.5#YD4I8;"0 M(F']GUGAZWHQAW]'KZFSA]S9)6(NA0R-4YD$,P'):G6EQ:2RVKNM:D"S2FH/ MI$JB>9-@DT.14ES"N@_L!IME[1)MV710HW.)%F)H7J'E(+FNA6U:LXQ=/6RR MHS#DQDX8JJ,?,34S%C?\UR8VR]CEU-A#UM@I88C8RA>L`S,;D"R7.H--;9:Q MRZFQ1^RP2PEC&+MYQ9Y\EK'+J;%SATP)#L1)`%W;M-!(G[%HH83!!F*;,KL2M*DIDS4.&T5-J)/]]GD8H#=; MW%@/I80A>Y_R!)AACL_5@D_+XGHR0C0.K6M*G-,OA@ M:O`Q*UA*&)SY`5YQK28=CUE&1!AHK[/),8N_!<9M.K$SK?X!WHPPC;-AZLMCFPVP!9QU%@33 ML\!XZT'4$(.U6T:3]W&4@^)+XYBSB,$'A\F.579]6[MAE&VY_#XP)0R^87WK MP=$"O/7@B%\R\!U]7;;[,BN/Q\XIFA?UE4+"F\CQ*GY!2<4:WF3#EPMV/8,O M*\-U;PS`AXUSOB^_YNV^.G7.L=Q!2G^AWI2V^&D$?_3->7AU_MST\$EC^.\! M/F&5\([<7P!XUS3]Y8?Z^#)^%'OZ'P``__\#`%!+`P04``8`"````"$`^V*E M;90&``"G&P``$P```'AL+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8=R!T M;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`" MNW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM= MKGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CM MA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLR MH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4 MAQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E; MG4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]?O/R M\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B M6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`-> MG]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/' MM;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U, M2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L> MFT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`'' M*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684 MZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7R MQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8; M^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O- MB&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.% MBW21#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P M'ZE0$+(/994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE: M!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IV MO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E M<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*D MK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3 M*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:&PO=V]R:W-H M965T3\E,RXZ M[_;AS%Y)8;35N8O0C@70\YROV35#I_4JDYB!+SLQD*=TDRRW<\K6J[8^OR0< M[>">V%(?/QF9?9$U8+&Q3;X!.ZWW7OJ0^24,9F?1]VT#OAF20DA)QL$ZKWT&4>*C>9'(RF2+]Z?T\FDWFBZLWN+!`U"9XQQU? MKXP^$AP:_*9MN!_!9(G.76:!H\_U7ZDBGC?9>)>4XK1C%A;;\[B>75ZOV"/6 M5)PTMT&#UQ?-(AYKMN>:I%08&D<+ M_+X)9T)X<+II]]5..]S+[6V)1S=@"^,(Q;G6KGOP5>O_#-9_````__\#`%!+ M`P04``8`"````"$`\VZANL\"``!X!P``&0```'AL+W=OL1XYA*5_#(>J:$7HKR([37CL223NL0;]J MV:".;)R\AHYC^;`;)D3P`2BVK&/ZV9*B@)/E?=,+B;<=Y/V4I)@WB@IXS M(H42M0Z!+G)"+W->1(L(F-:KBD$&QO9`TKI`-\FRS%&T7EE_?C"Z5R?/@6K% M_H-DU2?64S`;RF0*L!7BP4#O*[,%P=%%])TMP!<95+3&NTY_%?N/E#6MAFK/ M(2&3U[)ZOJ6*@*%`$T[GAHF(#@3`->#,=`88@I_L?<\JW19HEH7S/)XE``^V M5.D[9BA10'9*"_[3@9(#E2.9'DAFH/YP/GTM2>0$V?QNL<;KE13[`'H&7JD& M;#HP60+Q,3$G8TSU3YE"BH;DQK!8+DA"074>UVDV7T6/8"DY8#8.`Q_$B$E\ M1'E$F$J`O%$C)'ZN<08E_+WY1TDFR)>4+_SW;2XA4Q]17B*NXA'B:03OWJ[1 M!$$KG%B29MG(;ZW=.(QK*N-U>;+A*4C_1X$)*A!`J@ ME4\]^'M]#-C/?9:>O]EA%K:A\G0^\X65WG&\>&DG3U7V%E4&[*M*XK.FV#B, M4S69SL^.2^\X2?(7U9ZLW)=E/KQ_-[4)\N6EV97ORL9AG+R79K7-!"/2Q">Q M=702A_&Y9VX"N@G!J6QH2;M.!43LS'1+(&[<=8-W`X/7CJEH/(#!-^"&?L:R M8;T*.EI#:!SF4"[I1J=;:#'8#W0K-(P\^]C"'XY"D\@T#``!0"0``&0```'AL+W=O;.0H_7U2%*7*]^?QI?13R416,:0<8:A630NMFY7DJ M*5A%E2L:5L-.)F1%-2QE[JE&,IJ:EZK2"WT_\BK*:V(95G(*A\@RGK!;D1PJ M5FM+(EE)->A7!6_4F:U*IM!55#X>FHM$5`U0['G)]8LA)4Z5K.[S6DBZ+R'N MYV!.DS.W68SH*YY(H42F7:#SK-!QS$MOZ0'39IURB`#3[DB6Q>0F6.V"@'B; MM4G0;\Z.JO/LJ$(?N,U@VQ#G;`">R$>$7J?H@E>]D9OWYD*?)=.RC)Z M*/4/%YH*/<"(L+`5NG++5,)9!1HW'"!3(DH00#\.A7'UH",T&?S?^2I M+F(RB]S%I3\+`.[LF=)W'"F)DQR4%M4?"S(1M23AB60&ZD_[X502SPHR\=U2 M33=K*8X.-`VX5`W%%@Q60'P.S,IH0_U7I!`BDMP@2TR@VR$(!>5YVLP7R[7W M!"E-3ICM&!/T$;LS`BL!\EJ-$'A7X]M)/TM!,$K!(J"VK34`=ZLM'/@=(Z[\ M%M)3`AF:K@3!,9EW',^C5UXKSF)LRZ#:7"^CGDT[`>+L4+> MZ@>[/Q:R_(@0!`^%S-JC9C-B,9U2=`R]%`1PC4_/@4&_UP8G4,=YU]+WCK?5 MY`K`=;0G#U0F?-:.27+@-)W+^&,2CL1[4*+QHR5 MO=`PR&PO=V]R:W-H965T7GN8EV]J?K+:_[7[^:7/EU6M]8JRQP$-9;^U3TUS6CE-G)U:D]8Q?6`F6`Z^* MM(&?U=&I+Q5+]^VBXNQXKCMWBC0O;?2PKJ;XX(=#GC'*L[>"E0TZJ=@Y;4!_ M?^MR*:X*]+J]>WRE/'B`BY>\G/>?+9.;:O(UC^.):_2ES/$_4&"-.M] MMS\,]T6>5;SFAV8&[AP4:L:\-IM]CE$(-)N5>RPM;^3=>+YMK/;M`GZ M)V?76OK;JD_\^DN5[W_+2P;9ACJ)"KQP_BJH/_8"@L6.L?JYK<`?E;5GA_3M MW/S)K[^R_'AJH-PA1"0"6^\_*:LSR"BXF7FA\)3Q,PB`?ZTB%ZT!&4D_VO^O M^;XY;6U_/@L7KD^`;KVPNGG.A4O;RM[JAA?_(HETKM")USGQ07UG]QYV$G1. MX+&C$V\9DG#^M10'PVJS1-,FW6TJ?K6@]4!X?4E%(Y,U>.[3@\$,"?N_?$&B MA)/OPDOK"U)10Y'?=T'H;IQW*$S6<2+DP+X:.$1EQ#U#5$&XI;W;'D@DP($` MAB@@P7H4/K3*[2+WHL4B5;07J(JB&Q25$9N,I18X-2E>J'I)3$K@CME10H4> M>CQ4L6AK0P<-N0_"T7^;[`@YN`=$]F,=H#J02("B$1[TN$:Q"':7HM%3\Q0A M1]*H`Q2!5=N#GA?ZFH=$MI.E2U;#$Y0(8"O($=QO)$'6E?N#7\PNR M?;5J=JFY5HL^NK$08ZD M40>H#B02H&@D<-I/3V#+5C/H>UHIHXX4=EM6.RYCU>POU/U.!_,XNX3$K6W6 MGHBI-KGX+5O7KE>_(Z'V)\\WQ.,@[>V>H;ZWC^HE1,V\F%W3U>.D4T_YN9J[ MB"!):@P#H0:2R(BJ4(PI2>&T!B8XW&!>W)F9'4E6BLM&A!J<1$94I6(Z24KO M'P,$9YF-M6@.WJ[YZ@>A(LE)I M3+4M30U.(B.JTH=&F6>.,K.!.U+W/KD,QL\-W'"J?;'07D)H9Q\C3&1$50\= M.;V+X&PO=V]R:W-H965T MC"$A"0JI&JINDS9IFO;Q[(`! MJX"1[33MO]^UG5*@U=:\A-CWW,.YY]J7[?5CVW@/3"HNNA01/T`>ZW)1\*Y* MT:^?=U=KY"E-NX(VHF,I>F(*7>\^?MB>A+Q7-6/:`X9.I:C6ND\P5GG-6JI\ MT;,.(J60+=6PE!56O62TL$EM@\,@B'%+>8<<0R+?PR'*DN?L5N3'EG7:D4C6 M4`WZ5\P1L,3+MMP:$"8[LG69FB&Y)D*X1W6^O/;\Y. M:O3?4[4X?9*\^,H[!F9#FTP##D+<&^B7PFQ!,GZ5?6<;\%UZ!2OIL=$_Q.DS MXU6MH=M+*,C4E11/MTSE8"C0^.'2,.6B`0'PZ[72<+TDR_C_ M4K`KR[IT2S7=;:4X>7#R0+CJJ3G')`%F8T\$)K]M#_ABB:!K-QM%P0U9#>"(*;L#[11GP7-3L2.P=)K:B2+`)AM?:?F6S\(N9 M$U7Q):H,>*YJ9L;>85NP;E17OE->P$B@#?P7=DVX`NX46O;V?!Z%A<-J_-7PG&5S$P`=P*81^ M7I@1/WQY=W\!``#__P,`4$L#!!0`!@`(````(0!6<4SWQ`,``)<,```8```` M>&PO=V]R:W-H965T&ULE)==CYLZ$(;O*_4_(.X3,"1D$R6I M%E;;5FJEJN><]MH!DZ`%3+&SV?WWG;&!Q>9HE=SD`Q[>>3WCF3C;3R]5Z3RS M5A2\WKED[KL.JU.>%?5QY_[W[^/LSG6$I'5&2UZSG?O*A/MI__'#]L+;)W%B M3#J@4(N=>Y*RV7B>2$^LHF+.&U;#G9RW%97PM3UZHFD9S=1#5>D%OA]Y%2UJ M5RMLVFLT>)X7*7O@Z;EBM=0B+2NI!/_B5#2B5ZO2:^0JVCZ=FUG*JP8D#D59 MR%T\V"8E<;[]5"?I5L(L8?7;$B5\^MT7VK:@99!OJ).GA'U:R M5+(,*NXY$,0H0`,(O[T8>X#C.(-8<:?^Y"/JFP_6B=C.3V7 M\B>_?&'%\20ATA+2@-G89*\/3*10!H@U#Y:HFO(2).#5J0K<3Y!&^J+=%9D\ M[=PPFB]7?D@`=PY,R,<")5TG/0O)J]\:(IV4%@DZ$7B_Z/M!-"<+/[I!(^PT MX+W3(.1*#4^O2:7K@4JZW[;\XL!F!=>BH;CUR09T_S\GD`QD[Q'>N=!,L%P! MA7G>^UOO&5*?=D2L"7@="&(224]@]<##8`02<[T1A-$(%@N=Q?K".&Y@Q=5$ MH%PO`A*^W3=L0`[&-G"OA+!-W\\+/K1S%Z-5AV;T6!-Z=Z'A9'3!B`\BX_CO MQT48_(WB+JRXFH!M.M1C:1))3]CU@&>N-X*P:20RP\2:6*KTWX5K_VYE`DD/ MV#ZB6WP@;/JPPL2:0!_Y?C8CP2R$#9KC5IZ1M66I9VU+JULL(6Q:NC/#Q)J` M]0\ULHWTA&T$?]:N;EZ$32/$[EZ-O.>D)VPGZUN<(&PYL:9$K)&Q$_+6L*KE MDQZQK1!HU^NSHFC+C-V\'6.XL1HM&9B)'1QXHR)=-U&('I/CUB96Y\8=,QHJ MW95(=1F)HL72#U=O138&#;EIX"K:2I/=XAVC>SSP;;_)<'^2(AR&HQ2]/_2( M'IU&:NPN[QBC8E;;)0,SL7/3#";3(6P/DKACQG:"M[+H[3PP$SOPV`W90=HL M5&`W%QY^@-%V#FJS3-STR,3-3?,8SH(3-U8?QQVS4CX6@;^>M-9D#NMCGS[' M5*P]LH25I7!2?L9C'`&EX>IP+KW7!\;A!ISP&GIDWVE[+&KAE"R'1_WY"A;> MZC.B_B)YHTY)!R[A;*<^GN`/`(,?<7\.<,ZY[+]@LH:_%/N_````__\#`%!+ M`P04``8`"````"$`?B>5JL$%``""%```&0```'AL+W=OPFF\WL[C6-I9(6RP#= M]OS[/?4%5)7CNLG3$T#74J\KR[' ME?G7M^3+W#3:KKCLBS.^H)7Y';7FU_6OORQON'EK3PAU!BA4)UT4[P%5W@EP-NZJ*#K\W1:J\-*O9T4'VVG.G4M^JBNIA,(6R>T<"'0U6B M&)?O-;IT3*1!YZ*#^;>GZMH*M;I\1JXNFK?WZY<2UU>0>*W.5?>=BII&78;9 M\8*;XO4,>7_:LZ(4VO2+)E]798-;?.@F(&>QB>HY+ZR%!4KKY;Z"#(CM1H,. M*_/%#G/;-:WUDAKT=X5N[>A_HSWAVZZI]K]5%P1NPSJ1%7C%^(V$9GN"8+"E MC4[H"OS1&'MT*-[/W9_XEJ+J>.I@N3W(B"06[K_'J"W!49"9.!Y1*O$9)@!_ MC;HBI0&.%)_T\U;MN]/*=-R)%TQ=&\*-5]1V244D3:-\;SM<_\.";"[%1!PN M`I]G3E\\OCYQ)E[MN>3F3^8+90^'0B?XD*3F>,% M$!GBC<@J$F`P2[%J(R+$D%@%6Q4D*MBI M(%5!IH)\!"0C7,6(^QM:U`*)7IFP=89:F"H)1BR&GP)DJ3<:B36RU4BBD9U& M4HUD&LG'1$H=TO@9-4!D8(M!I0VFS%VY_",61$Z,(6@ZDX,V?5!?&QK9:B31 MR$XCJ48RC>1C(OD$DY9\>EPB))K:(9*(&!D7A$9BC6PUDFADIY%4(YE&\C&1 M$O651-F!.0E@0'>JRK<(P^+!.M\QP(6#D1V71$3.GQ%ZA1P$ MH^JP%U.Y.K9]D#`VT\*(.QS).TZ"_I!.^U'#9G2\A6QWU@<) MZ9P1ATI+=0-S?&C34W5#1&27-+)A9.P2(]Z"WI>=J>W)66S[WT46"=<8&:2I MIOTH>O-<"1$5V1Q&1IN*@=&FXH!L7M&XV'/5 MGSY(9)(PPC8#W:X[53EEP%WT%95I)!_+2(:03DQRY,YI,MH\-%Q.G2,?MFV? MF3M5,MN(@;-^EK%`LB6!4C(\RB%'&JS^;*'1"AEY,-I+T=N/^]C^,9*T@W*?%4D?DG@UEY@4E3G>-10%3'7\H?\M@*Q_.#!2E9)Q.7'Y:8) MIT)E$,X$8L(S3RLMKG*GM$C/."XMZAL\:T*ZI!$0A];S70%Q2CG!!!I.XHU` MXU)C`WV8:U^C]ES;LSR*[=F9[RC-0\*5G7'U\2D-%TMYU..+92**7RM];+'[(U&'H1P5X&]JO!X M$6[IE!6>+D(XAO5X>#/R0K-6XB/RQN1.?.2$\+"DZT1N"(\2.G^9A2^0L/Y# M-`NAI[[#O1!:4)W'?@B]F^"<'>/IT$(S9$>G\Y#:`R`6[W3\`;H6AS1[T5SK"ZM<48'6.PI;:@;]@Z) M?>EX'_F*.WCW`_4`+RO@71^"A\&ULK%A;C^HV$'ZOU/\0Y?T0$BX)$7"TD+M:J:I.V^=L,!`MP2C)WOY] MQW9L?&$IK?JR6;Z,/WN^F;$G7G[_:$[6&VJ[&I]7MCL:VQ8Z5WA7GP\K^X\? MR;?`MKJ^/._*$SZCE?V).OO[^N>?EN^X?>F."/46,)R[E7WL^TOH.%UU1$W9 MC?`%G>'-'K=-V>#QWFK(^VXPA;!_AP/M]7:$(5Z\- M.O>,I$6GLH?U=\?ZTG&VIGJ$KBG;E]?+MPHW%Z!XKD]U_TE);:NIPOQPQFWY M?`*_/]QI67%N^L.@;^JJQ1W>]R.@<]A"39\7SL(!IO5R5X,'1':K1?N5_>2& MA3NQG?62"O1GC=X[Z7^K.^+WM*UWO]1G!&I#G$@$GC%^(:;YCD`PV#%&)S0" MO[76#NW+UU/_.W[/4'TX]A#N&7A$'`MWGQ'J*E`4:$;>C#!5^`0+@+]64Y/4 M`$7*#_I\KW?]<65[OFT]HZY/:D)E6]5KU^/F+_;2'2C88&\8#,]AL#L;N=/Q M'*9ZE&,Z<,!SX)C`'AZ2#AWM83?[YTWB!)JL%F8]JXJL666Y",(+21#L0Z MD.A`J@.9#N0Z4$B``[((;2"#_@]M"`W1AGNUX7H5;861R`T# MB0TD,9#40#(#R0VDD!%%)UBTHM/]%"'65`[NQ(8A$1/6?(?1,IB9;!K#3 MD>Z%`P`1$-GA!A,UA6)AQ(5-#"0UD,Q`<@,I&.)Z]."7=TDXF97(ZX+\P)>O M!(%P;="9&2=2S MA2IW+HPX=<$0CU(K>4-Z6_.@_9=Y0TA4E0QDRQ!9)89,77HN>V-WIGH1B_?< MBV3@D`0R6#,QBISVP*K)GHOWG+60615M('YWM7DLA0B+*@Y#I*)B@%14`T"* MESY,@[=G2OG M5L-<^IY7\/=T+E5&TMG)1?1<&Z:_ M$F>1C8Z3)LL'J_F0YMV*3N<%"JQ=R M]T"<]:2$9'<)[-.T0>T!;='IU%D5?B7W!"Y);0&S2XS"#^%$@4K5\&@1QK1> M-#Q;A+`%F_9P&?)$%Z+9;\@ER0W[C1?"AY+)LYF$\!EAXD_3\`D<-E]LIB'T MTS?P60CMIXE'\Q#Z,A/?^.'FEA!;/X1FP+2/_!!ZHAMX$$(K8.*)'T)#8.*I M'Z:W\,P/H3$R[;,@A*8`<$0S[N':!_(!+BK@>@_!A^.8%-T>XY[_(!.("\/UWP```/__`P!02P,$%``& M``@````A`.)86INX#```<3P``!D```!X;"]W;W)K&ULK)O;YN7]?Y^ M^_)XU__W[_Z_;ON]XVGUI_?-J^'EEMMWZ+W&YU M^/[C]5_K_>Z5)+YMG[>GOVK1?F^W]L+'E_UA]>V9VOWG<+Q:LW;]!\COMNO# M_KA_.%V0W*"I*+;YT^#3@)2^?+[?4@M4M_<.FX>[_M>A5XUN^H,OG^L.^L]V M\_-H_+]W?-K_7!ZV]\GV94.]37Y2'OBVWW]7IN&]0I1Y`+G]V@/%H7>_>5C] M>#Y5^Y_!9OOX=")W3ZA%JF'>_5_SS7%-/4HR%Z.)4EKOGZD"]&]OMU5#@WID M]>==?T0%;^]/3W?]J^N+R]\VQY._59+]WOK'\;3?_;9TJ\UAEOVHQO MK2N%3%TD_>HB)Q>WD\GX^O:&:G&FR$\Z(_URQK/V0QH%=4E#ZG:=XZV5')(C MF[SBT9N+X?CR6OGS3"6'[$3U'UTH]=6Y'.P\-=[>6TUVPY#^H_.^T?-#\ES3 M0G'A&WT_9!>J_[RMQH,F7NKPFZ].JR^?#_N?/9K3R#7'UY6:(8>>DN/`:SJL M#<5?12*%H%+YJF3N^I2?@NQ(T\&"T@65`0;DGM9'%`(?X2,EHWS$ MO3ME8#C-<0A;<):Y"Q8N\%VP=$'@@M`%D0MB%R0N2%V0N2!W0>&"T@65`2R' MT-0"#KFBV:[[:<4QHG+=]6FV,6+DUN[P:6.C'W$J!&9`YD`60'P@2R`!D!!( M!"0&D@!)@61`RQD@]B`RC M3[8G9ZU1&SM`%D!\($L@`9`02`0D!I(`28%D0'(@!9`22&42RV_4B9;?SH>0 MLJ[=PYTZ;8@9,$#F0!9`?"!+(`&0$$@$)`:2`$F!9$!R(`60$DAE$JOC:<%B M=;QZ\*LY[)T!HV1LCS3$CH[QI1,=K1$[<@YD`<0'L@02``F!1$!B(`F0%$@& M)`=2`"F!5":QG$1+0\M)YZ-#6=N^:(@9'4#F0!9`?"!+(`&0$$@$)`:2`$F! M9$!R(`60$DAE$JOC:25K=?S_N2Q6,K9'&N)$A[L.;HW:Z`"R`.(#60()@(1` M(B`QD`1("B0#D@,I@)1`*I-83J*-Z$F9U>YG9IHTYT/-_K')-J'E1[M4&WYR'D8+SC=NI7Q$ M2T0!HA!1A"A&E"!*$66(91L9#:J[1%0VJUFVC\94=@`NQ8GF?D6QREXSJP\MZ M,`6,;'EG*Q:*%"#/G)Q.Z<4JQ8 MOM)H5,O;_E8;7?3WNQ>#ZM3.]NX4T4PCR^%M1J--X['=I@5J^:PE7;9D)--` M(!E->6?'%HH5=UG$6B(?,Q+Y1)`A/W&&:RI6+)\Q$OFYJCX&91I;#6RNC36-G$"]0RVK#?A'.+S9R%L.!S0;-LAR>&MEM&GL#.*%SFC(^ZPE7;9D)%T62$9# M?N)X)!0K[K*(M40^9B3RB2!3WO%(*E8LGS$2^9R1R!>"ZI/SRZ$3"*48L'+% MJ,/7:L^/OI:G]]M67,W)@>&*J3I/J6(,LXH6CDCT2HP M8XFHXHP=CE3G`N<<^<9E6'.\8'FR030)BXLFCHMFZDZ+W"T-FFM"ZS+NU04B M7R-Z^K#5$J0"S!)X\MYH;$XJ+!]J9#O166;.U#6CBEG9V\PU&MN-=+R_8*OK^C9O.+Z^ M=B9KGZ5E;;ID)*4%K'.VM)"MK"7YT)E@(Y:7$F-&4F+"6F=+3-GJ;(D9RTN) M.2,IL6"MLR66;/7+'JU8NB[-'D7J$,0=14-C%+UQ*FC.4JQAI)%,93-U#ZS& MC(3Y7*-1_19'/3OXM2.LY91X/,LXZ&R!0TIV[1V63NZM@T MMU8\.?N<47IGJ9&H!VQD/]6=V284*U:/&(EZ#.H)$^GZE)$L$#*4RMFJ?=04 M3$2J9"12E25E>9&&^(=XL=:QOV,H.[04YP.VU::"VRXC;Y&M$/HR67*/*!9#0&$VR#Q8JU(HWH MAU&L$$8^%2O.F&E$/XQRC0SY0C*:\L[45(H5:U4:T0\AV^'JG`F# M^YVK[U%[6L5%3C4R0[LQDO"8:YN_V0F+%8O[7)YTUU(C40\DG]E;[D98K%@] M0O48U!/)9ZH["_)4K%@]0_4-(5O1LEU&H!L;$(#4^)#JNG7N>FE2O-IW3^*WY2J?Y3&"W.3QN9IOGYV-OO?^AOL"Y'M,3NL7- MYT'33QZ]`4*/.I>/KNF[H7H9"RDW_$61DT*?&GVM'Q8.G](G2/4.WN4C$NHJ M^\JKZN698_]U3/KU3.(D3,=>5<]=+I]X53T+N)S:UMDT:EFG_JU'[S)A)\U' M(T\M^3&%UO->V)E"2W%/+;0Q#ZVB/;5&QA1:CU(Y75U":TDJIRN%UH%43E<* MG5.06OWL=_J%CAA(K2N%3@=(K2N%-O94ZZX4VB!3.5V.I\TME=.50AM3*J0>.KR\]T[>&I>P[L4;K%\-2U!:;0I82G;B$PA>X8O+(SA4[P MJ)RN,*+3-RJG*X7>&?'4;1260Z^.>.I2"E/H#1*J05E=-6`WIKQU.4;UHU>GJ%^ZZH;O65!*5UUH^MX2NFJ&]W; M4DI7W>B>CU*Z:D!O!U%?=]6`7B.AE*X:T/L&E-)5`[J8II2N&M!%)J5TU8!> M,_+4;27VSGQ(44*O;6$*O5CEJ?M93*'WJ[Q99PJ]9D7CK:NEML&U>;4 M4O5:1E?*F%*Z6CJGEJK[7LQ#[VMYZMH74^BU+4_=_E+*H)U>Z(//U]7C)ET= M'K1Y?U7O[0?#+:_''2;Z=]VY_H4T\Z@Z7/VNC3W@U]3G-Y04N% MA_W^Q'^H`MJ/A;_\#P``__\#`%!+`P04``8`"````"$`N,YZ-VH'``#!'@`` M&0```'AL+W=OP>'^V MP<8V*,[IS#-JI:JZMJ\)QC&*;2P@R=VW[^S#`+O#^>*J;T+\8W9V][\SNP,\ M?/YV/DW>BKHIJ\O6,*=S8U)<\FI?7IZWQE]?PT\;8]*TV66?G:I+L36^%XWQ M^?'77Q[>J_JE.19%.P$/EV9K'-OVZLYF37XLSEDSK:[%!>X75CBIBU/6POB;8WEM MT-LY_XB[RE/9?N=.C8]S=SF>7HF_\@ M[L]E7E=-=6BGX&XF!DKG[,R<&7AZ?-B7,`,F^Z0N#EOCB^FFEFG,'A^X0'^7 MQ7LS^'_2'*OWJ"[WOY67`M2&=6(K\%15+\PTV3,$C6>D=NI M_;-ZCXOR^=C"M[ MN6^/6V.QFMKK^<($\\E3T;1AR5P:D_RU::OS/\*(SZAS8DDG$J&ZX_U`[FQ*<+5]G.6DPWMKU<;=;`;O2XDBWA*ENNIM;& M-NT5$^I&P[5L"-?[Y@@IRL<*U[OFZ,AV<,4Y+C\V1Q/"3T0#BT.QTK=G.1/A MQ*/3S]KL\:&NWB>0\A`PS35C&XCI,K<8ET*H+E)_%*@0H(3XA`2$A(1$A,2$)(>F0*!+`-(@$;/^^ M,T^8&T@UB+B!*%H:[(01VZX&1@M5.:\SZF*$D("0D)"(D)B0A)!T2!2=8-"* M3K=#A%ES.7`2.T&&`4&(3TA`2$A(1$A,2$)(.B3*1.%\42;Z'S=.YD950!!M M]9?:ZG=&*)Q/2$!(2$A$2$Q(0D@Z)(HH<'8JHMQ>?6:MSEV0X>H3XA,2$!(2 M$A$2$Y(0D@Z),E%6EM-C<\IJD_98YB^["E(7LGQ$@`4 MM>VH=$;I.!;&X:R5N6(EU4Z4:'/35J<2]`8X MEQ#=#'1"U,=E+-'21,^:_DEO@)Y3=#,B$RO);N77Q\*)G;-:/$DT2#%)^KGX M2%@R8SEK;HA4PKG=-PRQ/YX>/,XMM=&^/CK76MJ<0W?1Y%B'J M.XL1W>PLD5:R,]-9ZXF?HA_>FZHDJ_;N4%(4A[`R&,$[4R)EZUFM5$$\M.I7 MW)?(XB\->*0$B$1NFJ;F)<3[P^"2W?>.8[3J'2>(T+&V'"G>IYNZR`:-7I'R(:1I+LL?<5HU7O*T'4^TH1 MC<0)A*`B@ZCU[CSMV=."OAE)I(;/1@\?:=6OLB]]+?M8"!"I2FM'52BM+$C1 M;CU,1TO]"(?:]QBC^[['!)'2HY[LZ<]Z5#.259;#@.-*PXLN&"XKJW#;_WB- M98I:58E)B91Q6UI6>-BPCR-?HB4;37\N:,$?$5.E-%9M5MT1LNP]K5/LG!XPHDA6%AW4SW]T\DR"? MHH"BD**(HIBBA*)40:H6K+#5M6"O..Y\OC>9'ZTR$PB.Y#YJK+7VS._)ADJQ MUC7$\R:@5B%%$44Q10E%J8)4?5A%.]3G)S$A"F`E)F1-W&_"GDF03U%`44A1 M1%%,44)1JB!ESG`XJW-FFQ%+_CMC@OM18T(B+2:TEV->;X4!X%,44!12%%$4 M4Y10E"I(U4]1Y%,44!12%%$44Y10Q#X$L2P6XQ)S%A]V MQ*OS'VIV4-1F[`4]$;B"266L2PQWV M^$*'!A_4OO!B06NQ`U7&['<6C&K$SV[APEO9$?]+\#_J:.G"ZTG:8&>[\#:/ M.NQM5PW-<]FQ-6_B."Z\91K@Y!_G&6H2.RYZO:9/(<:/1&['C MPOL&V@`>P&$AN*M9ISA\0+QFS\7O6?U<7IK)J3A`K,[Y`5^+3Y#B1RM?SCQ5 M+7PZA*T*O@/!I^("WL?/6>UUJ*H6?T#7L^[C\^._````__\#`%!+`P04``8` M"````"$`,H&V,8L&``"Z&0``&0```'AL+W=OF_:E.Y9E;T"$<[3 MYE*>XN\AY_MP>HN;9GOJ%-]LISI=&G5>74V602OO2=&L]]711DTQ6M= MGGL6I"U/>0_][X[5I1/1ZN*><'7>OKQ>OA1-?8$0S]6IZC]I4-.H"R\]G)LV M?S[!N#_L>5Z(V/0'"E]71=MTS;Z?0#B+=12/V;5<"R(]/NPJ&`&1W6C+_<9\ MLKW,7IG6XP,5Z.^J?.^D_QO=L7F/VVKW6W4N06V8)S(#STWS0DS3'4'@;"'O MB,[`'ZVQ*_?YZZG_LWE/RNIP[&&Z%S`B,C!O]QF470&*0IB)LR"1BN8$'8!_ MC;HBJ0&*Y!_T^5[M^N/&=%:F\5QV?5214*91O'9]4__#7MH\!'-VN#,\N?/L MML.,.\"3.]CKRNK,5]/E&2W/N"$_N"/^[80_1Z+#@*1JR)W-GL5K;(,,M MSR7W!!6$YWU=A!5%FX3G75UTN3T\14-W=M&&+&&31M*%3\S-3EILUFD2!7F? M/SZTS;L!*Q.FJ[OD9)W;'@DKTH=).R34]_()$HE$>2)A-B:,'%*F@T7P]NBL M9@_6&R1NP6U\;&.K%EMA0;*4A`UT$.H@TD&L@T0'J0XR"5@@RZ`-9/7_H0T) M0[01H_(%D,32A!`6PB700:B#2`>Q#A(=I#K()*`(`:M5$>+ZWB)R@5AO3%B> M4B[,U0'ZS(9O2&2JMX@$B(2(1(C$B"2(I(AD,E&&#L-0AOZ3ZX.$@24&F2:) MHB\09D2V)\EHH2JW'8R&W$`D1"1")$8D021%)).)HA-T6M'I=HH0:RJ'&(3/ MB)P0B`2(A(A$B,2()(BDB&0R408*QX,RT)],"!)&58`1;?:7VNP/1D*X`)$0 MD0B1&)$$D1213":**'!6*J+:QM(.!B)[(@0B1%)$$D1R1BQ'=)#11`H7FX*\JVY?$\0F&ZA"(FB*H+( MEA$I1P)&9O`8-'%FVDD3#D:#)IR,!W+,":W2Z10E@Y<4>N&JBS$=C$3HC!&' MAE9D(J7539WN2AP:1=4)HRU'LE((ZE8 M\,7H&(GVZ/*@"12+6,.23CB!=!5"I!AE2B@UA4AU)FMS98^1EA2L5:0!1U#L M#.-S5BLUJ[?"<3GT,Q!(%49S#(75DB;9PG74P)%X/RZS6*"QK42@FVVEPHJW MI>^$F7A/VU)E)*7>#\C(*D.8%C%KOLT1[(F2C&MUM%MNY8S3'0A$/^AIFH0" MN52SI:M]$47BO9Q9K'DI<"*LQL"I0#SP2MN[,O$>[^@VJ?%D@5B%\X-G'(VB M;56L>"0M2[II'=L*QS$E`HZ6X_!"@=B&MIYK=5(DHLBYQIL?`RP M"E<18RAZQZ1QUE-]6QNLQ'X8P.TF25.IW@@QBC"*,4HP2C$B]ZECBTP?=C_* MKK;JLCV4V_)TZHRB>25WGPY)NP&SBUE_Z<$'#8Q"YRL/ZO\KW`8'F)EK;\`% M^H3?9"Z\H+N+U@C4&E[(U-?>0)W@D<(`!X.;Y">Z%#4/G]PP7['W'0]N='`< M?^;!?0?F3W/OZ>HH_+D''_[8P5]X\)V,>;#VX!,"<]_U_*MJ;%V/5*W8(W`] M*."O<'L*\EWSB%R/5*[8)7:]^.J+Q/6@DL<.4-K"1-!0UJ`XW)Q?\D/Y>]X> MJG-GG,H]9->4GHTMNWMG/WK^V?/<]'!W3K^`CO`WDA)NNJ;D1-@W32]^0-/6 M\%>7QW\!``#__P,`4$L#!!0`!@`(````(0!@=GVIJ0H``!0Q```9````>&PO M=V]R:W-H965T,HB=&V%5A.I_OMAU21J@,UCMW=-^/))]8OD<5B48>^_?W; M;COX6AV:3;V_&P97X^&@VJ_KI\W^Y6[XYQ_JM]EPT!Q7^Z?5MMY7=\/O53/\ M_?Z?_[C]J`]?FM>J.@Y`8=_<#5^/Q[?%:-2L7ZO=JKFJWZH]''FN#[O5$?X\ MO(R:MT.U>FH'[;:C<#R>CG:KS7ZH%1:'VW=;U[`XG'S79S_-Z*#@>[]:)XV=>'U>,6_/X6 M3%9KUF[_$/*[S?I0-_7S\0KD1OI"I<_ST7P$2O>W3QOP`,,^.%3/=\.'8%%& ML^'H_K8-T/\VU4=C_?^@>:T_LL/FZ5^;?071AGG"&7BLZR]H6CPA@L$C,5JU M,_"?P^"I>EZ];X__K3_R:O/R>H3IO@:/T+'%T_>D:M8049"Y"J]1:5UOX0+@ MOX/=!E,#(K+ZUOY^;)Z.KW?#:'IU?3..`C`?/%;-46U0O=_;120 ME!8)201^>T1.#(QH(/SRP-"<_<3`"0V$7QIX+JL_+NDA&Q$ ME0>4N1N"WY!O#:RDK_?A++@=?87L7Y/-4MIX%C%;8*JC;.*#U`?*!YD/$CB@]0'R@>9#W(?%#XH+>`$ M`I:X"$0$R=)?J#@G<-3=$%:YE1.AZ^A2VU!UPRF/!4D$2051@F2"Y((4@I0V M<4(`;H@08*V^<)V@#"PUR#@K*-XR6&HC+(>64>1&+NZ,NAP1)!5$"9()D@M2 M"%+:Q(D37+03I],I@M9M.-B)I29V0@B2")(*H@3)!,D%*00I;>(X"F76<10+ M)ZZ)"Q,"9=P(:.+-_L2;_":(TZ?$*6QGIUK69(/:K9X(@ M_7B&6AG7&4*6-TSFW;0E$J42*4)]EX\MB9U?GURF[F!@6^%8+7&+P6F`#+3UPTBZ.=FFF9#71_@5>W!0=#N5RPH`[ M,]=Z]S/KJ57T/-5MBC>YWA3$/-">7#UP\LGDDM543VXT]G8?QN>YT?P%)9!+:;CG:28H#@1*)4HF41)E$N42%1*6#G,J*[6%/+"YN$5H= M+P%0^F[H-0ES=PW&--#:3A.)4HF41)E$N42%1*6#W/A@&V'GRB=%3G<=3D[8 MC0CEA$!)(%`JD9(HDRB7J)"H=)#K,W84ML_^^CBO^.F^Q`F%1O:VI(E^<*3O MILD&XM$52-%-I$%GQ6M/291)E$M42%02@@H*\FYLL$U.G;M$"C& M74*O(/8R(11!4]&%)XR\VI<:*QZH&)E;_(Q16R';S,P9.?+7WIHMC!7+EX3" M5MZ-&/8_IR)V7C91%V4'3*`XT,@I)AI-@G:?",>!U\*E-`8,V!G%,G:LA')N M!K:/DL:!-PN%,6#ETE%VPA3^FF:PE7'K,"%KU1&Q5AW;P++JTBKPN]W46+%# MBI!>*6T.94(]YW&FG2DD*ATI-S:7=9JA[#0)0<_0N1?ZMR@Q&=EA$4JI%%>, M3&N6":F:#5DC$XW9&1% MW78XN?%:/<4RIMQDC,S)*K.U*L MA%:2>0\38QYHUD)"R&[M&;ESY3U>4V2%OG9G#.9>@=Y[47V'-[SS<8F3TM9F2GHAX(I=C$B9"Q M4C00\HZM,JF5LY71*A@9K9)13\7#EMAN'#ZI>+J#MOO-D)";T]X\QVQEIPL- M-).:LM6T\UDQLA.$!AJMG*V,5L'(:)6,>NH5MKH7A$%WQDX8"+F%211^LC)S MDX0:.=E`:-ZV4[.QE]J*A]BI(81SMK)3X[1PR4-Z\@2[9#M`/U;0=:_MQ(V0 MFSZBH).5F?($NF!'M1V?54]#%&7.6-V!YH9C!A9&8P M9:1;E?G,+TA\W$X-.KT1SMG*"!>,2'CJ5%[=04PCFKV*FIK28D//6W1$?8#=BO MZNH8=KIV.?^Q M94K]LGDJLHP(V0DCNNJ$K#YY2<16N@J%TZFW62@^F9U$XF0YRT!\NHU'O&XL MV(I.-@N]8EHZ)W,3"YO?4\$\[[8OHD[;CB:UU2;_8[*"&R].F42B5"(E4291 M+E$A4>D@-Q;8W?JQP+;BPH]6X*-8L0-HA+>D&KU1>CXZ$]T]8>1N^KP4L75=ML,UO4[?GX+'OC#9/$``>D9,%G`5UX]'/SN=1N\[G4:?.YU.8`3P,M3>09X M4[+`]R!]1^9PI*W'GMOPD@34^HXDX7B!3]=[U.`(/BR71Y(P@#%]X85GS3"F M[T@\6\!G-U(KGB_2ONN*`[@N^`)$CDB"&_"R/V:SQ;+72WB?M,?!&:X%O:J0:O-A:9/K(J)L"^";];?52_7MU>-GLF\&V>H9%,VX? MK!WT5^WZCR-]2_18'^%K=.@@X7-C^-<'%7SV.<8/CI[K^LA_P*E'W;]GN/\+ M``#__P,`4$L#!!0`!@`(````(0!'$&@$/@8``%89```9````>&PO=V]R:W-H M965TN&\=8HZ5C]^_2C.D[>LJO/RLM:, MZ4R;9)>TW.>7XUK[YYO_Y4&;U$URV2?G\I*MM>]9K7W=_/[;XWM9O=2G+&LF MH'"IU]JI::Z.KM?I*2N2>EI>LPM<.915D33PM3KJ];7*DGT[J#CKYFRVT(LD MOVA,P:GNT2@/ASS-W#)]+;)+PT2J[)PT\/SU*;_60JU([Y$KDNKE]?HE+8LK M2#SGY[SYWHIJDR)UHN.EK)+G,^3]8=A)*K3;+T2^R-.JK,M#,P4YG3THS7FE MKW10VCSN<\@`;9]4V6&M/1E.;"PU??/8&O1OGKW7@_]/ZE/Y'E3Y_H_\DH'; M,$\X`\]E^8*AT1X1#-;):+^=@;^JR3X[)*_GYN_R/X0'@WTF18VF`(\E'^_F>[YO36K/LZ=*8K:PEJ#QG=>/G M**E-TM>Z*8O_6)#!I9B(R47@4X@LIO/ES#+@GK<&6GR@W0TTY_W=;]P19-O' MAD]^1^.^@0L^$.J?#[SSCBL^$#X_=T<#YI19C)/+[+M]3YW-43OE;M(DF\>J M?)_`.H)9J*\)KDK#05DQVB*RV M`@S,4HP0$6*(JP)/!;X*`A6$*HA4$`^`9`2L*!J`6,7FNP_@:UL)(3 MW+(8_OK`J=X1XA+B$>(3$A`2$A(1$@^)E#JD(:7^D^L#96")0:4-3%$7"`O" M]UL?9,UDYW9=4%<;A'B$^(0$A(2$1(3$0R+Y!`\M^72[1#"ZM4,DL65D6!"$ MN(1XA/B$!(2$A$2$Q$,B)0IO>RE1+`@+7IR??&&BC.P`(\KLJV_(+D@8YQ+B M$>(3$A`2$A(1$@^)9,I2,>7V[&.TG#LCP]DGQ"7$(\0G)"`D)"0B)!X2*5'L M<7_!=HDRL@.,*+-O*FN_"^IFGQ"/$)^0@)"0D(B0>$@D4Z!_D4RY/?L8+>?. MB,4:P'8S(,0EQ"/$)R0@)"0D(B0>$BE1;)"D3']R-VAU9`\XLMN^OFU^=@*! M[]U^8*R4_<#MHT11>!3Y%`44A11%%,42K!^#S5)DM,6-$XI&13Y%`44A11% M%,4GL8DNQAR():'MACJ_9T44++,PCR M!>I;V$"@F_)A'R7D(XIBCL80(OV%_5JKO0#OKC>;QJ!0+UP*%`O''%D MXDOW;6,LYTI!QF),JRP[ATW@+>?N>\>S5E(RCJ/A=F=:"WD-[L`Q-,Y<#8QC MR#8[Y/$HF^5GJ9NF+U3Z(8%`O7`H5/JH2"`F_+!4YC46*NT0V3?L*8EO<*;% MMT91<)_8)UF7*GG(D&UW5NS@I)!4&H_J"\+C43:K-,.R2:EQF6&I$>50R/3* MD4!,V5R8RE$`'F6V#S@H-78TRX0Z^DL>NV'"E-5RY-VQL<%`[=@5. M<)_:"E%&;/%D=^0>6Q`:C;<<.+F@S_1D.T]@*[VPM1WX"3_"YP[\XAWAQLS! MYHM>@>X4TFX/DI4D=H8!5\;&0.<(^8U=V8)5VU&K=G`%>Y*Q)[#@RECZ.\.& M*V-Y0BOCX*9#U:"C@:=FR[9+"$ZUK\DQ^S.ICOFEGIRS`Y3?K-U5*W8NSKXT MO'%[+ALXSVY[N!/\_2*#=_@,%_BA+!OQ!6ZM=W\1V?P/``#__P,`4$L#!!0` M!@`(````(0`O$!&)[Q$``"!=```8````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`#DOV?/CR8TY(K<_77X]^?CP_[;A_/FU;O+ZT8S$OG9Y\UN MGSX:D^=G]S]V^^WS_Y6BR)HJC<362%..GHT$.K9L1_G7=FR_BV\NH\LKXSW0 M45H/ARW_PF-##SO0\/VNZC5^-TI M1A(+Y="8H"@OZ_6[F\O+UM7-=?CJ1,=1E3]P?=YVFA'&TOQQVHE&,OSE`6L< MQ-$;CQB1$&DHO/5D$0LF[$\\641#)'^<>+(20.7)5B+I;2$8(93,'];K6\\5 MP11I-%7G:R!^8X23^>.TH4*!+ MUP<]'Z0^Z/L@\T'N@X$/ACX8^6#L@XD/ICZ8^6#N@X4/ECXH?+#RP;H"G$&5 M.P(-:E,24?UC"N:JZ?7A7.X(Q[DJ3Y?NH-V6&OML8Z9BATB72(](2J1/)".2 M$QD0&1(9$1D3F1"9$ID1F1-9$%D2*8BLB*RKQ!E:&1X:6G,K/C$O&S.2VB4K M'`>;$W,I,L^&1U'),]CRMN(,=GBV&K4[IB6ISE8B72(](BF1/I&,2$YD0&1(9$1D3&1"9$ID M1F1.9$%D2:0@LB*RKA)G`.7-Q1G`?SA;C1EW9$OBS=:F=V\]BHZSE4B/2$JD M3R0CDA,9$!D2&1$9$YD0F1*9$9D361!9$BF(K(BLJ\09;'G+=P8[/%N-VAW3 MDE1G*Y$ND1Z1E$B?2$8D)S(@,B0R(C(F,B$R)3(C,B>R(+(D4A!9$5E7B3.` MIHAWP@@>Y.X06E0=0T9=1CU&*:,^HXQ1SFC`:,AHQ&C,:,)HRFC&:,YHP6C) MJ&"T8K1VD#NNIGKQOZA&E540>>U!0KTUKT#E-*Z^Y+2\1&Q5E;#H*M*.4=M[ M7^ZI"AY31GU&&:.$P9]1EEC')&`T9#1B-&8T831E-&,T9S1@M&2T8% MHQ6CM45Q3028.DDH`HKM]U]%@`SE,03*^]\*Y4!?-KB^K"R91=.)Q. M?CDWRVIN_KAEU+'(B:=CW:=R3HUK/YZ.*IQ3"EMZR?I`Y3JTJ=5FBJKF;USS MN:I@?@"DYH=`:G[$:,QH`J2VID!J:\9HSF@!I+:60&JK8+1BM`8ZV'+O,Z:8 MPV%QZGVF+`DY2890Q]1R_213(N\^XXU:SW9T[C/6EEZ=/IO/N&/.:(".:FL( MI%=ZQ!W'C";HJ+:F0&IKQAWGC!;HJ+:60&JKX(XK1FMT/-AR(\!4>$(1\,;[ M3%DHF:9\?JDT-9.7)&U"*Y MZ>LS0>27=B*K.OQ8R2YJ6R2S]M@QNJ'D7ZIB\P#[Y\>KIO_*D<*RWBK[0.HL M`PHZRZW*.HL:5]YI#&!&G0V!U-D(*.AL;%5-N;L=SS^.O%>Q"6RIQRF0>IP! M!3W.H9(9]VN/"ZC4XQ)(/19`08\KJ[(7]+IUZ5W0-I6)T1F6>9R M(M,B^:=RNMX+2\?\3L;<@33;=(&DO'+L6!.9MF-4_LZCX8=N"C/5#$7.,JB" MSG*HI!9T/*0X\IZ\!U#)F]I1%;6],QY"I6<\`@H>Q!@J]R"\&3N!*G@04ZCT M(&9`P8.80^4>A/=XL(`J>!!+J/0@"J#@0:R@<@_">U-90_6K@W#C76R=$N]& M[A7S+*IFXNC&NS(=\^,NTU'G$R7K;\ M$LH"=M3;$DB]%4!!;RO76_,J;GOQL(:=@SE"5,ZYYXP=\"H%.[SZ03N\,*.@LAZK,7=>1-[L' M:%=?0R#U-0(*^AI#%4Q>$ZC4XQ1(/4Y MH.'E^(Y5->7&JD\+L;?&T545[KL]1BFC/J.,46GJL* MY@=`:GX(I.9'BBKF:6%853`_`5+S4R`U/U-4->\ES;FJ8'X!I.:70&J^4%0U M[\W(E:I@?@UT,.^&DRFZ:PT"SSIA\@R0\1Z#Y#J&-53E"4JI;S\.&/6L]V M%!5&+84MO3I](+TZF465%>65U9E!^^Z MT?8&;PTS!V=.P)JM1D[`ABN&![D;F$"2?([Q%?M5C0Y4^I;?M$1Q[+WC#:"2:M-1Q8N(?!`C=`P>Q!@J MYR!HV1LJ/>TI>YQ!%?0XA\KQZ%>=%U`%3WO)!U&@8_`@5E"Y!^$](:^A^M5! MN+%]6C7HFG1YQ1`JG;==H."\[5F5G;=1(_8?V5/8T2S1!U)O&5#0 M6^YZN[Z.O>>Y`G M:575G%NBW^5E^RQ@"KH<06573YLWO@/ M`Q`E9EIWC1T!!CV.H@AXG4*G'*9!ZG`$%/ET#JL0`*>EQ9U2^'<`TS!V=N=/K%_=^D3:[AFY\2FDQ:39N\C`A5-6V6 M'7^7-JVJG'GQ3=-+9:FU[*1->TCJ+(,J.,USJ,JTV?(GV0#MFE*&%LD/6I"U M1U`%?8VA"B:Q"53J<9U`%/=+ M.ZPU^5)B_91\:>3>C;Q$E2I.Q_RJ0505U&748Y0RZC/*&.6,!HR&C$:,QHPF MC*:,9HSFC!:,EHP*1BM&:P>YF4;RH3.N_W`9T6S1\`>\1#*Z^O(8Q]Y/1#NV MHQ,#QXZ8O#U6I8SZC#)&.:,!HR&C$:,QHPFC*:,9HSFC!:,EHX+1BI'Y.*A. MMC(&RH]]EA^_>]Z\?MUT-D]/N[/[[0_S(<^K&RF0'7'YE=';FT0^(B##XO-V M(GO3:WC42,SNYIJ6N)F8Y>V:EN:E?,KT4*GTO32O\)%3KT46,,1:W9')=U$_ M'=*9U^-6OI=ZJ`O[/!9#M4*[M)29TV6[A)3;&=KLH*7F)H[M\A"7F+J[-QR M&[>2VS+=>$,O/VF0L:\;,UGJEI;:41,_M[5^9&TT,4L7?`2R1)J8!="ZEFMI MJ;LZ7;DZ9CV#^\BZ:6*6-;A%ED\3L[K!+;*I-#&;Q;A%]I8F9H,8M\CF49DQ M=2VR2RLQV[*XCVRZ2LPN*VZ1/52)V33%+;(E*C%[H+A%=CC)L=6UR!;?Q&S* MXSZRTU?\U+7(5M[$[,?C/K*C-S';\KA%-O;*L=6UR,[=Q.S(XSZRX3E):UMD MWW-BMB5R']G^+->M+MUD44M:ZF)4=C-*2YTUV1.=F%V,[$>^`9&8+?_XW#&N9K^87K M\G_V=BO]Y^U>ODPMC[7R45CY$OE&-A;+UVG/S[YLMWO\CW%P_+;YQ_\7```` M__\#`%!+`P04``8`"````"$`HFK]/7<+``"/.0``&````'AL+W=O[X;_^>/ZK?Y>'0XKG:/J]=NU]Z-_VP/X]_O__ZWV_=N M__7PTK;'$7G8'>[&+\?CVV(R.:Q?VNWJ<-&]M3MJ>>KVV]61_KE_GAS>]NWJ ML>^T?9VDT^G59+O:[,;:PV+_*SZZIZ?-NBVZ];=MNSMJ)_OV=76D\1]>-F\' MZVV[_A5WV]7^Z[>WW];=]HU;QW]L=BUEF^9)S<"7KONJ3.6C0M1Y`KVK?@;^ MM1\]MD^K;Z_'?W?OHMT\OQQINB\I(A78XO'/HCVL*:/DYB*]5)[6W2L-@/X[ MVFY4:5!&5C_ZW_?-X_'E;IQ=75Q>3[.$S$=?VL.QVBB7X]'ZV^'8;?^GC1+C M2CM)C9.,1H].3G2B5K[*]'O>9'1^NH[TN\YD=V8;O1[9F0)E8Z>255#>A:BL4UT M!?0%5:R.J_O;??<^HE5*B*&XOI9;5%1*2\/RLW=F.*F MLCG0@OA^GUQ/;R??J8C7QF89L>$6N;50%:O<%B$H0U"%H`Z!"($,0>.!":5E MR`U5^%^1&^5&Y<9&M;3`)2L-$F$M;) M3I>(LN[388-8:N(7!)`"2`FD`E(#$4`DD,8G+%"ZF;!`/[EQ*C<\`YH$LY_Q M=9,/1C9Q!9`22`6D!B*`2""-3UA2Z-[#DG)Z]I4UCUT3?_:!%$!*(!60&H@` M(H$T/F&!*B4-M\TI%7T]"MK'KLF_O0#*8"40"H@-1`!1`)I?,("54J)1:I6_Q7!,Z>_]\-S M8%!0`)=!`3BKH0(0E8@J1#4B@4@B:ACB^5&2RE\?IRM!W0^#4C#(KP5$!:(2 M486H1B00240-0SQFI9[\F#]Y1TBT"J,+V:E=&A34Q%58$[JCE[+"=;2^2D05 MHAJ10"01-0SQ_"AMY>?G@YK04HREP5=G_0$A3P`5B$I$%:(:D4`D$34,\9B5 M3O)C5C6AE/.Y^X366RP9@P3S5>)U6!.#E2V`(@%4(JH0U8@$(HFH88CG1\DK M/S\?U(168RP-OD`S-0&H4$J=-AAO:92(*D0U(H%((FH8XC$K]>3'_-E]0JLP MEHQ!F/DU,0]K8K!R-0&H3`!5B&I$`I%$U##$\Z-$EY^?#VI":S26!E^VF9H` M5"2`2D05HAJ10"01-0SQF)6D\F-6->&>:OWZ8Q@MS5@R!K7FU\1-6!.#E:L) M0&4"J$)4(Q*()**&(9X?I<3\_'Q0$UJXL33X6L[4!*`B`50BJA#5B`0BB:AA MB,6L])R_-WY2 M8Z9:%_J;ID%!381/(IV5JPG4F&A5(:H1"4024<,0SX_2?GY^3M\[5+#!6=0@ M5A,@*`NT*A%5B&I$`I%$U##$8U;BS8_YDQHSU2*0U81&V7`ZS8V1?M'8O[8Q M1,V)>X(]#YYAEL[*UDV%J$8D$$E$C4%T("7W/#M*^?G9^:`BM%!D20"4IR`G M"XLH8UX:@F=YI;-R:3"^W#NCVEJY+`N+N/O@J8!T5M9]8U'OGF=&";PS,J/U M(,L,H#P%U5A8=-6_*DRG2?!\JW0&=M2517Y2P+.P5H/G(-W2&5C/C461?"@] MZ.=#KZ,+)`5 M$.3*B-;KH6-E._JY,E;.O;!6KJ-$U%B$V5'"XV1V_NC>?I8="M.FIW?#!:I% M=.<=`D_#9QO6J/]#BS[3A45J>H87T?.@8VFM=(TD2=!>V7:7E]HB=RUAT#.43V&0TMY>QR!- MI;5*]/O^:;C!5]:@WX'[":KQ8L):G;R8M%;V8K-@-(TUP.T^"T5S9+'ZY8C: MN/=`N?7+,9D'4YE;*U=2RV=_U,HV\+2Y'5"`J$56(:D0"D434,,07 M84Q+:K02B"2BQB!2$>2+ MYT=I97_%?$H^9%IQLX4$*#=6+#O:2JUH+SO!\:TT'S0'R+2<)6VLNKAUX56IG4SRY1&_BK3Q%]EQD;OOQ$U:OS2-N%29"[E MLE8;*^=8N'YJ8R?'H1AU!M9Q8U#DV)(IM0OYNG1BU";L@WU9BV:6)(/8_>TF M.*_E_?5IE;I;3F&1FK(3>LNXU[><[#I8GY7UXM_>3!=W+6&M3EY+6BMSK32X M23>V/7)[4P+93^\':00%O\P,N._-@\1K M<>_M][FQ\E"!J$14(:H1"4024<,0CSG4X9]4"S,4Z`91Y'X!!$>$W%G9958@ M*A%5B&I$`I%$U##$\Z/4\:]O0#,MIOU]W""O`')$!:(2486H1B00240-0SSF MOTA?T]<6H8(T**B)X+B3.RM7$]J7E\42K2I$-2*!2")2WXJX/T_0^='??N@_ MU=^V^^A$<]IFEU-+?,:"%O-&,QKS-['=4;ZI%,:=7__"OND-#9Z%1;K M0V.CET"Q%AH;G:-C+30V>B`=:4FH#QWM8RW41\N=<&P)Y9J.@;$^5]1R%6VY MII9>=X"W.;7TJB%LH2[1'M0A:D]ICF8YH2S3G^O%QDM9UGM(>.V$LJQE:-!2 M9->+DG0J>B/%NY#1%OHDZB$Z8^KR$4]+-<4QKDHYPA]FBP=:1CBDI:K)&*<9 MC$X@S5]L^NAIZ4(]'L4KT/-T&FNLA<[O--KHU;/+Q9*.1NB-CKD+=9C#%CKM M4G)C8RZR*VJ)]:'#*8T@UE*DU(?>D>!UEA3/,AH/O>18J.?4V(?>=2S4FXQ8 MRYQ:8L5*C[>I)>:M(F_J&39ZH_<@BSK:0J]#*)[8".B=`+7T(Y@,E4R?P[VM MGMM_KO;/F]UA]-H^T;8Z[<]2>_U!G?['T3S"_M(=Z4,XDF#TB11]^-C2IRI3 M=5)]ZKJC_0<-=S)\2GG_?P```/__`P!02P,$%``&``@````A`$^M]R\H`P`` M^@D``!@```!X;"]W;W)K5[L-5[%]EJ[2TC^OC->,+X!Z0O"P\PY>5*"UF$A(X\XO`BDK$HMB'Y_>OQYI8XVK`B9IDL>$C>N29WJ\^?EGNI M7G3*N7$`H=`A28TI%ZZKHY3G3(]DR0OX)9$J9P8>U=;5I>(LKH+RS/4]+W!S M)@IB$1;J(Q@R243$'V2TRWEA+(CB&3.0OTY%J8]H>?01N)RIEUUY$\F\!(B- MR(1YKT")DT>+IVTA%=MDH/N-3EATQ*X>>O"YB)34,C$C@'-MHGW-QH0=[6L"O1'\+UN?'=T*O=?E8B_BX)#M:%/V(&-E"_H M^A2C"8+=7O1CU8$?RHEYPG:9^2GWW[C8I@;:/05%*&P1OS]P'4%%`6;D3Q$I MDADD`)].+G`TH"+L+20^$(O8I"$9!Z/IS!M3<'8[,Z(S,6"Y,Y=X:FC3^,,VX M38/*Q]#3RW08%)))4T1PPK<96)^J@RU=$-74]3%"#(+>-/7T2VN=8`A.I0W& MPZK!J9G$9;7H7)'7U;66OK:@#8O:)MY\!.Z7&3"NS6`M$-C0,AG6,FN37F9" MYS:3M?2UX+[MO!(3[ZH2C&KC6TM;R718R;Q->5D).K>9K*6OA,(\=Z70VZM# M7H6U&0ZFMIA@6`P.:Y/ULIK*NT.&`"$9T--9#3AF_O1J:^AA)U2;T+ZC!U-; MS^R,GLZFN*+'OOX@JWYIZ+F-0`=6`IU?UU,OA1/%T`JX/:,'"/ZC/^C=Z8\U M#?1G8`U0__J\];<`W&$[`LTU,._HL9?6GK.#^2@,W MM_J:PG\L#K?(P_V72&F.#\#LUO_:5O\```#__P,`4$L#!!0`!@`(````(0"` M&3=0*@8``%H;```8````>&PO=V]R:W-H965T&ULG%G;CIM( M$'U?:?\!\6Z;YF*/1^.)`E%V5]J55JN]/#,8VRC&6,!DDK_?ZJZ&[BK,&/*2 MC*G3U:=/51\:>/KPK3P[7_.Z*:K+SA5+SW7R2U;MB\MQY_[S]^?%@^LT;7K9 MI^?JDN_<[WGC?GC^^:>GMZK^TISRO'4@PZ79N:>VO3ZN5DUVRLNT65;7_`*1 M0U67:0L_Z^.JN=9YNE>#RO/*][SUJDR+BXL9'NLI.:K#H454KP4YZ+]KI*Z3ID]_G:\5'7ZG_8%K$#*[M3Y8>=^%(]) M*-S5\Y,2Z-\B?VNLOYWF5+W]4A?[WXM+#FI#G60%7JKJBX3^MI>78/!J,/JS MJL"?M;//#^GKN?VK>OLU+XZG%LH=P8KDPA[WWS_E30:*0IJE'\E,674&`O"O M4Q:R-4"1])OZ_ZW8MZ>=&ZR7T<8+!,"=E[QI/QMDKTU;E?\A2*VH3^+K M)`&PUW%_:I(5$E+K^Y2VZ?-37;TYT#0P97--90N*1TC<+0QI]$L=6RDL42;Y M*+.H7+"(!LKS]5D$_M/J*TB::4R,&-@1!D,128>0E0!Z/4=8..<80`EOB]]1 MDH,H)3^D\\4W(!21#!$/7@\A'$$[F^/[W"1XYX:V%$'0YU62QHC!9I(:)]8% M,C.DF3ZS!$/SV3-[O%"(V:HR+OR(A1,2%EYH5"6TH*]M6K*QPM$=TQ5-#N+" MF/PH#&(L8:P+A,&:,GB_)!+,A`DB5A+$1$H87W!=[.AVVP\EE#9S*$DPI[3N M\Z(8B-&4:"RQ8R-=*^]/;/??WUER$.>UH7/'B$%>1@O%.;%CBX=^(!%J^R/$ MY"!.S.1'P1"#Q`1G1H*1V9&$F@#KF2^:&L5;F\T?:Y#5V_85RH(9]_O=+=!: MR;X/34^@-!JT1O_V?`Y(".!!;,W.I-287]^AAAYK4PL&S!"#55M$;%\FP@Z; ML924M$^KU>^0DFC:2H'H.U7+A1A-RO?9%D@$BQO6E-@L_Q9#`Q_>:!'3$1., M>*)SZ+BA36E)5YVN%WHPK-C+$\7-TP]9+8= M:U#7]1O3/^A6.JY9BX>QII]E[6+H[4.Y;/\6GFD?S8N$P[$R,H>_T_9#:Q_J MA1C4:R&\[8`8\?=P;=J`-ABS^#O,AMX>FA[1&Q(QFIGOKXTF6C("$&%H_)=0 M\YG#OT]-H:E76&V/\D'HJM<6#*<);URP=8<'7@ M9UF_:1/=:)WURT=C]32CAZFC#IU]EL7[MRS>**]G1U"W^U@XT3FZL@9CLLQR M>'_H\"(TF34QV\,7P:#+2=@ZCE'!9EF\/[1X8=T\-"_;PJUY=>E&HI35+'OW MA_8NN$O&&M25D=E_0L-BK(QRKTVW!87FW%FO^Z\>U2CF]/P$%6N0Y?3V%$G#OP$4.;U,4_R\[EQLNI5 M?KX0\.ZGOXJ?5F+XM**^0ZSZ`'S9N*;'_(^T/A:7QCGG!QCJ+3=@"35^&\$? M;755;^!?JA:^::@_3_`-*X>WV=X2P(>J:KL?\IU__U7L^7\```#__P,`4$L# M!!0`!@`(````(0#/1`C97`8````;```8````>&PO=V]R:W-H965T&ULE%G;CJ,X$'U?:?\!\9Z`(9"+.CT:KCO2K+1:[>69)J2#)H0(Z.F9 MO]\RQN`J"$N_=#JGC@N?JK)=,4^??A17[7M6U7EY.^IL;>I:=DO+4WY[/>I_ M_Q6M=KI6-\GME%S+6W;4?V:U_NGYUU^>WLOJ6WW)LD8##[?ZJ%^:YGXPC#J] M9$52K\M[=@/+N:R*I(&OU:M1WZLL.;6#BJMAF:9K%$E^TX6'0[7$1WD^YVD6 ME.E;D=T:X:3*KDD#\Z\O^;V6WHITB;LBJ;Z]W5=I6=S!Q4M^S9N?K5-=*]+# ME]=;624O5]#]@VV25/INOXS<%WE:E75Y;M;@SA`3'6O>&WL#/#T_G7)0P,.N M5=GYJ']FA]BR=>/YJ0W0/WGV7BO_:_6E?(^K_/0UOV40;<@3S\!+67[CU"\G M#L%@8S0Z:C/P1Z6=LG/R=FW^+-]_R_+72P/I=D`1%W8X_0RR.H6(@INUY7!/ M:7F%"+!;C<8/N63/Q[';><$/CLG\-_\[`V1S[8\@J1)GI^J\EV#-0<9 MJ^\)7\'L`%YD78@L]I7RJ%"@0KB3S]Q+ZPMJH(;J_O[,F/ED?(>*3#N.)SBP MH2@7__U7+!QUU<*FLY#U.C2VZ;(%^9A MR084""D042!6`*2%P5&HBEFVT;2CJ"IZ0':DZ3+MC7U">X1G=$43BJPD0-&< M,49&Q2\.`V\H%A&NQ/`"B$4$! MH(>'QV2W,J'([XU#`&;H84?O-CUFD68LZMU-/"M^/!B'@/+J)C@>J=]C>V4BMTA:)8YI1)!@AX0B)1DBL(E@-[TX4 M-?,=%Q.]#,X9;;DZTH,M379#PXJ6"%^4-"3AG+-HSA@CH^(7R^<]S'+YHN/! M\LE2\IALBUH]HW*5UD$_1<+>@^1$(R16$:3((LW7?$);-FFZ1F=41YI.:&^4 MDPUZ9&*7#>>,$3*27QGQ`R,6_Z&6RYIJNI*$6/R@.H8 MR@$U0J(1PM\@B*X!:D^H%"\$Q(UOD56OF9]=K[66EF_\LI]/L4?%BPB/'3R+ M7S82W&<'N'DXAQWC$#G`=.<9C_@*$XT;_8'C_<$]>L]^3 MZC6_U=HU.\.4S36_YZ_$&PSQI2GO[1WJ2]G`FX?VWPN\:&ULK%I=;^,Z#GU?8/]#D/?;Q'::+[2] M:/P1V]@%%HM[=Y_3U&V#2>(B3J'I,'8K4$<78OOG] MVV$_^%J=FEU]O!T&5^/AH#INZ\?=\?EV^.`,.QN1V^G,^OR]&HV;Y4ATUS5;]61[CS5)\.FS/\ M>7H>-:^G:O.H!QWVHW`\GHX.F]UQ:!B6ITLXZJ>GW;9*ZNW;H3J>#PG=87/Z\O;ZV[8^O`+%PVZ_.W_7I,/!8;LLGH_U:?.PA[B_ M!9/-EKCU'X+^L-N>ZJ9^.E\!W*Z9MO8<) MP+^#PTY)`S*R^::O[[O'\\OM,)I>7<_&40#F@X>J.6<[13D<;-^:>^V!38<)5[2?7X7S MZ^!ZJL+L<33%@7#%@:%-3\^X&8Z#Z^CPN<"!< M<>#BHID&H#DC`24^L[R],8Z,A+0BD\UY)B$`LW06+-*%&W0YAM[>:".>7W?;+JH;%@W7N2$`$!=*4347BQV^0 MJ"T6,0)P:<40+)@8DM:(\I@*)#-($"IJ+Q(X[F0DT%!@('_4KSJ0RZ-2A'Y4 M!G&B,L`49-1&!4>[+_&D-6JC$DAFD(ZH5+,L#S:[/A16Q_J`^FB!%(L?BD&< M4!!8M$N6""052&:0CGE#*^#-NW]^RMJ?'R)0R)S,3OW,QFBD>UQSTB*B%IU. M\&`^\X>EQBA4^H4#/IRS$SY#DIF0F.HLO*A^:+=H%C]:@B"=[;Q#/N^8K)PU M0FBBMX-.04J0"2]@.0RS8>[`Q4MEW8:,X:QA5:>4=E M.&?G:6RMJ)`D$DHEE$EH+:%<0H6$2@_RZJ]:4B]__5M>FS-MN&V+%G.,5LY! MFD@HE5`FH;6$<@D5$BH]R(]9-1!<,\&U+<\7'9^!:4-`FK2P*X2<^HR(^2%M M?E6885'OF9H2T[0ESR2TEE`NH4)")4(@"WX>J[:R-S<7[B!%PW0BH%@[NQUZ M.C%6$51S6U,C5@]2'`A6E/N,(/M39TV0KAI:F3E!'OTUV[.%M2+Z$J%0T_MJ M4KW-SZL).R1730**`P-Y"3/0)-"U,QP'K)%)<0P84#`9T;BY$LRY':A.7&!F MJU!8`V(N/68_3:I9ZDO3A<+"GLM&LPH,Y.XZ@[B[#FW@TLHJX#U?2DQ6,!E" M9J=H#:T1LNPYC;-R+"14>E1^;E1#YN;F@R*,_9N;`P-YYS-OU./`&-F))X@X M-2R54$:0;5?6@BHG(SNI0D(E01V%1_5OG\@!MGO6W2I`R$\".[5CLG*;%!P( MI<<1!^\_<2`VH.&$/V+*B-FJ9TV0=983U.NLX,YX6U$2C>R(PE_2[FH6OX`3 M!"IJTQ0NV$.5F*SL7D@0M@U_>>NM&5G6V]:;BFQ,5E95"4+09Y-52I!IJH/YE.4M(QI'KP19 MYIQH+'-!$#(O)NR)0$DT'>+L:M?=UNNR4T`I@K47!-DS+2;(E:(9",ML\X20 MM>7ZB?J7S+(.3+ M1Q1TM+)+GB#7U(:7$@35RCD<^&,,FH37ALF"+CSF1&\]%@3Y'MFI77[DT2_H MJ@D6F?Z99RFA::N=!FM%D%NHT,HJ*$&KJ=592I!Z0`A/P'A[E^%]*#BV:@GB MG%BL54&0(9X$[.=0Z1'["5-MM4B8\TOZPG)NNG,O2P@Y77V(D"M$A&SM2.":ZR*Y8 M#.35,82L588#/7T(KIRLW)TFN$JRZJA6G^OCH="*LG11'T\#736T?3QM@)2L M3*NRF(N"A$-<:2!DB7-B<:6!5D@\956SI"%2)^KAI*>3'RKGFL7O!@B"U7)* M,)M83%96&`E";G].D'\TL,*0H95J<5J/LC^7'G.B=XH00:['B!^_Y4<>O>H4 M_?+^7#.RK,O^G*RL@A*$W/Z<(--I3`+^XX=8'&D29(ES8G&D21`23_F12"P= MTE2ML%O"N#0O*^>1Z:C=TD:0<^@1Y`H16W%;>U*T@NU$>SHCR(IG+;ERLK)< M!4&6JR1(UK%(=;I]N;CH(;%F88)1Q+IIIXABLK+KFB#TP8L3LC)5*)Q.V6&1 M$;,K(O1OG>5$`WV7W3:;`DJD52JA3$)K">42*B2D/N&S\S*Y,)_DF0^@#M7IN8JK_;X9;.LW M];D=G*AW-RU,WP*&RWM@@M#8'7CYM%1O=;KN1'!'MTU\3#2A3PO9'?CF\+Z; M"ZBZ?(#S3GMPW>7Y?K*\-]6`.5[!C#K#NU["QP\R.'A^OU1/Y[ON3.&.;M28 M#WAT#U%TW4F"V5(]\^UBFP%;UQUX9`IC=!EC?N`)*(SINA-/E_!)A/02@_LN M'S&XZ.))@@EXZ,P7Q+CJC!'>L2S5:P/I/8$[ZD5*UQV8<.<8>,NR5&\/Y!AX MV;)CKYKGZ]^;TO#LV@WWU!$(?Z_=L)_/EJ?GCC%]Y/-1G^&(4 M:B-\"@A?"%?P2=98?0KR5-=G^@-?#1OWG6_1EK2I= MGY]W^:DYEQOU>]FI7Q]__^WAO6E?NF-9]@HHG+N->NS[BZ=I77$LZ[Q;-)?R M#+_LF[;.>_C:'K3NTI;YCC:J3YJIZXY6Y]5990I>>X]&L]]711DTQ6M=GGLF MTI:GO(?Q=\?JT@FUNKA'KL[;E]?+EZ*I+R#Q7)VJ_CL5596Z\-+#N6GSYQ/, M^\-8YH70IE^0?%T5;=,U^WX!WQ@1KT;U6^=Y/_E>[8O,=MM?NC.I?@-JP368'GIGDAH>F.(&BLH=8178&_ M6F57[O/74_]W\YZ4U>'8PW+;,",R,6_W/2B[`AP%F85)AU$T)Q@`_%7JBJ0& M.))_T,_W:M!3B-SL%(9'!PZ?/'Z],->V8=.1WQ@M9#YM")^BH\72M%=K M.MH;#5W>$#YY0W><)6ZG,:?IP@5YGS\^M,V[`KL!S.PN.=E;AF?`@HLE8Q+# M(OYL#<%XHO)$9#8JS`+6IX/$>WNTU@_:&^1*P4-\'&+,([8B@BPG40UD$,H@ MDD$L@T0&J0RR"=#`E<$:R*!?80V1(=:(6?D"C%Z9DA$B0C0)9!#*())!+(-$ M!JD,L@F8&6%)1ES?SB(52/1&A9TSIH(N3=!G,?P,($N]121`)$0D0B1&)$$D M122;DMG481J_(@>(#.PPR+31%'E_L!AR2(TQNB5EQA`TI`8B(2(1(C$B"2(I M(MF4S&R"0<]LNITA))JZ(2;A,S+-!T0"1$)$(D1B1!)$4D2R*9E-U)$F^C^/ M2R(S=X`1:?67TNH/0<*X`)$0D0B1&)$$D121;$IFIJPD4VZO/HF>SYV1Z>HC M$B`2(A(A$B.2()(BDDW);**D3L4/R\4*TJ4_5L6+W\#6A4U^Q0`+'HKL44E$ MYO-GQ!J>$%L&6(5$'X0?&0+++1PA*G-'$-DR,LF1@!$;QC9X8EK2C@F'H,$31JSQ>1QS MLAK\3X96$VG;G=N=#D%".F/$I-*SO"&%U4V?[DHL ME$\<3;88)^-<`D'(9A9%K+%&5C%Q>VP8B?[H]J![/!9:8TIQ8KD#2C'*9E+S M%"+%V=2;*V?,9$O!7D4>,.3`,3[,S]*E^6U%P^4PSD"@N3$K.8>8O$D..DB% MI2N5+I&0&?=9+-#862+0SFX8@4DZ7E(0<@4V3D>-69%P+6< M<7ZA0&Q^\*H]5XE$]]-T0\*)4!F%4X&8\-)&J<55KJ06)"WV#6X?8+JD/!#' MU_VU`KD\D8\RCL:#>2NBQH0(.')@4PY.&VNT9YF6P_;LTC&EDB+B,N8T^WC_ M8V?)79VE(HIU9CN&-!IR,T4FRSIC>Y;=-+$+B[IL#^6V/)TZI6A>R2V2299H MP.R*RW<\*%1AK\I\Y4%=AWGFPI4877VI`3P/O)!M>^F7!'XAAS<6@_NU)VJ5 MU,(G]VY7XGW3@Y=NK.-;'KR28OZT])[`)?R#O_3@Y>P*MSUXE\$\6'M0YF'N MNYY_U8VMZY'*`K<(7`^*K"OKA)IE7J$F^,2 M+B-TLF/W3=.++]"U-MQ%/_X```#__P,`4$L#!!0`!@`(````(0"T3(Z^I0@` M`-8D```9````>&PO=V]R:W-H965T'ZOR\&?_U9_QE-1ZU77$^%,?Z M7&[&/\MV_-O#O_]U_U8WW]J7LNQ&P'!N-^.7KKL$DTF[?RE/17M77\HS7'FJ MFU/1P9_-\Z2]-&5Q$(U.QXDWG2XFIZ(ZCR5#T%S#43\]5?LRK/>OI_+<29*F M/!8=W'_[4EU:9#OMKZ$[%1-TK[O)ZL)\#T<'^HH`=<]E%3/FW&7UF0 M>XOQY.%>"/1W5;ZUQO]'[4O]EC35X3_5N02U89SX"#S6]3<>FATX!(TGI'4L M1N#W9G0HGXK78_='_9:6U?-+!\,]AQ[QC@6'GV'9[D%1H+GSYIQI7Q_A!N#? MT:GBU@!%BA_B]ZTZ="^;L;>Z\U9S-E]`_.BQ;+NXXISCT?ZU[>K3_V044UR2 MQ5,L\*M8_,7=?#GUV0TD,T4"OW@K5]\`W*KH!ORJMHS=?`,+10*_2'*W9-.U MO[Q>"9A7XD;@]^9.K%5;^,7\MW>"@87DB'(OJ<&ZMAL3Z0YAMK#HBH?[IGX; MP0R&X6\O!5\/6,`SH,VD)WKCO><[,!QG^X-&;,4QVPPMSNX-; M&:,6+C[4.X*$!(D($A,D(4A*D(P@N8E878=N?(8'.`U,,7":(8H[06007UB- MH(6MW*X/ZKU!D(@@,4$2@J0$R0B2FXBE$]RTI=/'%N'10@[LQ%8BIB$($A(D M(DA,D(0@*4$R@N0F8G44]A"KH__G@LEI;`4DXHS^TAG]/@B%"PD2$20F2$*0 ME"`907(3L419.J)\//H\VNZ[1'Q9>XCE@"`A02*"Q`1)")(2)"-(;B)61WEU M_0G;):>Q%9"(WV\2.PG(RD[LA1+P8`;VJP-;3VU_1'T0^B,F2$*0E"`907*) M,(_?H24)%#6?(0FGL261B"&)!`Q))+"$LJ67Q&$(`E!4H)D!,DE M,B`)+Z0^0Q/!8XNBH+EX\A!%TDY!2SU[0AVEE?%\9[^)=%0O#7)IU1.$-'VJ M&WY`G^DHI,^12]!;+N);XX!D=[Q"[UZJ_;=M#6,,00-+BP\%IRI#92D'9)AR M*X@W8TLP&64)IB!/U*[>E#D%2Z1HEL+_(EF,D*D584XQJF=V1B'3`7C/.4(# M,O$2C2Y`6J8_Z\M[,L'6TNLD*SW(@SFW8&,^`3WQ5*J,I:+6?51(HR(%+6`V M]+.0K1S]8FRH]4L4Q#1]BE'Z)K*KZ'-L2).D%(9TL1 M,F^39,OL;&PU94Y'RYRJM`4])?2"F+1DM*!<&FHJ7TG,UL!QJ*/4$; M)%20X=(((1T5(V2:C7"E&&6:349YFBO'J`%G\1KQ!AEXN+.8*PC\8'_`)KQ=O$$B6 MEY9/%&3[Q)D7.Z:B]*B%"K)\(J-@;,7QA#UM8VQ@6H;0IAAE6N8CVAP;#+B' MUY@WB"-+4DLV.[9B*,MVC(#W($4;)06;.3(SQLFD>PIMBE.;-$)*\ MSJ:0X]4!Z_!R\P9U5'5J[F<*LJWC;+X[IJ),ZTC(LHZ"F+`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`"Q^N$`G-%N*/!]FRS!*9EO`2V[[<8!_LL`%D,GD+)>?(,BWPJ>R>2YW MY?'8CO;U*_^\`*;8PWT/RV\?X!POX(=4<+_.%?@JXJOHAX-OX6N)H?BM!U]1 M#/!L_0#>R0WPSX!?U(5N@ED`+Z=H@^T\@'K``[% M!_!U`"?#%-^"1/SLD5Z!\]I@-W@%CFT#?BA+VX2,P94AMAC:\)-(V@8.;H-D M\`J#[H1+>[D[YE'VJZP[_@-23_HNDAW\```#__P,`4$L# M!!0`!@`(````(0!B'3@M=@8``*<8```9````>&PO=V]R:W-H965T5G6AZK37:>KNHN>S>=O]5G[6K9=U5RVNCF;ZUIY*9I#=7G9 MZG]]B3ZM=:WK\\LA/S>7'-LVCKOX6?[8G37MLP/U*D^&]9\OC3JO+KHC,%K'^%HCL>J M*(.F>*O+2\](VO*<]S#_[E1=.\%6%X_0U7G[^G;]5#3U%2B>JW/5?Z>DNE87 M7OIR:=K\^0QQ?S,7>2&XZ0]$7U=%VW3-L9\!G<$FBF-V#=<`IMWF4$$$1':M M+8];_COJGSO)O_7NE/S'K?5X;?J4H+:L$YD!9Z;YI68I@<" M@;.!O".Z`G^TVJ$\YF_G_L_F/2FKEU,/R^U`1"0P[_`]*+L"%`6:F>40IJ(Y MPP3@7ZVN2&J`(ODW^GRO#OUIJ]O+F;.:VR:8:\]EUT<5H=2UXJWKF_H?9F1R M*D9B<1)X"A((Y(Z#S1W@R1U,<[:PG-6:#GO'<\$]X\<1 MWM)`X@5YG^\V;?.N0400?@,F28$0@*$A`B)$!(C)$%( MBI!LBDB!PGDA!?H?-TY"(RO`$'GUS;FR^H.1$"Y`2(B0""$Q0A*$I`C)IH@D M"AR>DBCW5Y]8R[$S9+KZ"`D0$B(D0DB,D`0A*4*R*2(%2OIJ?&S.R,'=GZKB MU6^@=*'*;PA@P_'(#DU"(L?/$'LX*O8,8!T=/1$Y`!,;]@;35;(C'(Q$=D0( MB1&2("1%2,80TR(SE`2!'N:N(%^:ZX\$@>46BA`661&$[!DRR9&`(0[,;=#$ MLA=RQ82#T:`)0^SQ8(XYLAKT3P:O";6C;,7I8"2H,X98E%J2B;18=W5Z*'$H MBZP3AO8E+9HU-QU%I=%`Q!()FHE.`AKS,AD=2?,'S(K^Z6@@F#-! M(SS91,\ZM%L,\`\$E M"Z.T+Z&P6M(D6]BVG&.1>#^662R@<:Q$0'?'2KF513952#O75":3"1HZF*PC MZ?4^H"-K#6%=1/[Z)H>F&P]\4,OA[H75N-X!ARSZS4_S)!2020.!CT!E3X^$ MP32W^/@C\UY*"F5_LBNR%E:J MYFE72XMR#S=Z1'/I!$50B*TB#,482C"48HA<*XZ38%JP:T)VCU.7[4NY+\_G M3BN:-W(%"$NTVPPPNY_TEQYT[;!SJ?C*@R;W!FZ"`XR,WV0NO*!%HE#!L>F% M3%#E30)OR!F'R>#:](DFE.+AD^O4&_:^Y<$E!>;Q;0\^W3'^M/">;D;A+SSX MAL4.ON/!)Q_&@[4'W3#&?=?S;ZJQ=SW2@&&/P/6@%[V!FW.0[Y9'Y'JD"<,N ML>O%-U\DK@=-*7:`+@T6@E(9@^)P37S-7\K?\_:ENG3:N3Q"#LWI'M^RBV;V MH^<=_'/3PP4Q;>9/\`>!$BYMYF1?.S9-+W[`T,;P)X;=OP```/__`P!02P,$ M%``&``@````A`!`W&ULK)C;CJLV%(;O*_4=$/<[!,@1)=D:PEFM5%6[[35#G`1-"!$PI[?O M,CX`7NPH4_5F,OE8_HU_+]LKWGS_*"[:&ZGJO+QN=7,RU35RSJ?I-:_[W[]9?->5B_UF9!&`X5KO=7/37-S#*/.SJ1( MZTEY(U=XT2B/QSPC7IF] M%N3:,)&*7-(&WK\^Y[=:J!79(W)%6KV\WKYE97$#B>?\DC>?K:BN%9D3GZYE ME3Y?8-P?YBS-A';[!5:5=7EL)B!GL!?%8UX;:P.4=IM##B.@MFL5.6[U M)]-)S)EN[#:M07_GY+WN_:_5Y_(]K/+#;_F5@-LP3W0&GLORA8;&!XJ@L8%: M!^T,_%%I!W),7R_-G^5[1/+3N8'IGL.(Z,"M;B\F\^74-B%<>R9U$^144M>RU[HIBW]8D,FEF(C% M1>!S1.1.0YLWG,F&EMWU?JS1G$VLU-^<+^MYW6BYX2U@`O.6# M7:YY0_C\8I4KDO3H;)B MNMF`90+\;/YAXJG*$Y79ZF`!3&T-2?NVLY?3C?$&B9;Q&!?'F,.(O8B@645E M/17X*@A4$*H@4D&L@J0'#+!%>@/9]W]X0V6H-V)4K@"=699BA(@033P5^"H( M5!"J(%)!K(*D!P9&P*H:&#&^%XA#@?['#9/*#!U@9+:4^\2>D_ZN:JZ57=630<)* M'Y$`D1"1")$8D801J]W*!J8L1TV9+,'%YIQG+VX)&0W)/Y(5-IP6[`RA(D-+ M&.E;PDE_'5FV/=QT(ANQI\NBAQ96JS)TAZ.^/0+UUY:Y4DWJHL1X?(P"COH^=5%=+B'Y MJ(L2\C%&R4!^:!B\_5W#'EMV]*!6\DD@J!1ZRTRQ9R^B%G(7]P1B/Y;HT>8+ MM&@KY?5<.>,#\;P["T*!.N%(H$XXYLBBF^K;SES.E6Q,1)M6>>@<+?[N;5B/ MI1HK(:$;,7^NR1%L`3WC%L/%M^=1UEHV]#B:61+Y`K'QV>IA&`B5KDDH4"<< M"94N*A:(":^6RKPF0J5M,O2-EH[(-_C)RX\^D7"/GX,F*T8''C(T:W_WM_O. M7D1U">%Q-.L2PA>(99IISU"J\<[ZJ<91IQP)F4XY%H@I6PNUQ$]X@#F2:K2* M1);-NUU->#92+O3.1K@%08NT7Y]RGQ#R>$.0$DGJ8Q1@%&(4811C1"]LZ*NR M'EGZL`L8]EN\(-6)[,GE4FM9^4HO5RP35K#$[.;'-6?BZD=Y$JX=.%5@,"HW MIP[=/_&39`528P_@>NFI37)%RJ773B-"KN7`ST;<@6L[\*,*\Z>9\P1NX`.U`P8*$]3`(](_&38.70DQ(_"%<.U%#`#=D'7+'=TA/Y/:U.^;76+N0( M63)METS%+NG8EX:7E<]E`Y=K;85YALM4`L?.E.Y)Q[)LQ!?:@;R>W?T+``#_ M_P,`4$L#!!0`!@`(````(0`_<`/UV`H``*XP```9````>&PO=V]R:W-H965T M[QH_B>-J6A[NF MU[IJ-HK#IGS:'E[NFO_Y)_CKNMDXG=>'I_6N/!1WS5_%J?GW_;__=?M>'K^= M7HOBW`"%P^FN^7H^O_GM]FGS6NS7IU;Y5AR@Y+D\[M=G^//XTCZ]'8OU4^6T MW[4[5U>#]GZ]/31K!?_X$8WR^7F[*2;EYON^.)QKD6.Q6Y^A_J?7[=L)U?:; MC\CMU\=OW]_^VI3[-Y!XW.ZVYU^5:+.QW_CSET-Y7#_NH-T_O=YZ@]K5'TQ^ MO]T+YK/GA^WO&:[?O;JH/^ MNRW>3]KOC=-K^3X[;I_B[:&`WH8\B0P\EN4W83I_$@BD.&V@1T&FU>D+I4VY@PK`OXW]5@P-Z)'U MS[MF!P)OG\ZO=\WNH-4?7G4],&\\%J=SL!62S<;F^^E<[O]7&U4M4B(]*0(_ M4:35N>Y[_8$0N>`(I55T^"D=/:_5Z_2'UU7X"YXP?BM/^"D]^ZWK?K\WN!Y> M#GDC'>$G.EZLH@<]4T42OTB/8$7Z3BX'`J*ZU#PB_3H?*Q5 MWA!=X1?IZEU=J&:['@?5L)JLS^O[VV/YWH"Y"ID^O:W%S/=\#WH7!U2="S7$ M?C?"8&@)E0U<1*DKV^*2-TFS`R921@9,9(R,B MF+5>*2.4SG5I([LP;[XBNT+&S"XCXYKHV54V6F-ZUE"=*B-L3""%M.PRZ5!Y M:=)]:^F>*R.47C#IB$G'BNC2UOYKJ8Q0.F'2*;/)%-&DN]9P7RDCE,YU:2.[ M'IP*OB*]E8Z97X[&$ND9)BNM13UKO$[)"IL4H):69$2T^(?DJ,GWK5S,R0KE M%ZA%\A$BDH\)Z?)6/I9DA?()(I)/$9%\1DC<6'2N/&OHK\@`E7-$E;*9:W%^ MYWFJ70$*VQ1@%K45S-$U%RQL%>G'`48K]H>5GON&9,*N=^( M*%J(.A>CS=$*'F"JXSN>M<`N4)XB1H@H8HQ:%R,NT>IBQ`3E*6**B")FJ'4Q MX@JM?MNC.4I7TQ+1-)](U*G>"E5S M>HJ(K`)$^LQG6B%:D=8<$6DM$)%6))%'5C%:D=82$5DEB$@KY5H96I'6"A%I MY8@J+3-'D'Y'CCY]0!+7A?9Z72/MBD(:T1(T(3=M"K$#,%GA0A(@HMZ9,?40 MC(2#UBZC$2ZOHE(EKQ$BZ5HI5:W3(D)+5"1%*Y(65F45QN M\)GV^2S*2Q(*.O(DTJ>:1#3`)M*J#R6T%+*C+EEA3P<2=:BG9QB1Y$-RU.7M MXRY9H?R"RT=&O)EP<>'Q%0FO M+TZ,M57>KJC1.18O3&%NZ]-6N6DM8F=?Z:>)!XCT=-OJ(1H9TY8=?\D*^VN! MB-0CB:CN,1J9ZO;]!EFA>H*(U%.FGJ&1J6[M0E9DA>HYHDK=S+6X_OB*7-?7 M*%HZ1N*EM5BU]1#^V$,&X MIV@/ M)V.TJL]QUU[/6J$"5*9#XPP1!0M1YN*A<8Y6,(UI!+*#,\Z5'S)6.58.Q?77R;6GY#MB^-+,2YVNU-C M4WX77QWVKV$545A]$OE0#4*+C^!3R6J3;O,.?$(I9J'-NSY\_L'Y0\]_@(KR M@E'/A^\.'+SOY]5Z;@6`38(OM@#<`Y[O_MQ9$D.)>/!R'WBJ^N*9R4O@^01Q MJJEJU0">+1#'50+/!8CC*H%S"ZA56PJF-@`U5PF<%D#-50(;?:BUJV3B#2%. M-1)8G"'$<97`1A7BN$I@DPEQ7"7Y$(:%*YUP"PH5<(T,N-2$"KA*X(X2*N`J M@2M'J("K!`[T$,>*'<)4<<6&5U*0)%=L>(4!):[8BZ$O7E/P#IG` M;'!-AM'0'SD=QD-?O)MQ*,'L<35O`FN.JWD36"-OJHW[L?[>O/[C M+#\I>2S/\)TX;`3@VV'X?P$%?+-XU8+GSG-9GO$/$4#]3X/[_P,``/__`P!0 M2P,$%``&``@````A`'([!,(>!@``J18``!D```!X;"]W;W)K&ULK%A=CZ,V%'VOU/^`>-\0(`D#FF0UA&^U4E5MVV>&D`1-"!$P M7_^^UQ\7L)W-9JN^#)/#];GV\;FV\>/7C_JDO95M5S7GM6[.YKI6GHMF5YT/ M:_VO;]&7!UWK^OR\RT_-N5SKGV6G?]W\^LOC>].^=,>R[#5@.'=K_=CW%\\P MNN)8UGDW:R[E&=[LF[;.>_C9'HSNTI;YCC:J3X8UGZ^,.J_..F/PVGLXFOV^ M*LJ@*5[K\MPSDK8\Y3WTOSM6EP[9ZN(>NCIO7UXO7XJFO@#%YR`ODIC\4^KHJVJ9K]OT,Z`S6477,KN$:P+1YW%4P`B*[ MUI;[M?YD>IFYT(W-(Q7H[ZI\[R;_:]VQ>8_;:O=;=2Y!;9@G,@//3?-"0M,= M@:"QH;2.Z`S\T6J[DK`[''J9["2,B`_-VGT'9%:`HT,RL)6$J MFA-T`/YJ=46L`8KD'_3Y7NWZXUJW5[.E,[=-"->>RZZ/*D*I:\5KUS?U/RS( MY%2,Q.(D\+Q"F'+L]HUVP$K'"T_, M:-Z7<<5;PA,SWNRAP^/AB9GN'!O4)NTC/#'376-S>3MX8D9SYIASUW9NBVF" M[9@+B/^X#:X-SF#NH68,\C[?/+;-NP85#O[H+CE9+TR/L*$-V4P,QOR>+\&0 MA.6)T*QU&#=8KH-B>MO8SN+1>(,"*'B,K\:88L06(XC;"6T@`Z$,1#(0RT`B M`ZD,9!/``%D&;:`J_@]M"`W1!D?E(S"*94E"8`0V"60@E(%(!F(92&0@E8%L M`@A"0)4K0MA@ENMK%7J"M%KK4.>#)ZR5-%"?Q?`%CDSY5D$"!0D5)%*06$$2 M!4D5))LB@@0PC*L2_&2=$!HH-7#<(`K4N#C[/@LBZ^@09*VD:MH.08-'%"14 MD$A!8@5)%"15D&R*"#I!IP6=;EN$1%,Y9#;6KJB MW.D0A-090RQ*+<@$?;PITUV^(22B2@JR9D'&<_0"AL1Y#A%8#?830U$D\X\B58-3(E2(T>5' M2.BW)57%%J-&'P4<6MQ2^B@HPL36[?V*?_'79'LIM>3IU6M&\DKLEDZP3`\PNOC+'@QT:JEK" M`]<+J4DD/'$]V-+4>+A`>Z(.DN)]. M!P%E_Q0_IZWA^K<::=R#Y,]IQ\G M+;MJ9#]Z?B9_;GJX(@0_P`407`F7\"$^)X6X;YH>?Y`$PR7SYE\```#__P,` M4$L#!!0`!@`(````(0#N<\T;;`<``"(>```9````>&PO=V]R:W-H965T=3KV[URPA&[1) MB(#MMM_^QM@#MH>EFZIOFNZ/\=C^>SP>S,/G;Y?SZ&M65GEQW1KF>&J,LFM: M'/+K\];XYXO_:6V,JCJY'I)S<L,C[O?O_MX:TH7ZI3EM4C\'"MML:I MKF_V9%*EI^R25./BEEWAR;$H+TD-?Y;/D^I69LFA:70Y3ZSI=#FY)/G5X![L M\B,^BN,Q3S.W2%\OV;7F3LKLG-0P_NJ4WRKT=DD_XNZ2E"^OMT]I<;F!BZ?\ MG-??&Z?&Z)+:T?.U*).G,\S[FSE/4O3=_$'<7_*T+*KB6(_!W80/E,YY,]E, MP-/NX9###)CLHS([;HU'TXZMJ3'9/30"_9MG;Y7T_U%U*MZ",C_\D5\S4!O6 MB:W`4U&\,-/HP!`TGI#6?K,"?Y6C0W9,7L_UW\5;F.7/IQJ6>P$S8A.S#]_= MK$I!47`SMA;,4UJ<80#P[^B2L]``19)OS>];?JA/6V.V'"]6TYD)YJ.GK*K] MG+DT1NEK51>7_[B1*5QQ)Y9P,H/14R<##>>B(?R*AA"7`_8PI&:T\"OL+6L\ MMQ:K=3/<@99+T1)^1+U8S)?K%3@;:+@2#>'WOKG!3)JQPN^'YK81]O![ MY]Q,B!J^B"Q\^`(,SV["HZ`)*C>ID]U#6;R-8*?".E>WA.U[TV9N,9RX0&V` MO1=?$%C,RR-SLS5@YA`Z%6R*K[O9N#CP= M^#H(=!#J(-)!+($)R-)J`U'^*[1A;I@V.*L]@DXL2Q,"+;")JP-/![X.`AV$ M.HAT$$M`$0*V.1%B!L'2GW,P)EBKK0$[O8T)"._<)(<W,]=KG.%Q? M$$D)XC5L6[&#'+QJ^D;M<_0:RUX5$:"X443@VV3,:K#ZE*?$')S(&P)Z= MSBS<(*8E-=;J"!RTVK0-78'@[4]NJ,GDH979[%ESNM8RMX\&38)M-D!`.PO1 M:K"S"*VPL[DVFA@-:#:'!'^7D+QX!'^=D`+)X6BNM:5TFGY`[BY&7$2#,>() M*XOEB:\[%$>M3%%`44A11%"M(50="[9>HP_QH)P!!#KL<`BLI>ER!9I#H MN@RWT=[-O,ZJTX?[@H:(`FH54A11%`MD-0>MJ@^K,>W%DTF*).[<:ZI\@1 M2%&'-YQ!JI#4T=Z_/-$0K%`*GZ*`HI"BB*)8H#YU6,%)U($[/!@NJZBP>OAX M>67R$E9).1S)NXP3>9<)&YY_>XI/X7?6>?&QJTZU0*#.<=BU>Z?^[`Q0^UAQ MK$83JTV)7HLNFE"P'Q0*O,151!((XXW5N;*\/Y"1E\6*C`)U%;=C M"B075QSQJ_6F*O*$E=59^8CD^"*^0K1J;MH;7Q&BSE>,B)9&K,*[8\Z-N9JG M$2FA,]5RC(-64N@@&EQ.#ZV4U^2-]AKGHQ7LXRX,-]H;4H!6W2!"1(.#B-!* M'83V0LV^E33;X[U!\+W,/X?PF^M+5CYG3G8^5Z.T>&6?.B!+[AY:S+_#N.;* M]B`K0(;0GD!^L:/>)_#MYK%9;:W%'K[I-,>(SBWXUM/3PWYFPTTB[?EQ#OZ; MH-,=S6VX4J,-]@L;;J!ZN`D]0/E%GX0;&]Y%*8]7-KR14NZ:T#7/3?J8S(7- M3DS:!DH*FQV<]`E4%B!MWXA=^XWM]?GQ5S;<#E#[8&4'?3R$..OK-US;<(4"?B:MY/"% M[I8\9W\FY7-^K4;G[`AA/6W.J))_X^-_U.)JX*FHX=L&ULK)Q;<]LX$H7?MVK_@\OO M:XN49%FL)%O1_7Z7]EFQE40UMN6RE,G,O]\&B<,FK#?_]X?KKZ??=VW!]>/EY'-Z7KJ]W+P^%Q__+MX_5ZU?G/_?75\;1]>=P^ M'5YV'Z__W!VO__OIW__Z\//P]MOQ^VYWNA(++\>/U]]/I]?D]O;X\'WWO#W> M'%YW+]+R]?#VO#W)?]^^W1Y?WW;;Q[33\]-M7"K=W3YO]R_7F87D[3TV#E^_ M[A]VKVG#^D)VNQW/X^%[U?'[X>? MW;?]XVC_LI.S+7$R$?AR./QFI/U'@Z3S+?7NI!&8O5T][KYN?SR=%H>?O=W^ MV_>3A+LJ1V0.+'G\L[4[/L@9%3,W<=58>C@\R0#DWZOGO9D:/ MI^\?K\MW-]5:J1R)_.K+[GCJ[(W)ZZN''\?3X?E_F2BRIC(CL34BGS!2OHGO MJU'U[@(K%6M%/F'EIA)7:_?I4`+N9:#I,@R!CK((TH[R:3O&[_-8 MMQWETW84$P%'D<0U.\TFP/84WM2B4KU<>_]ICG">S1=KI7P354KI60ZY+\.] M?+$=:^\[T@A1,5_^_LCO,`#Y8JW$[QIY#1WERX4C1W0C#6]T\3F/$3GS)1_Y M?;5:N;LWH0N<]1AKRWRQ7>OOFI1D>(")M(BTB;2(=(ETB/2)S(@,B0R M(C(F,B$R)3(C,B>R(+(DLB*R)K(I$B>`LJ>]((!&[08P(\4`$FD1:1/I$.D2 MZ1'I$QD0&1(9$1D3F1"9$ID1F1-9$%D261%9$]D4B1-`N;=P`O@W=\;&C!O9 MG&BZC4L5+]UFHD+X6SG1;E'=NVZW)>@S(\509Z0L4S._(,>EJCM#VKDH#S61+I$>D3Z1`9$AD1&1,9$) MD2F1&9$YD061)9$5D361349B#K54;(*A7AU>?Q5J"1MB;:RXL2;2S$@QUADI MRS0LQ/K.BW4NRF-MB=Z)=4G3RTG1M+>OZ^[4-?53`_`%+S M0R`U/V(T9C0!4EM3(+4U8S1GM`!26TL@M;5BM&:T`4IM.5<.<[MU9EI<>.E( MK7B3(JON2`O.=-.JG$F1J;S+AQ>UMNTH*MCJP):>G2Z0GIT>=^PS&J"CVAH" MJ:T1=QPSFJ"CVIH"J:T9=YPS6J"CVEH"J:T5=UPSVJ!C:LN=`:9BPV55G0'O MNZ*8DKYW2;&HG$>M:8F.O@5-/1>U&74LD@],@*Y%:JK'_?J,!A;)!TP-+5)3 M(^XW9C2Q2#Y@:FJ1FIIQOSFCA47R`5-+B]34BONM&6TLD@\QY4;:5'"*D3ZS M'2SL$:*LX",S!V-J`$F+[@"BLKL#:$*ER[4%9#:DJ+I']Y3\;8G)[$E__W17 M]F\9.C!3RX?4!5)G/:"@L[Y5Q9FSJ'3G'<8`9M39$$B=C8""SL96598:2G[\ M<>3=2$U@2SU.@=3C#"CH<0Z5LS'W/2Z@4H]+(/6X`@IZ7%N5/:&U2M4[H1N8 M29VY,]/4EBZ8F5DIRIF9%LF^N7""O?N0IGD&*$DJUFS3`I+M4=[QS,RT':-T M9D8E?^IV8$87+A]2''G[[`%4DG=S553WCG@(E0YB!!0< MQ!@J=Q#>BIU`%1S$%"H=Q`PH.(@Y5.X@O.W!`JK@()90Z2!60,%!K*%R!^'= MFVR@^M4@W/DN*^F2^6[DWO;*HF(FCNZ],],T57C34==R"TA:=-KXT[EM54B. M453Q;CTZL*.9HPNDWGI`06]]UUN]6O><#6!&G0V!U-D(*.AL#-5=MI2K7B`G M:%=?4R#U-0,*^II;%4YCM>)71A:PH]Z60.IM!13TMG:]E>_BNCG-G MI*DM7I"!LU*DDX$M!*V;]<=R`H9F!RUH,J MZ*P/53V=(]4:Y5YK6'T-M0MV2R.@H*\Q5)FO>\_5!,WJ:@JDF6P&%'0UA\K- M9-XN9`&5>EP"J<<54-#C&JHL:M52[%V?-A"DSMP9::J=%\S(K#CJS$B+BCFR M[*669F1%NMI:0,'5UK8JN[;C2N19[L",+NTND#KK650..NM#)=N0/&O3_G$` M\^IQ"*0>1T!!CV.HLC3IS9$)6M73%$@]S8""GN90R9KZ];$MH%*/2R#UN`(* M>EQ;E8;.6W0;F$F=N;/2%&8OF)59'=>9E185\R1=7IOF;[[\G:I%P1771L=L MQ97O_0G?@4"7=Q=(EW$ZC4 MXQ1(/K,G9%R0BZ9 MD4;N[24S5*C+-2-"+49M1AU&748]1GU&`T9#1B-&8T831E-&,T9S1@M&2T8K M1FM&&PX,D!+#F<1P:<'>_`6U=R%@U+1(GODBDBT@N41H7BAY6ZBVJM"Q M`Z3/,[I`:KZGJ&C>NTOOJPKF!T!J?@BDYD>*"N;I<;"J8'X"I.:G0&I^IJAH MWDN:W-'^W>M,5KPO;G5E M@^U-L:9%A;U&2U6%8XJ]W59;53BF#FSI*>L"Z5.3GJ*"^9)7&>FK"N8'0&I^ M"*3F1XS&C"9`:FL*I+9FC.:,%D!J:PFDME:,UHPV0*DM=UJ8BC=/"\TR[_J; MHCBKFSN3@E#3JIQ)D:DJSN;#CUK;=A05HM:!+3T[72`].SV+"D^4^XP&Z*BV MAD!J:\0=QXPFZ*BVID!J:\8=YXP6Z*BVED!J:\4=UXPVZ)C:`W$0'9\#[ M'@Q+5+TDT``J%F9B>HP(524/;@LH>'O?MBJ9V^EC1"G-N`\H.S"CB;4+I,YZ M0$%G?:BR.LE]U2MX#M"NOH9`ZFL$%/0UABI8*9E`I1ZG0.IQ!A3T.(1`C=`P.8@R5,PC_(?0$*CWL*7N<017T.(?*\>A7G1=0!0][R8-8 MH6-P$&NHW$%X.^0-5+\:A#NW+ZN&QUP-!RHF77YB")6NVQ90<-VVKP=V-$MT@=1;#RCHK>]ZJ]5B;S\W@!EU-@129R.@H+,Q5,$D.(%*/4Z! MU.,,*.AQ;E4XF5'=?RRT@!WUM@12;RN@H+>UZRVNU_W$M(&=U)L[+TU1^H*< MF]6PG?V@14[.]>N?3?F+UC19%W-NAOXJYUJ5K:Q6RUZ-NF,MRPT2]I!==M:# M*KCP^U#99WD5;\D/T*Z^ANQK!%70UQ@J)\EP;K6'KQZG['$&6T&/UQ!%?2XALH^/BS?TV:@>'CNQ)117C(QC=S;#%A43)C^TY2F_"E1VD\7 M70LHN.C:5F67>%R.*%U:R[K"N["LSGI`06=]J((9;`"5>AP"J<<14-#C&*J@ MQPE4ZG$*I!YG0$&/ARI+ MFQ5_D0W0KKZ&[&L$5=#7&"I97?EYHR?I$ZC4XY0]SJ`*>IQ#E1V=?YN[0+.Z M6K*K%51!5VNHLJB58\J7$*3.LAF9_3)/]D,;S[NW;[OF[NGI>/5P^&%^=>1ZZ;7(CP5]3DU[O"$_(I36:'QN#)VQTRC+CPZ=X9\K MR6!PB]3,$U,1/]=2EI9SIU)* M8-)RSIH4TA-3^F)K4D]/3`6,6Z2LGIBJ%[F#PUU&=?%RKF%23\Q[,=QC6D_,VS'<,*O+ ML,XU+.J)>2V&>W3JB7DGB!NZ]<2\&<0-O7HB+Q2>X5%)SN.Y:2FO$TG+.5N# M>F+>(F)CC5K22"NK7C9IUA)YEY;UK5HB[_V>X?>)O"3*?%-+Y%51YHUZTC@[ MH&8],>]A<8]6/6F?.QTM.1WFK;PS/>1TF%>SI.4V/SSY:;;7[;?=>/OV;?]R MO'K:?96+2"E]:O"6_;A;]I^3?4WUR^$D/\HF6QOY.2?Y$;Z=O,I7NI%MU]?# MX83_&`?YS_I]^K\`````__\#`%!+`P04``8`"````"$`ZSN=SZ$"``"[!@`` M&0```'AL+W=O\RQIRHI>9N9CK9PI?26,T]'&W%7&$$7BMAC3.EGP$<"T)/P$)85Y9\7PKG8""`LPL62"2,`T(@"?1"B<# M"L*?B`E8O[99[OEE; M3DG/,Z'SE"E83G/! M=?OB2B3S_TX&1DWQ@V6:23K,2AB-L"S"C=325O*3;!I'A-GC(DC@*@W684=M M$YSVE_9YMNUO`1L^P.[H>"6_<5NIUI%&E@`9S2Y!D0W;)QR\Z4`X;!#C86OT MKS7\)"3&PO=V]R:W-H965T`$/G"MIXW^>,.=%(S5UD>MG!E\I8S3TL;]4J_S204J)%_K7NC.7[%GP_)@LNGKF'Q0F]5L(:9RH?`1T+A9YZOF)7#)BV MFU*!`VP[L;(JZ"[);]:4;3=#?_XH>723=^(:<_QL5?E-=1*:#6/"`>R-N4?H MUQ)#D,Q.LN^&`?RPI)05/[3^ISE^D:IN/$S[$@RAK[Q\NI5.0$.!)DHOD4F8 M%@J`)]$*=P8TA#\6-`5A5?JFH-DRNES%60)PLI?.WRFDI$0X^9)(";!"*9^3EL;0##KL;59MAZKFA4!H&D1;[M% M\"`^=C=$3KTMY[3##EZ_VTW,FO.'R-S)U>M.5G/)MYT@>*X4(J=.\$Z=['MT MDB;O.L&L.7^(S)PLXA=.PHT0CIV6MI:?9-LZ(LP!3WL*!VF,CA?1+L6]_C*^ MR'?#&6#C![@@>E[+[]S6JG.DE150QM$**K+AB@D+;WHH'*X)X^%J&%X;^!-( M.$MQ!.#*&/^\`&$V_ENV_P```/__`P!02P,$%``&``@````A`,(4B$IG!@`` M]!@``!D```!X;"]W;W)K&ULK)G;CJ-&$(;O(^4= M$/=KC#$^(-NKL3DKD:)HDUPS&-MHC+&`.;U]JD]`=S%>.\K-LOY<5=!__]V4 M>U;?/XJS]I95=5Y>UKHY&NM:=DG+?7XYKO6_?OC?%KI6-\EEGYS+2[;6/[-: M_[[Y]9?5>UF]U*!C=33J M:Y4E>YI4G(W)>#PSBB2_Z*R"4]U3HSP<\C1SR_2UR"X-*U)EYZ2!YZ]/^;46 MU8KTGG)%4KV\7K^E97&%$L_Y.6\^:5%=*U(G.E[**GD^P[@_S&F2BMKT`RI? MY&E5UN6A&4$Y@STH'O/26!I0:;/:YS`"(KM698>U_F0ZL3G3CNY^;-\ M#[/\>&I@NFT8$1F8L_]TLSH%1:',:&*32FEYA@>`?[4B)]8`19(/>GW/]\UI MK5O6R)R.9Q"M/6=UX^>DHJZEKW53%O^P&)-78C4FO`9<18W9R)Z/+9,4N9%H M\42X\L3)8K2P[>EL,;^=.>69<.69\[ON"%7I<.'*\\S[$F<\$:X\T1Y-)_9\ M\;,QSGDB7!\<(RQ1^JQP?6B,2YX'5S'&Y7VJFF`_Y@;B0S;5MX=I,#M1=[I) MDVQ65?FNP9('Q]37A&P@ID/*"E\R-[1._N@`)BPAM7UMK&F MYLIX@Q61\I@MCE$B=B*"V)^4=57@J,$"65AM8)_^'-J0, MT4:,:BM`)]9$EFHG(D2*JP)/!;X*`A6$*HA4$/>`)`2L>TF(X4U+>(%$KW58 M\3TO*`/ M*(K]MRR([,6]($NQ1AO4>@,1#Q$?D0"1$)$(D;A/))W@H26=;EN$1%,YQ""V MC/0-@8B+B(>(CTB`2(A(A$C<)])`X<4B#908PH*-\\$-DY21%6!$F?VI,OMM MD!#.1<1#Q$( MCTB`2(A(A$C<)Y(HI'7'K]81Z9B:4YZ^;$NP#NP(`TO%@E[&2(K(DC%CM MZV3'`&L:Z5N3@3FLU78?,1?*/N*U04(T'Y$`D1"1")&8$7-"GE`2!!H=+`AT MH%R/'^65ZG&_.*2@+`XC/7$8Z(G#`)V$KE69R8[RVJ!6'$0"1$)$(D1B1@;$ M(][=;ER(;9:UTSL93]Q^NB6F4XLKH& M)Q!HWIHT[!)OE(^Z*%$^YFA"RTMV(F_3FXK=M3P'`D097Y3I:\7*]"J'72)II*&R,@M1%R`JQU)E62;2U=W: MA^XT%FL.X3[BGEMP,5U_T#RUEK&FCQJ0C;# MM\U\:BM;F"_*=#8+!.IN%@IT\V:1EZ,)/6B@;P=/H"[*%XANOS0JP+5"$=75B@3J:L4"X:W<)(W@ M`V-F?:,T9HY@G)T'QLKOA!V]#ZS.;CY=@;H]W1,(^I.VEC5=R$;T112\L-LH MKN&`DDWW$IWS$645_=4;81&/0124FXLF]QU+<11]VDNJ0O M@T3)1AQU4;Z(ZML(U0I%5-]&J%8LH@9L1#K*!VS$&E#)1ASU;6398WDB=G"R M1\7J)M45"!ZW=8-E*ZO>$U&0WXM27.J+J*_FF2]#]!"A2+SY$)&(DA]"V0W) MZ24=XUI\P2CPE]LIP[\$AW@M@,_W`;X MS('?+@-\[D#[CKF[<*"O'>!+!UHZS+<@T790(NBT'-(\X!QHN!S23@U]8\(W M0SD^Y)`>`N=`R^4$@]]`Y^60O@KG0)\!W]!J1CM3<.9\38[9[TEUS"^U=LX. M8(LQ[4(K=FK-/C2\67\N&SANAGT(C@[AKPL9'.6,24=_*,M&?(!;&^W?*S;_ M`@``__\#`%!+`P04``8`"````"$`2+R=./8*``#$-0``&0```'AL+W=O)@[U9;QX.A^3+(3F4Y=L_?^QWO>_U\;1M M#G?]X&;8[]6'3?.X/3S?]?_S5_;'K-\[G=>'Q_6N.=1W_9_UJ?_G_=__=OO> M'+^=7NKZW",/A]-=_^5\?ET,!J?-2[U?GVZ:U_I`)4_-<;\^TY_'Y\'I]5BO M']M*^]T@'`XG@_UZ>^A+#XOC9WPT3T_;39TTF[=]?3A+)\=ZMSY3_T\OV]>3 M]K;??,;=?GW\]O;ZQZ;9OY*+A^UN>_[9.NWW]IM%^7QHCNN''8W[1S!:;[3O M]@]PO]]NCLVI>3K?D+N!["B.>3Z8#\C3_>WCED8@9.\=ZZ>[_C)85*-A?W!_ MVPKTWVW]?K+^WSN]-._Y?R;U:4.*DIN;<"P\;9H==8#^[>VW M(C1(D?6/]O-]^WA^N>M'DYOQ=!@%9-Y[J$_G;"M<]GN;M].YV?]/&@7*E702 M*B<1]1Z=7*@X4A7I4U6CVA9H3 M59,^5"]4G*J*]'G=&&FEM7VESZO&.%?UZ//*,08417)213C) M";D\RH&,BC;(DO5Y?7][;-Y[M')IWD^O:[$/!`OA5H>7%*H+N%_%&P6:\+(4 M;N[ZI`"%THD6R??[:#*Z'7RGP-XHFQ7:!-PBUA8BBH7;Q`6I"S(7Y"XH7%"Z MH++`@&3IM*&H_QW:"#="&SVJE09&K-`10EOH*HD+4A=D+LA=4+B@=$%E`28$ M+7L0(J)@\>]!.B9$K;L^K?PN)H*I,^,K::,V+C'E,9`$2`HD`Y(#*8"40"J; M,`EH&""!V(:O7"?"#2TUBCA+E(C/_DH:B7WNUT9Q9]3%")`42`8D!U(`*8%4 M-F$Z4:>93I=#1%BW_^;<`E6TLC1R3&*.Z-.)R`ID`Q( M#J0`4@*I;,)T$HD6$^KR,FG->90H9"\41`FB%%&&*$=4("H150SQ,8LLRUTQ M(HFX>^6($26(4D09HAQ1@:A$5#'$QRPR+WO,(N\PE^G/7]AD!L?$ MZ)(Z.W+F/'+BH+/2*B:(4D09HAQ1@:A$5#'$]1$)FZW/!S$A\SLF@YWRJ9@` ME(B52=L06P>`,K3*$16(2D050WS,(AVSQ_S52[Q,ZY@87:9GQ<1LZ,9$9V5B M`E`:`,H0Y8@*1"6BBB&NC\CB;'T^B`F9]#$9[#Q0Q02@)`"4(LH0Y8@*1"6B MBB$^9I&DV6,6,?&5XU8F>TR,+O^S8\*YV<=!9V5B`E"*5AFB'%&!J$14,<3U M$#XQ@\=:H@-LTTQ,11TF*:(,48ZH0%0BJACB^K@IZN68"#$35<@Z%6)$":(4 M488H1U0@*A%5#/$Q_Z:T,^S23CV/*X6B+MV*%9%?4[0/>!4)*:DPV>K,>2"6 M&BOM/$.4(RH0E8@JA2C1)/=LRS!`S3$2Q0E:0)!K1"6G)X#SS28V5D4$E ML.;I,@>[$:GY^66[ M^;9J:&9IQ_#L*1&-K3U`EF+_=&4"%"LK)I.T"BD#L0((M.JL]`QGVI>ME;*R MM8**I:XX[72O-/*H(U*_2^K\U;S^2AWRVLDC,TC[%`X5HG70#3QTK_[::-3U M-=&(!M;5"V9.Q51;R>@+`J<\T^5&A%PCTU:AT<6V2FVEVAH[%Z]*E[=M\;4H M\DY;74^,V2K*-)6IJ!`E:)8:[N,`$5TB.N>6C!*),]6JZ,B4JHIT"HEO!H.A MN\%GVJ#=@=NED&-CA;:ZV%BIK71C(ZIX>9*"0^ MS$8U=RZMJ;'2%3-$.:("48FH4H@6#KGG^OC3\"O3APB3<$2Q0DP=65&46.HX MU[=45:0/HTY74:,N@U)NJNR*UT]O#Y1"N2>;.] MY2ADKS)I9$>1)&0J]E]/-JJ=&"^9;LJHEBMD'!>FGG+L)J/&0`M=,<<\FD1J M"WJ-331IP2XG"I',D)E("I$.5J`X][585[3.-XTN'CFIMI)'3N2^+I+I0KG0Y'F\1.6;R?B"C,'=V=(5,UAVW3GERI1`E5WK. M4XU,"I9I9,>7#_V#,F*FW'FB`+'2&SAX3:RLS MG8E&-"@3ZE#O"E%LA M%A.8[KX_/=5SO=J?>IGD3+XJ/QSV^[E+0>'TE4;1(*3_%.I3I+DIO"?V08NF?,&K$XVE%,^RUI_GUM;P< M+98^058TZ]Y)ISGW3CG-N&_"BW"\$$]%<T]6F51"&5^.K0G91ZX"M)0JI#7XU@.RL:S\H['OIN8R$> M3V,=^HIC(;[`\)6,J,0W`PDIFGJ]9>1-/+I&;_3UQR+WEM"W(#0>7P^*<$0E M;0\&W:*@W]"\KI_K?ZZ/S]O#J;>KGVCK'+97J*/\%8[\XZR>7#\T9_KU#)TB M]!L*^K543>^R#\4%]:EISOH/ZNZ@^_W5_?\!``#__P,`4$L#!!0`!@`(```` M(0"Z7SOKC@(``)<&```9````>&PO=V]R:W-H965T[%R\(FJI+ M7Q"^')]SS[WV97W]I!OR**U3ILUI',THD:TPA6JKG/[Z>7=Q28GSO"UX8UJ9 MTV?IZ/7FXX?UP=@'5TOI"3"T+J>U]UW&F!.UU-Q%II,M?"F-U=S#TE;,=5;R MHM^D&S:?S99,<]72P)#9E]@"#:SD]UW?0.^6U+(DN\;_\,!*M\&1`0?A33N<@K`I?YS191NEJEL0`)SOI_)U"2DK$WGFC M_P10W"<5N/K4;KGGF[4U!P+M!K3K.!Z>.`/BUW.!)!"[17!.X3B"C(/Z/6Z2 M=+%FCV!:_,/E#2#H]5#:)%T.64V2 M`-`XB;?=(K@7'ZH;(J?>EN^A1?"4-D2F!E:O&UB]1PG!4Z40.36`HW1TW/OF M+/][''#7E#]$IDXN7S@)@R#<-BUM)3_)IG%$F#U>\CG=)`X3`?C82+TKS7\`"1< MH5D$X-(8?UR`,!M^*9N_````__\#`%!+`P04``8`"````"$`IH1A+5$#``#] M"P``$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````"<5L%NVS@0O2^P_V#HWLA)@T41R"IHB7$(R)1` MRNYV+P0KT[%013)$UDCZ]3NTZD9.&0+)C>3,O'DS\R1,]/GQH9D<5*_KKIT% MEQ?38*+:JMO4[?TL6)6W'SX%$VUDNY%-UZI9\*1T\#G^^Z^HZ+N]ZDVM]`0@ M6CT+=L;L;\)05SOU(/4%F%NP;+O^01JX]O=AM]W6E4J[ZL>#:DUX-9W^$ZI' MH]J-VGS8_P8,!L2;@WDOZ*:K+#^]+I_V0#B.T'[?U)4T4&6\K*N^T]W63/!C MI9HH'!LC8,=5]:.OS5,\C<+Q->*5;%0"P/%6-EI%X?-#=*>D;5HAZU['T<'< M'%1ENGZBZY_0MJM@\DUJ9>G,@H/L:]D:H&7=ALOQW.RUZ>,O7?]=[Y0R.@K! M87@\'L>^XW-]'5]_.GK`Z=S3(@Q,P'#.L:Q-HW2^+61O')2O8?+/G(\L!L8# MH=,4!6A#X-9`OP1IAVG7W9CY[QJ2G*:8`G9EF]*\ROD/6FNG-1RMD"4_(=*DE.!:"H**%WDMR(O,$/.D#GBA%N7@F&. M*11QBDT8*9TA'"^6X"D8+G)6$KHXIH*>)_#*G"%9SKD`#C"9Y1*X\3O$W*VZ M182)-[Z%GF>?B%9-H(ET!BZ(*_"#LD1Y_AUJFP%8L3_%E:B8\H9<4\FQ;>8,8AA M&#BOW.UB.+,B+Q`KOXJ2(%IF7P7AW!;Z:S96'07+G2%^Z;F_"G^,^ZOPZ]6=QRE84;W0KP_>+V,W_%C'/FR@[I&S&_NEGGWX+J'Z_/T_/C( M[V2O-K!4G>S/#]$=;(U]8T&2G6SOU>;D\Z?!+KKK89N/+Z\OIA^GL,..WJ+P M>6^/_P<``/__`P!02P,$%``&``@````A`!R$&OZ5````J0```!````!X;"]C M86QC0VAA:6XN>&UL/(Y!"@(Q$`3O@G\(G[GI%Y4)18VL!]&4,2^+)&?!NZWZ^X(2IKCQ:7"9.!#`K/= M;K1WR5^"BZRZ@<5`:&T](8H/E)T,927NS:/4[%K'^D19*[E%`E'+"0_C.&'N M`K#:JVK@/(&*_0.H]$NT&O\C]@L``/__`P!02P,$%``&``@````A`#M?P*LR M`0``0`(``!$`"`%D;V-07B^CVJ^TVWR""ENC)@1+ M,?:B`*=;P$7>7Z--00N>>#X`$SM1$0C4HH):3]< M.P"DP-""!A,\)AG!W]T`3OL_+PS)65.KL+=QIE'WG"W%,9S:.Z^F8M_W65\. M&M&?X/7RX6D8-57FL"L!B!WVTW(?EG&5&P7R=L]V;ZY-O&\J_#NKI!CLJ'#` M`\@DOD>/=J?DI;R[7RT0*W(R2_-92JY614X)H67Y6N%3:[S/)J`>!?Y-/`'8 MX/WSS]D7````__\#`%!+`0(M`!0`!@`(````(0#A_+]<%@(``"\>```3```` M``````````````````!;0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@` M```A`+55,"/U````3`(```L`````````````````3P0``%]R96QS+RYR96QS M4$L!`BT`%``&``@````A`,U/P]Y%`@``=!T``!H`````````````````=0<` M`'AL+U]R96QS+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`+>O^GU+`P``\PH``!D`````````````````0!L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*8S=W``!```A0T` M`!D`````````````````LBD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`)4UM"DI"```?R(``!D````````````` M````\C8``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`"1_"+QK!0``#18``!D`````````````````F$@``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`"4U-6Z[`P``RPP``!@`````````````````FXT``'AL+W=O@T# M``!0"0``&0````````````````"\I```>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`(EW`(#2`@``O@<``!D`````````````````5:T``'AL+W=OL```>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`'XGE:K!!0``@A0``!D`````````````````6+0``'AL+W=O&UL4$L!`BT`%``&``@````A`+C.>C=J M!P``P1X``!D`````````````````-LT``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$<0:`0^!@``5AD``!D````` M````````````>>8``'AL+W=O\1```@70``&`````````````````#N[```>&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`*)J_3UW"P``CSD` M`!@`````````````````$_\``'AL+W=O#@$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,]$"-E&UL4$L!`BT`%``&``@````A`&9;X#43!@``T!8``!D````````` M````````5B4!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`!`W&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`.YSS1ML!P``(AX``!D`````````````````CE(!`'AL+W=O(KA2$0```;4```&0`````` M```````````Q6@$`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'8M2ZR5`@``H`8` M`!D`````````````````86T!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+I?.^N.`@``EP8``!D````````````` M````^($!`'AL+W=O&UL4$L!`BT`%``&``@````A`#M?P*LR`0`` M0`(``!$`````````````````!XH!`&1O8U!R;W!S+V-O&UL4$L%!@`` 0```Z`#H`OP\``'",`0`````` ` end XML 14 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
RELATED-PARTY TRANSACTIONS (Details) (USD $)
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Related Party Transaction [Line Items]    
Loss from joint venture $ (2,000)us-gaap_IncomeLossFromEquityMethodInvestments $ 0us-gaap_IncomeLossFromEquityMethodInvestments
VSK Medical Limited [Member]    
Related Party Transaction [Line Items]    
Receivables due from related parties 55,000us-gaap_DueFromRelatedPartiesCurrent
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= us-gaap_CorporateJointVentureMember		  
Loss from joint venture (2,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= us-gaap_CorporateJointVentureMember		  
Director - David Lieberman [Member]    
Related Party Transaction [Line Items]    
Fees for legal services $ 60,000us-gaap_LegalFees
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= vaso_DirectorDavidLiebermanMember		 $ 60,000us-gaap_LegalFees
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= vaso_DirectorDavidLiebermanMember
XML 15 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
BUSINESS COMBINATION (Tables)
 3 Months Ended
Mar. 31, 2015
BUSINESS COMBINATION [Abstract]  
Business Acquisition Proforma Information
The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013.
  (in thousands)
     Three months ended 
  
March 31,
2015
  
March 31,
2014
 
Revenue
 
$
7,453
  
$
7,091
 
         
Net loss
  
(252
)
  
(1,173
)
         
Basic and diluted loss per share
 
$ 
(0.00
)
 
$ 
(0.01
)
XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
LOSS PER COMMON SHARE (Tables)
 3 Months Ended
Mar. 31, 2015
LOSS PER COMMON SHARE [Abstract]  
Antidilutive Common Stock Equivalents Excluded from Computation of Diluted Earnings Per Share
The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three months ended March 31, 2015 and 2014, because the effect of their inclusion would be anti-dilutive.
 
 
(in thousands)
For the three months ended
 
 
March 31,
2015
(unaudited)
 
March 31,
2014
(unaudited)
 
Stock options
  
952
   
1,754
 
Common stock grants
  
390
   
875
 
   
1,342
   
2,629
 
 
XML 18 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
GOODWILL AND OTHER INTANGIBLES (Details) (USD $)
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Change in carrying amount of goodwill [Roll Forward]      
Goodwill, Beginning Balance $ 3,288,000us-gaap_Goodwill    
Foreign currency translation 16,000us-gaap_GoodwillTranslationAdjustments    
Goodwill, Ending Balance 3,304,000us-gaap_Goodwill    
Other intangible assets, net [Abstract]      
Intangible assets, net 2,668,000us-gaap_FiniteLivedIntangibleAssetsNet   2,826,000us-gaap_FiniteLivedIntangibleAssetsNet
Amortization expense 171,000us-gaap_AmortizationOfIntangibleAssets 46,000us-gaap_AmortizationOfIntangibleAssets  
Patents and Technology [Member]      
Other intangible assets, net [Abstract]      
Costs 2,478,000us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= vaso_PatentsAndTechnologyMember		   2,489,000us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= vaso_PatentsAndTechnologyMember
Accumulated amortization (613,000)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= vaso_PatentsAndTechnologyMember		   (549,000)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= vaso_PatentsAndTechnologyMember
Intangible assets, net 1,865,000us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= vaso_PatentsAndTechnologyMember		   1,940,000us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= vaso_PatentsAndTechnologyMember
Patents [Member]      
Other intangible assets, net [Abstract]      
Useful life of intangible assets 10 years    
Customer Lists [Member]      
Other intangible assets, net [Abstract]      
Costs 800,000us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerListsMember		   800,000us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerListsMember
Accumulated amortization (410,000)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerListsMember		   (381,000)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerListsMember
Intangible assets, net 390,000us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerListsMember		   419,000us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerListsMember
Useful life of intangible assets 7 years    
Software [Member]      
Other intangible assets, net [Abstract]      
Costs 986,000us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_ComputerSoftwareIntangibleAssetMember		   962,000us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_ComputerSoftwareIntangibleAssetMember
Accumulated amortization (573,000)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_ComputerSoftwareIntangibleAssetMember		   (495,000)us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_ComputerSoftwareIntangibleAssetMember
Intangible assets, net $ 413,000us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_ComputerSoftwareIntangibleAssetMember		   $ 467,000us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_ComputerSoftwareIntangibleAssetMember
Useful life of intangible assets 5 years    
XML 19 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Mar. 31, 2014
Concentration Risk [Line Items]      
Accounts and other receivables $ 5,025us-gaap_AccountsAndOtherReceivablesNetCurrent $ 15,273us-gaap_AccountsAndOtherReceivablesNetCurrent $ 5,381us-gaap_AccountsAndOtherReceivablesNetCurrent
Accounts and Other Receivables [Member] | Credit Concentration Risk [Member] | GE Healthcare [Member]      
Concentration Risk [Line Items]      
Accounts and other receivables $ 4,200us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CreditConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= vaso_GeHealthcareMember		 $ 14,200us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CreditConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= vaso_GeHealthcareMember		  
Percentage of accounts and other receivables (in hundredths) 85.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CreditConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= vaso_GeHealthcareMember		 93.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CreditConcentrationRiskMember
/ us-gaap_MajorCustomersAxis
= vaso_GeHealthcareMember		  
XML 20 R47.htm IDEA: XBRL DOCUMENT v2.4.1.9
BUSINESS COMBINATION (Details) (Genwell Instruments Co. Ltd. [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Genwell Instruments Co. Ltd. [Member]
    
Business acquisition proforma information [Abstract]    
Revenue $ 7,453us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_BusinessAcquisitionAxis
= vaso_GenwellInstrumentsCoLtdMember		 $ 7,091us-gaap_BusinessAcquisitionsProFormaRevenue
/ us-gaap_BusinessAcquisitionAxis
= vaso_GenwellInstrumentsCoLtdMember
Net loss $ (252)us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_BusinessAcquisitionAxis
= vaso_GenwellInstrumentsCoLtdMember		 $ (1,173)us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
/ us-gaap_BusinessAcquisitionAxis
= vaso_GenwellInstrumentsCoLtdMember
Basic and diluted loss per share (in dollars per share) $ 0vaso_BasicAndDilutedLossPerShareInDollarsPerShare
/ us-gaap_BusinessAcquisitionAxis
= vaso_GenwellInstrumentsCoLtdMember		 $ (0.01)vaso_BasicAndDilutedLossPerShareInDollarsPerShare
/ us-gaap_BusinessAcquisitionAxis
= vaso_GenwellInstrumentsCoLtdMember
XML 21 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT REPORTING AND CONCENTRATIONS
 3 Months Ended
Mar. 31, 2015
SEGMENT REPORTING AND CONCENTRATIONS [Abstract]  
SEGMENT REPORTING AND CONCENTRATIONS
NOTE C – SEGMENT REPORTING AND CONCENTRATIONS

The Company views its business in three segments – the Sales Representation segment, the Equipment segment, and the IT segment.  The Sales Representation segment operates through the Vaso Diagnostics subsidiary and is currently engaged solely in the fulfillment of the Company’s responsibilities under our agreement with GEHC.  The Equipment segment is engaged in designing, manufacturing, marketing and supporting EECP® enhanced external counterpulsation systems both domestically and internationally, as well as the development, production, marketing and supporting of other medical devices.  The Company’s new subsidiary, VasoHealthcare IT Corp., formed to conduct its healthcare IT operations, reports through the IT segment.  Operations in the IT segment began in the third quarter of 2014. 
 
The chief operating decision maker is the Company’s Chief Executive Officer, who in conjunction with upper management, evaluates segment performance based on operating income.  Administrative functions such as finance, human resources, and information technology are centralized and related expenses allocated to each segment.  Other costs not directly attributable to operating segments, such as audit, legal, director fees, investor relations, and others, as well as certain assets – primarily cash balances – are reported in the Corporate entity below.  There are no intersegment revenues.  Summary financial information for the segments is set forth below:          
 
 
      
 
(in thousands)
As of or for the thee months March 31, 2015 (unaudited)
 
 
 
Sales
Representation
Segment
  
Equipment
Segment
  
IT Segment
  
Corporate
  
Consolidated
 
 
          
Revenues from external customers
 
$
6,390
  
$
1,063
  
$
-
  
$
-
  
$
7,453
 
Operating income (loss)
 
$
1,087
  
$
(635
)
 
$
(355
)
 
$
(383
)
 
$
(286
)
Total assets
 
$
11,142
  
$
9,592
  
$
159
  
$
15,405
  
$
36,298
 
Accounts and other receivables, net
 
$
4,363
  
$
576
  
$
86
  
$
-
  
$
5,025
 
Deferred commission expense
 
$
2,412
  
$
-
  
$
4
  
$
-
  
$
2,416
 
Other assets
 
$
3,832
  
$
715
  
$
-
  
$
73
  
$
4,620
 
 
      
    (in thousands)
As of or for the three months March 31, 2014 (unaudited)
  
Sales
 Representation
Segment
  
Equipment
Segment
  
IT Segment
  
Corporate
  
Consolidated
 
Revenues from external customers
 
$
6,241
  
$
850
  
$
-
  
$
-
  
$
7,091
 
Operating income (loss)
 
$
523
  
$
(1,082
)
 
$
-
  
$
(531
)
 
$
(1,090
)
Total assets
 
$
10,209
  
$
7,728
  
$
-
  
$
11,986
  
$
29,923
 
Accounts and other receivables, net
 
$
4,535
  
$
846
  
$
-
  
$
-
  
$
5,381
 
Deferred commission expense
 
$
2,319
  
$
-
  
$
-
  
$
-
  
$
2,319
 
Other assets
 
$
2,836
  
$
432
  
$
-
  
$
13
  
$
3,281
 
 
For the three months ended March 31, 2015 and 2014, GE Healthcare accounted for 86% and 88% of revenue, respectively, and $4.2 million or 85%, and $14.2 million or 93%, of accounts and other receivables at March 31, 2015 and December 31, 2014, respectively.
EXCEL 22 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V-V8Y M,69E-39C-F,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D)54TE.15-37T-/34))3D%424]./"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K M#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE. M5D5.5$]224537TY%5%]486)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%#0U)5141?15A014Y315-?04Y$7T]42$527TQ)03$\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D)54TE.15-37T-/34))3D%424].7U1A8FQE#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D]21T%.25I!5$E/3E]!3D1?4$Q! M3E]/1E]/4$5203$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-%1TU%3E1?4D503U)424Y'7T%.1%]#3TY#14Y44C,\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D9!25)?5D%,545?345!4U5214U%3E137T1E=&%I;#PO M>#I.86UE/@T*("`@(#QX.E=O#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D%#0U)5141?15A014Y315-? M04Y$7T]42$527TQ)03(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2!296=I2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,#@S M.3`X-SQS<&%N/CPO'0^+2TQ,BTS,3QS<&%N/CPO2!&:6QE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^4VUA;&QE3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^9F%L'0^36%R(#,Q+`T*"0DR,#$U/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V-V8Y,69E M-39C-F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#8P-V,R9C-? M-S9B8U\T9F9C7S@T,&)?-C=F.3%F934V8S9C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'!E;G-E6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA2P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ,3(\6%B;&4@9'5E('1O(')E;&%T960@ M<&%R='D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D.R`Q-C8L-#4P+#,W,"!A M;F0@,38V+#0S-2PS-S`@3L@,34V+#$T M,BPR.#,@86YD(#$U-BPQ,C3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!S M=&]C:RP@870@8V]S="P@,3`L,S`X+#`X-R!S:&%R97,@870@36%R8V@@,S$L M(#(P,34@86YD($1E8V5M8F5R(#,Q+"`R,#$T/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M/B@R+#`P,"D\3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@ M4VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V M-V8Y,69E-39C-F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#8P M-V,R9C-?-S9B8U\T9F9C7S@T,&)?-C=F.3%F934V8S9C+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E2!T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!; M4F]L;"!&;W)W87)D73PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!O<&5R871I;F<@86-T M:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@R,3$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M6%B;&4@9'5E('1O(')E;&%T960@<&%R='D\+W1D/@T*("`@("`@ M("`\=&0@8VQA2!O<&5R871I;F<@86-T:79I=&EE'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-C`W8S)F M,U\W-F)C7S1F9F-?.#0P8E\V-V8Y,69E-39C-F,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9#8P-V,R9C-?-S9B8U\T9F9C7S@T,&)?-C=F.3%F M934V8S9C+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL M93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E3L@=&5X="UI;F1E;G0Z(#,V<'0[)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E28C.#(R,3LL M("8C.#(R,#MR96=I6QE/3-$)V9O;G0M'0M=&]P.R!L:6YE+6AE:6=H=#H@,3LG/B8C,36QE/3-$)V9O;G0M2!T96-H;F]L;V=Y+"!T;R!P M:'ES:6-I86YS(&%N9"!H;W-P:71A;',@=&AR;W5G:&]U="!T:&4@56YI=&5D M(%-T871E2P@=&AR;W5G:"!I M=',@=VAO;&QY+6]W;F5D('-U8G-I9&EA'1E;F1E9"!T:')O=6=H($1E8V5M8F5R M(#,Q+"`R,#$X+"!S=6)J96-T('1O(&5A2!,=&0N(&%N9"!":6]X($EN2P@86YD('!R;V1U M8W0@<&]R=&9O;&EO+B8C,38P.R!!;'-O(&EN(%-E<'1E;6)E2!R97-T28C.#(Q-SMS($-H:6YE2!B=7-I;F5S6QE M/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^26X@07!R:6P@,C`Q-"P@=&AE($-O;7!A;GD@ M96YT97)E9"!I;G1O(&%N(&%G2P@5E-+($UE9&EC86P@3&EM:71E9"`H5E-+ M*2P@9F]R('1H92!G;&]B86P@;6%R:V5T:6YG+"!S86QE(&%N9"!A9'9A;F-E M;65N="!O9B!%0U`@=&AE2!T96-H;F]L;V=Y+B8C,38P.R!4:&4@0V]M M<&%N>2!O=VYS(#0Y+CDE(&]F('1H92!J;VEN="!V96YT=7)E+"!W:&EC:"!B M96=A;B!O<&5R871I;VYS(&EN($IA;G5A2!O M;B!E>&ES=&EN9R!C=7-T;VUE2!O=VYE9"!S=6)S:61I87)Y+"!687-O2&5A;'1H8V%R M92!)5"!#;W)P+BP@=V%S(&9O2!A8W%U:7)E9"!A;&P@;V8@=&AE(&]U='-T86YD:6YG('-H87)E6QE/3-$)V9O M;G0M'0M=&]P.R!L M:6YE+6AE:6=H=#H@,3LG/E1-/"]S=7`^('=I7-T96TN/"]D:78^/&1I=CX\8G(@+SX\+V1I=CX\9&EV('-T>6QE M/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^5V4@3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V M-V8Y,69E-39C-F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#8P M-V,R9C-?-S9B8U\T9F9C7S@T,&)?-C=F.3%F934V8S9C+U=O'0O:'1M;#L@8VAA'0^/&1I=B!S='EL93TS1"=F M;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R<^5&AE(&%C8V]M<&%N>6EN9R!C;VYD96YS960@8V]N2!A M8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E2=S($%N;G5A;"!297!O65A&5R8VES92!C;VYT2X@5&AE(')E65A3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY4:&4@<')E<&%R871I;VX@;V8@ M9FEN86YC:6%L('-T871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H(%4N4RX@ M1T%!4"!R97%U:7)E2!M86ME'!E2=S(&UA;F%G96UE;G0N(%1H92!#;VUP86YY(&5V86QU871EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY.;W1E M($(@;V8@=&AE($YO=&5S('1O($-O;G-O;&ED871E9"!&:6YA;F-I86P@4W1A M=&5M96YT65AF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&IU'!E;G-E(%)E8V]G;FET:6]N(&9OF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E2!I6EN9R!E<75I<&UE;G0@:&%S(&)E M96X@86-C97!T960@870@=&AE(&-UF5D/"]D:78^/&1I=CXF(S$V,#L\+V1I=CX\9&EV M/CQD:78@3H@ M)U1I;65S($YE=R!2;VUA;B3LG M/E9A6QE/3-$)V9O;G0M'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^5&AE($-O;7!A;GD@ M9F]L;&]W"!I2`H5DE% M*2X\+V1I=CX\9&EV/CQB3L@=&5X="UI;F1E;G0Z M(#,V<'0[)SY,:6%B:6QI=&EEF5D(&%S(&$@28C.#(Q-SMS(&=E;F5R86P@ M87-S971S+B!4:&4@9FEN86YC:6%L(&EN9F]R;6%T:6]N(&]F($)I;W@L('=H M:6-H('=A3L@=&5X="UI;F1E;G0Z(#,V M<'0[)SXF(S$V,#L\+V1I=CX\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$ M)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[ M/"]T9#X\=&0@8V]L6QE/3-$)V9O;G0MF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^ M/"]TF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ M(&QE9G0[)SY4;W1A;"!A6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQOF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O M;G0M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0V('-T>6QE/3-$)W9E M6QE/3-$)W9E M"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P M.R!B;W)D97(M8F]T=&]M.B`C-C0V-#8T(#)P>"!S;VQI9#LG/CQD:78@'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@ M3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[ M)SY4;W1A;"!N970@F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W=I9'1H.B`W-B4[('9E6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0MF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)V9O;G0M3LG M/B8C,38P.SPO9&EV/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE M=R!2;VUA;B3L@ M=&5X="UI;F1E;G0Z(#,V<'0[)SY#97)T86EN(')E8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E2!A;F0@:6YT97)N871I;VYA;&QY+"!A2P@5F%S;TAE M86QT:&-A6QE/3-$)V9O;G0M'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R<^)B,Q-C`[/"]D:78^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E&5C=71I=F4@3V9F:6-E2!A2!B96QO=RXF(S$V,#L@5&AE2!F:6YA;F-I86P@ M:6YF;W)M871I;VX@9F]R('1H92!S96=M96YT6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;BF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)V9O;G0M3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O M;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#LG M/CQD:78@3H@ M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#LG/CQD:78@ M3H@)U1I;65S M($YE=R!2;VUA;B6QE M/3-$)W9E6QE/3-$)V9O;G0M M'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+V1I=CX\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG M:'0Z(&YO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW M96EG:'0Z(&YO6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG M:'0Z(&YO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@9F]N="UW96EG:'0Z(&YO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@9F]N="UW96EG:'0Z(&YO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M9F]N="UW96EG:'0Z(&YO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO'0M86QI9VXZ(&QE9G0[(&)A M8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`T,"4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&UA'0M M:6YD96YT.B`M.7!T.R<^1&5F97)R960@8V]M;6ES'!E;G-E/"]D M:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M9F]N="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW M96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@9F]N="UW96EG:'0Z(&YO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z M(&YO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@9F]N="UW96EG:'0Z(&YO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO M6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W9E"!S;VQI9#L@=&5X="UA M;&EG;CH@8V5N=&5R.R<^/&1I=CXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L\ M96T^*&EN('1H;W5S86YD#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O M='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)W9E3H@)U1I;65S M($YE=R!2;VUA;B#L@ M=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG M+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO M='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X M+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@ M3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H M.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC M;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X M+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X M+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$ M)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W=I9'1H M.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$ M)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E3H@)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z(#,V M<'0[)SY&;W(@=&AE('1H2P@86YD("0T+C(@;6EL M;&EO;B!O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E2!T:&4@=V5I9VAT960M879E&5R8VES960@;W(@8V]N=F5R=&5D('1O(&-O;6UO;B!S=&]C:RX\+V1I=CX\ M9&EV/CQB3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY4 M:&4@9F]L;&]W:6YG('1A8FQE(')E<')E&-L=61E9"!F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E"!S;VQI9#LG/CQD:78@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E M'0M:6YD96YT.B`M.7!T.R<^)B,Q-C`[/"]T9#X\ M=&0@8V]L6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R M/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@;6%R9VEN+6QE9G0Z(#EP=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X="UA;&EG;CH@"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^5&AE($-O;7!A;GD@ M8V]M<&QI97,@=VET:"!T:&4@<')O=FES:6]N3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$ M)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M#LG/B8C M,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^/"]T9#X\ M=&0@8V]L6QE/3-$)W9E#L@=&5X M="UA;&EG;CH@;&5F=#LG/CPO=&0^/"]T6QE/3-$)W9E6QE/3-$)V9O;G0M M'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0M M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E2!M87)K970@9G5N9',@*&EN8VQU9&5D M(&EN(&-A6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@8F%C:V=R M;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U M8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U M8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U M8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@;F]W M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W9E6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#LG/CQD:78@ M3H@)U1I;65S M($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B M;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO M='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W'0M M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P M,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P M,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P M,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M'0M M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^5&AE(&9A:7(@ M=F%L=65S(&]F('1H92!#;VUP86YY)B,X,C$W.W,@8V%S:"!E<75I=F%L96YT M2!M87)K970@9G5N9',@87)E(&1E=&5R;6EN M960@=&AR;W5G:"!M87)K970L(&]B7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`S-G!T.R<^5&AE(&9O;&QO=VEN9R!T86)L92!P6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M#LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^/"]T9#X\=&0@8V]L M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SX\+W1D M/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\ M=&0@8V]L6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@"!S;VQI9#LG M/CQD:78@3H@ M)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/"]T6QE/3-$ M)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE M9G0[)SY!;&QO=V%N8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S(&%N9#PO9&EV M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[ M('9E6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQOF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O M;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE M/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB M;W1T;VTZ(#1P>#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@ M)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY46QE/3-$)V9O;G0M'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^06QL;W=A;F-E(&9O M2!O9B!O=7(@8W5S=&]M97)S('1O(&UA:V4@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z(#,V<'0[ M)SY);G9E;G1O3L@=&5X="UI;F1E;G0Z(#,V<'0[ M)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M#L@8F]R9&5R+6QE9G0Z(&UE9&EU;2!N;VYE.R<^/"]T M9#X\=&0@8V]L6QE.B!I=&%L:6,[('1E>'0M M86QI9VXZ(&-E;G1E#L@=&5X="UA;&EG;CH@;&5F=#LG/CPO=&0^/"]T#L@8F]R9&5R+6QE9G0Z(&UE9&EU;2!N M;VYE.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)V)OF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M=&]P.B!M961I M=6T@;F]N93L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T M;VTZ(#)P>#L@8F]R9&5R+6QE9G0Z(&UE9&EU;2!N;VYE.R<^)B,Q-C`[/"]T M9#X\=&0@8V]L6QE/3-$)V)O M"!S;VQI9#LG/CQD:78@'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V M86QI9VX],T1B;W1T;VT@6QE M/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO;F4[('1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO;F4[('1E M>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO;F4[ M('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO M;F4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A M8VMGF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R M9&5R+6)O='1O;3H@;65D:75M(&YO;F4[('1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M8F]R9&5R+6)O='1O;3H@;65D:75M(&YO;F4[('1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY&:6YI'0M86QI9VXZ(')I9VAT.R!B;W)D97(M;&5F=#H@;65D:75M(&YO M;F4[(&)A8VMG"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@ M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@ M8F]R9&5R+6QE9G0Z(&UE9&EU;2!N;VYE.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN M9RUB;W1T;VTZ(#1P>#L@=&5X="UA;&EG;CH@"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT.R!B;W)D97(M;&5F=#H@;65D:75M(&YO;F4[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY!="!-87)C:"`S,2P@ M,C`Q-2!A;F0@1&5C96UB97(@,S$L(#(P,30L('1H92!#;VUP86YY(&UA:6YT M86EN960@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E2P@<'5RF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE M.B!I=&%L:6,[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+V1I=CX\+W1D/CQT9"!C;VQS<&%N/3-$,R!V86QI9VX],T1B;W1T;VT@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@ M3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[ M(&)A8VMG#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O M;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(&QE9G0[(&)A8VMG M"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X."4[('9E6QE/3-$)V9O;G0M'0M M86QI9VXZ(&QE9G0[)SY"86QA;F-E(&%T($UA6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB M;W1T;VTZ(#1P>#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`S-G!T.R<^)B,Q-C`[/"]D:78^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT M9"!V86QI9VX],T1B;W1T;VT@#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O M;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#LG/CQD:78@ M3H@)U1I;65S M($YE=R!2;VUA;BF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(&QE9G0[(&)A M8VMG"!S;VQI9#L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O M;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T M97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`W M-B4[('9E6QE/3-$)V9O M;G0M'0M86QI9VXZ(&QE9G0[)SY!8V-U;75L871E M9"!A;6]R=&EZ871I;VX\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O M;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(&QE9G0[(&)A8VMG M"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T M;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R M9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ M(#1P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@ M;F]W'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(&QE9G0[)SY!8V-U;75L871E9"!A;6]R=&EZ871I;VX\+V1I=CX\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@ M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG"!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@ M8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V9O;G0M'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`S-G!T.R<^)B,Q-C`[/"]D:78^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3H@)U1I;65S($YE=R!2;VUA;BF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T M>6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W9E"!S;VQI9#LG/CQD:78@6QE/3-$)W9E6QE/3-$ M)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R M/CQT9"!S='EL93TS1"=W:61T:#H@-S8E.R!V97)T:6-A;"UA;&EG;CH@=&]P M.R!W:&ET92US<&%C93H@;F]WF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'!E;G-E("T@;F]N M8W5RF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQOF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY46QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@ M3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY/=&AE"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC M;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N M.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P M,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)V9O M;G0M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C M7S1F9F-?.#0P8E\V-V8Y,69E-39C-F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO9#8P-V,R9C-?-S9B8U\T9F9C7S@T,&)?-C=F.3%F934V8S9C M+U=O'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&QE9G0[)SX\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W9E#LG/CPO=&0^/'1D(&-O;'-P86X],T0V('-T>6QE/3-$)W9E6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#LG M/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H M.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY!8V-R=65D(&-O;7!E;G-A=&EO;CPO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,24[('9E MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M9F]N="UW96EG:'0Z(&YO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG M#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P M>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D M9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO3H@)U1I;65S($YE=R!2;VUA;B'0M M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[(&9O;G0M=V5I9VAT.B!N;W)M86P[('1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!F M;VYT+7=E:6=H=#H@;F]R;6%L.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R M;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE M.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!T97AT+6%L:6=N.B!L969T.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD M96YT.B`S,C1P=#LG/B8C,38P.SPO9&EV/CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAAF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`U<'@[ M('9E6QE.B!I=&%L:6,[('1E>'0M86QI M9VXZ(&-E;G1E6QE/3-$)W=I9'1H M.B`V,#%P>#L@=F5R=&EC86PM86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@-7!X.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W=I9'1H.B`Q-S9P>#L@=F5R=&EC M86PM86QI9VXZ('1O<#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[)B,Q M-C`[($9O6QE M/3-$)W=I9'1H.B`V,#%P>#L@=F5R=&EC86PM86QI9VXZ('1O<#L@<&%D9&EN M9RUB;W1T;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H M.B`W-G!X.R!V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@8F%C:V=R;W5N9"UC;VQO3H@)U1I;65S($YE=R!2;VUA;B#L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN M9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO#L@8F%C:V=R;W5N9"UC;VQO#L@=F5R=&EC86PM86QI9VXZ('1O M<#L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E M;G1E6QE/3-$)W=I9'1H.B`U<'@[('9E'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V9O;G0M M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`W-BXS-R4[('9E M'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W=I9'1H.B`Q+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I M9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N M.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`W-BXS M-R4[('9E6QE/3-$)V9O;G0M'0M M86QI9VXZ(&QE9G0[)SY$969E6QE/3-$)W=I9'1H M.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R M:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`W-BXS-R4[('9E6QE/3-$)V9O M;G0M'0M86QI9VXZ(&QE9G0[)SY$969E6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H M.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R M:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Y+C0E.R!V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[ M(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE M9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q+C0E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y+C0E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y+C0E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q+C0E.R!V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H M.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#1P>"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#1P>"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA3L@ M;6%R9VEN+7)I9VAT.B`T,2XT<'0[)SY.3U1%)B,Q-C`[3"`F(S@R,3$[(%)% M3$%4140M4$%25%D@5%)!3E-!0U1)3TY3/"]D:78^/&1I=CX\8G(@+SX\+V1I M=CX\9&EV('-T>6QE/3-$)V9O;G0M'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R<^1&%V:60@3&EE8F5R;6%N M+"!T:&4@5FEC92!#:&%I28C.#(Q-SMS($)O M87)D(&]F($1I6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY);B!*86YU87)Y M(#(P,34L(&]P97)A=&EO;G,@8F5G86X@=6YD97(@=&AE(%932R!J;VEN="!V M96YT=7)E+B8C,38P.R!4:&4@0V]M<&%N>2!A8V-O=6YT2`D-34L,#`P('=A M2!S;VQD M('1O(&ET+"!A;F0@=&AE($-O;7!A;GDF(S@R,3<[2!I;G1E M'1087)T M7V0V,#=C,F8S7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-2XT<'0[)SY/ M;B!!=6=U2!A8W%U:7)E9"!'96YW96QL M($EN2`Q+"`R,#$S+CPO9&EV/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z(#,U+C1P=#LG M/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.SPO9&EV/CQD:78@6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O M;G0M#L@=&5X="UA;&EG;CH@;&5F=#LG/CPO=&0^/"]T M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO M='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)V9O;G0M'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`W-2XY.24[('9E M6QE/3-$)V9O;G0M'0M86QI9VXZ M(&QE9G0[)SY2979E;G5E/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`W-2XY.24[('9E M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q M-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`W-2XY.24[('9E6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(&QE9G0[(&)A8VMG'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[ M)SX\9&EV('-T>6QE/3-$)V9O;G0M'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M3LG/E-A;&5S(')E<')EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E65A2`Q+"`R,#$W+B8C,38P M.R!4:&5S92!C:7)C=6US=&%N8V5S(&EN8VQU9&4@;F]T(&UA=&5R:6%L;'D@ M86-H:65V:6YG(&-E'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M M'0M86QI9VXZ(&QE9G0[)SY.3U1%)B,Q-C`[3R`M M(%)%0T5.5$Q9($E34U5%1"!!0T-/54Y424Y'(%!23TY/54Y#14U%3E13/"]D M:78^/&1I=CX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T M.R<^26X@36%Y(#(P,30L('1H92!&05-"(&ES&ES M=&EN9R!R979E;G5E(')E8V]G;FET:6]N(&=U:61A;F-E+B!4:&4@&5R8VES92!J M=61G;65N="!W:&5N(&-O;G-I9&5R:6YG(&-O;G1R86-T('1E2!E=F%L M=6%T:6YG('1H92!I;7!A8W0@;V8@=&AE(&%D;W!T:6]N(&]F('1H:7,@3H@)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z M(#,V<'0[)SY);B!!<')I;"`R,#$U+"!T:&4@1D%30B!I2!R871H97(@=&AA;B!A MF%T:6]N(&]F('1H92!C;W-T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M6QE/3-$)V9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^5&AE M(&%C8V]M<&%N>6EN9R!C;VYD96YS960@8V]N2!A8V-E<'1E M9"!I;B!T:&4@56YI=&5D(%-T871E2=S($%N;G5A;"!297!O65A&5R8VES92!C;VYT2X@5&AE M(')E65A3L@ M=&5X="UI;F1E;G0Z(#,V<'0[)SY4:&4@<')E<&%R871I;VX@;V8@9FEN86YC M:6%L('-T871E;65N=',@:6X@8V]N9F]R;6ET>2!W:71H(%4N4RX@1T%!4"!R M97%U:7)E2!M86ME'!E2=S M(&UA;F%G96UE;G0N(%1H92!#;VUP86YY(&5V86QU871E'0^/&1I=B!S='EL93TS1"=F;VYT M+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY.;W1E($(@;V8@=&AE M($YO=&5S('1O($-O;G-O;&ED871E9"!&:6YA;F-I86P@4W1A=&5M96YT65A3H@)U1I;65S($YE=R!2;VUA M;B3L@=&5X="UI M;F1E;G0Z(#,V<'0[)SY4:&4@0V]M<&%N>2!R96-O9VYI>F5S(&-O;6UI&5D(&]R(&1E=&5R;6EN86)L92!A;F0@8V]L M;&5C=&%B:6QI='D@:7,@2!A6%B;&4@=&\@;W5R('-A M;&5S(&9O'!E;G-E('=H96X@=&AE(&%S M'!E;G-E(&ES(')E8V]G;FEZ960@=VAE;B!T:&4@8V]R M6QE/3-$)V9O;G0M M6QE.B!I=&%L M:6,[('1E>'0M86QI9VXZ(&IUF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E2!T:&4@<')I;6%R>2!B96YE M9FEC:6%R>2!O9B!T:&4@96YT:71I97,N)B,Q-C`[($)I;W@@:7,@82!687)I M86)L92!);G1E6QE/3-$)V9O;G0M'0M86QI M9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^3&EA8FEL:71I97,@ M6EN9R!C;VYD96YS960@8V]N6QE/3-$)V9O;G0M'0M86QI9VXZ M(&IU'0M:6YD96YT.B`S-G!T.R<^)B,Q-C`[/"]D:78^/"]D M:78^/&1I=B!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97([)SX\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W9E6QE/3-$)W9E3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX] M,T1B;W1T;VT@'0M86QI M9VXZ(&QE9G0[)SY#87-H(&%N9"!C87-H(&5Q=6EV86QE;G1S/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE M/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE M/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H M.B`W-B4[('9E6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W9E6QE/3-$)W9E#L@ M=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/"]T6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`W-B4[ M('9E6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0^/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE.B!I=&%L M:6,[('1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M3LG/E)E8VQA6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT.B`S-G!T.R<^ M0V5R=&%I;B!R96-L87-S:69I8V%T:6]N'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA3H@)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z(#,V M<'0[)SY,:6%B:6QI=&EEF5D(&%S(&$@28C.#(Q-SMS(&=E;F5R86P@87-S M971S+B!4:&4@9FEN86YC:6%L(&EN9F]R;6%T:6]N(&]F($)I;W@L('=H:6-H M('=A3L@=&5X="UI;F1E;G0Z(#,V<'0[ M)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E#LG M/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^ M/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[)SY4 M;W1A;"!A6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`W-B4[('9E6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W9E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9E#LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0V('-T>6QE/3-$)W9E6QE/3-$)W9E"!S;VQI9#LG M/CQD:78@3H@ M)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M M8F]T=&]M.B`C-C0V-#8T(#)P>"!S;VQI9#LG/CQD:78@'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(&QE9G0[)SY4;W1A;"!N M970@F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0MF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M'1087)T7V0V,#=C,F8S7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!&:6YA;F-I86P@26YF;W)M871I;VX@9F]R(%-E9VUE;G1S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)V9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV/E-U;6UA6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M#LG M/CQD:78@3H@ M)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/CQD:78@ M3H@)U1I;65S M($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)V9O;G0M M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#LG/CQD M:78@3H@)U1I M;65S($YE=R!2;VUA;BF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&-E;G1E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO M=&0^/"]TF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V M86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N M="UW96EG:'0Z(&YO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@9F]N="UW96EG:'0Z(&YO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO M'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`T,"4[('9E6QE/3-$)V9O;G0M M'0M86QI9VXZ(&QE9G0[(&UA'0M:6YD96YT.B`M.7!T.R<^5&]T86P@87-S971S/"]D:78^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG M:'0Z(&YO6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI M9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N M="UW96EG:'0Z(&YO6QE/3-$)W=I9'1H.B`T,"4[('9E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&QE9G0[(&UA'0M:6YD96YT.B`M.7!T.R<^06-C;W5N=',@86YD(&]T M:&5R(')E8V5I=F%B;&5S+"!N970\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z M(&YO6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ M(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@ M3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@9F]N="UW96EG:'0Z(&YO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO'0M M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW M96EG:'0Z(&YO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A M8VMG'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@9F]N="UW M96EG:'0Z(&YO6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E M#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@8V]L M6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`S.2XY."4[('9E M6QE/3-$)V9O;G0M'0M86QI9VXZ M(&QE9G0[)SY2979E;G5EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X M+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`S.2XY M."4[('9E6QE/3-$)V9O;G0M'0M M86QI9VXZ(&QE9G0[)SY/<&5R871I;F<@:6YC;VUE("AL;W-S*3PO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@,"XY.24[ M('9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W=I M9'1H.B`S.2XY."4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY!8V-O=6YTF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$ M)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE M/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`S.2XY."4[('9E6QE/3-$)V9O;G0M M'0M86QI9VXZ(&QE9G0[)SY$969E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P M+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H M.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3L@=&5X="UI;F1E;G0Z(#,V<'0[)SY4:&4@9F]L;&]W:6YG('1A M8FQE(')E<')E&-L=61E9"!F6QE/3-$)W1E>'0M M86QI9VXZ(&-E;G1E"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M'0M86QI M9VXZ(&-E;G1E6QE/3-$)W9E'0M:6YD96YT.B`M.7!T.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO M=&0^/'1D(&-O;'-P86X],T0S('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Y)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R M<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R M+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@;6%R9VEN+6QE9G0Z(#EP=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN M9RUB;W1T;VTZ(#1P>#L@=&5X="UA;&EG;CH@"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAAF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X M.R<^/"]T9#X\=&0@8V]L6QE/3-$)W9E#L@=&5X="UA;&EG;CH@;&5F=#LG/CPO=&0^/"]T6QE/3-$)W9E6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE M/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M'0M86QI9VXZ M(&-E;G1E3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E2!M87)K970@9G5N9',@ M*&EN8VQU9&5D(&EN(&-A6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P M>#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O M;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O M;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`P+CDY M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P M>#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W9EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE M/3-$)W9E6QE/3-$)V9O;G0M'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(&-E;G1E6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E"!S;VQI M9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D M:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@"!S;VQI9#L@=&5X M="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N M.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O M='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)V9O;G0M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V-V8Y,69E-39C-F,-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#8P-V,R9C-?-S9B8U\T9F9C7S@T M,&)?-C=F.3%F934V8S9C+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W9E#L@=&5X="UA;&EG;CH@;&5F=#LG/CPO=&0^ M/"]T6QE/3-$)W9E3H@)U1I;65S($YE=R!2;VUA;B3H@)U1I;65S($YE=R!2 M;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D M('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@8V]L M6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M)SY$=64@9G)O;2!E;7!L;WEE97,\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SYC;VUM:7-S:6]N(&%D:G5S=&UE;G1S/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O M;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY!8V-O=6YT"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R M9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R M:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA3H@)U1I;65S($YE=R!2;VUA;B3L@=&5X="UI;F1E;G0Z M(#,V<'0[)SY);G9E;G1O3L@=&5X="UI;F1E;G0Z M(#,V<'0[)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&-E;G1E#L@8F]R9&5R+6QE9G0Z(&UE9&EU;2!N;VYE M.R<^/"]T9#X\=&0@8V]L6QE.B!I=&%L:6,[ M('1E>'0M86QI9VXZ(&-E;G1E#L@=&5X="UA;&EG;CH@;&5F=#LG/CPO=&0^/"]T#L@8F]R9&5R+6QE9G0Z(&UE M9&EU;2!N;VYE.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)V)OF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=B;W)D97(M=&]P M.B!M961I=6T@;F]N93L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN M9RUB;W1T;VTZ(#)P>#L@8F]R9&5R+6QE9G0Z(&UE9&EU;2!N;VYE.R<^)B,Q M-C`[/"]T9#X\=&0@8V]L6QE M/3-$)V)O"!S;VQI9#LG/CQD:78@ M3H@)U1I;65S M($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R M/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E M6QE/3-$)V)O6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO;F4[ M('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO M;F4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M M(&YO;F4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@;65D M:75M(&YO;F4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE M9G0[(&)A8VMGF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO;F4[('1E>'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F]R9&5R+6)O='1O;3H@;65D:75M(&YO;F4[('1E>'0M86QI9VXZ M(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V9O M;G0M'0M86QI9VXZ(&QE9G0[)SY&:6YI'0M86QI9VXZ(')I9VAT.R!B;W)D97(M;&5F=#H@;65D M:75M(&YO;F4[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG M;CH@6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F]R9&5R+6QE9G0Z(&UE9&EU;2!N;VYE.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M<&%D9&EN9RUB;W1T;VTZ(#1P>#L@=&5X="UA;&EG;CH@3H@)U1I;65S($YE=R!2;VUA;B"!D;W5B;&4[('1E>'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V)O'0M M86QI9VXZ(')I9VAT.R!B;W)D97(M;&5F=#H@;65D:75M(&YO;F4[(&)A8VMG M"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@ M9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=F;VYT+69A M;6EL>3H@)U1I;65S($YE=R!2;VUA;B3LG/B8C M,38P.SPO9&EV/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B#LG/CQD:78@ M3H@)U1I;65S M($YE=R!2;VUA;B"!S;VQI9#LG/CQD:78@F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6EN9R!!;6]U;G0\+V1I=CX\+W1D/CQT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)W=I9'1H.B`X."4[ M('9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(&QE9G0[)SY"86QA;F-E(&%T($1E8V5M8F5R(#,Q+"`R,#$T/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`X."4[('9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(&QE9G0[)SY&;W)E:6=N(&-U6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O M;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E"!D;W5B;&4[('1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG M6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@)U1I;65S($YE=R!2;VUA;B28C.#(Q-SMS(&]T:&5R(&EN=&%N9VEB;&4@87-S971S(&-O;G-IF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE.B!I=&%L:6,[ M('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+V1I=CX\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@"!S;VQI M9#LG/CQD:78@3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E#L@=&5X M="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE M/3-$)W9E3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY0871E;G1S M(&%N9"!496-H;F]L;V=Y/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^ M/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M)SY!8V-U;75L871E9"!A;6]R=&EZ871I;VX\+V1I=CX\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ M(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M<&%D9&EN9RUB;W1T;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D M9&EN9RUB;W1T;VTZ(#1P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M<&%D9&EN9RUB;W1T;VTZ(#1P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@;F]W'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$ M)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY#;W-T6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-EF%T:6]N/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D M9&EN9RUB;W1T;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO#L@8F%C:V=R;W5N9"UC;VQO"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@ M9&]U8FQE.R!T97AT+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R M+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H M=#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+V1I=CX\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY# M;W-T6QE/3-$)W=I M9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@ M6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF%T:6]N/"]D:78^/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y M)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P M,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[ M(&)A8VMG"!D;W5B M;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R M+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[ M/"]T9#X\=&0@;F]W'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W M'0M86QI9VXZ(&QE9G0[ M(&)A8VMG#L@8F%C M:V=R;W5N9"UC;VQO"!D;W5B;&4[ M('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T M<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L M:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@ M3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@ M,G!X.R<^/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E3H@)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO M=&0^/"]T6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!S='EL93TS1"=W:61T:#H@ M-S8E.R!V97)T:6-A;"UA;&EG;CH@=&]P.R!W:&ET92US<&%C93H@;F]WF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'!E;G-E("T@;F]N8W5RF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO6QE M/3-$)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M)SY46QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`W-B4[('9E6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY/=&AE M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T;VTZ M(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R M+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B M;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P M,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC M;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT M+6%L:6=N.B!L969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&QE9G0[)SX\ M=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W9E#LG/CPO=&0^/'1D(&-O;'-P86X],T0V('-T>6QE/3-$ M)W9E6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E M6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E MF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI M9VX],T1B;W1T;VT@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)W=I9'1H.B`W-B4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY!8V-R=65D(&-O;7!E;G-A=&EO;CPO M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=W:61T:#H@ M,24[('9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O M='1O;3L@9F]N="UW96EG:'0Z(&YO3H@)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@9F]N="UW96EG:'0Z(&YO6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG'0M86QI9VXZ(&QE9G0[ M(&)A8VMG#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W=I M9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB;W1T M;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R M9&5R+6)O='1O;3H@(S`P,#`P,"`R<'@@'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@<&%D9&EN9RUB;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[(&9O;G0M=V5I9VAT.B!N;W)M86P[('1E>'0M M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U M8FQE.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!T97AT+6%L:6=N.B!R:6=H=#L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@ M9&]U8FQE.R!F;VYT+7=E:6=H=#H@;F]R;6%L.R!T97AT+6%L:6=N.B!L969T M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E6QE/3-$)V9O;G0MF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E M6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&QE9G0[('1E M>'0M:6YD96YT.B`S,C1P=#LG/B8C,38P.SPO9&EV/CPO9&EV/CQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA28C.#(Q-SMS(&1E M9F5RF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`V,#%P>#L@=F5R=&EC86PM M86QI9VXZ('1O<#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=W:61T:#H@-7!X.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R<^ M/"]T9#X\=&0@8V]L6QE/3-$ M)W=I9'1H.B`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`P,#`P,"`R<'@@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E M;G1E6QE/3-$)W=I9'1H.B`U<'@[('9E'0M86QI9VXZ M(&QE9G0[(&)A8VMGF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[(&)A8VMGF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A M8VMG6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W=I9'1H.B`W-BXS-R4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY!9&1I=&EO;G,Z/"]D:78^ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W M'0M86QI9VXZ(&QE9G0[ M(&)A8VMG6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`W-BXS-R4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE M9G0[)SY$969E'1E;F1E9"!S97)V:6-E(&-O;G1R86-T6QE/3-$)W=I9'1H.B`Y+C0E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q+C0E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H M.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R M:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ M(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q+C0E M.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA M;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`W-BXS-R4[('9E M6QE/3-$)V9O;G0M'0M86QI9VXZ M(&QE9G0[)SY296-O9VYI>F5D(&%S(')E=F5N=64Z/"]D:78^/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@;F]W'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`W-BXS-R4[('9E6QE M/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY$969E M'1E;F1E9"!S97)V:6-E(&-O;G1R86-T6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W=I M9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N M.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H M.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F M=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM M86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L M:6=N.B!R:6=H=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`W-BXS-R4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE M9G0[)SY$969E6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!T97AT+6%L:6=N.B!R:6=H=#L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@ M3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`W-BXS-R4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY$969E6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN M9RUB;W1T;VTZ(#)P>#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`Y+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@<&%D9&EN9RUB M;W1T;VTZ(#)P>#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ M(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`W-BXS-R4[('9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[)SY$969E6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI M9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG'0M86QI9VXZ(')I M9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[ M(&)A8VMG#L@ M8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R M9&5R+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L M969T.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O M;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`Q+C0E.R!V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!B86-K9W)O=6YD+6-O;&]R.B`C M9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W=I9'1H.B`Q)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F]R9&5R M+6)O='1O;3H@(S`P,#`P,"`T<'@@9&]U8FQE.R!T97AT+6%L:6=N.B!L969T M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N M)RP@5&EM97,L('-E'0M86QI9VXZ(&QE9G0[(&)A8VMG'1087)T7V0V,#=C,F8S7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE M/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E MF4Z(#$P<'0[)SX\9&EV/E1H92!F;VQL;W=I;F<@=6YA M=61I=&5D('-U<'!L96UE;G1A;"!P6QE/3-$)W9E#LG/CPO=&0^/'1D(&-O;'-P86X],T0V('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^ M)B,Q-C`[/&9O;G0@3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0V('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^ M)B,Q-C`[)B,Q-C`[(%1H6QE/3-$)W9E3H@)U1I;65S($YE=R!2;VUA M;B6QE/3-$)V9O;G0M M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M'0M86QI M9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@3H@)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R M=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W=I M9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I M9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG M;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W=I9'1H.B`X+CDX)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X M="UA;&EG;CH@6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC86PM86QI9VXZ(&)O='1O M;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@ M=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(')I9VAT.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-E6QE/3-$)W=I9'1H.B`P+CDY)3L@=F5R=&EC M86PM86QI9VXZ(&)O='1O;3L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A3QB7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'1E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V-V8Y M,69E-39C-F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#8P-V,R M9C-?-S9B8U\T9F9C7S@T,&)?-C=F.3%F934V8S9C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V-V8Y,69E M-39C-F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9#8P-V,R9C-? M-S9B8U\T9F9C7S@T,&)?-C=F.3%F934V8S9C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-L=61E9"!F7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!M87)K970@9G5N9',@*&EN8VQU9&5D(&EN M(&-A2!M M87)K970@9G5N9',@*&EN8VQU9&5D(&EN(&-A2!M87)K970@9G5N9',@*&EN8VQU9&5D(&EN(&-A'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA65E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^-R!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-C`W8S)F,U\W-F)C M7S1F9F-?.#0P8E\V-V8Y,69E-39C-F,-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO9#8P-V,R9C-?-S9B8U\T9F9C7S@T,&)?-C=F.3%F934V8S9C M+U=O'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]D-C`W M8S)F,U\W-F)C7S1F9F-?.#0P8E\V-V8Y,69E-39C-F,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO9#8P-V,R9C-?-S9B8U\T9F9C7S@T,&)?-C=F M.3%F934V8S9C+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D(&%S(')E M=F5N=64Z/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R,S$I/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'1087)T7V0V M,#=C,F8S7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!42!4'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^,R!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-2!Y96%R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC&UL/@T*+2TM+2TM/5].97AT M4&%R=%]D-C`W8S)F,U\W-F)C7S1F9F-?.#0P8E\V-V8Y,69E-39C-F,M+0T* ` end XML 23 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9
OTHER ASSETS (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Mar. 31, 2014
OTHER ASSETS [Abstract]      
Deferred commission expense - noncurrent $ 2,493vaso_DeferredSalesCommissionNoncurrent $ 2,988vaso_DeferredSalesCommissionNoncurrent  
Trade receivables - noncurrent 1,612us-gaap_AccountsReceivableNetNoncurrent 2,171us-gaap_AccountsReceivableNetNoncurrent  
Other 515us-gaap_OtherAssets 458us-gaap_OtherAssets  
Total $ 4,620us-gaap_OtherAssetsNoncurrent $ 5,617us-gaap_OtherAssetsNoncurrent $ 3,281us-gaap_OtherAssetsNoncurrent
XML 24 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
GOODWILL AND OTHER INTANGIBLES (Tables)
 3 Months Ended
Mar. 31, 2015
GOODWILL AND OTHER INTANGIBLES [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
The components of the change in goodwill are as follows:
 
 
(in thousands)
 
 
Carrying Amount
 
 
 
Balance at December 31, 2014
 
$
3,288
 
Foreign currency translation
  
16
 
Balance at March 31, 2015 (unaudited)
 
$
3,304
 
Schedule of Other Intangible Assets
The Company’s other intangible assets consist of capitalized patent costs, customer lists and software costs, as follows:
 
 
 
(in thousands)
 
 
 
March 31,
2015
  
December 31,
2014
 
 
 
(unaudited)
   
Patents and Technology
    
Costs
 
$
2,478
  
$
2,489
 
Accumulated amortization
  
(613
)
  
(549
)
 
  
1,865
   
1,940
 
 
        
Customer lists
        
Costs
  
800
   
800
 
Accumulated amortization
  
(410
)
  
(381
)
 
  
390
   
419
 
 
        
Software
        
Costs
  
986
   
962
 
Accumulated amortization
  
(573
)
  
(495
)
 
  
413
   
467
 
 
        
 
 
$
2,668
  
$
2,826
 
 
XML 25 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
INVENTORIES, NET (Tables)
 3 Months Ended
Mar. 31, 2015
INVENTORIES, NET [Abstract]  
Inventories, Net of Reserves
Inventories, net of reserves, consist of the following:                                    
 
  (in thousands)
  
March 31,
2015
  
December 31,
2014
 
  (unaudited)   
Raw materials
 
$
592
  
$
583
 
Work in process
  
691
   
679
 
Finished goods
  
846
   
636
 
  
$
2,129
  
$
1,898
 
XML 26 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCRUED EXPENSES AND OTHER LIABILITIES (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]    
Accrued compensation $ 433us-gaap_EmployeeRelatedLiabilitiesCurrent $ 2,917us-gaap_EmployeeRelatedLiabilitiesCurrent
Accrued expenses - other 1,090us-gaap_AccruedLiabilitiesCurrent 1,098us-gaap_AccruedLiabilitiesCurrent
Other liabilities 1,843us-gaap_OtherLiabilitiesCurrent 1,612us-gaap_OtherLiabilitiesCurrent
Accrued expenses and other liabilities $ 3,366vaso_AccruedExpensesAndOtherLiabilitiesCurrent $ 5,627vaso_AccruedExpensesAndOtherLiabilitiesCurrent
XML 27 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
OTHER ASSETS (Tables)
 3 Months Ended
Mar. 31, 2015
OTHER ASSETS [Abstract]  
Schedule of Other Assets

Other assets consist of the following at March 31, 2015 and December 31, 2014:      
 
 (in thousands)
  
March 31,
2015
  
December 31,
2014
 
  (unaudited)   
Deferred commission expense - noncurrent
 
$
2,493
  
$
2,988
 
Trade receivables - noncurrent
  
1,612
   
2,171
 
Other
  
515
   
458
 
  
$
4,620
  
$
5,617
 
XML 28 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)
 3 Months Ended
Mar. 31, 2015
ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]  
Schedule of Accrued Liabilities
Accrued expenses and other liabilities consist of the following at March 31, 2015 and December 31, 2014:
 
 (in thousands)
 
 
March 31,
2015
  
December 31,
2014
 
 
 (unaudited)   
Accrued compensation
 
$
433
  
$
2,917
 
Accrued expenses - other
  
1,090
   
1,098
 
Other liabilities
  
1,843
   
1,612
 
 
 
$
3,366
  
$
5,627
 
 
XML 29 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES
 3 Months Ended
Mar. 31, 2015
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES [Abstract]  
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES
NOTE B - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES

Basis of Presentation and Use of Estimates

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the unaudited condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the SEC on March 30, 2015. These unaudited condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the unaudited condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.

Significant Accounting Policies

Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2014, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.

Revenue and Expense Recognition for the Sales Representation Segment

The Company recognizes commission revenue in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.  These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.  Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.  Commission expense is recognized when the corresponding commission revenue is recognized
 
Variable Interest Entities

The Company follows the guidance of accounting for variable interest entities, which requires certain variable interest entities to be consolidated by the primary beneficiary of the entities.  Biox is a Variable Interest Entity (VIE).

Liabilities recognized as a result of consolidating this VIE do not represent additional claims on the Company’s general assets. The financial information of Biox, which was included in the accompanying condensed consolidated financial statements, is presented as follow.
 
  (in thousands)
  
As of March 31,
2015
(unaudited)
  
As of December 31,
2014
 
Cash and cash equivalents
 
$
117
  
$
159
 
Total assets
 
$
1,083
  
$
1,047
 
Total liabilities
 
$
1,047
  
$
878
 
 
 (in thousands)
  
  (unaudited)
Three months ended March 31,
 
  
2015
  
2014
 
Total net revenue
 
$
371
  
$
329
 
         
Net loss
 
$
(135
)
 
$
(148
)
 
Reclassifications

Certain reclassifications have been made to prior period amounts to conform with the current period presentation.
XML 30 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
DEFERRED REVENUE (Tables)
 3 Months Ended
Mar. 31, 2015
DEFERRED REVENUE [Abstract]  
Changes in Deferred Revenues
The changes in the Company’s deferred revenues are as follows:
 
 (in thousands)
     For the three months ended 
  
March 31,
2015
  
March 31,
2014
 
 
 
 
(unaudited)
  
 
(unaudited)
 
Deferred revenue at beginning of period
$22,532$
18,019
Additions:
        
Deferred extended service contracts
  
211
   
237
 
Deferred in-service and training
  
3
   
3
 
Deferred service arrangements
  
10
   
5
 
Deferred commission revenues
  
1,849
   
1,770
 
Recognized as revenue:
        
Deferred extended service contracts
  
(231
)
  
(227
)
Deferred in-service and training
  
(8
)
  
(8
)
Deferred service arrangements
  
(23
)
  
(24
)
Deferred commission revenues
  
(2,890
)
  
(2,771
)
Deferred revenue at end of period
  
21,453
   
17,004
 
Less: current portion
  
11,400
   
10,294
 
Long-term deferred revenue at end of period
 
$
10,053
  
$
6,710
 
XML 31 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCOUNTS AND OTHER RECEIVABLES, NET (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
Mar. 31, 2014
ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract]      
Trade receivables $ 9,270us-gaap_AccountsReceivableNetCurrent $ 19,734us-gaap_AccountsReceivableNetCurrent  
Due from employees 116us-gaap_DueFromEmployeesCurrent 110us-gaap_DueFromEmployeesCurrent  
Allowance for doubtful accounts and commission adjustments (4,361)us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent (4,571)us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent  
Accounts and other receivables, net $ 5,025us-gaap_AccountsAndOtherReceivablesNetCurrent $ 15,273us-gaap_AccountsAndOtherReceivablesNetCurrent $ 5,381us-gaap_AccountsAndOtherReceivablesNetCurrent
XML 32 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
CURRENT ASSETS    
Cash and cash equivalents $ 15,269us-gaap_CashAndCashEquivalentsAtCarryingValue $ 9,128us-gaap_CashAndCashEquivalentsAtCarryingValue
Short-term investments 109us-gaap_ShortTermInvestments 111us-gaap_ShortTermInvestments
Accounts and other receivables, net of an allowance for doubtful accounts and commission adjustments of $4,361 at March 31, 2015 and $4,571 at December 31, 2014 5,025us-gaap_AccountsAndOtherReceivablesNetCurrent 15,273us-gaap_AccountsAndOtherReceivablesNetCurrent
Receivables due from related parties 76us-gaap_AccountsReceivableRelatedParties 21us-gaap_AccountsReceivableRelatedParties
Inventories, net 2,129us-gaap_InventoryNet 1,898us-gaap_InventoryNet
Deferred commission expense 2,416us-gaap_DeferredCostsCurrent 2,200us-gaap_DeferredCostsCurrent
Prepaid expenses and other current assets 440us-gaap_PrepaidExpenseAndOtherAssetsCurrent 363us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Total current assets 25,464us-gaap_AssetsCurrent 28,994us-gaap_AssetsCurrent
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $1,443 at March 31, 2015 and $1,397 at December 31, 2014 242us-gaap_PropertyPlantAndEquipmentNet 266us-gaap_PropertyPlantAndEquipmentNet
GOODWILL 3,304us-gaap_Goodwill 3,288us-gaap_Goodwill
INTANGIBLES, net 2,668us-gaap_FiniteLivedIntangibleAssetsNet 2,826us-gaap_FiniteLivedIntangibleAssetsNet
OTHER ASSETS 4,620us-gaap_OtherAssetsNoncurrent 5,617us-gaap_OtherAssetsNoncurrent
Total Assets 36,298us-gaap_Assets 40,991us-gaap_Assets
CURRENT LIABILITIES    
Accounts payable 567us-gaap_AccountsPayableCurrent 462us-gaap_AccountsPayableCurrent
Accrued commissions 1,151us-gaap_AccruedSalesCommissionCurrent 2,247us-gaap_AccruedSalesCommissionCurrent
Accrued expenses and other liabilities 3,366vaso_AccruedExpensesAndOtherLiabilitiesCurrent 5,627vaso_AccruedExpensesAndOtherLiabilitiesCurrent
Sales tax payable 199us-gaap_SalesAndExciseTaxPayableCurrent 247us-gaap_SalesAndExciseTaxPayableCurrent
Deferred revenue - current portion 11,400us-gaap_DeferredRevenueCurrent 9,882us-gaap_DeferredRevenueCurrent
Notes payable 164us-gaap_NotesPayableCurrent 163us-gaap_NotesPayableCurrent
Deferred tax liability, net 112us-gaap_DeferredTaxLiabilitiesCurrent 112us-gaap_DeferredTaxLiabilitiesCurrent
Notes payable due to related party 1,056us-gaap_NotesPayableRelatedPartiesClassifiedCurrent 1,039us-gaap_NotesPayableRelatedPartiesClassifiedCurrent
Total current liabilities 18,015us-gaap_LiabilitiesCurrent 19,779us-gaap_LiabilitiesCurrent
LONG-TERM LIABILITIES    
Deferred revenue 10,053us-gaap_DeferredRevenueNoncurrent 12,650us-gaap_DeferredRevenueNoncurrent
Other long-term liabilities 705us-gaap_OtherLiabilitiesNoncurrent 811us-gaap_OtherLiabilitiesNoncurrent
Total long-term liabilities 10,758us-gaap_LiabilitiesNoncurrent 13,461us-gaap_LiabilitiesNoncurrent
COMMITMENTS AND CONTINGENCIES (NOTE N)      
STOCKHOLDERS' EQUITY    
Preferred stock, $.01 par value; 1,000,000 shares authorized; nil shares issued and outstanding at March 31, 2015, and December 31, 2014 0us-gaap_PreferredStockValue 0us-gaap_PreferredStockValue
Common stock, $.001 par value; 250,000,000 shares authorized; 166,450,370 and 166,435,370 shares issued at March 31, 2015 and December 31, 2014, respectively; 156,142,283 and 156,127,283 shares outstanding at March 31, 2015 and December 31, 2014, respectively 166us-gaap_CommonStockValue 166us-gaap_CommonStockValue
Additional paid-in capital 61,943us-gaap_AdditionalPaidInCapital 61,924us-gaap_AdditionalPaidInCapital
Accumulated deficit (52,685)us-gaap_RetainedEarningsAccumulatedDeficit (52,433)us-gaap_RetainedEarningsAccumulatedDeficit
Accumulated other comprehensive income 101us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 94us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Treasury stock, at cost, 10,308,087 shares at March 31, 2015 and December 31, 2014 (2,000)us-gaap_TreasuryStockValue (2,000)us-gaap_TreasuryStockValue
Total stockholders' equity 7,525us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 7,751us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Total liabilities and stockholders' equity $ 36,298us-gaap_LiabilitiesAndStockholdersEquity $ 40,991us-gaap_LiabilitiesAndStockholdersEquity
XML 33 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
DEFERRED REVENUE (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Changes in deferred revenue [Roll Forward]        
Deferred revenue at the beginning of the year     $ 22,532us-gaap_DeferredRevenue $ 18,019us-gaap_DeferredRevenue
Deferred revenue at end of year 21,453us-gaap_DeferredRevenue 17,004us-gaap_DeferredRevenue 22,532us-gaap_DeferredRevenue 18,019us-gaap_DeferredRevenue
Less: current portion 11,400us-gaap_DeferredRevenueCurrent 10,294us-gaap_DeferredRevenueCurrent 9,882us-gaap_DeferredRevenueCurrent  
Long-term deferred revenue at end of year 10,053us-gaap_DeferredRevenueNoncurrent 6,710us-gaap_DeferredRevenueNoncurrent 12,650us-gaap_DeferredRevenueNoncurrent  
Extended Service Contracts [Member]        
Changes in deferred revenue [Roll Forward]        
Additions: 211us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ExtendedServiceContractsMember		 237us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ExtendedServiceContractsMember		    
Recognized as revenue: (231)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ExtendedServiceContractsMember		 (227)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ExtendedServiceContractsMember		    
In-Service and Training [Member]        
Changes in deferred revenue [Roll Forward]        
Additions: 3us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_InServiceAndTrainingMember		 3us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_InServiceAndTrainingMember		    
Recognized as revenue: (8)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_InServiceAndTrainingMember		 (8)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_InServiceAndTrainingMember		    
Service Arrangements [Member]        
Changes in deferred revenue [Roll Forward]        
Additions: 10us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ServiceArrangementsMember		 5us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ServiceArrangementsMember		    
Recognized as revenue: (23)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ServiceArrangementsMember		 (24)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_ServiceArrangementsMember		    
Commission Revenues [Member]        
Changes in deferred revenue [Roll Forward]        
Additions: 1,849us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_CommissionRevenuesMember		 1,770us-gaap_DeferredRevenueAdditions
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_CommissionRevenuesMember		    
Recognized as revenue: $ (2,890)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_CommissionRevenuesMember		 $ (2,771)us-gaap_DeferredRevenueRevenueRecognized
/ us-gaap_DeferredRevenueArrangementTypeAxis
= vaso_CommissionRevenuesMember		    
XML 34 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash flows from operating activities    
Net loss $ (252)us-gaap_NetIncomeLoss $ (1,044)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash provided by operating activities    
Depreciation and amortization 212us-gaap_DepreciationDepletionAndAmortization 99us-gaap_DepreciationDepletionAndAmortization
Loss from interest in joint venture 2us-gaap_IncomeLossFromEquityMethodInvestments 0us-gaap_IncomeLossFromEquityMethodInvestments
Provision for doubtful accounts and commission adjustments 9vaso_ProvisionForDoubtfulAccountsAndCommissionAdjustments (8)vaso_ProvisionForDoubtfulAccountsAndCommissionAdjustments
Share-based compensation and arrangements 19vaso_ShareBasedCompensationAndArrangements 153vaso_ShareBasedCompensationAndArrangements
Changes in operating assets and liabilities:    
Accounts and other receivables 10,240us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables 8,194us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables
Receivables due from related parties (55)us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent 0us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent
Inventories, net (227)us-gaap_IncreaseDecreaseInInventories (225)us-gaap_IncreaseDecreaseInInventories
Deferred commission expense (211)us-gaap_IncreaseDecreaseInDeferredCharges (7)us-gaap_IncreaseDecreaseInDeferredCharges
Other current assets (76)us-gaap_IncreaseDecreaseInOtherCurrentAssets 3us-gaap_IncreaseDecreaseInOtherCurrentAssets
Other assets 1,070us-gaap_IncreaseDecreaseInOtherNoncurrentAssets (184)us-gaap_IncreaseDecreaseInOtherNoncurrentAssets
Accounts payable 105us-gaap_IncreaseDecreaseInAccountsPayableTrade 147us-gaap_IncreaseDecreaseInAccountsPayableTrade
Accrued commissions (1,095)us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities (461)us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities
Accrued expenses and other liabilities (2,267)us-gaap_IncreaseDecreaseInAccruedLiabilities (1,449)us-gaap_IncreaseDecreaseInAccruedLiabilities
Sales tax payable (48)us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable (33)us-gaap_IncreaseDecreaseInPropertyAndOtherTaxesPayable
Deferred revenue (1,078)us-gaap_IncreaseDecreaseInDeferredRevenue (1,014)us-gaap_IncreaseDecreaseInDeferredRevenue
Notes payable due to related party 18us-gaap_IncreaseDecreaseInNotesPayableRelatedParties 0us-gaap_IncreaseDecreaseInNotesPayableRelatedParties
Other long-term liabilities (107)us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities 25us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities
Net cash provided by operating activities 6,259us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 4,196us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities    
Purchases of equipment and software (45)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (136)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Purchases of short-term investments (38)us-gaap_PaymentsToAcquireShortTermInvestments (40)us-gaap_PaymentsToAcquireShortTermInvestments
Redemption of short-term investments 40us-gaap_ProceedsFromSaleOfShortTermInvestments 40us-gaap_ProceedsFromSaleOfShortTermInvestments
Net cash used in investing activities (43)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (136)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities    
Debt issuance costs (60)us-gaap_PaymentsOfDebtIssuanceCosts 0us-gaap_PaymentsOfDebtIssuanceCosts
Net cash used in financing activities (60)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations 0us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Effect of exchange rate differences on cash and cash equivalents (15)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents (12)us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 6,141us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease 4,048us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents - beginning of period 9,128us-gaap_CashAndCashEquivalentsAtCarryingValue 7,961us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents - end of period 15,269us-gaap_CashAndCashEquivalentsAtCarryingValue 12,009us-gaap_CashAndCashEquivalentsAtCarryingValue
SUPPLEMENTAL DISCLOSURE OF CASH INFORMATION    
Interest paid 3us-gaap_InterestPaid 0us-gaap_InterestPaid
Income taxes paid 65us-gaap_IncomeTaxesPaid 13us-gaap_IncomeTaxesPaid
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Common shares issued for prepaid directors' fees $ 0us-gaap_StockIssued1 $ 175us-gaap_StockIssued1
XML 35 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Variable Interest Entity [Line Items]        
Cash and cash equivalents $ 15,269us-gaap_CashAndCashEquivalentsAtCarryingValue $ 12,009us-gaap_CashAndCashEquivalentsAtCarryingValue $ 9,128us-gaap_CashAndCashEquivalentsAtCarryingValue $ 7,961us-gaap_CashAndCashEquivalentsAtCarryingValue
Total net revenue 7,453us-gaap_SalesRevenueNet 7,091us-gaap_SalesRevenueNet    
Net (loss) income (252)us-gaap_NetIncomeLoss (1,044)us-gaap_NetIncomeLoss 1,128us-gaap_NetIncomeLoss  
Biox [Member]        
Variable Interest Entity [Line Items]        
Cash and cash equivalents 117us-gaap_CashAndCashEquivalentsAtCarryingValue
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		   159us-gaap_CashAndCashEquivalentsAtCarryingValue
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		  
Total assets 1,083us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		   1,047us-gaap_VariableInterestEntityConsolidatedCarryingAmountAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		  
Total liabilities 1,047us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		   878us-gaap_VariableInterestEntityConsolidatedCarryingAmountLiabilities
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		  
Total net revenue 371us-gaap_SalesRevenueNet
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		 329us-gaap_SalesRevenueNet
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		    
Net (loss) income $ (135)us-gaap_NetIncomeLoss
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		 $ (148)us-gaap_NetIncomeLoss
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityPrimaryBeneficiaryMember		    
XML 36 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies)
 3 Months Ended
Mar. 31, 2015
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES [Abstract]  
Basis of Presentation and Use of Estimates
Basis of Presentation and Use of Estimates

The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and disclosures normally included in the unaudited condensed consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these condensed consolidated financial statements should be read in connection with the audited consolidated financial statements and related notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the SEC on March 30, 2015. These unaudited condensed consolidated financial statements include the accounts of the companies over which we exercise control. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of interim results for the Company. The results of operations for any interim period are not necessarily indicative of results to be expected for any other interim period or the full year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the unaudited condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company's management. The Company evaluates its estimates and assumptions on an ongoing basis.
Significant Accounting Policies
Significant Accounting Policies

Note B of the Notes to Consolidated Financial Statements, included in the Annual Report on Form 10-K for the year ended December 31, 2014, includes a summary of the significant accounting policies used in the preparation of the condensed consolidated financial statements.
Revenue and Expense Recognition for the Sales Representation Segment
Revenue and Expense Recognition for the Sales Representation Segment

The Company recognizes commission revenue in its Sales Representation segment (see Note C) when persuasive evidence of an arrangement exists, service has been rendered, the price is fixed or determinable and collectability is reasonably assured.  These conditions are deemed to be met when the underlying equipment has been accepted at the customer site in accordance with the specific terms of the sales agreement.  Consequently, amounts billable under the agreement with GE Healthcare in advance of the customer acceptance of the equipment are recorded as accounts receivable and deferred revenue in the condensed consolidated balance sheets.  Similarly, commissions payable to our sales force related to such billings are recorded as deferred commission expense when the associated deferred revenue is recorded.  Commission expense is recognized when the corresponding commission revenue is recognized
 
Variable Interest Entities

The Company follows the guidance of accounting for variable interest entities, which requires certain variable interest entities to be consolidated by the primary beneficiary of the entities.  Biox is a Variable Interest Entity (VIE).

Liabilities recognized as a result of consolidating this VIE do not represent additional claims on the Company’s general assets. The financial information of Biox, which was included in the accompanying condensed consolidated financial statements, is presented as follow.
 
  (in thousands)
  
As of March 31,
2015
(unaudited)
  
As of December 31,
2014
 
Cash and cash equivalents
 
$
117
  
$
159
 
Total assets
 
$
1,083
  
$
1,047
 
Total liabilities
 
$
1,047
  
$
878
 
 
 (in thousands)
  
  (unaudited)
Three months ended March 31,
 
  
2015
  
2014
 
Total net revenue
 
$
371
  
$
329
 
         
Net loss
 
$
(135
)
 
$
(148
)
Reclassifications
 
Reclassifications

Certain reclassifications have been made to prior period amounts to conform with the current period presentation.
XML 37 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT REPORTING AND CONCENTRATIONS (Details) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2015
Segment
Mar. 31, 2014
Dec. 31, 2014
SEGMENT REPORTING AND CONCENTRATIONS [Abstract]      
Number of segments 3us-gaap_NumberOfOperatingSegments    
Segment Reporting Information [Line Items]      
Revenues from external customers $ 7,453us-gaap_Revenues $ 7,091us-gaap_Revenues  
Operating income (loss) (286)us-gaap_OperatingIncomeLoss (1,090)us-gaap_OperatingIncomeLoss  
Total assets 36,298us-gaap_Assets 29,923us-gaap_Assets 40,991us-gaap_Assets
Accounts and other receivables, net 5,025us-gaap_AccountsAndOtherReceivablesNetCurrent 5,381us-gaap_AccountsAndOtherReceivablesNetCurrent 15,273us-gaap_AccountsAndOtherReceivablesNetCurrent
Deferred commission expense 2,416us-gaap_DeferredSalesCommission 2,319us-gaap_DeferredSalesCommission  
Other assets 4,620us-gaap_OtherAssetsNoncurrent 3,281us-gaap_OtherAssetsNoncurrent 5,617us-gaap_OtherAssetsNoncurrent
GE Healthcare [Member] | Sales Revenue, Net [Member]      
Revenue, Major Customer [Line Items]      
Percentage of revenue (in hundredths) 86.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= vaso_GeHealthcareMember		 88.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_MajorCustomersAxis
= vaso_GeHealthcareMember		  
Corporate [Member]      
Segment Reporting Information [Line Items]      
Revenues from external customers 0us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		 0us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		  
Operating income (loss) (383)us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		 (531)us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		  
Total assets 15,405us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		 11,986us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		  
Accounts and other receivables, net 0us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		 0us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		  
Deferred commission expense 0us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		 0us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		  
Other assets 73us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		 13us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_CorporateNonSegmentMember		  
Sales Representation Segment [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenues from external customers 6,390us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		 6,241us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		  
Operating income (loss) 1,087us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		 523us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		  
Total assets 11,142us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		 10,209us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		  
Accounts and other receivables, net 4,363us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		 4,535us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		  
Deferred commission expense 2,412us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		 2,319us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		  
Other assets 3,832us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		 2,836us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_SalesRepresentationSegmentMember		  
Equipment Segment [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenues from external customers 1,063us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		 850us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		  
Operating income (loss) (635)us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		 (1,082)us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		  
Total assets 9,592us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		 7,728us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		  
Accounts and other receivables, net 576us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		 846us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		  
Deferred commission expense 0us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		 0us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		  
Other assets 715us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		 432us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_EquipmentSegmentMember		  
IT Segment [Member] | Operating Segments [Member]      
Segment Reporting Information [Line Items]      
Revenues from external customers 0us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		 0us-gaap_Revenues
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		  
Operating income (loss) (355)us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		 0us-gaap_OperatingIncomeLoss
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		  
Total assets 159us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		 0us-gaap_Assets
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		  
Accounts and other receivables, net 86us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		 0us-gaap_AccountsAndOtherReceivablesNetCurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		  
Deferred commission expense 4us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		 0us-gaap_DeferredSalesCommission
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		  
Other assets $ 0us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		 $ 0us-gaap_OtherAssetsNoncurrent
/ us-gaap_ConsolidationItemsAxis
= us-gaap_OperatingSegmentsMember
/ us-gaap_StatementBusinessSegmentsAxis
= vaso_InformationTechnologySegmentMember		  
XML 38 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT REPORTING AND CONCENTRATIONS (Tables)
 3 Months Ended
Mar. 31, 2015
SEGMENT REPORTING AND CONCENTRATIONS [Abstract]  
Summary Financial Information for Segments
Summary financial information for the segments is set forth below:          
 
 
      
 
(in thousands)
As of or for the thee months March 31, 2015 (unaudited)
 
 
 
Sales
Representation
Segment
  
Equipment
Segment
  
IT Segment
  
Corporate
  
Consolidated
 
 
          
Revenues from external customers
 
$
6,390
  
$
1,063
  
$
-
  
$
-
  
$
7,453
 
Operating income (loss)
 
$
1,087
  
$
(635
)
 
$
(355
)
 
$
(383
)
 
$
(286
)
Total assets
 
$
11,142
  
$
9,592
  
$
159
  
$
15,405
  
$
36,298
 
Accounts and other receivables, net
 
$
4,363
  
$
576
  
$
86
  
$
-
  
$
5,025
 
Deferred commission expense
 
$
2,412
  
$
-
  
$
4
  
$
-
  
$
2,416
 
Other assets
 
$
3,832
  
$
715
  
$
-
  
$
73
  
$
4,620
 
 
      
    (in thousands)
As of or for the three months March 31, 2014 (unaudited)
  
Sales
 Representation
Segment
  
Equipment
Segment
  
IT Segment
  
Corporate
  
Consolidated
 
Revenues from external customers
 
$
6,241
  
$
850
  
$
-
  
$
-
  
$
7,091
 
Operating income (loss)
 
$
523
  
$
(1,082
)
 
$
-
  
$
(531
)
 
$
(1,090
)
Total assets
 
$
10,209
  
$
7,728
  
$
-
  
$
11,986
  
$
29,923
 
Accounts and other receivables, net
 
$
4,535
  
$
846
  
$
-
  
$
-
  
$
5,381
 
Deferred commission expense
 
$
2,319
  
$
-
  
$
-
  
$
-
  
$
2,319
 
Other assets
 
$
2,836
  
$
432
  
$
-
  
$
13
  
$
3,281
 
XML 39 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 40 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
ORGANIZATION AND PLAN OF OPERATIONS
 3 Months Ended
Mar. 31, 2015
ORGANIZATION AND PLAN OF OPERATIONS [Abstract]  
ORGANIZATION AND PLAN OF OPERATIONS
NOTE A - ORGANIZATION AND PLAN OF OPERATIONS

Vasomedical, Inc. was incorporated in Delaware in July 1987.  Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Vasomedical” or “management” refer to Vasomedical, Inc. and its subsidiaries.  Until 2010, we were primarily engaged in designing, manufacturing, marketing and supporting Enhanced External Counterpulsation (EECP®) systems, based on our proprietary technology, to physicians and hospitals throughout the United States and in select international markets. Beginning in July 2010 the Company, through its wholly-owned subsidiary Vaso Diagnostics, Inc. (Vaso Diagnostics), began its sales representation business via its agreement (the “GEHC Agreement”) with GE Healthcare (“GEHC”), the healthcare business unit of General Electric Company (NYSE: GE), to be GEHC’s exclusive sales representative for the sale of select GEHC diagnostic imaging products in specific market segments in the 48 contiguous states of the United States and the District of Columbia.   In June 2012, the GEHC Agreement was amended and extended through June 30, 2015 and again, in December 2014, the GEHC Agreement was further amended and extended through December 31, 2018, subject to earlier termination under certain circumstances and termination without cause on or after July 1, 2017.
 
                 In September 2011, the Company acquired Fast Growth Enterprises Limited (FGE), a British Virgin Islands company, which owns or controls two Chinese operating companies - Life Enhancement Technology Ltd. and Biox Instruments Co. Ltd. (Biox), respectively - to expand its technical and manufacturing capabilities and to enhance its distribution network, technology, and product portfolio.  Also in September 2011, the Company restructured to further align its business management structure and long-term growth strategy, and started to operate through three wholly-owned subsidiaries.  Vaso Diagnostics continues as the operating subsidiary for the sales representation of GE diagnostic imaging products; Vasomedical Global Corp. operates the Company’s Chinese companies; and Vasomedical Solutions, Inc. was formed to manage and coordinate our EECP® therapy business as well as other medical equipment operations.

In April 2014, the Company entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. (PSK) of Chongqing, China, the leading manufacturer of ECP therapy systems in China, to form a joint venture company, VSK Medical Limited (VSK), for the global marketing, sale and advancement of ECP therapy technology.  The Company owns 49.9% of the joint venture, which began operations in January 2015.

In June 2014, the Company entered into a Value Added Reseller Agreement (VAR Agreement) with GEHC to become a national value added reseller of GE Healthcare IT's Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support.  This multiyear VAR Agreement focuses primarily on existing customer segments currently served by Vaso Diagnostics on behalf of GEHC.  A new wholly owned subsidiary, VasoHealthcare IT Corp., was formed to conduct the healthcare IT business.

In August 2014, the Company acquired all of the outstanding shares of Genwell Instruments Co. Ltd. (Genwell), located in Wuxi, China, through its wholly owned subsidiary Wuxi Gentone Instruments Co. Ltd. (Gentone).  Genwell was formed in China in 2010 with the assistance of a government grant to develop the MobiCareTM wireless multi-parameter patient monitoring system and holds the patents and intellectual property rights for this system.

We report the operations of Vasomedical Global Corp. and Vasomedical Solutions, Inc. under our Equipment segment.  Vaso Diagnostics activities are included under our Sales Representation segment.  VasoHealthcare IT operations report under the IT segment.
XML 41 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
Mar. 31, 2015
Dec. 31, 2014
CURRENT ASSETS    
Accounts and other receivables, allowance for doubtful accounts and commission adjustments $ 4,361us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent $ 4,571us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
PROPERTY AND EQUIPMENT, accumulated depreciation $ 1,443us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment $ 1,397us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
STOCKHOLDERS' EQUITY    
Preferred stock, par value (in dollars per share) $ 0.01us-gaap_PreferredStockParOrStatedValuePerShare $ 0.01us-gaap_PreferredStockParOrStatedValuePerShare
Preferred stock, shares authorized (in shares) 1,000,000us-gaap_PreferredStockSharesAuthorized 1,000,000us-gaap_PreferredStockSharesAuthorized
Preferred stock, shares issued (in shares) 0us-gaap_PreferredStockSharesIssued 0us-gaap_PreferredStockSharesIssued
Preferred stock, shares outstanding (in shares) 0us-gaap_PreferredStockSharesOutstanding 0us-gaap_PreferredStockSharesOutstanding
Common stock, par value (in dollars per share) $ 0.001us-gaap_CommonStockParOrStatedValuePerShare $ 0.001us-gaap_CommonStockParOrStatedValuePerShare
Common stock, shares authorized (in shares) 250,000,000us-gaap_CommonStockSharesAuthorized 250,000,000us-gaap_CommonStockSharesAuthorized
Common stock, shares issued (in shares) 166,450,370us-gaap_CommonStockSharesIssued 166,435,370us-gaap_CommonStockSharesIssued
Common stock, shares outstanding (in shares) 156,142,283us-gaap_CommonStockSharesOutstanding 156,127,283us-gaap_CommonStockSharesOutstanding
Treasury stock, at cost (in shares) 10,308,087us-gaap_TreasuryStockShares 10,308,087us-gaap_TreasuryStockShares
XML 42 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
DEFERRED REVENUE
 3 Months Ended
Mar. 31, 2015
DEFERRED REVENUE [Abstract]  
DEFERRED REVENUE
NOTE K- DEFERRED REVENUE

The changes in the Company’s deferred revenues are as follows:
 
 (in thousands)
     For the three months ended 
  
March 31,
2015
  
March 31,
2014
 
 
 
 
(unaudited)
  
 
(unaudited)
 
Deferred revenue at beginning of period
$22,532$
18,019
Additions:
        
Deferred extended service contracts
  
211
   
237
 
Deferred in-service and training
  
3
   
3
 
Deferred service arrangements
  
10
   
5
 
Deferred commission revenues
  
1,849
   
1,770
 
Recognized as revenue:
        
Deferred extended service contracts
  
(231
)
  
(227
)
Deferred in-service and training
  
(8
)
  
(8
)
Deferred service arrangements
  
(23
)
  
(24
)
Deferred commission revenues
  
(2,890
)
  
(2,771
)
Deferred revenue at end of period
  
21,453
   
17,004
 
Less: current portion
  
11,400
   
10,294
 
Long-term deferred revenue at end of period
 
$
10,053
  
$
6,710
 
XML 43 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9
Document and Entity Information
 3 Months Ended
Mar. 31, 2015
May 08, 2015
Document and Entity Information [Abstract]    
Entity Registrant Name VASOMEDICAL, INC  
Entity Central Index Key 0000839087  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   166,450,370dei_EntityCommonStockSharesOutstanding
Document Fiscal Year Focus 2015  
Document Fiscal Period Focus Q1  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2015  
XML 44 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
RELATED-PARTY TRANSACTIONS
 3 Months Ended
Mar. 31, 2015
RELATED-PARTY TRANSACTIONS [Abstract]  
RELATED-PARTY TRANSACTIONS
NOTE L – RELATED-PARTY TRANSACTIONS

David Lieberman, the Vice Chairman of the Company’s Board of Directors, is a practicing attorney in the State of New York and a senior partner at the law firm of Beckman, Lieberman & Barandes, LLP, which performs certain legal services for the Company.  Fees of approximately $60,000 were billed by the firm through each of the three month periods ended March 31, 2015 and 2014, at which dates no amounts were outstanding.

In January 2015, operations began under the VSK joint venture.  The Company accounts for its investment in VSK using the equity method.  At March 31, 2015, approximately $55,000 was due from VSK for equipment the Company sold to it, and the Company’s minority interest in VSK’s loss from operations for the three months ended March 31, 2015 approximated $2,000 and is recorded in Interest and Other Income, net on the Company’s condensed consolidated statement of operations and comprehensive loss.
XML 45 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Revenues    
Commissions $ 6,390vaso_CommissionsRevenueNet $ 6,241vaso_CommissionsRevenueNet
Equipment sales 719us-gaap_SalesRevenueGoodsNet 483us-gaap_SalesRevenueGoodsNet
Equipment rentals and services 344us-gaap_SalesRevenueServicesNet 367us-gaap_SalesRevenueServicesNet
Total revenues 7,453us-gaap_SalesRevenueNet 7,091us-gaap_SalesRevenueNet
Cost of revenues    
Cost of commissions 1,523vaso_CostOfCommissionsRevenue 1,602vaso_CostOfCommissionsRevenue
Cost of equipment sales 175us-gaap_CostOfGoodsSold 144us-gaap_CostOfGoodsSold
Cost of equipment rentals and services 188us-gaap_CostOfServices 181us-gaap_CostOfServices
Total cost of revenues 1,886us-gaap_CostOfGoodsAndServicesSold 1,927us-gaap_CostOfGoodsAndServicesSold
Gross profit 5,567us-gaap_GrossProfit 5,164us-gaap_GrossProfit
Operating expenses    
Selling, general and administrative 5,719us-gaap_SellingGeneralAndAdministrativeExpense 6,041us-gaap_SellingGeneralAndAdministrativeExpense
Research and development 134us-gaap_ResearchAndDevelopmentExpense 213us-gaap_ResearchAndDevelopmentExpense
Total operating expenses 5,853us-gaap_OperatingExpenses 6,254us-gaap_OperatingExpenses
Operating loss (286)us-gaap_OperatingIncomeLoss (1,090)us-gaap_OperatingIncomeLoss
Other income (expense)    
Interest and other income, net 40us-gaap_InterestAndOtherIncome 56us-gaap_InterestAndOtherIncome
Total other income, net 40us-gaap_NonoperatingIncomeExpense 56us-gaap_NonoperatingIncomeExpense
Loss before income taxes (246)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest (1,034)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax benefit (expense) (6)us-gaap_IncomeTaxExpenseBenefit (10)us-gaap_IncomeTaxExpenseBenefit
Net loss (252)us-gaap_NetIncomeLoss (1,044)us-gaap_NetIncomeLoss
Other comprehensive income    
Foreign currency translation gain (loss) 7us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax (39)us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
Comprehensive loss $ (245)us-gaap_ComprehensiveIncomeNetOfTax $ (1,083)us-gaap_ComprehensiveIncomeNetOfTax
Loss per common share    
- basic and diluted (in dollars per share) $ 0us-gaap_EarningsPerShareBasicAndDiluted $ (0.01)us-gaap_EarningsPerShareBasicAndDiluted
Weighted average common shares outstanding    
- basic and diluted (in shares) 155,945us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 155,454us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
XML 46 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCOUNTS AND OTHER RECEIVABLES, NET
 3 Months Ended
Mar. 31, 2015
ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract]  
ACCOUNTS AND OTHER RECEIVABLES, NET
NOTE F – ACCOUNTS AND OTHER RECEIVABLES, NET

The following table presents information regarding the Company’s accounts and other receivables as of March 31, 2015 and December 31, 2014:
 
 (in thousands)
  
March 31,
2015
  
December 31,
2014
 
  (unaudited)   
Trade receivables
 
$
9,270
  
$
19,734
 
Due from employees
  
116
   
110
 
Allowance for doubtful accounts and
        
commission adjustments
  
(4,361
)
  
(4,571
)
Accounts and other receivables, net
 
$
5,025
  
$
15,273
 

Trade receivables include amounts due for shipped products and services rendered.  Amounts currently due under the GEHC Agreement are subject to adjustment in subsequent periods should the underlying sales order amount, upon which the receivable is based, change.

Allowance for doubtful accounts and commission adjustments include estimated losses resulting from the inability of our customers to make required payments, and adjustments arising from subsequent changes in sales order amounts that may reduce the amount the Company will ultimately receive under the GEHC Agreement.  Due from employees is primarily commission advances made to sales personnel.
 
XML 47 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
FAIR VALUE MEASUREMENTS
 3 Months Ended
Mar. 31, 2015
FAIR VALUE MEASUREMENTS [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE E – FAIR VALUE MEASUREMENTS

The Company complies with the provisions of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).  Under ASC 820, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the “exit price”) in an orderly transaction between market participants at the measurement date.

The following tables present information about the Company’s assets measured at fair value as of March 31, 2015 and December 31, 2014:
             
 (in thousands)
  
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
  
Significant
Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
  
Balance
as of
March 31,
2015
 
Assets
       (unaudited) 
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
14,666
  
$
-
  
$
-
  
$
14,666
 
                 
  
Quoted Prices
  
Significant
         
  
in Active
  
Other
  
Significant
  
Balance
 
  
Markets for
  
Observable
  
Unobservable
  
as of
 
  
Identical Assets
  
Inputs
  
Inputs
  
December 31,
 
  
(Level 1)
  
(Level 2)
  
(Level 3)
   
2014
 
Assets
                
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
8,149
  
$
-
  
$
-
  
$
8,149
 

The fair values of the Company’s cash equivalents invested in money market funds are determined through market, observable and corroborated sources.
XML 48 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Tables)
 3 Months Ended
Mar. 31, 2015
BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES [Abstract]  
Schedule of Variable Interest Entities
Liabilities recognized as a result of consolidating this VIE do not represent additional claims on the Company’s general assets. The financial information of Biox, which was included in the accompanying condensed consolidated financial statements, is presented as follow.
 
  (in thousands)
  
As of March 31,
2015
(unaudited)
  
As of December 31,
2014
 
Cash and cash equivalents
 
$
117
  
$
159
 
Total assets
 
$
1,083
  
$
1,047
 
Total liabilities
 
$
1,047
  
$
878
 
 
 (in thousands)
  
  (unaudited)
Three months ended March 31,
 
  
2015
  
2014
 
Total net revenue
 
$
371
  
$
329
 
         
Net loss
 
$
(135
)
 
$
(148
)
XML 49 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
BUSINESS COMBINATION
 3 Months Ended
Mar. 31, 2015
BUSINESS COMBINATION [Abstract]  
BUSINESS COMBINATION
NOTE M – BUSINESS COMBINATION

On August 6, 2014 the Company acquired Genwell Instruments Co. Ltd (Genwell).  The following unaudited supplemental pro forma information presents the financial results as if the acquisition of Genwell had occurred January 1, 2013.
                                                                                                     
  (in thousands)
     Three months ended 
  
March 31,
2015
  
March 31,
2014
 
Revenue
 
$
7,453
  
$
7,091
 
         
Net loss
  
(252
)
  
(1,173
)
         
Basic and diluted loss per share
 
$ 
(0.00
)
 
$ 
(0.01
)
XML 50 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
OTHER ASSETS
 3 Months Ended
Mar. 31, 2015
OTHER ASSETS [Abstract]  
OTHER ASSETS
NOTE I – OTHER ASSETS

Other assets consist of the following at March 31, 2015 and December 31, 2014:      
 
 (in thousands)
  
March 31,
2015
  
December 31,
2014
 
  (unaudited)   
Deferred commission expense - noncurrent
 
$
2,493
  
$
2,988
 
Trade receivables - noncurrent
  
1,612
   
2,171
 
Other
  
515
   
458
 
  
$
4,620
  
$
5,617
 
XML 51 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
INVENTORIES, NET
 3 Months Ended
Mar. 31, 2015
INVENTORIES, NET [Abstract]  
INVENTORIES, NET
NOTE G – INVENTORIES, NET

Inventories, net of reserves, consist of the following:                                    
 
  (in thousands)
  
March 31,
2015
  
December 31,
2014
 
  (unaudited)   
Raw materials
 
$
592
  
$
583
 
Work in process
  
691
   
679
 
Finished goods
  
846
   
636
 
  
$
2,129
  
$
1,898
 

At March 31, 2015 and December 31, 2014, the Company maintained reserves for excess and obsolete inventory of $783,000 and $815,000, respectively.
XML 52 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
GOODWILL AND OTHER INTANGIBLES
 3 Months Ended
Mar. 31, 2015
GOODWILL AND OTHER INTANGIBLES [Abstract]  
GOODWILL AND OTHER INTANGIBLES
NOTE H – GOODWILL AND OTHER INTANGIBLES

Goodwill aggregating $3,304,000 and $3,288,000 was recorded on the Company’s condensed consolidated balance sheets at March 31, 2015 and December 31, 2014, respectively, pursuant to the acquisition of FGE in September 2011.  All of the goodwill was allocated to the Company’s Equipment segment.  The components of the change in goodwill are as follows:
 
 
(in thousands)
 
 
Carrying Amount
 
 
 
Balance at December 31, 2014
 
$
3,288
 
Foreign currency translation
  
16
 
Balance at March 31, 2015 (unaudited)
 
$
3,304
 

The Company’s other intangible assets consist of capitalized patent costs, customer lists and software costs, as follows:
 
 
 
(in thousands)
 
 
 
March 31,
2015
  
December 31,
2014
 
 
 
(unaudited)
   
Patents and Technology
    
Costs
 
$
2,478
  
$
2,489
 
Accumulated amortization
  
(613
)
  
(549
)
 
  
1,865
   
1,940
 
 
        
Customer lists
        
Costs
  
800
   
800
 
Accumulated amortization
  
(410
)
  
(381
)
 
  
390
   
419
 
 
        
Software
        
Costs
  
986
   
962
 
Accumulated amortization
  
(573
)
  
(495
)
 
  
413
   
467
 
 
        
 
 
$
2,668
  
$
2,826
 
 
Patents, customer lists, and software are included in other assets in the accompanying condensed consolidated balance sheets and are amortized on a straight line basis over their estimated useful lives of ten, seven, and five years, respectively.  Amortization expense amounted to $171,000 and $46,000 for the three months ended March 31, 2015 and 2014, respectively.
XML 53 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCRUED EXPENSES AND OTHER LIABILITIES
 3 Months Ended
Mar. 31, 2015
ACCRUED EXPENSES AND OTHER LIABILITIES [Abstract]  
ACCRUED EXPENSES AND OTHER LIABILITIES
NOTE J – ACCRUED EXPENSES AND OTHER LIABILITIES

Accrued expenses and other liabilities consist of the following at March 31, 2015 and December 31, 2014:
 
 (in thousands)
 
 
March 31,
2015
  
December 31,
2014
 
 
 (unaudited)   
Accrued compensation
 
$
433
  
$
2,917
 
Accrued expenses - other
  
1,090
   
1,098
 
Other liabilities
  
1,843
   
1,612
 
 
 
$
3,366
  
$
5,627
 
 
XML 54 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
ORGANIZATION AND PLAN OF OPERATIONS (Details)
 3 Months Ended
Mar. 31, 2015
Company
Subsidiary
State
ORGANIZATION AND PLAN OF OPERATIONS [Abstract]  
Number of contiguous states in which VasoHealthcare has been appointed exclusive representative for GE Healthcare Diagnostic Imaging products 48us-gaap_NumberOfStatesInWhichEntityOperates
Number of Chinese operating companies acquired 2us-gaap_NumberOfBusinessesAcquired
Number of wholly-owned subsidiaries 3vaso_NumberOfWhollyOwnedSubsidiaries
Noncontrolling interest (in hundredths) 49.90%us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
XML 55 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
 3 Months Ended
Mar. 31, 2015
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS [Abstract]  
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
NOTE O - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In May 2014, the FASB issued ASU 2014-09 “Revenue from contracts with customers”, a comprehensive new revenue recognition standard which will supersede previous existing revenue recognition guidance. The standard creates a five-step model for revenue recognition that requires companies to exercise judgment when considering contract terms and relevant facts and circumstances. The five-step model includes (1) identifying the contract, (2) identifying the separate performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations and (5) recognizing revenue when each performance obligation has been satisfied. The standard also requires expanded disclosures surrounding revenue recognition. The standard is effective for fiscal periods beginning after December 15, 2016 and allows for either full retrospective or modified retrospective adoption.  In April 2015 the FASB issued a proposal to defer the effective date for one year.  The Company is currently evaluating the impact of the adoption of this standard on its Consolidated Financial Statements.

In April 2015, the FASB issued ASU 2015-03 “Simplifying the Presentation of Debt Issuance Costs”, which changes the presentation of debt issuance costs in financial statements. An entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense.  The standard is effective for fiscal periods beginning after December 31, 2015 and allows for early adoption.  The adoption of this statement will impact future presentation and disclosure of the Consolidated Financial Statements.
XML 56 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
FAIR VALUE MEASUREMENTS (Tables)
 3 Months Ended
Mar. 31, 2015
FAIR VALUE MEASUREMENTS [Abstract]  
Assets Measured at Fair Value
The following tables present information about the Company’s assets measured at fair value as of March 31, 2015 and December 31, 2014:
             
 (in thousands)
  
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
  
Significant
Other
Observable
Inputs
(Level 2)
  
Significant
Unobservable
Inputs
(Level 3)
  
Balance
as of
March 31,
2015
 
Assets
       (unaudited) 
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
14,666
  
$
-
  
$
-
  
$
14,666
 
                 
  
Quoted Prices
  
Significant
         
  
in Active
  
Other
  
Significant
  
Balance
 
  
Markets for
  
Observable
  
Unobservable
  
as of
 
  
Identical Assets
  
Inputs
  
Inputs
  
December 31,
 
  
(Level 1)
  
(Level 2)
  
(Level 3)
   
2014
 
Assets
                
Cash equivalents invested in money market funds (included in cash and cash equivalents)
 
$
8,149
  
$
-
  
$
-
  
$
8,149
 
XML 57 R41.htm IDEA: XBRL DOCUMENT v2.4.1.9
INVENTORIES, NET (Details) (USD $)
Mar. 31, 2015
Dec. 31, 2014
INVENTORIES, NET [Abstract]    
Raw materials $ 592,000us-gaap_InventoryRawMaterialsNetOfReserves $ 583,000us-gaap_InventoryRawMaterialsNetOfReserves
Work in process 691,000us-gaap_InventoryWorkInProcessNetOfReserves 679,000us-gaap_InventoryWorkInProcessNetOfReserves
Finished goods 846,000us-gaap_InventoryFinishedGoodsNetOfReserves 636,000us-gaap_InventoryFinishedGoodsNetOfReserves
Inventories, net 2,129,000us-gaap_InventoryNet 1,898,000us-gaap_InventoryNet
Reserves for excess and obsolete inventory $ 783,000us-gaap_InventoryValuationReserves $ 815,000us-gaap_InventoryValuationReserves
XML 58 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) (USD $)
In Thousands, unless otherwise specified
Common Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Total
Balance at Dec. 31, 2013 $ 165us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ (1,755)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		 $ 61,508us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 $ (53,561)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 $ 108us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 $ 6,465us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Balance (in shares) at Dec. 31, 2013 164,705us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (9,481)us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Repurchase of shares 0us-gaap_StockRepurchasedDuringPeriodValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (245)us-gaap_StockRepurchasedDuringPeriodValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		 0us-gaap_StockRepurchasedDuringPeriodValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 0us-gaap_StockRepurchasedDuringPeriodValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 0us-gaap_StockRepurchasedDuringPeriodValue
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (245)us-gaap_StockRepurchasedDuringPeriodValue
Repurchase of shares (in shares) 0us-gaap_StockRepurchasedDuringPeriodShares
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (827)us-gaap_StockRepurchasedDuringPeriodShares
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		        
Share-based compensation 1us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   389us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 0us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 0us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 390us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
Share-based compensation (in shares) 1,280us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		          
Shares not issued for employee tax liability 0vaso_SharesNotIssuedForEmployeeTaxLiability
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   (9)vaso_SharesNotIssuedForEmployeeTaxLiability
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 0vaso_SharesNotIssuedForEmployeeTaxLiability
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 0vaso_SharesNotIssuedForEmployeeTaxLiability
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (9)vaso_SharesNotIssuedForEmployeeTaxLiability
Exercise of stock options 0us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   36us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 0us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 0us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 36us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised
Exercise of stock options (in shares) 450us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		          
Foreign currency translation gain (loss) 0us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   0us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 0us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 (14)us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (14)us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
Net income (loss) 0us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   0us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 1,128us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 0us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 1,128us-gaap_NetIncomeLoss
Balance at Dec. 31, 2014 166us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (2,000)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		 61,924us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 (52,433)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 94us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 7,751us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Balance (in shares) at Dec. 31, 2014 166,435us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (10,308)us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation 0us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   19us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 0us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 0us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 19us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation
Share-based compensation (in shares) 15us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		          
Foreign currency translation gain (loss) 0us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   0us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 0us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 7us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 7us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
Net income (loss) 0us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		   0us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 (252)us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 0us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 (252)us-gaap_NetIncomeLoss
Balance at Mar. 31, 2015 $ 166us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ (2,000)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		 $ 61,943us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AdditionalPaidInCapitalMember		 $ (52,685)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 $ 101us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 $ 7,525us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Balance (in shares) at Mar. 31, 2015 166,450us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 (10,308)us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_TreasuryStockMember		        
ZIP 59 0001201800-15-000011-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001201800-15-000011-xbrl.zip M4$L#!!0````(`&N`KD:KZ0NX2I,``,17"@`1`!P`=F%S;RTR,#$U,#,S,2YX M;6Q55`D``XG_5%6)_U15=7@+``$$)0X```0Y`0``[%U[<^(XMO__5MWOH&7O MSDQ7A817'J0?6X30/>RDDTQ(S]VMK:TIQQ9!T\;F2G82YM/?<^0GV(!Y&&QP MU]8.L:2C\_B=HR-9EC[\_6VHDQ?*!3.-CZ7J<:5$J*&:&C.>/Y9L45:$RECI M[Y_^^[\^_*5<_D(-RA6+:N1I3#K77UH/?:9#54'N'^[@)R7UX_IQY;A"VN9H MS-GSP"+59O.4E$FM4CTE/7LX9!;YS`S%4)FBDWO.#`L(')&;F_8Q:>DZD:T$ MX510_D*UXW(9.W][XCH!7@UQB3_9Q]+`LD:7)R>OKZ_'^.38Y,\GM4JE?L(, M80%Y6G+K`X/?YU3'XB=%^-7?(O5?Z[(V"-(\D:5^5<'B*@+9ZLD_O][TU`$= M*N5I?K![+6@8YN;LQ"GTJC)A-FK5\WG".C7\!L8+%=8D;4'5XV?SY<0I@V;5 M>KE2+=>K7B,P\[.BC/Q6?44\R1[<`FS2F&RB41;?"13$5+A4- M>QA?4;/XB34>T1.H03E3_0:FD:"-:92GVJFF;5A\'"^$6QBC*M7F'/QC5CNW M-$8#AL)4$=]*%F&3ZF03P=3X!E`05]T:\1GUH22F`7U3!_$-L"1&AA=%F'X# M_&-(-:8J^K%J#K'Z::7N5T[BG^#7A'Q`A[H4TE4>:)](![M$LWTL"38@W M\MF`T_['$O9;]CH[?A-:B9PXA&1<`,,:%GVS"-,^EE19KUJI6J;/GJSKUZ80 M?:RQ^\Q_RC1\WF>4$\D8G9#&TU*[^TOI4P7^7=2;E8OS#R?3C;VN3F+ZAKKU'KN[F MJ_.T1&\U,A)_&\N&GD5[XJ:.[_=ZS@-X0!.K\GPTRM3V$X"YD[BN%O+B^KI194D9H<_AZ9Q.$:/R'MX)G^@EL(, MJG44;N`L]"#L'B_T'AH_%V-E=IRAI:KVT-9Q=>;.&E".Q9P.$&4OM&O`'(T> MA'\DUL-^N4PC"40TC5F@4T6_5YC6-=K*B%F*?ABPF"?[#J"0XAPL"12*)/D@ MS5XDR0=G\B))WF62O&/C%TEA]I/"%"&2:-Y0)(6920K3G!\$"]&YF5ROOQ`] MHX.=8GFA0,QRB"G6(0O4 MQ&S3*\:H3(]16=N3N`QVBKE8'N9BN498,1?+T%PLST@J\ND",05.,H23[6P: M+U+@3*;`V3%^D6%DYYW=KJ%03&>R.9W)#D2*-;:],WM^/B:;V.B2GC[D4O-O M"F?*DP[N;E%.A=5!+AD55^.VK@@!@J@*#AUW?5DREMX1VVA\S]E0X>,K:E!H MQ>!GOAUG%=4$_K2"K; MK6GL!6X7(6:FP,7`G30\%IC9*69R&6=6&U)[BD[%`QWA>8Z&)4GN!>"2#*Z+ M9#_4839;(3-5^'>-OLF'DM0C50>&J9O/XX-Q@,72%RZP]RY03*H*J&<'ZJFN M'Q31OHCVV<_W4W6!(M\O\OULP[]83,O4PLAV-H@4JV%9-7KJF^.*#&^7`TKV MDLQ\8;B8D.\';E=;$]BC0;:83N00M>O.:`X^UA;Y0I$O;#4&%Z]P,Q4`,^!1 M^<)OL:NO>`&5EWPA9B%=!1ZY5,H#$]^O<`NO.A@J_'LXDKY0PZ:WU!7^]Z_* M'R9OV\(RAY0[D/U"?Z:*;@U4A>?\\\VH<"Y&HR)N&)]S31$@-=8FQ3)YW)Z` M`MS;1=F._.P@=@$D@G1+E5^MK.Q9QOHSI;G9]O74OU8?%U M>?:Z[$RN-NSLAS6_*@;((AG-;>#(SFQQ:X>3MT`HC>FVQ5YHCZHVEQ_\=]Y4 MW=:H]IF;0SR8RK:\[_[=TPKO*>\-0*]7XW@"^W649XI*RL!!H!D>6+:)ULYP MI)MC2J4%[D9(H4#M0M3.U%J!WLBRH2?GY9UP";"%E0S3<`DTD>8&F."O9M M&;&^'C!J!3!J^_LN9PU@U`M@U(N(40`C6\#(Y@0X09H0PL^\<@Y.))+ M[[ZXF:V#_0H;RZ/#642@O&?VK5>%TZD&!P24T$K>8HWL%VSSF M<,@$VLBME//HM5AD=QXU2_`"1JO`J&OT*']A*L5Y*5<8;B8Z$"#-%KV`TBI0 M\K09%!U*2)HI>0&DR&;0`DBY`5+&]F4N#Z1B<,O*X)9[*'7>8)ZL4I`6KL'IL:0 M&1@"M`6J%U?C<(F$UC7C5+5,?JV\,.V&4=#<4,GY]U7)Q7]?$07VO\E5H#4^L:+U18*'GT*:6WRM#+L]Q[??YA M,L/Z#:K;>3_%91U]Q%QX%%7,?NT_F1X""SCM*9PR/$Y.8]`[J+RE@G(%PT'" M/6K*>*6ZW@7X7WWK7JY*N3Y'6&,PS(NK#%K?@0#!\FY'#\Q+S M$U9P/,50=]?4,(?,F-_A(N5.]Q@EZI6&Y$ZBML8,BSBOZ?"VD54-JE"_F,N[$YV2T_U(NMZ"VABW(9UUY M+I>=`HVR2[\$"XCK\`^T'YNBE3[U%5V`2)&6?D]MFW/9#Q.JHI-_4863CJ$1 M##CA?MUZ3C6LU7&"TF(6RMX6['ED?'ZN356.@N1>AK=87KPZ3I7$C(13G)ED M?$8Z,MJ3_X6QN?S=,%\-T@.KF0;52%<(F_(P1TYEK/L+5O5J.A470\T!ASH17`A$,*G8,'VY- MOZ)3;S$[_\*(N8C,-%N26=(&4SZ;?!QE1I9[Q8MYZ`T5'0D&4OH!;@;-:88> MZ#.#W$X!5>&,,\I14`'+%[/T6ZMW][5SW6VW;HY(][8=YF225L1D%%\MZ*1K M:/2-_$)CU.-6D36@PF)NP@G43#(11N29WG5$Y+%?@MS9%BZ8:*#D&+Z" M4^J0CPF&%+E,YG[$(VJ#*PI/I8@BZR>G35`@O/*!-=S.HE&J'#( M_`P/15R,"B*=K)(L2DW&IRD2,QEQ(^8"5IQ:"9GYM1K'2HA$E!E\N177.SY? MW&&U4OYULDML%XR+[AG*)#A$^8BXR]($UZ49]46??>YR:!T;ZD>8DM]Z3:*G M%D9/&1+26A5@_^$D:1_;%<#1Y7P!SL_6%.!>&6,U`MY!X"&W08`;ICPQ79[6 M1ZX!*KJ):0[Y]R-.Z*YT<*O_S!+.)=,F0AK MK,/\KP_URWUER/3Q)?GQ$6;I@MS25_)@#A7CQR,BGQP1`=#NOR>RMF!_TDM2 MK8RL]Z4?GJWW<11#=/V[K%#_D%^4(:C]W^]J%6K M[TFKW7[XUKDFG7_>=VY[G1YIW5Z3N\>?.P_DIMNZZMYT'[N='C)W`MR%&/5^ M/G%RXOV>JI*6+,X39N!4^I+4SSP5>D"A;R-J"*")Z#&M`0RP>@@[8%P!PQ@Q M^P3*@!E=-U\QT"L6^8H'J9!Z]8B@K26!:P"M7'QQGS8NTQ/5:8ZD+@FS0&9U MEBD=&U;/*BDJ?@ENH%]+.JP*Z>5(T7!,PY%0_BU&BNK]O1G.7IEF#;!IY6\A M!KC_2R,ODL>/I2?3LLRAW^\+A8`#@XPG@F6.WA.7W[)3]Y+41F^Q2K:TY3MP MBN?U$:&LFJ@Q('VVD.KK@,'D!?4+BH2DGBL@SI/)-9A`>#W]M2+_88]$WK[I M*ON5LN>!A`[IBW`0<2[J`@.*Q]+SG]+FU#6'.2% M^CX)@6#S<-A"B)[MURG!;P[$?2#6YBML@RA,6<]A#&,O2&DSW4B2SN@A%8F- M4^H%QJ&TNXC03W]D#YL&Q][Y\-]B@-G&&%`XX>:PZ^=KA1]NP`\;F??##0SY M.1_=-Q%#/(O,S/AL0[$U"#':YM.]M`/O4OI9!3:[U,:2\'=G3N=G?WM/8L>1 M)T7]_LQ-V]#*H!:3PZBAJI3V^]OS$F\>KYI#G,C+FQQ6\A=OFA@CJZ?M1>(N M#\($G<;.OZ++'-LTA:3X/^MHN;F.P!R+=B!QHU[?R`"7P.C+VS<5[!6`/VC` MUXZ:U?/\07X+HUQ?_MO^*.>O5I>=M>HMCG03(J?B^(D0L!DV4G+'U&`A*5:/ M*LU*IMPQ?4P40,PH$"_R!\1-CPNQ"Q(9F!+=3;_%3&N46$D!Z82)A6N76\RH MY_GTBN_;LI`-5H\N&EN;`"5;[-L-V`K8'Q;LSZJU/8%]VB-@8X8G;'NZM.;2 M^0J&2B3Y-F,`,$0TTW[2Z3HK*NGFD:FMJ&Q")[M*KNM'];.S7<6;1N)XDSZP M"QG=6VMJZ9LHN%AO03N:O2_VMWVSRG]MS6&J/%X[+[.[H/?,GM MV-'MX<'&7NYO*0>!#&K-V@$.?5VFGL+O>Y76U? MEB0?'%1/:^?UE(7I&GV,%_@REP0W/!'WXT7R;^?C\_^4[T;X3:S\XLLI$D'9 M9A0B#PEHFX:O;%^<911\.N.3E*PY:Y+`4[^(_SYH#WTU!?BL M[:L7:2-IGE9["E3#[T4Y%5#BF"ABEZSJ7G(_R?PRFF_4S](>I789*U,8F%:* ME1>-M!'N'X6U30WZG=XNA[I<:F*N\V92$QF)>BDXX;I1[[2>]D2CS:G&+`)2 MJ_+3>JG?!R:^!\J=(..\C@SU&]3[TB$_4T6W!JK"4P-UP"4R>36^HH8Z&"K\ MN]1W]'-CUTPQ+8/3QJ4*(C7D?>H2>+/]%?=[K?/*\W%GRAOW7&DZRY-&OG\9J? MR_-:GSW)8 MB!*WWEIKNUF*TT([$MGGR*C"8:/2K-BR49 MO7^XN^\\//Y+GB[2^?5;]_YKY_;QB"BJ:@]MYWP:#1-DEM/^?R>FY"H6^-[73$L*`LF]2L9IM&(K#ILA)OLJR<1'.K- M2'C8K'I"!-W$%[\,XW2`9^&^4,(,^)O.48I,RMKA-EW9Y,84F*#=]1^5MY5D M;T:RJ&6ZW+&`R8)2)("N)J&FR:.)%9V,%*:5F4%4981O&R-2^37OH6+7:#O5 M5C+/6;59F[)0//44^4RB9>!S.L0LXG/!9%#!,XT4F`.1OLGEVWNK;^L84()F MJC\`$D7[PW:.LH^>#^91^FSR:Y=.-`5<*R,ZG=@YW?E\(F6L]=B0@ST_/X[;O>?H?=VT/E=O^-V>4^Y/(X2Q+1CX3IY+\.: MO5R-XPGX-_ZY)V3&K<14I]VD/ITQ;T(#6S&H8\F[D;S[:(\MVAF.='-,J937 M$3>199NGM9Q:=BLFG!O.(LJLG=6:.=7F#@/?]*TB60I\%^>G.37H+B+<`F56 MZXV\!IM=#B/;](]5AY'J^6DC1=,^FCCC4V0>&%'ZC$0TR82HTFQ.)8* M_2:9==1AG+A(W&^"G0NS_S]DDDW;>W M`6%WM/FN>MK)N0N+B-$[DV\'!*WC\VY:4-2O>N':;8,+40Q(.C1.XSK-JY( MF5RU>MT>N?M,[A\ZO<[M8^NQ>W-42WL-Q]^WVL7O[A=S?W73; MN[YT8^)#SR=3CSMW0@HY&T[?!,7G'6$!2JWHD34[NT0$7^RP_GCF/2*/`RI? M"\F;N-P;H#1\":')NT.<@(<3=V8HALH@X@HOL`DR4&":_T2I02#*CV#.J!&8 ML",YKLFW3Z_,&GAOG9#XB#,@,L(Q[9D:$#AU?8SE=&0Y;?&2DF\&'KTK[T"C M4MNM(,&M@\<@'. M$608P(P.93[#@`(DY-Z?4W'NSSDFCU(_:YK7%22,9A^FCIXB&\0)Y5GV<>337LGG.>WK8$%\Q1Q^;TQ^ M MSLV&0$[8.G3F675(VQ3\*Y[)?@ZB)`R.^>24_5(,S( MM4N@X9$#=#U1^6I6E4IQZ3EOW:>HNFSU;5`.HNHX5^.`$UI\I<_`)QH/PQ[> M/C@5=3B%M!:#7X`V5-]0^0X*](9&Z<60MMM#=RG7&B@`IWX?465).Z*K@JJ5 MH0]_)\V73134,ZA9&1(^B$U0= MK*LR7FL,C,&=M7IK8(J0\1Q/FV=+WRFEV85TM"=%CC\&&4"`,'$LU\'/5?@) M0O@;MAE7[2%>$JG20#DH(F<4ASA\](>M.=,[U]1!G`\@Y_#H<4%?%-V6O#(0 M<#;G<@B'_W\V475/F.GMUGL39Z4+IC*Y"4&W`'V80KB6O77&=Y.TPX[TV7>D M7LAAIT?_M<=\ER"@!-*CX1!')Y M,:7E'IR(Y";/,B;A=S,FJ$H*[RE]WFI6;F`:#B[<$?)/>=.B/U=P`S3"`&-. MK-3"7:;Z25`'ZZ3]#C(ZG$I1S,WE7EB*U]1CZ,,1$.(3YS@MD>WH&X121X"7 M_V_OW7\;QY%_T=\/V9W`'MF6;,EZT0ZQCW9LB2P6/U4LDO70X8DY+(7,WK<1U&!8 MM7P(XH\ZFK#?^19@2L%B60#>@I*CFF6@0<>7LA4^:[-JV?#`BFE(:.PB6DE] M,Q>!K'/-B1I^2H&LJ6\K+:C+A\(78R#'8&L;#0_I0FK#O9_*UW[-#U<#.7-I MTA:'R2"88BB#!$<26@`.8[/Z;%.^"L1(1A4"G<.WN(\)%CX8L,&XP$CD2W'P M-N]L/2X0J9F^J/Y\K%'+AQ'_*1HKOHHXL5'7P+A#JS[RV.2;1PJ++EK$,?BD MJXQH=$^JP3IVYI2BUHB&_:`#_%4;QQRA$TP!O]XL3);EV3[?0$0U&FZN@FTA MLHA=R6\.(B0V!GO?&HFF'L!CH4,\31J<$[:W/E-;S?E/,C&;1HW#NR!/2RNH M6[TM??'WTK3+KLJBY:N9(#,63S:64\E^@TT*F[=KW'.`(4.NL-3V,:WP<=7) M2]%RB_'9TZ>!\,0655PV7H)1Z\&HJ3_JEK\!#C<=FG\JD_Z*KY_6EMZG5:`H MV3+_1$T*JD6/+?G!VW&G\\&\!XQ>F8O*'"\K<' M_D8HN`1A&PQ@`0R33"VVF;:#-8ZH46R!9JCZ@MG7,8,]+,L\_"D\"O2W5MQ\ MCRRB^"$;4("<#Z;^576V;+]##S9:.)WA+HF=^C"$7A`QYF=_[KD-VG:5(3S: M^L655$O;:B1>E3A/-=U=+*>+==(3R@K[CQR:S#%GD;5"J94%K"U=5UW100__ M$\O]7<$=VZ:AD`:L";-^HT+NU:FJK!0EE;.MGXK-"HXBU_24,E"&#*P=XC0/ MP%.L)BM6.B54S M6E;LE$"O!N@]L4RX1BJ""KB!XVM;#<5`I44KA-S7;-$*)_=RZR:!7L%@1T.Q M"E[GW;KMK`V6T(B\$CWT=F'?E>@PUWUC\BUHUKO/MW$I.=C;_M[KEYT\WY:0 MZ!(Z_9[,__@XMRDE"X#WW/']97='LL'*KD_,IK MT9/859O4#;QEY:Y:;C9*&VQWJ!S?9D/"7,(\)\P[\CI4WM%404;)UR<[Z!#Q M5D-"0T+C[9KF-V"4&Y8C[[FDJ5+>8,^4;CGG*LW,$L;QS"RSF MZEH86&W98=8M/_4"?.]GD8JR.@1Y@/Q'X]DRMJ*H@\]1_L\B.3FC=*%^JE8R MT?[CZ0Y/7G)G6RP`F<1R#6]E!/5?C+T'KV'6&74M0W'S24#YG1[U@YLQ1CJ\ M`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`L8.>_+YQUTP7O`]AO!U'FGW\G,P35RCX>/=2#Q7%&&V85S#R,OK<63;G(W M[H]1=>/?4,\1INA2N1-[-7I3!&_V"F,?^*7`[>-59']\)?]/4+9,^8E\^/7A M^N;JX8%;R^O3E@>:HU@J-_T0LX>&N2B?<,CY$!KWJ[5KN9N>^C MC_X.J2)G_H_O-\J#'EMP0:U\3W)&EI_D)_GI9#^E:QX9UI2W`QG6),.:Q(YE MD6%-,JQ)1J$4[EN&-4E`R;"FT[C?E6%-,@)$AC5)4$M0R[`FZ5HI?>8$8Y*$ MB83)J9K>,JSIK82`R+`FB>E3P[0,:Y*VMS2JCMBHDC"1,'FSMK<,:Y*1'C*L M21KK$NQB'W4W9<-7%-:TVUL_#`RX5)TY6YS8AZO_>#JP'=VO6^2.I^"_-C6; MJ@XE9Q\I__1^,T(`WYV84_PGU@)_/W@]>'EOG,#N8(B!TEL/R\G3MT"CW@@< MV3/J7KLW*G'4&GZ@T7O91C9Q+U7;7NGF\S?52(K*4CI[!S)6.ED&LM%572/( M`D"EWQF,Q1U"-\,D#,>#+#+4T`BRR(/2:;>KF80/NO4]-4ZL@%S\_DVU=53T MU^B+1!WWRG1U5Z?.A]7E6O64VQG[9<7"QA)?6MW9P`I[]8&:%-[2X6.F.#*E M?S0LXT&)`K!,&19E68Q31#=?@"+8`>HF.N?2%0&B_J0NF8%5XI`SW=0,;\I_ MU]+X_?[\__4L;`3&I%%LE$PT5W^AY"MKS,&8*G*-,4=H&)&)X^"79U_H"S6( M\C[G5'U2=9L-*Q8MF(SP\,D/J_#C+SJUT=MOQ7IG$Q3^=FTN/==A/RB99F.D M]+(@.('BRJ%LD,*" MD,T&$5G_EPOL&HRQVZ]?KQ^_7MT\/I#)S4=R>7OS>'WS^>KF\OKJ@9QAV@5R MLSTL:['079:#`+NS6#5':F(MQXP#^>[H/YJZ\?=WKNW1=^2'&@E*-C'2"8J: MYL=5:XUGS-^Q@[ZWG,?C9BV/Q\ZI/^!@MJ%JL@\@=0ZQ:;QN*E&?;<]S/O)NFSW3CY,%7/E(-;9*L5PMNS@SG;+$*$!0\D#6\J+T@[$@A=@F&T1` M3]AGES\]@BGUGOZ`EG``0+H!"RQ[)4@L!*L6?*/Y]8$UW=:\A>.J)IH*J,;B MS^(<69X+RYGG4)P4,!S4&3P19]5P8W;P0'VM57^%)*;EPMH);^MLJE5MKM,7 M'%5`C,,$Y-F"=:SE/ZV;^`L^I!(@2U]X"V)Z;,0PC\Z61+T@J'$8+ZJM6YY# M#/J,?(9O&/Z66%EX!:^PY#E,[\;)_Y4Q)^"R$T`W%-+U6=6=H*$IVM>"$H`T&J##9G.ON"AN`MG6;F-1]M>P_,U14 MSK=XK"U<,)>."U^VR%*U\3;/HVC*D*EE&(CWT`,B<46US`=\^4ZU;^T'%P?+ MS(@[:C_@.UF6^F[<9KF^^02F]$6[K:P/;D\_#8XHP5:H8D0/?$3LF1:Y=AR/ M3G>0?_C=C[)I.&\T6@EAF1AC#`?]FU^2S&7#X6+(P48G3 MVF:D]KK][C"9VGCK=1&=P.`DHN&QPD2K'BP5-A@@^0B?1*\=0'RGST/E=Q$? M]5#W`#)`IM@`?"'DC[7(+>R68[[R(X]>Q#4^P.E,^R,NCOHCG51$^%9 MX`Z$]SH'$0Y&QIR:#EIH:VDM6RS3)5@*C^KW%IFXKJT_>3PU%*SIH.EA?4X8 M5M0<;PT:N9U!$P5],,X[O?XFGM*Z$F%T^7PMSI7VJ)M[>+"Z8IH)]9GB0%1- ML[Q@TVZQHTD;K&B='4VR`QTR!R,9C#IWCDE+K\@O5#7SD@!^VXZJ@\6HI MS:#/_#HIU+FQ8A?D MD6ISTS*LYU7P8*IN#KIC)LMEU&7RO2SH,99FCG5S[=(%5XXA70%9OAYEQU;X M1>#-'OS.WEHKSQ$0[#^1Z1)W77.EC"038P.#> M2T%5V,U-/FU0TB@;7+@JP$OAA4LX[.QD4L/8*2(.^]:0GC(X?ANB@N6DJ`W1 M4SJ'\16-8J=%+K'LR_9I\I_YJ`[S$YGXRHEJ>5*J"L$RT3J+N>J^957C:/`W):;=6?'+">GP*\L<]).7I1-2KP&PVZR=H!H?[&7?116MM0)5*:A MG+H?!X.DQMQ?2J(H-0_A44="6(!*(P)`.&V-V%1Y%]UAJ9GB2L_)4TZ^):6) M7(6[.CTBSJX/:GS1RS@L7[3J']A96+UV3_:R?.)<[G0>CJJ=$R#!+,$L#IAK M7(6JS0SW<>,P*!JQZI(G^JR;+!S)FF%$B6Y-:URK-@=>JU#'._]+>=*6+>=A MI]/J=SN-2T*A"[=V]ESW[Y0NY,FJUE;%06G;'=!^8>SE%UV9**E_M M>3WK8^*'P6X?K[\Q<_]@,LJ0LVK2D@O"H),PH"4\ZDU9GU-MUIVR/K1/PPP' MOJ,KN]>U5K`MU0ZW4/%O M::Z+CN6.6!>XS6'YQ'V"FK__E79=K0>P9R.A!+O:P=:[2$DD2R2?[A+5V&:J MX5MI:7K6O8T22JSE+DI"^6`HEYHRXHBA7,$*E3612F,[JQKOU0_B127ROS^3 MC#`F;#Y2&S-R.ZW1N+:;T\,3SQSM/D[*SBG+SG!8VYG\,\<_767J"XF M:FPD`X`,I'=Q.%'C*L-5N"[S=J]$10]2=V1?J.#\2S<_( MOK1LS"4BMV32K,PKZK#&M(]M2U;1PB-A?KHP;[337X(?XF/T_^\720O6;+T941@7*0SH",C)57E-&O>2J MJ)LT)HW]V@QJ3S.7T$??);21\5^;/BD3*@_8/0-H/XJB%@*F'`91"PUPH&`')^:D)B,M:N' M!_.A$L5_``,.5?S#X>'27R4&#M!_Q3"@*/GXL%DTDT26`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`318&U M)=32#/\)@W4;KZG9W5E3R7:SLY*M`4Y5J1:G=BO( MI8*%G2L!U<$%GD='"Z<:BX!W=J[K!;E4H$!T)4PZL%!T9SBL4IE7+G0':"-]1MD>^2V$.MU&LJ$LF4VOI`D!WU[`/&[Z=0;-1J^N-0IO_IF[0X@F7M8_.+&_) M.;F_NKRZ>?SR;W+]\/#KU4X^FSE?ZG#_L5T?R3=0?)@\?".A]#^9U M\O`K^^6\/2:<$:-.I_U3L'C-;&L193DAK[H[)QKT9RVH[83/*S^UB(J1$8#O M.34=_842$V@/CGILOA(P+#LN"*9J3\GK7-?FT*)A$,=;0G-T2@DT\*);GD,H MK$\,Z4EM/'OZ5`6<7I!'&$[8HF93U06VJ60&%)P[+EV2A36E!C#73FS(G:LN M?/$?3[?A/1R`:H+J)*X%!%!;TQT*[)T^HT``P90I!$>?PB0`:0%?"%[+.DSA MV-2@+RH\/&/\PJ\TW=:\!1*I48=3O$F>;FJ&-X5^SY3W1,?Y@_G$'G"V@EY: MY*RS_:M#EZH-H\:K7QCE`GLAUA,@@ZD3A[!R]6NM=-^#FD*2N97&BI^#;>#` MK\B3I0U6$SS6>T]4`S2(ZJ8^A7S*1`3RX:S_/N#]?^,3R]A*5R$7X3L=9.`2`(#N+RHN(Y]T$Z97!PH?7/B"+307QZ1)(_:GZM+^>;L; MUZ4/P#`C)K)W`$AH6`VX]I$^N>0:FF#`O[0<=UVSSA23586\Z<@EFAHDZ=@G3! MM(-D>5P%L+4!'P:EQR:7D6'X%NB*@$:8,P2J)FL!_]^A[L6:51;`R.\=,Q3B M=0#/5JAC`5;JN"C3L*S03;06%UBL.LYD:5-@51N`GR2"CS',1U_'P,\9S1N M@M^+[6DVMI3);5=`7;;]XB`7=;#UI?H+7G,[9!I0&H@)K)6X/SO_]O!/\I5. M\3(>=I,+G1GN::#K3?_=SO)S$JD>Z06U>JC;+I MD#N0R(>Y:H/Y\4%U=(T)R4?=\.#=38X$+\$[[!7V`FRF_,?S[4B[&Z.(C6!/ M/_4.8N?V4GT@BHX[&EHF6&HY26(<<7"]9@#ONTW!:F1T()J'G+\@T`+FZ M!)-&0P6'IF;PB@L`F%L&;(]`[>DO.EKA3RNVOK^R[,H@`>H+M=5GV!]Z;`&& M=2_>H4,LSV7+.B[6N!(S>X1+N%*?X(KR"'E;P MQP9?CL?*93M4"VTA9K&R2;9I:"S&!T5PTP6[`_8#XZK/$;:?G48F(@=19+#Z MTQ?B":>0SUTPY^[WIW2; M[ZW9D?LKF_`GO*1P]7,.AA>:-"\!T^-WY2E? M@U&F<<9H[IJ(BQ`\8!B^5U[XMP/V9/!W.<@(7`/;[;_&:,G@3)\]2&R-96,D M<0UYY^,4'JYY.FH6#A[(&*9Z.28'+N^+RJAX"=F<9KK`3V=LGV5Y#H#8X:'< M_(=Z5$"*ZVFQR)!2PS^:0FSW>!$;J=SZ@8E*OOY>SSQ3]::X&=N3 MG40`_$N0E0&RK6`X";(R8NS$3).<7;4_,`.7'_15EN*KW)(0QY&!5O#\L^-^ MIZZ8FSKCO24(CPF$2FO8%ROM2*7QV$5SCM08C)U]`;F,'Y0\VVJ%^8WWKO,9 M0QA%3N%04LJA&A(X5!L5VCV&O)'5HTI"_NU`?C2LK;YPQ9"O>H'L)9]>I:_G MAQQL51ADWJ3Y659:A.HMU-+R%U1MQ'9[M>VE#L]?4#VR).S?$NP[K4&GMF+< M%<,^-6W';L^S5/>0R%TFO*:EW[EK(V$>Q%,=?K`I^DJC`ZFF.G/N18T?8K?- M6PXIK+W;V97?VCTT=FM>PEL3;H6<_SYHEK.-Z)U M#AN_[SIW'GC%K<53I812!2_Y[F0EA5-UQLIZX/;>;NH>1194]KK=`P_2FP2`)>.#&,NW@ M3_0UQ6WG?(#_W.AC\YW(W:(8O8 MA,UPPM!-GZ*;%F@5'"&.HL1U+<']9M./NL<+RV/;]3DS)+"\,QHE;&2:^E3$ M'^A4G(`.-0OS[-/?)1M;X16YTMO;;+[SD$-\>YJZWJW'0 M+_2%&D39=@%)^RR::XB49\$D[91Z>8!O]!E,*MB2,4&X1<_\M2^>L)(L.YN( M?7MM+KVZ);FS6Y*E]!:VODX.Y*?42XK`_FI:.R0T_HTO1EWQ?2*EZ#0/MU/J MY0,/MX_CGAWC;-C%_/@E_F62C[QPTE+"9K."N6!/\[!$'*Z1Y)3!NN6;@MU< MSL?5JBS>E`.0@A"H6C=*;DANE,*-'+3N"L9HD#^'N0?UE8OQJ&@]H[K+]EUN M7&@2G>>@F&(*FH5ETA7Z,?U),7N*.77(F9\DB_V>>BU:J*)T^V*\R_W@($X> M[`BQAYA*O#;*G/;B-5Q&R:@^,F\0I=<:#`:EV&@%8%JC!X^4(BE%I;/@7`J0 M%"`I0%*`I`!)`9)V7`E25,%6L[((IGTRU%"_-<9P[9&A2H5QC4R2,)$P MD3"1,)$PD3!I*&`W_>;E>"Z(&G0(;?K^Y2U.1HK;SNE-A6#T)NC/LI2DG()3 MF8(RXC3*MP\JL(D.]O%N*AE47(4FQC%4#QTYLY7/[):WN9S5$YC5QDP>.;=- MN-(*/*]R>UE-/ND@@O"T=S3B3T5R<):8Q MF#:;<>I'8N/("2D'ONDRF05AUH-^4LD-$M"_'ZX%H0EE:83#EP-N)&7ROPZLD!(AT+I M4"AA(F$B82)A(F$B82*\%[O,*R/SRJSOB60\LFCQR*.6TBNURI`,ZI="]-:$ M2&;%D`(D!4@*D!0@*4#2C"M!B`ZL%UE^5;FPNEU4RHY\U!W-L+`MA_R&3Q+V MZ/^DUKB+O1`V?(+EZE@?-[>/5^2*\)D==13E)_)IWN3ADHPZ[7#\G?9/,>3X$%RP`P56^"Y"1O@&<.PL]KK? M8NSG]Q>1W)!?@5P[Z+85+^"G.V1*9[J)E?T*%BXAM9*JZ]$(8 MZ,@RC:XLT[CQ*9T+NXI#R#*-AWF2;+4LRS1N]RW]-07W`CNE7F29QIPNN;+0 MFY3G-]^++--X>M);U/HZ.9"?4B^R3*,4'=F++--872Z:4N>B#@?]IC)-R+P; MDAMOCQLY:)5E&J4[K?3#D'X8LKR/]&:24B2^%$EW0"E`4H"D`$D!D@(D[;@R MI$B6:92QQL<5:RQA(F$B82)A(F$B82)J@HOTFY?CN2"291K?U&3(,HW-T)N: M`[*XDI13<"I3(.MG'$/"=EFF\51G5I9I/,59E64:3W=N99G&-[^CD64:A9D* M6:91E)F091K%F0M9IE&:-K),HYS@K0F6]?SDM,II/9)IE64:79GV1Y9IE),J MRS2^W4F5R2H.M1IDF499IK%YXZZ.+!#2H5`Z%$J82)A(F$B82)A(F`COQ2[S MRLB\,NM[(AF/+%H\\HG5]Y%")(5(9L60`B0%2`J0%"`I0&]%@$[,C,M4IE'H MNGY1)3561RVM!MOF!G'?-E.U*9E2E]H+5G_/G0-SG^?^,RT2^>;R[:=EVQ8@ M6,4&'ILU;C;4>TRJ;YD5+A2-W67GG]A1?ZN35]^OAO^.\:*#"0=PI$[F!)3)%;X!(5,4-HU M<.'!FKFO"&EAV(`RZH%X!91MO!"RIW\H=RXM@%HX_2BDCU2;FZ`@?35^HAO/W=^?==S]W>J,Q MK(A9V,&)W6!%`0R4-OALL[Z;#^-!1RPV5`7^/6P8#8JPH6K!.%@Q'B(8PU$1 M5A1>-,O#1<(RN7OL(V8E"S?T`S1#?4/?N6Z"(3K1-&_A&-UV;V!;UQOR[NWE`W!]O@Z62X[;-K M!X/,=BWT42/U;(+W43_J9-Z@Y*6^"(A3QU,_8`?#JAA4GB%5#KL.-IJ4<2^S MSLS+I.*+2ZID5VWXC"MC2MFBU8SMTLN^F1$#-768RSTE\P9$+'U3XRY8&0TR M6Q%Q)GV^O?WXK^LO7S9'^MFRIJ^Z81QD`'2[[=X:,4%KAW>;9>7N=D:C/=T& MS>-\;T&"1+=9Y#>\SB+L/FL+!4$K,$N;K(U:"*_#]MT^O/LYZ1XR7UQ1[-:R M-O_7F]O'*_(+"2\KE9](,*MD)S>?KS]\N7HXFMO9""7/ MSS9]!A/;?"9_Z;8`U2V\VD?PP)^`-O;GJ^H0FVKH!C`EL*M(O'XJVK MR>+^V"[GB>>1(\Z<(@95EX0%F`EBA'473P&`W_9:T*6SI"P9J+%JD:5G.YYJ MNL2U&`&J]A]/=W2VS;%FY-/G*[PO?J!+E[<#;2@7T>TZF^Z-7C),IFF]3O1YB`W%&D*N\/%6\5D M:M#EJ_-CO5A(\C:HN7-TPF`7\QHU#-]]XN_OVN_8W\Y2U8*_RR'$=^.`K?U? M8P24GZRA!E64/F\IX>#=W"&L342$\]>QJ1^)[@)!VHXH<1T5C^4YH"WV!1$< M7S3OFX*<FW++9=N(,MURRYW,ND0Z4>TWEGPM MDO-/EDWA*Z)YMDU-;45<6S4=@]VZ5"7G!_&B$N$_('5.=80>$(6P,\%.K?!B M+2JE5G7-#:&FH[RS2[\H(=ZQ57[C3.;,,U5OJKMT6BA@.\\<5AOF*SO!K:G_2.WG MKSNY4/=Y;&PO*P]CJS[1J#7_YT`>^![]F9R$]1:LCSBM;6A0UZ/:-_*=]H47 M&`FE4O+CR^RY)WLETGPUI[6F:P%;YG.'MUY;ZXCNNQH5MF0'2-$%3YBIEMPH M?BX\'`A\T*,K@2R!O`7D4:D9PT1V34A? MA$1U38A'RJJQ8-"J%BOIEG"B;@EG`Z5;EYB7Y)A0.@]JN\674G,J4M,O-YWF MJ4E-U]]HE@O(8# MSKJWD=6O7XU8NX+8LDT6_1*$/1(:;Q4:IW@=M.9"^\;OA1H4BZQTB'A`+:$A MH?%V[,NZ+]"E_5#C`>"H7=O.3EJL$G''BKBFKJ3KMHY%O9)N[-0P[^5:8X>& MN2_7JCTS/.LIC1T99K])=29_>D?Y!(Q?ZNJXQ MMY;\UW75&MC=\1%OS2$)MU`UOK MA0/Q?[JI&=Z43NZ'0+TO(:I3!,YK&:QG"K&*I0NC)H5-6M!`/K=DUW9-? M:]694^K7HV#-\]L[>,`RB0IS:*R.);6#UH MDX)-,?,__^T'SSE_5M7ECY\M:_JJ&\;$G%Z'I2`GC.4?=4SZ2/,Z@?# MTO[\^7__+T+^]G_.SX/7`!11%6LRF2(0%CC5Y^?\VIVE7?$,W7^ZZ_M=N<=F5(-9L=P_O[NO/ONYW/@<;N]/:CD MSJ)!V);CD#O;FNGN%KWX&_^I('']_F"X3EW4=&%2>B$IO2RD*(/>7E*N39`P M2LZ^P$_OR"^/?P3OI[B@DF^Z`NL`45^^\H*G_U/)2/__4&;TZEG MT-M9<@O;WU)ZHR[HY+ON_'YIV4O+!EW\#TLWW6_P..@D3NX.EK;+Y^@EC%(W M/5QZ;I?49HK%(4\4]#0E_O./ZG=<)*^^P_("!IENJO:*7+MT`5_>6"8RRK8, M`]NXQF)=1GU^8%WRYUB':]VQWM;["KHJ#-'>8`=+2R7UC4U$/B5X MKK2[O:9F`EX&MG(;YNP#-2DL'^^3>0>/^D_ZSQ4$8!+ZMOJHE-Y\\Z2T#R'8 MQ=F!O8L^3:62.G?P'6*X$HFZH. M_4CYO]=F\,8=?P&LPRDM2*O2WB(V0Z=5CR$G"GK#(F,('B=GP0OO<;-VRS9O MEYYM8]EXOJ/8/SSVEO_2)*Q'7V""AEL:8V^/C8TLYQ*P);R%1_;1HWQ]O:?< MX?5.A5TKKJ)^,_N'"4W@^N,WX+\?\*KH1FK/@'?U+=K0B^QY#ADV!ZUAF<_G ML*@OB*&K3[JAXZ,9L8NV`6_T2_1NP7%U]DUI>L^UCRSOD41[GU;-,#90O+8' M8/1/C/A9%C\6RS5,OYT2A]?I##*L&AN=-C&NO'9UKS<^?%QIRH7.*,SQE%S. M5?LYR\""-_P7"HYJWTQM]%;_OOF M=4?W(HT\ITX=*>-]DUU@X*$VNLQ,-EGLX:+K?&>?X1+KJ[8QY-SA[-WBY!C#C>4"0?XI3&MS MJ[I_6.Q]__7U[6*5^]/T7@4:;\YCOWT*/\.8'U1<6EWU>_;#OSO;6E+;706K MI'\HRMXNJD5Z^X:TJ_/:!I7WB&S?&5FF085W-M$N56>'TBUBTH2#(?YTT*1_ M>EYL>K8LQZ0^JB4XIZO!YKEK-H*3;Q?XCR5<+6S"(6JX!%(*J,Q$.OBRL&J1 MFZ0Y\W^%WQ)XDF4/W=D\YXA:+(.(GM+)H$;'FUIG-Q&?=%-WYK`$H(>/PXA" MCZQ[ZE#[)6E%\-\,WF.OP4NWL^"5@^@>=#?1O;>?AD:3!0JCK3O][*.Y5U\) M>LG9.C272C`\]35XJ#B]_?&F6\>^;BHC-PM8^J--K9.9W/!1$OGBD=_0&X\P M=[P$9QW_A03?O;VJ\^D<^$.UN..HKR$[F^^79U M\WA[?WWU`%)U]9C@!!M\?++)#_4Y[>[SDXWM!=A2C>K`]E'18DZNNL.^1*_0 MF648UJMN/O^(!"-1"10GN02O.P?CP\&H4QHY9-C\=6SJ1Z*[,'YM!QWR4[%/ MF_/8/)(S>:#'&]0H6D&1VF#N]'Y,`SKSP0.&X;OSAW\[2U4+_DX;HQ\6X5K+ M'\F"3G5O04S+I'D'[S?#HB8V&@KB$-KMOVY%8:P]Z/^&NFO]EVC4&8+X4@>T M@\0<*;=VTY@_<">5W'RY?/:R;IT8S4)P`#6#PPG9GR$G0'.1%<*XDQ\&R>D0]F&Z8KLM+A%1#$L] M:U:\;[1Z2PE":TH*)9:%PO)'JK&`A.;@W#M).!^VO&1>14I?,/;8$@7%9D\G M:>@X\TS5FV*83V%K(\_\EZ:YJF5JQDX1+RG&IC`L+$]:]N=52N.]".E"UL[Y MJLH8DA1,?S!3ZDB(L$;0&\J$D#KNIE(@],?E)/S.<"8A1@9V*492C"H0HU$Y M:3U%$2-15^^Z\R7^R[+_1/>?I6UIU!%V_:X]EWA^Q5-[%O$#=$2UN;,'XW+J M6->@(^I-RR@1?ZJ('Y93DU84Q->X*N8[\!1AHQNZ$#VCCTY5*^7>@[RCL-L/ M+<716)+QW*4XJC6W1[URTO854RR'%^FH/Q6FE).W*">#[AN0DP97Y5[N5;EZ MNW5OGM&C,+(9D])V_Y$FDR4+531?^!SOHP,^>95VFW_'D MF',G2?O\42A*L:3X^ZBO_"$@\'5#`B0AJR9!X>K,?K MAM35.?"->%1!!AY+.Y&:6R_V3&K^O"SAI>/AAC1M-UPV71FS!VRHTFQT,=7) MTU;OH&QB3A]<6#_FE@&FAN-G`3^$?[WV>$.T]W53-=698KP'G8VHXD.H;L42 M9>T@.Y9-ZR"$=C=3TR2V70V!V?+;#ONIS$PBT`*]TN*).UAMB"E-3DB5-:*5 M-7E[>_WCP^D,G-1W+[^,O5/;F_NKRZ_C;Y\$6T MZ->=)6L>XQ&MA$?_+=$F-UGQ%U@J%[S(B`U+"N8L?XX;\B%+AC\YK$9,F`J- MI[^P8\A36167+'N%'P7@2TF!E(=&3^8;53P2,E=,8^;KV+)=R-/[V&HY(:0P MK=77N>[2<^0O,)(?"90=3EA2$&'C`8$"SGRQ8`PV@,,`(&/OZ@>O0(#*(R$B M8>E48M\$BF-+#SXJ#:_'$GC65'29F#%DS02*[?03!+(R;@V[Y=A#(@<_';(BU1W'%-84HG[F M[3J7I'JC21J,QQ#"042IK:*Y(/Y6$G%-(TXL:Z6*4)YCV'5,\,:"59O'RWQT M6G.Q6'S\"N*-[T,:%,&L=(AH#TEH2&C4I$:3PQZ;MY^C(CM$G:+[)RO07I4Z M/8@+(L=CU1X*?7`\5K6FTEFOU1V4DP6@TKBK:KGP7LJ-E)N\BBC5OLG9Z5#%*A74I5TRL43H4*TC/=LN+52KXIQ@K7:G'.>22N.QZL]% M(`5'"L[.`\5^JS,L)Y]>\Y)SW)&,6YX,6+W/\-"5?L'7X:G'SQN=N;Y&#S)_Z\]4OEV3R;%.*FVVB MVI0XWM,?5'/!1(EMPS'.#'YPZ'\\_&L)H[2F#A!D><:4M<3:-%;HJ.VPJI!, M#OPAM(BWA&W]ZUS7YNSI:+1$=V#>'3IM$6VNFL]T*XY2V(G+)R"O=Y"$8+!#5\FR83`>DB-H.SM%"_1/9^1]/ MQPK22W7%.FBQSN,]JK;NA,W&II(SW6$3O#5OT,-<=:&/%70!D*.,(/[;6F#M MJVX8!`G'P1@K?W[3D1;'Z/:]*6)B:4-;-DS:.@M?D-\.4`3,@]%SD@&.CF6: MU$C"3@/`2'?BWXX)/BCB)0S`P9@<&(9M&09.KAY4LT1W\3DP'V;-G3OO-\-L MONJF90.B@E*4MZ\FL!"TRQVUT:%/?:8?5NMM\T>R1!4-XU%%6/KRHC<>1P,^ MN.]HT*J+<40@#;W]Y\G-]?_W^3Q^O:& M!0O=?9GA9[+J]4'6ORF^I8F(X!;)46N3:U"_*J,JUL MV4O+9@H9).@C-=177!/A\S\\4$7*>#2,JZY?30-CW%&_^8`*5+'#-\ZOND-! M%X-RM.D,X,Z4%^BM(("IT_[IE89_*#^UXK^`KD_[R7/2?MF(D-K\V:;/NN/: MJNFF/1%C3>P16!;B#P%?04Y1D\>?86/$X6VS%YP6D:G,33.SG50OG:SE?.;JFPTK$>#>WG"4&)"&RP1Q_!BN/+_>_ MFNC<31Y)"A),<-QY:02\, M(*]ST/FK<^L5DW2$:%DQ2)&/NOIL6J`M-,?'U=GF]^]AU/19-3G:F'E@4S^R MD,_UDP>&$(KMBZZRI]30_CU#LF(P7S=:8E!_#Q:/.P>CAOQ"5<.=:Z@ESC;> MC#_/\Y#,HX=#*G#IQ+7L,X5%#CAWA=RT=2VTK-+5F":(Z81K M!(Q)$3"=5M)V!76VNL!MSY0U#_+'_P@`Q5[OMF-!G^JSJILMKMS],)8H34Q" M\S//9@>@.[O9C"0=M>*[**K:AHYZD=H+G0N(;Q=KH$"`'*+IMN8M@'EL>5A3 M0XQKL1<1=BB-FNHYE$DVT#:#)_P%BO4_3-U#[8HNW7A`R$^(B0>Z=,.94]83 M_*B:OQ'ZI((5_-FV7D%*KYBNA_T/,/>+OF"@//O$Y$DE'\`6U9TY^:;;`'YR M[1@888F;#JZ;^)X5U!'NC(AOE()B?+7(Y1PE&&:!FY4@.?PMS()P#CW-:+#T M,#@]ACJ7?'&G?$G\H%O?84P@$1X7JTOK@O]ZAC^]7T\Q!*TBGKXO@]64J7%< M@EAC:^LA(&2YGI0!7^7DL'>G3`Z?/`8KD\*`[#];:PL#ON3K`H)KZ0XY"B>8ZM2W'=NK74H%J_ MVJ5B?XJ;2N2S83TQZ\1>7@1#<5+CW@/XA:#[B7$CWN`#Z%>VWXD9N1A:SYG% M^>T?4U@89(^L0U,AL(8J,H!(W`)"-*C+500#H/&5@L6L^C8T"4:#EO62P<,* M-W+'8N';F;,(&%6QN4<\/\?A,W=PS_/N<%!'C3] M'#4*+#Z@&BS.%]`>+5]]P*/OV1(;O-QB@%%YSP9564Z%2&4`G^%IF'<23(AO M1:*`!V]:##V@-?^P@%:"B9]01D-E^>WAG^2K/UNAIH4O08\%43*9HL6!&+I3=F)5S]FUR'_T9&K9@"3%C$^869H>$AOT+ M:TUEK=E!:US/Q4SAZ\?_ZY![P!A?[^XFEP\`29VK](FMS?678*,&5"\\7,28 MQGQ@H(,MC#5SV=;;"508>]CFJ:O"0^^6?Y+*]A>+I<'&P%IJQ9>3V(9P'3\Z MK#IX;+D"(XVL,0)F3O/08HAVH4`>_0ZK)EM=_3/8R"".CMA9TK,I>=K>M&`3 M3W2N&C/.LE\NUY936(9?_<6*;&Z`6JRQ-1;SA:*UH=5AV6(K]L9^`QX/-.Q1 M87SB/<-#"2@/33T\7?%%'BQCM*(9')RY:O.]".RLV(*2;&?YOX**,BPM./GY ME_==CRG,S>WIUNRP%[`CUP*13.T(?WT?G_*`M-@4!NH6/["M,A-(=N[N.#K? M)."H5/)LP0)L,K`^XXD.SOZ4KP;L^:_6DWX)3"A])7_\&E_`@4`02V;`H2B= M+U4;=DNX)5F")")U"PMV@A:S2OFBXI\R&%-NWG'B@;/+(` MRE;\FM3Q%Q$06M[,\0#Y7WA'@^HG;DBB4H.)3+4`]UES?!/)[+70,O+5T4[# M%A,!OOC[`G:XR>ZBIK'V'I@Q>[]NS*8TO:Z28D/S!QQ=`<'/81M[[T6VS^RC M\W_JLJ-:6)C.\-ILZWH#'KAFOW^!7_<>]>].B7;>Z7?6,J*M-5X631O)&_?1 MI+1[O8.(NJ=^^MLKU<9#.2C'OW>_LC`=GEJ?80QT-J@YDFN67#'H- M.MV;69+EHE,ZHX/&"):.[ALK=ZH^/4>%JK+SS`,'NYE2=/=@H^ZQ]VO3[SO3 MF`\8+9I/:#=AFL-:QL<[9/U5-:;29S`?7&N>P8FF>;!R,M.#)TY$>FPZIR8[ MTN6-U#/RB!1&R1HAO)>CY$)."6Z."V7IYWP#/D@_'[PPEJ"Q\J&Z!HU5A/JJ MUD%VMER8OPP^WV`#C+XH@<_&E>DR^_'#ZM+`72/I?#[>P MS(13JA2&+58**U#9F9161FJ.CUTYP=7K5L(MRXQN;_VMQ-G5]R78]'3;>HL] MS)_UGRP(A?X&$-*ZJ9KJ?#/2:^>F&F^ME^J*N?=CO(%KA1*L75 M49:)F8-N=LH\YNQBS1)\W_0@S&7C;'RN.N2)4I.HRR5>3--IS&LOP5]O_3XU M.KXGUQLN)%L,8<3=SKC;W;7Y+Z2&[SIN`Y>2#%/7BS/H^N83*()1C#O[.TG@ M5G!7FD9R:(D^A)>J>537:(OD[C;%6WTDT/G!OR@%3DW\6\8TDJ-'@R?ST=S? MHKFS3?-V)R'1T>;$5\-;S`V?"!XHN![T1_UU2=GJH%3B\BVQL.?IY29NYU'. M[?IB5\J-TFB03&/"5KY$*G/?,8W;AUK1'G<(7H91/G4P:*P,["<<\&GWU6.2/XV#TL%D+_!QF'I(0Q,](0X M:N%C(UH?4!ZN]CLIJW_M\I<1<0?+7W=4?*2-P*=242P('U@3A\>Z)E;*U\)K MXGFWGUW=?;)LBO$7W&E56Q$,"74,SE(,D4JS,U/NP[%QO\U+O\E8S=F).7V, MVI^$60E8D>!']7M14W7C&*0:(H^%=_DV(T,A.7>``U#]R*S/DTB4:;^7AI#Z)+M;53-*N@K_+#D-92N14YD&<5?71CRMA9F68AZP M0HI,6:ZTHBXL(EE$M;GQB\+\XQ"89GS/:]W7W3[^.`YU M'4SJ5N"&OC]0$D:UV72)1&7RCAETVH<2M>MX*MO!X6&\%NY0L#/:\)'+P<0, M9\G%N7+H&;+2;7I8E1R-#P\>UB[(9SW5%07TI=YB9F=A25=ZQ=%3XU7>4.D? MBK@ZV26*YT&OVZEUH<2;?O70]NMXQ\3N)2][/U:0SK90 MXLC-C+[-,+O3VY\9/D9-O#G,B$[M"-.LO`5\:QA^38V_OVN_8W\[2U4+_BYG M6$%ACW;[KS$",E2^REQV\M`R-'FJBH64K[>L6<@Q:'JPM]77N>[2<^0O,)(7 M0\E;U&US&NF"E5QC270MS\&4H[SR&/_AX%HLQB.*8BI1S/5HNWC"*9ZPF.J!-58,FC+ MP&=2`>OXU)QYINI-,;7K^])GI6JASL6?W-/8,#?2X)BU'&FR3FJ^'.E'K"K" M`^O"0E#4#VT^!T*#/?MN?5&@H&$3511/N42B"/4/.ZW>N+;RAX+4")5`/DD@ MCT>CXP-R78M59=7"4Q:K[6*>#2U1Y92U+PR&Q7@KDJ[>QQ*$D!=-`$)E: M'NRN#C%,CN=X(>?PFS)$>ZU!I]V45/B9?206R@`[ZB5$CVPW7CYUV;+`*@G>P3NHNU-7W)O:M8)9R]/S&D4P5`L3+%G)H)PXEH:,Z:#^XJD(N MNF,`>YA;MLO+?_.T[^R)OWJI\9$E3%EE(WO@(V./M9BBV$YWO=XXKRA]R/K: M3J.7-5DA<5ED(#=Q/B;\2L,Z(X[A@G^S!PQL/AP^I"ST*G%ZVSO(C3=<+]4) M$*B&:M5S02'![BLWY9/HS0-XKO"MY.XQ1%TT,XX,LU#V..*%MW,.Y#;V:OEX MBK7>U""*BW+*():J/@TRZS.K.QZZEUHPPW_1?P\LW]@>O,C6J;M10"-#/\T, M)M/N8=/4RS&8>ZJME0/:S49*5C]31;'W)8G&//GZ2OXY- M_4@P19>N)9=/SQXC5R=!6Q.:0%?P4:RR\Y>PP\6$2?;F",A$5V_SF'E[\E&C]D*@% M<$]0[2D'-%CY[I`%JC,8;(X@M8.ZZ,Z"JTZODY]NO_P7P?I?*Q)+ZI4YIC]6 M0"R>%.ST`_Q#I;I0[6?=/&?70S^2GG(1AG%CY'^T3'U92P%P?_5E\GCU\?QN MB),08-^R\5%]`6/LBTZ?0)I5L\74_C<=3P_GJHY? M!1D",*><:J["\0]_M#JP4""&-YQ.`[TVZ(BP" MFA)V4H'OX`#^;=E_,D%3@7B3K4H`0A/3%+CL:4-])3.@@]7JHMJ?C,:07#X; M^#_R007@3I$+7[[15RGVZUQ["I)N\TQC3`F&)@2\-==%@IN0O'384I`E4`Z@)O+''RK4DJ),> MVP/R7)4M8L(":IFI@X!%:(J[,W8@XN<;8GM\/YL0RDF,@+1ZTF_8Z]\Y&\<9(R>]SN][B:S]_54,=V9BA?V.X-1 M_U"Z[V$J3%!=L/.SGDV6O!L,:Q!5;45^\__=:9*RUV-O\W=.R!#->3#!V%F.=IE)5!M4^#-?0^AWW7'Y`-!:C,KZVKCH MV73*C>6EC3_"TC;3OX.,PCQ,*>[B=9/E;^)K#UAUFLL]2U9\&50="Q]883XN M6"2F&Q8'UY(\Z3TL8&"A32F0Q9;X)XHV!1\*4L#L&&.%9D=D&T1%B#6-+E%[ M^!:U!LR'-=8FCNXR!J)-8T^9QT!X\.,L016`0!,/P+LC3T@KN.K:E+_Y>FG;9=<1;_8XAEY+]IMHZF[?0,KW".MO,Q]D4&7[2&`!#)-,+=BSNU'Y>*)&I5TT0]512Z=O MF)Z!YS8\R9,_7K`][0Q6*!.FP8!9C!+KXCD+<#Z8>MR!ZJ9F>/Z>C2D=3>-= M^%>@25NQJ/%P4\;/AGSR^;@Y0B]JRCJU;W[25=5;RMY821ZFK4;B.1GSY!?< MGVDQ(KV^G(LRO6*IV?`&/?Q/M=GP=ATMQH$U8=9O'4D7LU*4E(2Q?BHV<\.) MG+U/RD`9,E!3GL@<8G!R>2/WA@[7FNUBUTQ$8[]4'7X+3<\/:EQ M71,QR]JI"WR]@U5:[9%8R6EE.D$)]&J`WA/+A&LDAZ&`&SB^ML6R+LB-VTG+ M?P)=IC0K3@=57 M]N;3V$S?_@9^IS6),_4!\YSPJV^#GE2"_?66!(?]S?LMS[IC/P4].]%MR M@H^]F1A_OXSB82WSVJ4+9_)==WX/NPIZXOW\_A"$FW[`1$S4<8+?V5LA[?ZW M_*5]"6?:@\WT+9SV[#P[;BPS M#]>;&E9&_#4RK%W97Y@4LF&LCR(/"P>=GE*3/.;+J35LCXL2=AT+ MQ7^DVMR$Y>%Y=81S'!M(-([:!*7B-:I2SAVT1K%$74>#O$K7^&:15Y^*KI2) M155T=[P'CY&$LNQ(FZ/V^V432A.RG#S[/4A)%&0D"O)$?5A=KN6Y MOYWQ5$5,IA)?6MWQM$@?HJQ(F22LVTF'2S4\V-0W`O!@F`V:D3!C-0-XG<6K M!UF@=_'AP7^FN!QU!\-46F.]5$QSSDIQO5XNFOG:QU-4:KI#R:/ZG=SQ7'BI M=5W82YC;GKT";_@O%*H\.DX0CO0^ZAU`I@(&O02T9!F`-J=3CQ>4B%?5(;\] M,N?K'1E7@U=O9[&"-^PM$7*N!A_KS>C&SP-3TH5Q_O*88);\3'?<(*$=3VS& MT]\GY61?RZ6"F/@1!U%9ZOD#/B%_=^2`KXG9G;`.P]N-/FC8/SK=:W:_5WVF M3$?\Y#NKJWV^\(9ZW5T+W:0+./5UY;K:0D`%]RQIF*HCLYOTQ7]#@*HI3=I; M\O^O+2:O&#[W1>=MAH+5D(&T&?[DGL:&N9$&QZP^;LDZJ4XO@N0!?]R10OX< M"#7]^H[2=Z>TF3AI7QV^P+1Z8[$R%LG@$PGD@X`\'@GL9=;T8E5=>JB4@$D; MJQ-'%5NE"!8^VTAD3N)&7H!="[M7 MJ4K?'S3H:K1`KF/PBHW?72*;C]"FK+E^24>IAV)(D)V*Q/>)XKO7KVVO4C&^ MJU['>BF0K][&$H>2%$P#061J>;"[:CHA?8F.@Q/3U:>ZX;E8(/N!:I[- M:Y9>???K@++8!RPSZKEAT="@)#RYHS9YF&,UXSP^A_$^HRZ#'C]!A['^;F=! M;]`9ZTL$%\4*-L59JOU&KH;FU9WB:7#V?P&->?='0E,(Y='=$QHD2>JJ9Y#>=7?V8QJ@[P_",+U7[6S7,43YB*4;MD5T*N*T,O MPE/P*EQGV7BYZ8]Y/D[A86HBXR)I-9OTXL%>LK@:UNK;\RE5X$I9"P7W^*D# ML=WC1:QHCHS5]WID)6@ER,KW;)0@.YG<;=L[JLRJ_8$9N-82;=;*LKH=<`@L MB%M0@Q>YU9Z)C_MBN0[4._D2A$*`4&D-^^5XW`OA1E:U-T&-;F79%Y#+^$') MLZU66+U\[SI?/*ULXW>VU;L1E75G6^TQ=7?JK,%,Q[/?[$21>>R:Y"Y1U&9_L7:!IMD>GY$M4<#R?IP!_/_:Z M,$F**MO(IES_!ZST8WIYYBJ+I26*E7,O)S=1-:?N_'5LZD>BNS!F+>.A=]/4 MA%X`IW+U7U\2D/2+LZ$:^V=[[19HVPG@+209JE:M[9'K M4\M!DXC"FEU:2LXPQUPGJ8%?8Q5;[S?M/"'>[+(503"$,[34I MAS)Y5LZL2\>YNI>A0Y)N5&6RKB-.UG6<3DYK^WATO8>-/#M6J>K^N9&#R\3] MURGG-]H[X,;"B+LR=Y<$_!L"?*^K79]3E"#^3Q*(@@)1K.R/0G@E"94$+'Z+6=4J(1,F5>")**PUJ+1& MO=HV0#)/F(2]*+"O,Z5._Q6@Y=I:_-%^C1LG4D&$OX6C-R M3['N;T+5W[#YX*V57Q#VE%VB]R5%6^.@R3EH^QQLI3I#[RK`.DB8^_1*J>6Y MQ"0A-9T.^:G8I\UYK-[U:!^2,_F\UY*HSE\I8XML#8+S3MXOQF; M+Z=K#<4]W#<7YK4'_=]XR&3\EUQ^\:D#VD%BC@/4W33F-_!2R!\V/*2>14I?<'88TL4%)L&'<(/F/_*@W0JU47E>Y%7S\+RI&6_5UX: M[T5PP;A77\E"!?SKJE%K5LV#F5+'P?D:0:?LT9MUW(T5?!N7,! M.J+:N^;!N)QRR37HB'H=ZR7B3Q7QPW+2PHF"^!I7Q7P'GB)L=#_IIN[,Z90\ M6]:T^<3?0MOMQ^R>+8*Y/>J5XQ=93+$<762"E),W)B>#[AN0DP97Y5[N5;DA M9^FC,[=ER6@A2T9W6DI)J9[+52G"1RM(`90"6%+H;4D!]T(+8!WEW'=[^R=F M7<<]KDO/O^@OL,^]-EW5?-;1-Y@7A<^5@)TWQ5J*&DHJ+G]:80<[,[%C(7;, MB:^:*XZ,44<9_N3XR=CUB-\JYW!4F*0],Q4;V[H9UZ/:I?9T4\72G$W[T;0)'-\ MBZ]IJY"$M:9K`=NFTWA5F),9Q>MS^&Y4V.[8#I%O!A^I-CB2YXPDRU MY$;-28;K]N6XQ'.1(B>MPJ42/V7G:!%NFCNMWE"L1+`GFA-?`KER((]J*V9[ M//DI)X- ME"-(85PM#_;LIJ742*G9E)I^K[%*[\<@-4VE5:Y[@UCPM++$G*^-^23G=HQJ MS"DYOP]3Y>4#!N5<157JJ%2_D[[$^`EA?-RKK4)3Q1@_P2IJU:]?C4?5-FC+ M'F"I[J!#Q`)2$AH2&F_H.FC-A?:-WPLU*!99Z1#Q@%I"0T+C[=B7=5^@2_NA MQ@/`45O6WI6(DX@3]$JZ;NM8U"MIF:WCR+)UG/64QHX,#\S)<7I7TE)JCDUJ MNJ-R\BJ>J-3(2K]U7]<=::X.L:_KJC6PN^,CN*RK'E<2X2>+\)[2F.-6=;EA M3N6"I9'K:'F"?C(GZ!(:$AIOYW+EP4_?).]7A#CM%D<@Y$6(A(:T+!N]B):6 M0XW'?N-1.>F]Q>*Z1)S`B!N44R[PJ$U@&1N=[TJML=-"&>5Y:)3G4,9&2ZF1 M4I/3?6/<6%3C,4B-C(V6<:/".;.(%C?::RXKB8R,E@BO`^@_`2O5F1< M=/,G.,=\@BZA(:'1T"F<-/]/Q#@JW>(0OV9ID(2=S^Y.A*U;M]49'6$]HK)%6E17Q4^6 M3>$KHGFV34UM15Q;-1U#NBM*QZL#F170>\6Z>M MB0>Y#_1Y`720>[K$<`?82E^;,\M>,#NB19Y6X1-Y3GK]=\)&8VU^6/D_BG(* M_.`M%JJ](C/=!)6JJP;1(VKA;9N="CN<:(?H#GQV\7MW3IZH8;VR\V#LI;K# MM4U,%OF$L,$N`C:41WD6*C=[K^GNI)%#="%ZEF?WAURU@49XULUS_`.6X.7F MY=OY..'R[3!1S&L6Y#&L]UI>X=F=,CJ>>X=7BG;,CV`S@)(V\EU&5*#PSG2S M:IT:WI]4W9%_/U.]@DZV%M]]?W2$C@#TH6T.#ZRJN8][ MN*K[0*.JRJ0-? M))[HUC!LON$17F0EF//,ZM5_/'V9-*\24!)0A\SJ]2.1$WN*$WMIV4O+5MT] M.0+EO![=O)JL3\QQ(_S4GJ*_5#XV5@%+8=RO)#LSVUH0>(;:IFH0S2\N7%F6TG)S?!].Q]Y3XU-S\-@[X*9<.@:M M&NN]"!+[*J5`2L&&VV2K/:@MV924@H+L.%+`/UF&('4"SR74&Z?CU*`NOG%BX[?:>/1?B&[0ZXS>3UO?X73TFFH:9[1VBFE-BN7-J$YMJ5'_! MG%[0@TGW!%[+(\ZWI#RJ'7&OU17,WUVZ?4@IJ'O$_6%MY_Q2!J0,""D#]5UU M21$0[4Z]X5B0:@JGO!1SJCMDTQH<=B MH3L.)JVGWY?4=/9D[I*GBF])9U1=YKFGR&M6`:1@.UC\I&5`QL9+],LU0`P) MJ*W"DY2`@NPX'K"+@&NIV:5F?]N:':U[L6PHDI*H M=L3=UJ@KUA&`/#R74E#WB(?*$1Z=GX0,G#+<14"V6-N@MX-KJ=N%T>W2]5&* MP-L6@5YKT!$K[7M>WX`?6#'L\*_8,"KD M77X=KK6IVRQ!'$Q3CNK>=(%OG.EF6,'9S]+)?T@!PJ[BQ'9J=6*L'MQI*[WH M^\TRO*7DY3AX\K/JQ[3)JZMH&S_K$ZAB6T,%:".VKI>B)?63(BM,IH*ZJ,:K M$<=A[5F)((D@66SV+4^D+"Y[*O-XNL5D_>U1=WPQ'HGI),[ZJ+(F8/MBO.N8 MHC*WD#W]'KL3R"@942(Y/0U:G9Y2YD%/Z5-:%;@DJ$\6U*-^J6>7$M(2TDU# MNM1;60EH"6@):`EH">@RO09:[?%Q6M+U[)=K=*'FWM'EU\[++]SE^$R4@02! M/21*$>Z*=4:G\I*J>P5Y&Z7P*Z MD.[O=X7;JDC-?X1L/7E!`2-I+-QE0G.B0MLP3U28%: M.#-,`EH"6@):`EH"6@):`OH4`7V\=O1IWBV75;:NNLM-,U)D^GCDNN3%=W=>#Z;X_L!WR?L`;^ MY_RX8][.OO[.ZW35OIMI:VX%OO4[2KO?DX"1N9M M^B:,*CX)^,-S7'VV\K\,*EUW!T'/7X`9NL'9:%/->C:AVRE1':+"WXYGN,A[ M+4Q2CUG?W+GND&_75V1J`5Y=>,XO;D,PQ3Q.*69/-U1]X1`+ZS91@3K= MU`QO"I3JO`-5TW@72""0.T57@&F,KVH MJ<+*OOG9D,AD>G:5W#K:73RRGPY1Q` MEUNI_M0%OM[!8LKR4N];RIWLNE8V"?0W`/2>6"9;TM(=`F=?D_F?WR-UX:A<<1XJ? M3CXG!9'O\I)NCX5#E9Q?>2UZ$KMJDZ*;W@LUO4+Y<>1F0VXVU@;;'9;JSRSW MU!+F0L*\(Z]#Y1U-%624?'VR@PX1;S4D-"0TWJYI?@-&N6$Y\IY+FBKE#?9, M*;?DPY'-=:%JQ%*8I#!M"%-/X,NT1H6I<$3PWD#<,`IXK3X23VAU']5'2@_U M#=Z[L5SJ?+%4TYF8TT\\"-1\CIHXT=!?#J*4N%(6;,LB75E$+[L1]<-@G;78 M6YL^J_:4A_TFQ_&J.\M784CM6N`:,I,]NA;'@\?%/R9<3-7-E[=[N=SP]5>1 M2]-,@6QD?B>Y"F]J.,,/M>^RF+C/>Z,5GX4C&+0!4K'_C\*DC M;E?>M-9WT]HDEFJ*?WU+%[NU.5L5TW7[W*XV?7QJ2"W1#']R3V/#W#CJP\P4 MOP);G=*XH2\/7@1*AB;P00MK<=SJ#-OBGJQ(SP$)Y(Q)*L>M8;<<>^BDG0-J M6)$^>I3,;&M!Z&)I6"M:ZY(D;Y[KS`RKE)J07A"N2\2)C#BQK)73=Z%(UO$3 MO+%030TO+VPRM;PG=^89:U<0;WP?TJ`(9J5#1'M(0D-"HR8UFGB^*8#]'"NE MK$XQ+_&BRNQY!W&A&NG=>U$HB"&4C]"F3*6S7JL[J"TJ)-ME0?U<< M?E/'W_U6NU.;NWDB.`79`DK!D8*3ZT"QW^H,:TNX6;'D%/8%S^VI'56(XJ6C M2%A8BGS4'?OU[= M/)+[J[O;^\?KF\]D7,*W]Y/'Z]N;A\T)C7U\LLD/27->S4CVU4QZ MC!S5R8M.7QVB@S'UY#FZ21V'5XS"5$<.AX"SQ@GTSQ%I26P7T(VV6]SQG;7U3'0L` MK3Z;%@Q9M/=XCFV3:\;ZP(-9_59SK%/0V%/_W"6#//F.F& MP?N8I3KQ`TE+RW3TL!@8*`&P.RW/)NHS,(N]_ZJ[<_+YZI?+S9%ML0,I"^@! M0J;4@9D#*6L1F%QOIFJN9_M_VG]2)KAL_N&#Y,%;?\%W2*'6$3ND:=3NJ38#Z*5E M+R]:>(<"S<-FB%5,`YJ8H,S7'N6X!&)!%FVF+-)-B:%3,L6%U*SCM+E.9\$$`6:F5-/9\>U"_1-X MJ3NITG[)WKSZ3C7/U5\HN9W-`%PV%MBS<&(`#G]X)L,H%WH`)F)1-4&B.8HI M6",>4UC!M,(3+&P(;^>>5*R^AZ7[0NIT4P.QB<_L9+K03=UQ\8$7U%2\1]1R MVIR5XF,6`&V1N0?-HHX"?:0AQ[C015%*+M7F)I@LSR"/-F5.L39PDI4RA$=M M:K`*@/3[$NL"PL[:@`6>?07@IRITEP1B)H`:J%Z'U3F0"UFXZ7?6U`A, MCZO"U/#<_VM+UM+608\`QGCIFR?50*ZM/X-(;U4Q$+6#AH@,*T-7=%0@F M5CY\L,5>PU571^BX^#T`C'7- M`L!09DH2J(0`GTUA+O()%0%V$6B"\BC/0N5F[S4%SC6B#87HV3C-X+YJ68<6 MSK-NGN,?L'%?;D9>GH\35MC#1#'O84(U@47**'SI5]\Z-E%)&XGZ MZV9(5WIEN5JU3PQC.JCOR8T2K5]")$UGCI/&:C&C1\/4]$A+X(T@G''W) M`R&KYGX8&5=A'V%8995PW8SH2L/3*0;@-;9F[3$TCB)JMLRV M>+?K!V[U]^^?-`LOLA+,>68U//*4@)*`*F-6KQ^)G-A3G-CPF$W.ZXG-J\GZ MQ&-DX:>VM(081VMZGW2""A+3]-IBAHAFOVRX]Z\O_80!H=N' MY\!PJ5U9U%.YT7*'T['WU/C4W$+W#K@I1]!!JSL6*[:\WM!5*052"EAUYD%M MWM!2"@JRXT@!_V09F6/]JAWON81ZXW2<&M0EKM\NKJ4A(XHA,VSU^D=HR-1P M#E!C.I/LYP"W&^[IY`P+.,RT.JUQ3I4E&(@Q:#N$7<'K50[8JR1(_#M@73[D%)0PXC[P[=6QU7*@)2!]1'7=]4E14"T M._6&8T&J'9Q8L2!O!]=2M8NBVFLMCE6>%+Q5]X*/=$9MFV)"C[`0KE\PH-F# M`7FJ*)+.J';$G59/D=>L`DC!=K#X2_4O!P'3WY6_9@V M>745;>-G?0)5;&NH`&W$UO52M*1^4F2%R510%]5X->(XK#TK$201)(O-ON6) ME,5E3V4>3[>8K+\]ZHXOQB,QG<19'U76!&Q?C'<=4U3F%K*GWV-W`ADE(THD MIZ=!J]-3RCSH*7U*JP*7!/7)@GK4+_7L4D):0KII2)=Z*RL!+0$M`2T!+0%= MIM=`JST^3DNZGOURC2[4W#NZ_-IY^86[')^),I`@L(=$*<)=<:Z$3JD^0:5/ M:(WKE83T:4#Z#&L[ENK(+_Z<2NTO1>44]BI2]TM`%]+]_:YP6Q6I^8^0K2`EH"NF`%V'&Y:?HEJB6JFT9U9]P:BW?I]H;OTRLN4";/ MV,25]*IS#?2[I293DC&24!+0$M`2T!+0$M` M2T"?(J"/UXX^S;OELBI9R:,O<26ZVO%U6J.NO'&3H#XI4/?*+;0F(2TAW32D MA=M*2$!+0!?ROA;.1U4B6B*Z6('7SO'?(M==_ND/SW'UV3[SB$(D7&B(4'IN2M2I#?>;NC>6&6N3S%?F%JH8[UU2;$I7[@\,+6+UH M-/@K>W(T^BO6-+)YLO(6?'"65'/U%VJL6NR)O_0N.@1&9.!M.+[9_ZO_@[+Q MR[@+OT!CZD[/_`L4] M75HVYI'[J#N:83F>31^!IQ\,2_OSY__]OPCYV_\Y/W^@0+7YW"+/U*0V!I,# M">ITH9NZXV(:NA=Z?LZ?CIIGKWSF+TS,Z63M\2ON)T`TF!KH[I[._OY.PW&T ME;;B6NQ3MZN\(YZI\U]_;;<[[\B4:OI"-9R_OSOOOOMYT.XI[78[/J@LO38P MKGXXKGZ&W%[BI1.5_G]P55=B@#"$``J+%:!L>[RCXT9=`;MOO-CRT+,/./ M;=#K"C`VIC4J&!L.K7F1RS*ZRE4*+(/G+K471#=?J.,B(<[V4."I1WCH.GHF M&8=[-+RB;"J#[8:KH"W+ZJ.TQSEH8U,/5H0'-HKJ@+WTT;-QCN_`:K.F+?)- M-;SM513?BKW$W^&OL!=V&089V-OI;B:=[",[!@$.'7.PA7F\YA M'88%F5SSI+RI(E%T_'N$)48>HVZ-.$Y;D@AM\;%2%DZG.A9B!+/K3M6G8,63 M2W6I8ZZBQM@6DH0479L^/8VSZIZZJF["KU>J;<+/3F,<"B@)"&F<-=G6UXJY MLF?EK94A61?EBEFR=[DN46=??:>VIL.N"W;3#ANUM40Q=DI1T]>.XR7TSGZ[ MY?T$!$P%5=MYAI"!JU5S:<_HNH-MG)0\PIP*MT:(E**`2^96=AU<(Z.*ZN22 M>72HM5.G]BE@_90FDQQ$_-4=#%$*GK`ETZH4)R/?`:8R3%CS=M&RN>8'VW+V M[_D3,PMP6F')8%7.6^2&NHC&3Y8]H[KKP=.%Y)5WR/[_`_86[ZQ:B=T^O^B, MVEE0MXOD$V#R!O#+9G(J0/.S.(5]9&+;JOG,:"9/JS4VWZDK]O7D5;5A)GRU MT2*!XG`(*%).0QD]6ZYW-FI5M@+M06O&?,G; MLBK876A?-A)7W33"^IPJI@#KQ57TE0-Z'RC'F4SW\ M7\()::$",SSFA'.'?I]X^N*ZMO[D,8]BXEKDQC)Q>+;%7`[A!9="LVXBE_SF M>>-ATW[+\88?K?5F@U8/UQ5(V?9$%G[`#CV8YD+,M;W.X]/Q4:T? MXBSMF>RO0DM[_[BLKB97E2K.ON6J4OX<'+JJ#$;'M6,41DM5?5,,&Y">7/#K MF:;2-O-'=6[5[(ZQE/#N^G>,(=,<;+>%F5@T"X9W!IK(87=M[S<9N#:*E+O" MA'N:M1N_-J(+`]='PVAH"0U736?"35Q)=#YP.A,CP]<:2`E$S!(`OHF-[79+ MIRO+!5P>NKZIMLX$.Q2L*]-EBN#2,AW+T*>HQN`OU;97*.Z3!282:I$)RS1\ M_D&WOJ>*>M!XT#9O.MYPT"QOE;>9LLE*;$RGSH?5I:$ZCC[3->;,<#OCW3") M3Z;@S@9NV:L/U*3PE@X?,^KCWKKSP&'C.RK><[4J`N]'W3)Y_VBAC6=`$[K! MAE(N-[]$#0L+Y]%P5(BCL3&*P%9QD%I02R3Q]5\4,QF")3QYH;;Z3,F-QS*S M63/?ZRB>,Z=%/JB.KO$<;KKAN=OAA4%[?G.\M=L9:RO6$FMG8D[]5O(%(B:$ M>?5[_?5#K,/H$)TM.X,UDM@RWDA+4)`M'SP']NZ.0R8:6*@.VS,ZY,ZV/EGV M0HVQ8>H/P+#@X24PCIERS*B;@L&JVK%OWY]_IN8K-0Q8KAS7]GCNGTOK@GQQ MIQ=;(OZB.M:/&P1^@6[NJ,V&<6U^Y#T$7^QUF`Q&%1L4DUZ?K!A5EQ:0E"2L MW0W;$EB>F\X3X_*&")?.Y0YLHMH7;:4(I\,BD`\J9JN\C$I!XN[*@Y],=XTC MP0OL^>CQZ.G#[/WQB*^8V?JHD_Q,VX+>N'L(^3AE#JK4.U"H\`-W;T9@_\J3 M$%PY+G3CPM!^NX,E35L1S.Y)6'K/;:0ZM[-X0X`%:`:6XZ`1WD28'W2O_7KQ<$$^3R9W[]XSMB\]V_%4$#?78J_&NN)Z/W]!+JF-A^]`\`Q7 MDA`%47\.,?$7')[.3I^BX7FFZDUQA%&ZY#P\W\7ID#VQF8G:ML#L6N@NMASG MF^-I\V3V7,#"B1T`.S&Q,1#/<]IFIM696YXQ!3J@5951#.^8F)X8&,8H9I/& MV9&A/4X?/W$V+40'GMY2&,0FDR\YH/\OK/VFZ4$K/,,Q@7YQ\0>Q.O\GR^F, M#Z^H:OMYH1,R*JL.$&/`;R'!@`)LR$_(W.8)F2_((^-/P>GU!Q)'\`-.$O6`M=1-9#>^#GE!YN'?G^&KNL-D#_KC\,<Z5=H3<>=F;[`[-:>`9T%,^=/,^-]^",\;X&YYHLX:]5![AJ"9F>@D^U#HV!9,4E5^$-F3?0OT3&!C:("R]MN-X"YZQ M`CBF`IQF,T25R^811158K2Y"^/.R:>S5V-D%RJ8O&XC8X',Q$>3R$5LZH%44 M+``QCB>%$E_OY)$D;&)+%)E::X6_)?'"SSL/3_EUUGE3FNK,RCR#':0RHH"^JX3%:=1A@.N5L"8?_?[:0=4]HZ>W(GW^HL1S=[8%4 MLK,N3&L362WL<3V#H1Y[/WH]>/OM6NA[V'HTZO@&U`#Y$*#\AMLZUMJU`_D4 M*I6'F/+:M(0*VS]^@R`Q8"HN\,`U(,N),3MNY`<8]IR(C(VU):>NW">)>:0A M%$'85K`Q8U)K=B#)-O_`J+CQ,7FV*:-A3?K\5_'-VQE[;_VU\*W]HG?7_[<_ MB,R-AB.XAIT2,NJ`$?BO'C""3GO@CP`^==LP@FXP@LR-AB/PCX-O9^1?OZ'CUX#V!?:B#618E*F`]!`>M_&GV M$GUG6R\ZVQ6B!$TM[\D%BV^]A(L6;1UCEN_:6,)F0"(_^HWXZ'5@'8DVGY.8 MF9WK)'O;0S4Z7CJD=R$YD"_7XOFH)!;PPUINV6CQM`+,L(ARV:V/.#F\'TNY MQ-XH)[=4]OX:&5/.%)G];J%!.6RSI_.<%(A9NE@:UHK"1EO]'AKRJSSNAA$I M#JS//)T#`.G*;_A1_1[<$ZX:3/VSB86]M![(M\-\`6OD87DI4BIGYG[_X_KX M=FB6K\J9M--'OC[^')`&IG+6E,^$RI0,B*6-H[F*GV1P!1+SLFB1RX1+./_= MX%70_^S%V'N7!2[CNET_:"%?7PV/+,ML]0=^BIT#1Q;91;C78&=1F+9I;02Q M9_Q',+%3,;MF$&0,2^^A`AISUB+L^+4(,]'HN+CS2:!U@T['O9UMMU743.QW MNG%2DSNICMJ9M'@Q6B M#)/X_.CT^.1H@.*03'#\3VX MNOQZ\3#%$2=E@_N'._Y/-#@[/CL^.3X9C,EB3?'++!F2E_ M?!9_/`<,#;C2,?O\QO#YT2Q)%I]'H]?7U^/7LV-"7T8?3DY.1__^]?8QG*%Y M,,0Q2WAIZ&C`Z3^S],=;$@9):G&!_>V91E+`V6A;EI9"_&\HR8;BI^'IA^'9 MZ?$;FQQE*HK/@$(D^5N-/K.)._'3*/VZ)>6"L$'TUFSNO<%@XS]*(O2`I@/Q M]V\/-UON5<#('$UP&$3'(9F/Q/?111C2)9I!4(JW=3%"BXL>)C$D\$ZB?\'XQ$>"(2ZF/"_YQS M![&[Z3A@L^N(O++?XF`YP?QK$S,:%=.=47<+T7+PG"O\.B;S!44SSH!7Z):P MCBT%E]VN^5^"2&3@QQGBR:-]"W7BBT9P)<-EE-I^R_]?*AJ])8B+W2HD#&G/ MRE0)J49$PE+1D6A_"2V;G96<-F/3@#VG;1GO@KP$P8*W::??CU"4,/F+<-#W MPY/3K,']+OOY]TVJEI*CX!E%YT?E'Q.<"$OECZ.^5)5YNZ)L]>=,W?SGLL*% M$%_0LNX!#:40_L]2?.L=AHQBQ'@?+94VY'&<2_XI)?.:'XE6V8)2GP<;KD%" M!CDUH1-$SX_.1(?S%8DN7];[["T:A8;^&XG#):4\>51"8Z3)3-?0^!0TB!F: M"&I8LW!^[T\X-SJ.E6%4?BMEA;$Z;'O4_YZB18!E#UGV14Q6.7!DMH(X^@9N M5772Q%(%FC-"`6J0O`SB'_V!^..,T.0)T;GH6K,D[>Q4,&$BR5RC)O$PZ@!; MS&%6"\CB^L&?N%ZB*>)*\UX6T]5U$TGF"S6)AW$%V&*.JUI`%M>?_(FK'%CF M`\H'%(DN]'U`Q91'M94"DLN&RTKN8>P=;33CP"[,OVZ*&(2+02G_Z^J_2ZYU M)++213(.*%WC^.6?0;1$%6`X\62>`_)X")$FUIIQ`I28@>74'["89Z8T?5T7 MGDHJL?!X")8FUL*2BD6B?^-9.=^ZYFI6,*'ZE#FC_,G#"!MT-P>RS)C%ZP=+ MO/H=ISN.:%*X*@4+!!-UO=1$"<\H8K6=R&&8?7(0TBWLQ@F4I^B[F"4)N9F"?X-90L+ MNES;QX2$?\Q(Q+5D0O-D78DZE#QSDIWRJ$OD*"Y!1``3HY`"[MSUE$'NFL&<$[T-L-\>QAE>#^\F? MX#X&4=H$7[V%F*&GX,T8:""U7)^P4?L*`#E/F)ZZLM4<$HJWD M>PVMKY!P,=$A^VO$^;L"8DP/9J+*%.5[208@HP`AU\EI1[V1Z3`@0$7[-S>=*9\V:&,RGV,FSA\8X6.F+4-&1^LY3$`F MPJ&A$P><)>K)/>9Y'P*8.-%Y2"E9^,M09SR:.*_K?A.'T5*\5:&RQ]Z2T/[2TV2"A9I!=!_@R4T\ M#A8X":K[="U4,B7IJ/JK;2T'G4!=4:J8[2B1ICM=X5ZV>\OY,IVH2UOKTED$ M;C^9IR<2OJ'D;LH[]?66L`EWWC:Z<1\40'=R75?`=57*OUF]!W$:*N;=T(#& MXAQHP20^.,4AKC8X<(;,]Q"&0T*JLX,Z`B=$#Q]7F+,ID=01JLUS!HI\5WR= MXI`@9G=!1YA2%NQ?3_N)HH`MZ5J+(3U!YC\5P2$AR.J`C@"D*E5,O M'W236`L?W6>Y5;?V^9"@8S&^(^#42WWGLR"=#-R=9T[:TL*_D5K!>NUI4"-- M?1>/_C3HOD^Y0HRS$Q;/NX+,[*DN*30G#O;I*D7.L#T7JQ'GW[:\RK81+0BL M=.KM-^\$`E#K8`@P2`-V<7UM:W:I)9!)=[_K2KJ"LCDLFMX>DMY7A>*P?F`/ M0%GHXFDIWP=1U6NW_/_[O1&ER=4S/:*[.N>HF7T&4.;H MUE/VMP$1)?F<:G7KH>J;W'18_M;C>2ZA!/=AMN3_!<5H6IM?M5!M3WEIJ/K+ M/>H0$*A%I213DK4Y^Z61H6IN>IX\R#6_YH[99+\E3X!Y)OF"IH2BK4V(7;TE M-."FX#B@ZQON6@9:_-U#226\=512?V.IC?9"%TU>,5#(T9.*HK\;J2@O_YZ2 M>EY1?)'W4A6_]+L#67:]:Z?)-%^+.XR+7[VP0MR5I3@2:2)1V).3]#B)J/$^ M`5E3GA$LB]KNBJZ)V,-^R'QKE1YX1IKB8*!.XV6\(/;8`J:1X=\<8%'W1T17 M.$26"JF@4M3)$I6788;9Y%(S2U(\G'M7M6_$UG"4'%"04#6^]8S4UMB/\5%9 MFC/%6#R+T",?CM>RF(UPF\KTA#V;*951FE;]6#(G_]@?/`$1(!9C2F#5R]MD MZ+(<'R?EMOJ;\6H&J0J9OH959XYS7`N"]M)+$F76VWQER/1DI=BIR-Y'$*T& M.D=3)1'8E?*@?06W+*:FUB0$.L&S3U^89@6(::A= M7-+-F%2_5^=+\N_]C0]0.A.U>11%O+YP,9GC&+-$:+A"F8;5X8(3DQP]`)D\ MP'0M;J2AS6JP2_%I%QLHUK^>]P-BB'M5W$)XR9-V1-([?-2``=%N-TL;:3V% MAXN%=E18I'DX]K2T![:4"&D5%#)4M:+OEG$?*Q($,BU?\FF'6I5B4]3&OYS% M#2!E3=7YRDJWO6\YG''+]E=#.'ZB08Q"\(T3/$D_5\6M,E_EIL7*C2[ ML;HMI+BUNX-"O,?J7KSK`OJN%++D=]]V4RJ>+/3KX89[1#&9\-B(@VKH$FW^ MKLYU-V`U/N.@8^USKZ50\9Z2%>8(^++^C8E+JC?O[O#V[(+#<[6Y<$71/%8' M%*T(RW=S[B2LOY/-P3JM!$_D(N21ITA[%73%?>Z,\ART`V.OW<$VT$%V<%2U M.[B#/NDI:0<]/-R_6E,?\$R9$X\.GKX]9-8A,EV?0NL`E,;'U*R3BOM]="!$ M:)(.QL2FG+LI!)!.3/E#!""F@X!D$P>UC4F@#AXNAS?J`I*6^T+E`8B#1MDP M?"=-_%N:UEATC>,@#EOJM#H*,W=:P<)Z[PO<32_1`T1VY@HU+NC<]B5BI:CHC./)CSK*F1Y-J=45E[>DC7G/XP6`0PV]%H0U^L-$H-DMG<.O5KS, M@S]XG0?3'L/5?!&1-9*C*.>.HIW?W%LT\1\F6-WBE7V0(4 M'X)[HL&DOE'=AOOBK:A242B[&5MZB55\LV M8]:W^T;FPP2K@\.Z[Q$8=9'@]6E?B+[BR=,J#RA$>"7J(&B\9..U)E@E[V%" M%^ZNO:5;I2H2N"=>`U=N$)0FI&=*LN;#BEP(LQ:Z9N;#Q*Z#PSH'KUD7V9'U MZ$ZU3F[A?9_(`A^(VATXWI^9LL[N7S"&:@N,CES051S)=0@@:^:B?:_=2"4D M,'_RNKFMO/0`GL-4W_@$H#],()K=LK2'A5Y3,Q&8R MW=9U)Q[E_=Q:G@/!H;-[VLP7)+BS;5]@@+(>` MU`;.:1F9,`T\O#ZGY3,3S;;B=W%F`JR)?[,?5],I"I.[Z=5;.!/;;A^"!-W% M:K]4TD03UBP(;JSO#[$[N&8G?+J5Z]=[=H;%$%[M+E$2X(CU=N>*63OU.K,3 M3Q9^($]O^4+JE^ME-=]$6K%:3=I?_7>+('&RN531006)&FXNP+_V)5N M-#LR+%2RDZFC>D<`@5G:#!M:V?X=>+^((O(JCO@J1E>Y?9J\TH17)AHWWG<$ MK%V\TC`5N96HN@ICV%]WHW"6PH/NA=1F77_D2_5I.UE9_-3CS&RFQK\(_2/= M&!`BQM*;_L2-Z'2EV,0$YJB::N+H\PI?19!($T,KM^_F8C!/$+%GV1OEML4<$2=(M78@)0 M:K59LZJWX3#B+(8VXMYJJ4&Q].DGN-$EVY0TE9D MHW+?#4A!E7PW8@7Z1IKB3?EUFO;V1LC=:NFSPOFZMU9I,/UV[=A*W^,#6<8( M$'=KRT]FJ:1OUGBM4OV;ZU7.36MA`J0VK1"\$XBX60H#B%6F?X.\@BWZ-*=/ M;EZ'6&\!+)PE?K]>QLCN^Y"O]\FA6.'8>O.65-/BV(O4KCBZ\>7)!66##M]KZLACH$E[AZHKH+`2DRW7=A+\F]2MGZ/C[%202O1`0`' M:G%SP!A*\&\`#\N]L$P+S*O>0P1F;7.`:.4WG9_-/H@_G@.&^"__`U!+`P04 M````"`!K@*Y&W!Z[_A49``"$>@$`%0`<`'9A`L``00E#@``!#D!``#M75MSV[B2?M^J_0]:G]>U M'<>3W9W49$_YEAQO*;'+SLSNVRF:A&R>4(0.2-K6_/H%*%+B!9<&"`I@DA=? MI$9?T!^`9J,!_O;7UV4R>T8DBW'ZX>#DZ,W!#*4ACN+T\<-!D1T&61C'!W_] M[W_]E]_^[?#P$TH1"7(4S1[6LZO+3V=WBSBAI-GL]NZ&_HEFIT>G1V^.WLPN M\&I-XL>G?';RZZ_O9H>SMV].WLWNB^4RSFPL269EJVQ&4(;(,XJ.#@^9<"KEVWOVXR'(T(PJG6;O7[/XP\%3GJ_>'Q^_ MO+P8?)X_/;-FY/C__L\OP^?T#(XC-,LI]+0P8S2O\_*#^2U`Q.C[>RA!3LO\.:[)!]='CR]O#TY.@UBPXJ%=G7`"$U^6N/OK*)=N*O MQ^6W6U+**):P;IA=TN`$W:'%C/W^_>YZV^XY MR/`217$8)$H4^ M'&3Q;[OL+A.NQJ*1`:$`:K* MN!FK>(<2-LQ6`5RC-$,/23?Z$R#P.'NC$E0\#J09S8P-*CF=9AO(AFO*X&*OT">/H M)4Z2VM[KE$XTC_%#,J@S(5R-5;Y.*9YR3*A+OJ!\@)8"1D/PB8O-)%=:?8=" M%#\'S.IAB@(9&RO^,8C)'T%2H,\HR`J"RJEZ@+YR?L9JSG&6W2+"EA.F2FWJ$5)FR-VZQV(?V(E$M)UOKO+LZ^#3!@@+#Q#!S3'@NQ M0I#%V-,BKZ%B?QP)C'6)3YXD(>@S3^LQ9UFP3I MS>)FA89[!LK99@SWM9S=+(5P-3-;09&Y<@)&(X9$YKK">=L(B,SUY#`9(QPR M5Q#`U%(P9*XCG\](H=`@3`+XV@V$S+65LK,8!IEK*.8U7HQ@KBV8]=XBA`'+ ME*&DO9E6_]Z'<3M9`Y(L#`?)^CK+Z*+5$$%P2O\,-X//+-<"XVRLNB0_9CG= M9C=&LQ2=C9!9LYE2LQ``X6NAG M/^BS'>Y9"_2LAGAV@KLQP[I1`KH]QCO[B'/&2^^,D-<9%-&D$5L/F#>&;N$%(.U^6*H"?:('Y&;,(9UV2P;+OFGP<)VWZ_?T(TEMA*N:4S M:DH7I'*P6S,7)&L?YHULT9"X&H<%`P3%P!6=7_/U=;K`9&G\4"+GUU0S(&&M M:?5G4]EM+4:E>J6W"QH1?]F8P>GAQ%: M!$4"",[`.G)XV]48+X,8X&P3A2O6-O0M61TNT?(!$9O*MOE:T/2)*D7"X@$= M;CO"HKY<[DVM*4CB-&;C;4[_;0E&KSFBD\IV.F+J#ID>1A-K//>YTD*RIHRO MTN!5?;\JRF*M4JE:K02'+5T25IV("7?@E(-F$60/Y<@ILL/'(%C1$73RRS%* M\JS^A"U6OQR^.:G*$?]2??SWK7ZT`]`U_7/[%)`$#RCY<"`FH*."=0F/X-B5 M.==I2.CC,[I$F]_7:;_3[W"2?,3D)2!1QU;#UE5':+=N]](.BV>DW5]T?JU% M55.MX:JQ('@I]2@>V@<[(][/^G)F.9YI\\>$?E%5(CO#55]':D=21.5S.2F= MEN(V*!8`Q+M M!@!,U`TF!PJNI<-04;.L8/'./2PV)0<]Y):*G@?EX\J2;;RV,E]-F!@Q:,)& MDX&_,!K2$T!8:8JH8/8?/L)L,Q2&X`S"00XT.8T_#;'6 M3YFS3ZIP]`O.-^K0Q[ZKY2K!:X2^!J]U"OB(1QAKKI'>/VD,6,W]Y/+`WLAX%+&5]"A;!? M?418-2^:0PS``+2.31]D\)X8NHI)87;RQBG.RA*TUB;%=1KB9;E50>=@%#^F M%P4A*`V;9:1G:53^EVRJ;:)_%%E9HOL%Y3<+.E]WL#BND,I+8PGQ$M-[Z5$U M[L=2HQX;;E/M5)^=.1U(<[^K^JWSG9<`DNFO]GNG=>TNQ^GD6M7R<(EH\[#U M97?CL/IR3(\UBF=@BY=$;\C"U&Y>>ZI,&^Z_O_7*X>WZ0QL>[QDXW.>,I1?;P-6)#O:4]+D5QU0>%WY?=07G>T_/!VOB+# MU'38I`!GWB_M^.VXTU5S^J^S,G/5@46KVFB=_[0J>=BY6:NJ:!Y!MBI;=4#; MJC#`&76K\G1.[5L5++O)P*H@\%4.=D>MZ%8+V][3NM?#[@$NV:4G5B7!+GVQ M._>I;L"QO.(`+P.RW*WZ5R8Y76#VL-#8N/!KORO?Z!K`;I\;?Q4<7:K^M84C MKHBCB].\[W*LU7$?7C6X('7,E7)T><#+=??YF,*]?MCIS%UKY"H_\4=`8N:4 M^O#:YA#\7'!(&$A=/9`KJ=UMBM!'9^86^HME"IZ#I`QZ\HN`D#7U#N]TE5:; M>O,$UL91)@;J36QF?#,?HQ!5;KS`1'BQ&<,WIYFHJ;4^6[(!W[Z74#J8H$RD M8TS-Q'_(6>D>30R:RO1B/TE7>\*HN*-&!FI+L!<[ M7_=T?L^J4+1QUV==:L;_MBXNZW[K/U+D!FEZO\?,BZVN:1?T:O@26MT+\"2_ MU-?Q:>+P"45%@FX67`/J1]7NB-5K58]D:*N]%@WKC&LCLW7'.U1(\YCP-.J/ M10:=KR^2(,OB1;QY8>?-8M,OG++D(2QD88J2A=LB9DW@B:(5O8YJ%4;"-!"& M*TK)7CSJ=17D#U=N,:U)TSIQH-747:7U($CA05VDG$,5:I0Y!RWQ/Q(>>R71 M7B*25PJ^3TA*"\?W`4IORLSY2MZ2>!F0]3E*:;^$,?V36^QFUEB:8A`W=O1\ M8333"5,,P+YIPE%'`7&*02RX/SONM5P._$I09\=ORO[[WSA"U9/[Y^`?F%P4 M64Z-(;V'B_I`CEZK^H`.M)7#8RF=%\[>TG"7[9@]HI/NL@4@W1Y6D9&Z*GC5 M="'6,KE5]0J3M#GF(I/@1:2S>[[HV76^;EE&E]3MN*_F`46.8C#'7OYB`,>] MYC8,T&B_VPQ!:T619K@TC1Q)VS).!D1,4/4WC\"3[,5P2&%`!_#S%L:R&1AY M,KV8-[\$2VI;2SWNXZ"2KL[/B^G<)1XD'L=PTYJPZ',L$_1B3M^'LWN/L.[= MS7NJ-_2W]`%=T^,6GK4%=R-^0G]#09(_A0'AGP83$U1F\0@IV:TLFD(,'RM=]IY.4(.PTM\Q\`4MO'C" M)ERD088-P'B3Y>\4'G%C%2D-OX#+=6H>.AWTZ[C467<%;TXYEU=13#>MWG@] MGBAEK=.DQ@.HB<-;.DK?=`WM?IS7-W'4'[NZFU+'`5AH1RN*`K#.,[-7LS(G3VD-/6"SZ>9B/B:2!K>)R8X,Y+:?&75-/;TMQ>Y MU;P=&N;T;3#'%"ER7Z$/A%_L2EI-L.<2&=QQZ'6@?U MN81??X3[=8:W5TWE^E!O3Z&YH"A*32BJFIQ[4`#U6R?8]Z&%[7FQ%/U- M>=?3]P]SQAL&#<-CW7)$@$YR.W\T:ZO(VX*5$XF<[V(CU=#9JAU233>WMSXG M],KI'_I@E`(5P\XZ\9EK'5_R;,7X>7SIY_&EG\>7?AY?LOL8LPN:1>_>E))U M'E;Z9+X$H9)S3$`;=8\RB=EZ.F>LOU*9L*BC2RD..':4TXLU!%8:AQD[?EY, M`7W=J438@M&G%#Z4-"B]"BEZSN4^IXCL5*P+-7/^TTJ#J9]3@0D0U$&#`R@` MXP5-+.A&"4`T>!,;7!`4Q7E/4_Y^`X2V1H2T+I'31P&2*Y&O85)0RSY2OU%E5\6F-/UF<160-$X?F1&E M^G/!?K]MMG7.R1I;=TFX829LWF=GM[?;/.UT=H6@[S/>ZS3_&$!JUM\<:2[:5GMX-[`/M/E_S M&7"R"GN09&=]DTORY#2-U4$V?`74\`[_M(X->RRLCG([O%@S^0JRQR5N#@!* M+AT[37)WZ9]]8%0X%(0]9G%MDFDH!G=3L^\1H;UTCC<8Y>6L/`&I-`?F&*;> M[(Q=+5<)7B-TG^/PV\V*6ECFS&48;J4:23O^Y>%Z,5\O MIJLJ9<>T$YS!$GR_W1GO?3\!;ZNLTO4RAY_C,U61O,X>(B3LDQYD<2;*S(["NX*# M9=[N!GN0/;'#=_07N_3C.4@8*K;67<89>VBGQG0G`=UV]>0`;^=HTA@'-=B\ MRYHSCU7ERFD*KI07BY.-#N`E1ZWSM3A/N$B)CC8*QNKH44>)1:6GEQ+=&G^^ MWO[YMQ@1BIVG]1P]HX23W=1KU!TLBD9.BK.#GB#E%(R44S!23K\GI/#-MHZ4TPY23AWE MD>47$]4)Y5HS^_*OTV?:?9C$>Y+W">/H)4Z2VM[K-`_2QYC9ZSQ[SJQ$\_@9 M13NM-D^`PJ2X1I-Z`(.:N)NSQ.I1?)P]9#D)PFX=L5XC=4>T&KF:U'1X8613*/%[T]!HTFRAFGV60BP#&PW^YLTQ3CQ2E5B4F?2/\5ME!R]7)5 MD4\>.%R[+2]1E0@OWGXI49.&Y<6R2((<1#-NP=15,WW&]-A2:`C'O` M!$PZPJ;W$DZ)3>?KS:'Z),AXQ[0,6JJGL7Y+3XY1@8$FG]\4/<,_\J22K9CR M^C*]2"=(--[I*SP+8MA:C4!^:X=%"@9@DF,0T#_`>;*K@`*(?,$_'AC[90N> MPI%;N+`7/,KK%T9%Y'@7^=S2!Y;-]M#N38/<+40U8=4K,D+_'@:D$P_6,!L( M!IX\!@B9'"]FHTI!&39D<)@\`D9TNE=%!?5]5?,X$WA;0E&?&^%13,_S:D,' M^I\KP(M<]^8(+2+W>)&_!`1U+!(=-82WV1T_A+29('8,.F,HFF`B^ZGQO1:D ME%49&T/&KP8Y"T-2H.CJ=47#1[0M@FE4VX^OPR5:($)0=(>>45HXOUBOH\X9 M(10D9>JGE]:JQK5&BPK(H!;NKA#&SZ4NUVE'SSN<)!\QH6,GZG2!3I/ZFF%0 M$T<3FXY+L9'YS;D,(*V\GA@DQ8M@N*,@_TV+9.>'H2DF`.\7P\D30ZYWEOWO'J,[2C*W5;6:0*"D?MJ!@U0 M*"&DK%Q0"U,CR*LJA9$PU-ML]PI%O"($^S"2%AS8`])XQ0575;+\'I'G.$07 M."W/CO&W%6'$]66E"F+OPF;^B_RT;(9[OW%]J4+`P"E$X/?KM)+'RAD(525. M'[D^5Q-6MLL()^)KL*TF?I8Q'V=LU_)V&O&'M9*N+@07TTW$P5!+3?PKX3TP M#RIP+[L1-\[8:E>I)J@%49`U;AGFDTW$MT`[35PK9NUXI_X.E:>95@')UW1. M23.Z<+#,G.L=[$JOVXY>O21#!5$H>>5"-;FS4'N.'H/D(T)="WN?5Z8T/G4BA\;3PT^?CP@%8B]E*"A>HPRP8XQ@+1^')*23L#=&K;J(D#. MVHL]Y.N43K.(O7:3:Y,Z.#,1I_HXLY09C,^G,:> M!+5C8>#Y7B;>H>]Y>P^VG"_=<1CJ_O'V&2YC@D)*?!D\ MQ]$\1C307`;\MZ%!2.M'+"FI!R%S/TVE89W(L[O$E)R9%T-YMUSQ@_7^IPBQ M0S.<",,&JUY(;,)JVE&(Q6ZT$I<,T\>+7(%(1>[:!2.N=U$5Q.ZB&2LPPIK= MP0>9'%*XBU2F\ME M>)9&E^S=[2ABHFX1N7\J;S:YQ$D2D.T'7808-*U!HM74=YR8]X,65+3$>'&Z M=_?\Q-4\[]B=!_)0=F%Z"F@Z]NY2P"@`"C,CL M5D/0'AY71L(D69MAV!DO-WO3RA]04ERG69T<2M+%"_P M/(^X:580;66Y@M:?V%N2I'MX0PERN8.TZZEL=*-A6K-#1G!__B]!&E M8??.PTHI]N,AR!#]Y/\!4$L#!!0````(`&N`KD;BH>QU?FT``-P)!@`5`!P` M=F%S;RTR,#$U,#,S,5]L86(N>&UL550)``.)_U15B?]4575X"P`!!"4.```$ M.0$``.V]:W/C.)8V^'TC]C_@K7O7P`DQ1LN!R0@PJ[ZT%U.\5P@G>T.CP^ABGZ$$9!M`F#';J.PRBE!L[0?'[Y`YKL=HAK)2C&"8Z? M\/:'MV^9<^KEUS^S_[L-$HQHHZ/DS]^2\#^^>TC3_9]__/'KUZ\_?'W_`XGO M?SQ_]V[TXW]_FJ\V#_@Q>!M&24J]X>\0E?]SPC^F'KIU4U>6'S5Z8I`I_@5ZZXZ=_H:QR'9#N-MNX;WG1EJ_&K M-(A/`)6VL_Y?P'VK!4W=L8_F]*^:7_PMQ=$6;PO/S+8B=W+7/-ERRT?;9%.S MNF.]"(F%7X<;3/#FAWOR].,6A]3PZ(_LC[?LC[?O1GE'\;_I1_\S>:2MH_]+ M/^R"^\(<_R;_\9WP61JF[`LTGOU8;RW3K[67=JGD$&]PPT.K!?^SN]T9_5*U M0&=-DQE]W%&WK+;`T=O/J^]0N)7)CH\?(?;9O_]8MKG]/2=Q/31!O"D:1/_4 M?(E"OR.;`F';LJ@5H5\KDWUDBTP/G0HNV0*XR M+D.X7&=(]L#YDK+MN`.<2*#O5YWG(D@)O/V5R:$"BF4B0W+ M`UB@B6$\ZKQ0JA7\`-@^*4]^(;M#1($]B-GU*!^[I M00QJM6@-VS+1WA`7&[:+=*4/->`5J@7NBZ+^*(,R(1_PKXDP,8N$B`UBK3HI M5)9/R@U.RDM:C=V3^%E(":%$C0D-B=X$J-FSBWN1:37EZP@663IM64([@#C8S:(M_O:?6)Q\)3+U M0J0IT[\"J5NT7'H(C6MJ#H'.L=C(GB'^$-&G/D!9%C<"_)F%=45=O%%0B&R= M%L[D\9%$JY1L?ET]!!1CRT/*%M79Y@@QM@$*=:`K%?JC7F'>,@7TGC1\T!DX MDH,+(BYYAC)95!'V@BL0')`ND1*R2*';H)36RXFGXLL%@0_TD^8`5B/5F(YO M25F8D&_8M#TE+S:OFY07:973\M5E)_["_#Y),VD*(7++99*00[HE3?6!NX!7L1(1FH/+Z8K&8KM/R`KF^FJ^EB/5G/ ME@LT65RARYO9>G8YF:/)Y>7R\V(]6WQ$U\OY['(V7:$OA97_;^"=77H4$--X M-?9]2748>Z"6A^93),$.TS22_8I4=#FV.@B`F9)M44 M\$WCY03@&UG.\EIG?7$W^FY?IU=H^M_7T\6*5G.LW%NN?Y[>H/ELAC0]],FWO,GW`<:7R7^`TWWLEZ8%!.HW^5J-C M*7\HO3B8``$YA&0&O9TR#3#Z$R9,1V9'Z3,4X=0/IL/@(>`U.'IB$BO5190% M^#L5+HUZ,8,9`Y!C*P`=@1"*R!U]BH+=CGQEAPF@.Q*C+3G''0JJ!C;D M\3%,V#$2*-C^[9"D;#HX80;^Z8]G[_]YA((4?:*P?$#O1V?9:1!,C3[\T[_P MAU?4]^,M;43^_(^OG1Z:3LX^/]H=F#."G!N-@MHG.'2DQ[DM>IS_GL"K43P5 M0L]/A]#W3L;I(+=6$/I>A]#7#L[WIP;G>P_J_[)QVK)?)2I=?'%0Y(N,.YLG M4S@SF_9NEO/K.-AB_^BE#+)R:MND5!=IJ6>T'17F,@<.UU"ZU=]R??':"94Z M*UXR>UW(`B^8=(.6#Y,RM;8MZ$\+S\MM:55JKDJ[8%1IW\7DB]J5,:L:%MH9 M&KU%T5'&0U()8J_CE3A``&:5BEIR-7T,3J]\JE9=[8B%Q*N(MBN%2]NTJX6P#L6*2+.UC.59>=(' M)[#5)2.@^%6&?.(3J=KZHRXF+3P*,>L51V;8;:E1\V%68U14ZU,M?)J@4KXG MZ$LFZ\G:K33"RO*B'0U=79%IJ`N*JM4A&<*6>%3V]6?^5[_B>_M?GV?6GZ6)]QO8"%5[0MN)F M\'1B%]K$+:Q:R!;1\06>DX0MX"_O MUL$W><8ST6XG-IBVO?P%\>EN,I]J8*M&\6Q^M::`,@U_ M)EH-X6/&@2[ZR#95%]V MBNU:Y:+2A9)Y"LUQ^1#MZ=.W880VV?.!*:6))S'Z\1MT$2O4R*&RZ1L5Q%T: M1%9-"UM=E\KZ"2@"[Z*T^E6Z7.=T*=#C25<$"KN>/=HN1Z4&8)(G7RL%V3RR!YH,/>IW"+MQ?/GQ-,O\1RSZZ]#:/[R28-G_B4H.Q0 M*8TWRFZN<-8^=8IQY'9V^6M[.VJ7?:5U]F^$2=/&BZ0<27^6OF;;WE$B6 M!+OH%BG53+=OKC3Q9C4)=G"LS&[&]K1O579_U7C@%-8)?<0"*!I)Q\1,+9N8 M^S\U#6`;4U274/>D@W:_BKG!\>1WP)N&?RC$#[HQIK(HM[R;12G%8,@.L$D2 MG+;.X`0)%WV?1K@ORY7FK?9N$$]*^NH-C*LRQ=Z9H:\F!P6;=`E)@VE*O1JU M`!Z&HU*4AMMP=Z"U+U[AS2'F%?#TVV9WH$7R!_JCLJGQ0YJW?AK$$:V5DVL< M\TLS+I[%!B;?PA8/W7LJ2.S24]\,X*YM5M.'\V8JWS-I)R!6SPV;?8T,\2K7- M-CG,JW57TB1:V,M.8*]89.>?%3;9%379A67H"[.+N.&7G7K;\+>79X70LYI4 MCQXL9M!&JSU+E^QBT"OR&(01*`VVQ97IK2KN)&V5#MRGHY8O\S33,"%+'V?\ MOEKT)1/U,B$(@*`ENCA8$`*7FGIB-KUX1CAPWJ!#YD-[3<.F33N526%SV+(D M:X5'-4FM00X+DHJ?>CI)RFH$UZJ13;T:X0KLO:^B*MG3JB3A53*3/&:G6J+ M`O[)P'22SP3K9GS;,[OR&=SN<3)ZXUQ_6G#-+BQDQ<2+]EBF")@@RY? M\5;D:VFRK7,JF5J*:,E806+#JOT$(G:@!ZA(;WSY^>9FNEBCR6HU70]]U8XR MT>W"$V;Q99M;LFZ(V_N>NT09V5'"PNT-QVOJL-5=;1V.UC33`0L M^`RV+;;D\^)ODV\2\J=H5^V?DOVFBCY4VG=:S$=.3I(2638*\3$9^7(NE'%X ME8D($M\AT]!%D(3)\NZ:(HBV)LA/FEB%]U%X%V[8V1+9QKO*]=>RBT5MF,I_ MPGZF>K*ECW,'Q9R%YJ@(V=M\QWOFAV6Y%:P2^YBIIY`^5JL9IW_K!J:4M?[* M1D-$!1MF-5)%MRV3ZIL^Q'9M3@2J72@IK]`<%P]1Y:D7.SMU`25&OWZ# M5F*%&F-4-GWBPG5,/I#X,9A%=^P_O*'B&<1NRG+F*)7M$TKASC'/])X-Z:')I0--.2,:FO8)U;3AV-^2=P9TDQH99S_PSM.20.OII8J,EJ&-94U1!/[ M\HEO_,\8BU\R`7$_^B)R93@.U;0A[M#-42'KRJ@D<#III M(FG$]!-&-57=U)'`CT_<.V:'VAE@!CV>4`_0[S7T'/9^-4\N5D$-?7?M$-NV MQHO\W#[O.*F!![!WE$8.WD?63$![2H'?4^+3WI*BJ5=KT!S)NA.J@;@*N[Z^ M.*']#5,;^/VATX%8MN+G',4^K.5=DL?;,.*S*++]SA#11@ MP@^$EU+U\<7GU6PQ7:W0Y?+3Q6R1;8+Q;?E`&6T!U711$9-+I"7BD]RZ3PRZ M"I,-[?X/,=;-]L.4Y*P2*MGGE\"-\XS@D6UHTQCA(\!7._MM@2A?5_$!< M16QC<^/%=(UFB\N;Z60U16^NIME?W]//T.5D]7.V!YK]P>[C_&4RGRZ&?J&N M$ZY(_WC7"6]BI4I[<^\GAK>U[JJ+8YO8IET7D^7;COD?%:TSE.FA0I%"/U<= M>'KAU.B6]&>G@K=_?=LDO0SB^#F,[G\)=JTU72,=96_6TG'"\X87T_YKSP,W MC91'W9MX-B>XR$Y);'X!#2ZET5N$V>4/=RAKNH]DEJ%%RV)%,"'L;:CK:2OT M=RJ8&O5#6;!7:1"G5I#:K2\2&E)B]1;?AQ$[5NFW@UBC#L<&9-M=C#/,GKNM MG20>K0#U7`'4UP[)\U-#\MR[JN=#$,:\>>4@IJQ^AGA.:"CS97)0Q M=6I.5IFMC*_5_B2,GG#"SE\,(_1((OR,'H/X5YRBNT.T3=@1C/G9C?QB7@G9 MO1S_J&"F9;P&`1#2"TSHB2_U.QSW=T&2\/YP78#*S7"&WL?CO/L?K?L4C>6H@A_A1M'[`7N,B])=EATTBU8;Z;;E_8F MWJSROH-C)?&-[8TOEY\^S=:?V,Q\-EV_Y,>43!?LC!)O]F]TPQ*Q$.(&Y4W, MU#AO[M]'TL,I#B>T2_J>B*S]J`DAXIO%)6R M>\WYI%5QSX>@=P-J5+HTK88%OFM\V*XC8>YTO(98&6>"*&&29V@?Q.B)+SVP M.W6V9+<+XLI-.Q[4EU!\D,X!;+-5H]RD*,B7#[3\A!]O<2PG8?UYFW+%*]DQ4@NVJ'1?1-[M81_>V MA=2%,0A \C`-6!+UT,"@J%3,T>%)O"'?721ZWTYJE/7,-@];?(9(X`&*Z MNN&M5@+\TP_OWHW*0N#?T/F?WIV]>\?_E]^RAX)#^D#B\!]X^V]H],__?/9' M*O+^7][QP0#_]_L_\7_GXF&2'/`6!2GZ1&'\@-Z/SA`-XI^X_!7>9-C*/_WC M&:(Z>[QA=\?MGJF#/_WSV>B/YV?G__H^<\#^??XO_-^Y`W)(DY0^8YN=.GGQ MAKCR#2<*.$E9V]Y%(K3B`.E6A[PBXZ8P;V3N,\2?G*$9Q^;+C+\^;8,`X$G2 MYL5QDL5#GKM%4NT47I>RA^^J74=5JL`%$.LMS49FKV=C;RY-U0573`)9)*14 MJ"I(&-&VZ0\O)L-MJ2,'U5)VQPI;3OE2G!X1&30S5SM4[XT?MD3M$I<_0)$WC M\/:0\CWE])>^#H:_V-(NX.1)V@+BAD[1AQ3'*W*7?J5AFT6T[[@/:2#YO9VR M)46X3B5M`W0L4$_KQ?(`%NQ01T:8G7$AXL\JE0$82(]8M:FG56^2$.AO0#;2 MWSE*8_ZJR$V8_+JF'L7O6.DEC\Q32/;FF]2V79;IW*BYI=8>UP00DT!,Q)>W MGP"1)L8A:9))JE2GD,:V/\292^ZLT0O*:%,1M,V:HVFGI&EZ,>),75E$&7_N MJ0'$6$48830T?#GJ*.G2L.P/6RYPM'E@+X##^AJ)N(PY+7';_&DX<,HBL2\C M+HE,B!AUE/.U)Y+A0,4N1:PT'&MH*IDF].(1WYY9SRFX>!@@*6591=(ZP8ZV MW7*KZ<:,5G5M>5GGP7W$D#@K620,B(Y`1R4U=QJV_:'-FDTP:0="52'I&"@3 MLC[\86;=CGPJ'LP&/4=%8?'&'_M&BGHHE8.1N#% M'[9=XYA]$-SCD8YI`E$9RVJBMAE6,>Y@@[K6F1&]FNKC\@.VLA3G-U&R+24/ MAV@;XVWZ,/RV$D#@5<22!$A#JHJ6DE`MZX[Q97$M4^^H#[A&370%FPTY%"\\ MD_0!QQ1P&QP^L6X_>=V@DRYFVD'=L,N944)VX9:WC4^UR6:TE&)E[I:(]>>5 MT+#EBDCE0\,FN>JX]C2;\/5G@DH=5F(6@A8_A!H-;BBL>D0+\?!!(22EA*VA M@L"L6SK`AP4R13$5_!@#J$*II(&VWA?(JRG@16T?[PGML?#_0\(H_87V5H<8 M2S:W:"6/5%!(]N:#U+9=4NC:6H#U@-TP[>!-#XPJ(>9'R>,V\HTU.@GQ.TQ_TR^(K M)H(B$E).-'0D]!!:=@HABU.7.C?=\3,J\R<7X;.5A1!B4J\'2=)9R?Y0&G9& MDK6L:)$PTS8?UK)K^=`*'0IS]BN%AF4]Z&L*@CJ!O4,4[#+,)[FL#W!OA:L% M<=&/+$+UD%@R2&^!@"IH2PB+]SWH7#@JF]7>NO4*C>L<7DA=H;ZK MP20\T,Y!?"L#S--P=(OQ-DQ;ZVOB21>(;$$RM6Q??JFL6Z46P)&255K]<292 M7PK-=\CY,3$#BCKI$)P&L51J-4[I[0]'IT.2DD<"",SIG$/:H;8ROIA^F M-S?3*W0S_66Z^#SUYI8Y.`0$C`)%2-;?(Z,0D?"S%+%.P,.R2=0T? M)D2KJ8Z/__RS7\1I!5'!%=$/KJ9'H:%B1-VJ+R0P'BH:CPY/,"`\S6WP8*>= MIK`;`[[F'+97;.HVKNLSE#,;O;FZN!WFQOJLGMY=?\2-!&61E_>PNX2B9GK0 M)A8]FCI4YWMUK.`@?<#H%M^'4<0NRZ&(8!^\ M5%3`TJ`&%OV/FA(8/7?4M1:V#<%PWNXT7V*\SVW$^]R?#DV].4`L).[>;&\0 MJ)LU?J]0=UZ:THT!MFN;!.8X2?Z,-OFJZ)[$;!3K%<5:L,BB M,Y2X&E)TV"H@TFQWB6]?'V!@O:(18CP:!%0F;.>2BRP,-+1+%G-K5UL`?)QF MN:+IKMMB1=V*=(26H@UX+=&"U3P?L6)\EJ)MW-5_0]M(9-8(YA#-4BKP6!,'F M&#H@R*-YA\;N),&!IW`%T!8\*P>AZEV<;OL=\(!4H!%U]>S-S3P&H`#OPU,? MJ:K7A>_!\^"HU48#C__9D/LH_`=N'C8&%1=34"!NEX`M!V#Z_931+\+W08I- M5L1D+@TX*#8Q+O^-@J2HBOS:&B2/OYQMRA@IN=;25#!-XN4$<',UWRAUUA=I M@NT+9\>L7XJ^3N#!JO/>R/-AMG(=?)N'P6VX"],0:]X"5>O8!J#V6:Y-T?9L.F[7V,-R$_I(G^O9-,[<9+2P6[5_`.:&5B?&S[SE"Q(^E><3K9DGPHF>'K8./8IG6STIG0'KTYZ MG>[M4#._J]WQS?1RNEC/_XIFJ]7GZ16:7%XN/R_6L\5'='VS7-"_+Z>?J,1J MZ%30!WO$(A2:N:*#N7KRZ-R>H4AAL>/KT0(G?.!=XU&7[52@VJA41W5]1`V@ M9YRB(K`^O<\S-&&DO>M0C!FT_SW@#S0NT\?]CCQCZ12;6JKH0V52?1."V*[5 M94JE"R6E%9IC^A`QV"-_-BG;KPDJ-O>Q//X+#N\?&*D#.AP-[C$_@I16L@FSE"!R M2),TB+;4_K!T[XL_8A4,]231T6`U?_1JDZ^IQ2R%F*4*URG!^@YZF+\>/,_X M_!;=LH_YQ.PV>X#>A!':DMTNB!.TQW'&[>^]YG,'WG;FIP$/KQKA)QDUL(NYH:RRCC,Y=$JM.YXO5RMT/;U!E\M/GY8+M/IY2JJB(H@O MI_\VVP4<.@''1LX&/UU'-\8E3H\Q3'V0,B=)5KE4!R=^$<-DP&$^HH`,&91C M`IN8<5:<-)UT!@:M-N[N\"9=WDV_;?A1^S=!BI?1 M99`\T(J(_6?Z]T/X%.S8@DTSSW90+7*OD6I?;ADXLUJYF/M5,M#4W#C3X%<] MYSHHIDITG$H?Q#AB]R'3[+ZANGS4P/_`I96!2=L%7J1_V!O<-K!2X[NQ]^%2 M0+X,E4^F:]\S`,L79-?+]V6XSH/]T@OH44EHD(WQ9+.)#]E=5>R&*@^V_<$! M0#K&J,%!G6J->#`_IT"?9[=)L6>> MW/@&C#CI$I<&PY1Z-6(!/`S,ITLZWB01#::"1A*9&GM:,E9(T[!JGRMB!WJ* MB/3&V2-T?.85,V1!;!%"\9N+>-`0;\-?:&\PU'\(POB78'?`DR3!:3*)JB.W M3SA@&\&VR^@</8PNB>"BQ(%!?_9+L($G[;FVS!WIV#_-=WX:`G6>TWR2;3 MG;5.E28<.1UGYE!A@1WFREPA[FO8/.,0^>146*MG./N^JNG1U3<9/K=>/!__ M_#G$,<7.P_.<#BUV@D,CS92:.5"C9"NO*=TXR540CZ#\HS'%X MI"$X1&D"'#H)]97Z0CH#/`Y/T;XYQU75XZK8\:?&\;*T.65%TTPZ13'#7Q=F MYQKF&GRW0M6$'Y=6VX>ZB^KF!$6-DUKF%>1'V?J!$]L6\Z2]M0BKK?$M7YJL M:]CW5RO6\L$@RY,5N^7@D$2J;,JM>[1JXH8?EI,K8`7&JAO;2=:7U9SC=]&_ M)`T1;:9!%Z\[JXP[25+=7ES6JH\_3&8WZ)?)_/,4?9I.5I]OLJ.EO-G(#0JX MB-=&[Q>KM(2L\^]-X6/3JA5T>_`I7-KII-ND&4S7%N\@WIP0T<`QB)E@>[7> MOCY,JHR?*G,V7BPX=8.6B-"F$9F5+**KM3!BI'( MNH,C'R'^3#O5QLJ,I%?UA(K*B&OZ4I.5$I&:KC=5KU]8AY:U#=L@3[U0-:K- MDU6D/#KBT#[$)-NS[6%LR&W9Q\;-HOTA3?C"P+EP8S9`LIFK19*VZ-2V[:36 MDKH!$4FB/5Z%]U%X%VZ"*$7\V!^TO$UPS,]B0YD2>L/5T/GWGFSAAL1?1"MU MH"2<:BL)&26S[16=1F`ZC_Q?!\+>&;J.0_9V*2V> M)YLT?,+H4Q#_RF8D[TB,9EM:-5/&[8IIRIQ?(Y_YU02$AE^"R.GY-8+Q:^0M MO]Z#^?4>S*_W#OGU_C3\>M^+7^]EW=7GB,BZJO<^4ZD9>PV5!$'24^D]C$KO M_:!2&(4IGM,\N9U%*<5&2"/*<^/G!-\==O/PKK6MPD"E(!=(I2_+`$ZLOXUM MX%1)/JB9NP4*`=HV.8&\G@J2]T;^! M0QMX9',!7/0MET6E<%9@G:$GU'3C=SJ1G2DNLKHN/+0 MHPM:>V`+QGE`M,$90&(+F`^4+1D$[B<8MNGZ;DB7G*$J%?RY$G9(*A@/ M_MQQP=.!X0*WMM""A/5=(!=VQW]J_H2SAA5W':E=&!C/%NO)XN/L8CY=G:$( M#WQP'C#:,"8V8@(F'=4#$NSHP3FPC#J1E*3!KA^R>O0:1POC2J<0Y)W"JT28 M>5XWAE@[7]O'V/D)"I6*JW[P.M<7((O7B+5S]U@[][,VR(YVV]%,(CT[K:.V MOGH0:[MCI,C?B2;$%*X[,E9J4RO:)S6LPU]1FAK>DN&S1]G2@32-QVS`)":[J)\MOG6@[PXF"7#FB" M$5\59C#IFT:`A!?[]I'LM$B1O6UKI`2:,K#W!B[(S8F(W?;8O1:OOY^;;5!O M;3?BXSY_7M(UPPFX/`>\N`O2AU?KGKS,^Y&0[==PMVM@O_EQ_EN4'_?D5&'( M)FL:-E6\J(F./RZ75W^9S>?#0KOUDQ/USU6'9R%1!6!=RV+$C&:T]C@.R78: M*1<"F]:AP1O1Z.7_/$-3?KQB*UJ[C M($IV?%O%9/NW0W:[2',"$B;R"&$Q@H#XP\DQN%]A#;\ M`KO-,TI+83^XJ8F]@(OZ"(FI)]8344WEP3G,K'<<:E?]$%8;(E;$4$7N]>%, MD^-M`,V'''Y#=CN:0+X&\5:2N`42C6Q=D[#$G8I-AT.(MA<(59I:X\OL_NZ0 M7=<=Q\_\V-9'FA7-&3JDD47`%-)-$04Z,B+.)#RY8;Q%A/ ML0+['\T\&9H0@%$3[&S;07`K5L-K4M1M/>Z5(VZY!,$=% M-*]?7#1E]04HG$/6$[-H0Q[QG+;G`_W:[8ME13-F1CKY#P+4Z8EKD!<'PS43 MORI"P.V,F1!B4$5_(R$=R#W11[3#&I8T9L@@/0)7YQE(O+J^EB-;U"]*_5?KF^F/U.UV2]3-%^N5NC-YR@X;$/:JWWOS22'#A(MYBGC)Z): M2Z%-+HE-3X8,ER1*P^@01O?+/8[Y*E)R@>](C#.Y=?`-)]-OM.$DWH91$#_S M`X$6]$>GFC0`M'WWL[Q84`XTG'@2#D\L>[+:.UMMF_7)'/=MA1<#]KUGY>TM MMT'K6EY-I,R*#UG*+4VD-88S/*H*$ZM.Y>6,@^_F=RZP-A%X@G8.F`A&PK%$ MZ0:5?HILDHYBP[:O`,U?VAPN'ON<4!OE]C?IMCZ,$7^`( MMQ>K-%*U6DP@925WMNPZV%6I]J1/7&+-(N?0BH-F%?XY>H,SN>]]R!+RP+88 MKHR"B)PMA3:Q)#;=H<9R;RGUT1$P92]%'Z/\.7J32[P*Q"CS>5?(>)%'<7(= MA,T=CY*GS;Q9/+6%_,R>_9FHIFD0SBL:E82($[2G'WN"Z49X1%AN_Z82"&>" M0NA6;0R)V!@'";["V7]GT62S85M+:>.>V=U"ZSC8-B%FIE3B&Z34'_8`-Y;9 M`/>H(0G4T+AX0GG#'PU.'1-`D#[A:A$-H-_@']BC1[3DIW]<\E=PTFR;FY:4 MZ->.DQ$Q^/$OVDE3JQ5501HA0E,(?\]V<&38S!7RUVU?-S;E0PLGX!QXT-%HX]4! MLRFJ&\R/)[\.XC3$2=YF;:\!49;V'VIEZP16N3M)GP)H@!FSM0;'-WB#0W[M M9X*V!YQ-7L>9/*T&N8)OW`9A2LER:*1U=%?941-?WX*3P]MA3P5Q;1?9\M[K MJD!YKHMRY;.B1_OMP1W)*UL!Y&-R&NY`U&39,4JJJATL2 M53?5JM"9V]D,K=\.M:O<7#Z.VI'H_FV*XT>T*P5\XSD`.?K251M14`4KM`*H M9!7>/6+W9+.)#[0V,V"U7$4U']E2<3$;V7#B?"Y2[,]X)E)D9IQ_CO*%S(0? M[40R"OM+7`4X='.3BN`!9B8;VMIY2:$WCXAYA>\PS1[;RX<@O@>P4B(O'T\V MY>W7V'4/IQDU"GT:EM,"&^/B0[0ACX]ADK!3=')F^D9!&1+49;$\6-I"N*ZJ MJ7U%?DX!/90R6922:4$'6FZ7III^ M3K&U*"@R3<53'%:JF`:/1D_MU*I$OUTM5,I^6`*E;L"IU M?%ZSLHQ9LY4K2Z#UJVK8);W M7#609]W8S6\7Y.#.S!7*_>K8BC'=#7["T4&_K58BKYTN.\H[F[/(/;@YC`GD ML]O$1=5&.5T69Y_ZQDY9^$$3%(((0>E3Z;F;7Y1Y/L+E.Z[S#?+O&YG'C3KE3P+O)"2B4]//LL.B")MSEI@!3[[IV M>)0'V/F/$?4&X;Q`5LKOFJQU+E>LGV0.O>W/C*I-_7'E`WZQNV^<%(5:R3]) M1'1=6R[QI3#LM!@:=><)(7?17!UX8P<"77%6)^U6L+DN+BS?7ZNQK: MM*U7E69QE:IU`LJ=&1^`B6/3>0:MRP<]$[MHED>=>3(3Q7/&N^T_?;0C>XKW(#;[]Z MLE5*-K\^D-V6)NGL)/H;Z>6A';6E_9E&VWH64/IS.^,`<6V6"?069;F@JOF' MXC8'GZZM[(HS94X`!U^7%92&U(D!T`:/4L-US!9>TN=BDT=^>AI/:]K,`%&6 M)@:ULO6\H'+G-BT`/)ME!:W!\2K@NWN";[X>8@9"CI+JT'CJF*ZRHR:ZO@4# M\CP[_;AHVHR?C-CBLTKHR%NQ4&]^BLS:Y:'"@YIO4L7Q\?#J&U<1EFW:/'.R;9A MD]">EZ%]/D.+EQ98Z8V/L,`.>W]CWI8/810F#WC[D9!M0ANVO+O!"8Z?!&M5 M8(UF!Z32L`5MN0\'"U)0GR`N:*R,B^?HG@EXPA``"$3$@45)0B>YLI!E.E^G M09[%U2.P/PNP&]4R\Q&"7)AG:D3N4*'PFC&IZ[RM@G+8Q9^\B3?!UT\!38)A ML(-U"%J%9G^@4+!%2JD+NX-IH#<0(=5&QO0Q>BR>>\(X?>1%A`/%1D(WJ:Z0 M;1I/PW/M*DPV.Y(<8KS&W](+ZO)7&S*8KVI]-UYXP2A5E$9(0,K`2-C3TA%R1V)Y M>.*4I):^5*V5E!@=47V0U3T.Y)UFJ9*F MNU&^M3P`9_Y"XE_YEA"6_T#C;;U&DT,J#5M=K\%X-\?WP>X#;K&K]7G^.U0^[\F4HR6;?&@: M5:&^+CMF?_'2:\<^1RPZX6;HR=QV&(CF%ZSC]2A2165#;SCLE>\6BV]^DPL4 M:!0(](5ERZ3Q@IEN!X#4A1*M8J7QFGD[WNGIS846BM`1Z(_=@')+MH9IB24G M:+`V'R,W;PZ%T7?CR@-/+A[K`P/)U$H7'`PYC5)IT23:ME]JD.<\I7@[`TK$ M[3%`Z,!E=E0Y!!)$;B+/G)6,R6=;DMK[/IC+>\,A-2+$C-)&34HOH::$;`HO M)P"@BX2L=-87??5DS8$W?<50TZ=R*UCS),V7I]?+.B&D6?663U\Z M//0YTQ`?GF3'XF)Z\8J(7E`Z]+>V'B(W;76J2N?%;`C8.`_V\\W-=+%&\]GD M8C:?K6?3E3=\D,55.2#4+X'(==3C0T\60(2TU9-$+JNJ)UQ0I6W=$5NDCHP[ MD#IGYLO%Q[?KZ*SSVBXP<&2>6BRN$*K]?+R/W]>SJ^F-ZL_H.E_?9ZM_^H-)6%P,1@J&Q%5 M:<%DY.P+?4D0)?PPJ'4<;+'@LAS][N!>-@IB=[/1E^5=O#K8:-RG'')YN?R\6&<)8;G^>7J#;J:7T]DODXNY%[N5^Z&.6`1!(UET,5?+'-W;,Q0= M[$U5]&F!$R:PJ0ZF>Y:=3WB&N+[X$C<_-U\/3Q39I,I@3!ER4N93\#<27QZ2 ME#S28F#R+6QN`I(+Y#^?2*`G\]LF;1:V4NLJQDJ4QOQS='R`OK!'`U-,$3(" M_9'KW&C+5H$OLS0POTUIJ"+TN`>7SRSL2N)4OIC M4O_WF4@3^WWM%!3I;JA!%Z.$3;&&_3 MA^3[@?G<&X;$,B(:V:&KR5H2Z=>NX7(-><*/M'VM6_X$YZT6:<5`I<@@()6^ MR0+@Q&I>@/M3I@"HF>H->=O&G:I>'>=K!!#2/8`-&@.T:XP%>QN,G(O@$2_O M:O7)%7D,PJC!`*U<_DLIY'IR3VK9)N%T3E0L4^N.V6-V_DF]'D9?,IF!^:0/ M+S&,1)TY4I4J731V!^1(2@>DR[O\[C\2-:M@N<"1%6V!WG1HFG0PSREUHN:! M4&F\O/DX6!U1$48"_>&;L&_*UO$N MMN0$&=:F_.3FS4$Q8FF1/6")L?(C^3,9UP<3DFFT+J`8<@)L@=/+('FXCLE3 MN,7;B^?/"=[.H@]A%$0;.LB8;-+P*=LK0D<>871@`X]CZR7KR7:-%FG6DM&^ M!+32#*MEC'C;AV?W#N][VT-ND0.C`+_/`IPQ..?S M2XOT^[Z1?N_?@"FO=NP.F#H:50^8C(VZ&3`9-N,$`Z9N+>HP8.KBJ#5@(H41 MWP=,74&L'S#U@!!HP&1H'S!@ZM3B%YKJK*8XJZEMX)3F8M#7OSGN\E@YK-RP M'+;/K:#;YU>7Q.PG+U=)RUZRLC5V[MD$FX-M"TUQ2Z=\.,]K@NL*G]XP2W14 M\#TZ&D.EM3-4VJLLR/Q.."F6_&7G4K0?97@%RM_-A;\7%9$Q@TP75-8-@4MU32UP1'8R^T)AB4<&8UP2", M\[`F8*<_)[;F"@R-J6L"L#$W60SH_E0U@5ES.B0R$P?MFB`LM'VO"4PAJD]1 M'8`"RE!`NX`,9=3"P=GDNB8P;(I;*NEK@J.Q%UH3#$HXLYI@$,:]W)K`;*FT MHU$K-8+KI5+#9IQ@J;1;B]SE.O52Z6NK'CHLE?:`D,W<9K!4VJG%`Z:ZKY/- MAAQ8`^_I5XGHGQO^>B`[<"I_\7(6565".JK;[[`\SUFS>$QR%BSVSG"]VV`W MO=EJCCJWV?$R9F<^+=;SOZ+9:O5Y>H7R8Z%FBX_H^F:YH']?3C]-V3E1OES\ M9A/%Q!F,FBFNM_%Z?K/4UN&2&XTOS=!E1HZVQUFI68H?I2G,5*](5'"]OND( MZLEJTC%TJDPM1K;&J\_7UW.>(B9SM+K\>7KU>3YE;VDNEHNWEY/5SXA=(;GB M&86]Q/EAMI@L+OF_+M>S7SPX#M8<4Z1GN!O)`6JBE@+,_`Y)]...G&S'[?3; M'D=)DSY:N9+(,KG^Q!5;MC]AJO&D8:="-[_8@?"#Z[*=W&'"TKB1B]P7Z325/FP`,$Y):DK('X M&9!J*4ZN@V=V^.@-W@4IWEX',9])V@5)$MZ%>"N^=;6#YI%^!IJ]B0CV99>2 MIF[5Y#2S-N8*:)]IH.V!I_TXTZ0?QT-?(-<%.Z1W4)LT!ANI$]K0MQ?4UE-8 M3U47E.QZ=[+V+6&I#RC/Y'SRASI`BAA100-YF[9A&]&L]9PMAN+6!#JY1 M)$.(1E].Z'U8K5/`[I2,`5H99X+LK#-V1F]X?R"'!"5#UGKE&LVAO@9G_?&E MH!6^YZM&$JY+Y1H,%\A9XG7+L@LVRYQ`."S6K3`WR3_W@S[RB`I(H_SQQ51I MJ8@((K$[."TN:)*,<)+@9++Y^R&,W-^1Q'T0AN\(]U_&#/8JX"^BCCI"8/VT=$8%DEIU"R]XX0^NF M.ZY&56"5(FCRZG`D&XI8`-*0`Y-CWY#/^\HV@FCE\I]%(=>3+5++IGD8<,B7 MSI>*,&K=D"<*Z09)40MM-4G2; M##LE06GR>ZG1AV8X;?B]R&C2H[@5$LVL9O%8;H%-=YG-Z(ANF58%V<,?]ZL* MF@C7D*.[!<)":%L^QEMBUWYV,SO26ZI6P8%'QWOW`X0NU1DAPHMT5\R>?L)L M,"]+>6*I9MIK2MD"?-VNS0?9["_9,]]&=9(`BIB@/S7EY"@ MKB`D@LCF<%R([X,H_`=_;_.21`G9A5O^CTFTO3ZN=))H>9>_'!'L^.I<]JJ4 M9&;)ILV"9W9L]F6EC598Y;#%!BD9;\T/Y%(Z?V9"K"*9.`12(QW9,%]+7O;: M.URJ8UO)+\GC/L8/=-@5/N&R)/E`8AS>1]G>HLWS.@ZBA)U+P+\@_]S'"R;_H',P[%M-D@2G"7L17_BVB%*F6@JU96QDM:95%[L2%'ZT.46HE[\P M&?!G'K!>&KXF:56_MH!R3?$68\3V7.'"WD2TRD,G2+#)Z/7/TQLT6:VFZX%/ M"NF/"54>[@2*_A=02DV;742I7:E2N>D$C?-\-?ZE8T)R2V5W3+1OK1RD9Y3W MA_)>T"::K0^]:V:!D*UT:][@5(-.4-\E`:(/DV192Z["9$,'#X<8K_&W]((Z M_54.2(5P&Z-"87NP%9BWOK,?Y`Z(<)D!/_MM5:3%=-#$0\H0@9Z$-%(/SD'E MHO!3N.J'J%$Q/,@S4"F&OC!!Q"6'7G-Q`#5]T=@;:X,/IB53!,6`_QK'(=G2 MSV,<)/@*9_^5K>!:,PA8L8`:=#A3"6O"J58BC%K3=>K1P$F>-#950U[<6=-(^X7L>!K?ACA^6KY[J5@I6T2X1M`%ZH6E7,]\J9UHFR)7S M_FI'HONW="#WB':EJ`>D4(>YR0UM0`04$>JTF**P[!1)=H=,2C?=070<*E4D MSE`I\WIPI!H;]032X&.B2LO$!])II"1)U];!=!*[UDL-J0L3?EP*,JRO>55Q M+AG@-U<307`\F=+F8`RX#E+IRPW"9_GW;CSKB?&:->O3L"+K*E"WY:-DHO*.7'U])_PP/\)"]<'YF([M49[+9 MQ(=@)QOH`R2/^4DAV1O+4MLV>V6]&S7*U=KCR>7E#;N*:OK?U]/%:KKBKUED MLP3SV>1B-N=WQG@S50`)/3&.49,N4J4Z>32VAV02?YEB3?*#AJYC=H9"^GQ- M<9+2]D[II_O'=HEKKECR#*S8GW9`5V`6_I2Q,,+W[,1L=0UAZ%S#31-CXVOZ MJSP$[(``CV=4YBJHT#E#7.N,8_FH^-L!L[1NLX]1F'^.-NR!'X13Q5C`,$TP MQ(P2*(DH)+7M%DC64[["3P\,59,ZK4@XH`HA=/G:`*7)T?T0Y4,6/O87JP<2 MIVLHJJ9WZ>"!A8MD29E@*^D%` M&$I4U9,NB)JZ2:2N+)GD_DX%3W=EO\JC%61*BOU5B=#9;P>AT-+>&D0'[4JH M+1S'>+M*R>;7ZR!>QOQHC^TOP>Z`KW&\>@CB)C7,E(K.!*C4EZX@-U:G>TT\ M*ND*-S0^RJ*$"9^Q:_C0$Y-#;\((;?&%J'BY2.K?BJN,>%Y42KV'*#07OUF=Q^ M!P".J@A<90CD#\_XT'SH.SGZX4)62W4"AC]U$N\!DBP\RK0K$A1FW[J@50)4 M3;NK>P1>X&1H*;>3=K""@)5A1V0J#3OFD@M3Z9D:AB0$JJL9?PFE0`&&F*)@Z4G5ZFG(UC3@U^::&U7IDQK6I!2K3HH\)IK(C!HR":)F)YM%44= MW5H^AN3;/@BW^0T?DVA;>3E-_"J"@4;).[U&?^[I?+@8O0-]:H@(LC+.!8\7 M$67#\^R5YWROOP_'J9G@@W0.8(N..N4&)6&^3@-*F\-YJ#\+B!R5D,Q%.2*K M)W>Q%2]-WO-'-JM[SKY5K.Z@\EQ4W3PSJ4CAHB=N#8I;F:ISO0?9J6.D=.0Y3*DWNR%N')PH8.1836BP(4KC+7[,,.CK M?ATSK)`^D6RR&*)?YR[M.Q*%*+]F2DU[F"J0>M,0T2U^OCZAEUKM?XK?P5S M^E^?9]>?IHOU&8IPRF@8;#:'Q\..[1U!6[R/\28,BM[DGT9G?_SC^_;F`#X: MI`_?__0O[*%WNP0`,"+FX6[Q5:K58*G&NF.TVNP]M([Z0#7K*:IO;M5?W#I# M5/!U04O>%UC!UI!YGPY](9'_'$*)GG01V+0YO)>;5U%#IL7> MHU]^7JRK[\_?3"^GLU\F%_/IBC)BNO;F)7I5/`DX`'4F"(2K!)#:&A#VO"N] M#B@M*Y?A`(XR[Z!YI(F!9F_Z@'TY&&&;>U>SSLS:^&8ZGZRG5V^O)ZR>6M], M%JO));\O=&CFF4.'](YIDZE@(W4&&_H^+7ZM%4\=_%J$[HC-$V4U/E=!51T_ M#V$_+:8EA=AI0#ULF29LZCR,\"S%C\UY7ZBXNF>JB+NA\]&!W=(.Y*L#;>LF MY%1%7Y@DXJ)^TK,-!#TGA<$"\?"H"2!?PXMOA$LNGJM/)M]"(/44BIKR4*3H MJ'=MNSH!,>5>N_2L$F,-LGYA#_RDI@HH@(Y3'4)8M]FV`>DU99Z]H/`5>0S" MYGX(N8"`DH6`1>IE)EU1K&8=2J6*4I,RV2./2-,(F80<[1]93H),5@;VJB4O M0%UEGW3R#B:NZ8,L3NNI'9RBOS&:\`.84,PW>#3I!\0!H(N!3`>J-2'=B3<3 MA0EFBVJ3:'N%G_".\(G[?)-@BVP`V2/3E+*]:::P;I=C>D=J@NGTQX4(7V7: MED)#$PH2:](A)$TJ*=3J/-+:'Y!$*>TY\78:Q%$8W2>3?*&<<*[ M'=1"$F99NNU!;-;ZMAVE&Q/J5"^"J-*E`(XB*IZ\(*-+%F.Y(&7:)Y0E'!WR#-^0^"MD8Y)KLPLVS M?",`4/Z82+7RO6FB\>`@O<(\JOD#L3'.Q;*]9GGY6]%!=X1B[`'S?H4P4 M?DN;Q61--BIZF>Q?2B:CT!>,S\HSC.4/S@&0!B,7@5P;;VB([!I5(MJATL2 M!X;Q'A4!9Z^&Y4%_B3&7E(IF06^7@1:B?NZBRZK8-@SX^;':\N#=JFZQ/K<1 MZW-_>B7)=@N-E+B7LK:Y0F+7P0L>:D\&\&YLI/"Q!U-MD0#\XDK`BS9$*&VZ M0XBU61>-CX[@&-5SH#<;:^R`!=85&J)ER!F21K.$RX]*&7&JM+3X*+3J:JC: M=&!`@.JB8S&O7>6`%TM)ZC#*\:];<12**Z"O6&\8G;+!STP[PS@0#K'JT$_O7*-@E!?I\&@O?0/]V4D>]X=L M:][RKM@%6MR&J>]+;#MH=3WV'%C+$K::Y+!CL]Q$6!JRZG1''&S[1\HP=[EI8S[8^5>RS7'?%U*L;OJDKQ'WYDN:LTT>8%5T`5I9#;?D2 MIUR[W\3+C."@S+#=O-.G@T814\L-I6UU-FAG`8_KGY>7&+35UTDG M:;?\!CYDW,TF/N#M/`QNPQW_(L`95:AB.U-J%>UE08TKEZ-1F&M@"H,8JZ>G M3`-55+Q),5#@B-.'04BEJ4%C0T)[D.>38M?%N`GHUAYPF^.<-G)]'K,X![-^ MC.$,S7Z,"3Z$49CB.>ULM[,HI9@+:3LK4]#2'@JJV.JA](K66*YSY:8&!WJ% M<1QDK$;Q3.,M5T&E3GV%QAN*@V$DI+A)@&4,U]D0,QSFV0."LVO((NKE.=]G M`"Q`86HM;3ZLU]20/F M6.O4G1LE!["Q;AV\JY&ID5\'0U1C_PZP/^I0T?HX?AV"%MH1[2EYX<<8]^*0 MA!%.DLGF[X@[$F22'B*\N%`9\8;4<`D+2 M*F,EXV1+24PYB6VW.',PO2?UTP-BC>FZ0L;CB3D;P-).M/5!EA\39WGQ>BQF M9]$=B1_YSLN+Y_RA/I%WLM)*\H96K!'3R*_#+8]=V@'CM+GE\>KP^!C$SVQF M/H@V8;!#%25^6T,Q[O&%\=U`*,P&G1$A2Q1&!L5)I$.;AF.(@VZM4QL8BE:F=B@4^Z5-(^-M?#LD>;3\[!'W\Z)]AMW6KIZD[V&CUS48VK.4=`Z]N MIFK,&P#+.*9V&Q/,U8N]J^KY!'/MWF^_YI:[8%&89#I"0Y9A#,R)\XMQ>SQ( M+J"8A$C3BBF]8LWV<0*0-6@6T;$N3E*^=L;>A]%.&X`U6UD#H&DM6VA].9P2@/J&I0B8M5IJ M*%10H8,*)5]R`!Q$0NX;15?&>:T1,=>!OD^+9`=#=[!?BS`>07'L\9C\%-#6 MCKU=8MN/,?9DLV'+8\F"I#B9$UJ[3Z)M/N\9W=_@#0Z?P._T=[,D>LG?U)+- M-Z?-?#LZZ*1C,\!O5G>P/B[4^`')V2L;I:PW?6)W',I>L^X.",5KUV9&I>]A M=VF;!VE'FB&5(VZ0%KQ>MCRR5OIQDR8@+GO6%>)1L[:D\+^.T`^-P0$U+A_D M0V"`S^'HVQB>RRZ2TX@5!)6*]66DQ+!5"JI]*#FG4AVOIA\_31=K=#.]7MZL M9XN/:+*X0I?+Q27]]&:RGBT7*W\N$--%FIA%I<$CB4:-.$JKWC"E,I$U#R,\ M2_%C:\NQ@8J$06(5RVP2.7')+(4_$Y9)S8R5$\#H"Y-&7-PSLBD!HB">+H!J M$HJT5824>QN:G%?D,0@C,0OKS^IT*Y[9X55FS0&!:H8!3*G('RGQ)?O0#^`W M8M)&>/NG%$(Y$Q-@MJH_-#B/_+D*D\V.)`?%W0)P#4F_(=2PW&T(?+C8:@[V M:M)WR*R`BC4ON`,"AZ+/T$1/W64(E%4]AM37:1!I;PD`[L\"&$>B0J:4I:-R M;Z;XG4)2-J7O!).#3N'C';5Y_Q%'.`YVDV@[V3Z&4FW/8Z2UE2: MD=*QNX`I]>8GQ(W=2LG`HYJC8$/C7/8,W6?2?#(]J,D/S4\CC)`^$6R2%*)? MYRG)468Y) M_"BY)-097P148X/1&UJZ)USD^X%I(HT:`?[0#?`W16LX%]MQ`0.C^B?#P33: M&J-`6_:(E5X3#F2EBC$0VF6(%22<6^MG9=:-`7!.^T_^^1FJ/'FI`#BW!8#S M07LW6B*OYO57$EDDGN&U:!V%WWE@/ M+/$[]V;M3QXR$9"%/[($S'/A*I[$TO"@7M[Q.VT?R&Z+XR0[$TBV#\5$IPE] MM8XM-JB\."$(P"&(,UH[X\OEXFJZ6$WY>LAJ.9]=3=;T'ZLU_0];-%FAY0?Z MK^7E?_Z\G%]-;U9_0-/_^CQ;_Q6]^1P%AVV8XNWW_NQT,<*2B)/04$MHJE(7 M,E?OSPIG]&&^ M_,O*=S+*02'FH#)X4NJUM"2,DU@?GF@9_=G-DB1B0RG1D9<0V2;5Q+*VN":R M[H1L"D<@MDGUQ]D35#[RXV!)4*Q%#-*%1$(AD9J00W+[PY.(7PZ0G0=U3;)# MOO6]EE:EW7LI5.SU8E(GCGHSG3]@KZ8V(^O=+B;SR>)RBE8_3Z=K[_LT/63$ M?1LHI-(^3JHMZ>LTWH:G:W%"?W%4FZK/4\DV"2J6M<5,D74GE%0X`G%1JE_L M0_*LJU.&6$0H720D3!*I"2DDMS\@=^B(\0;O*5`?@@1OKPYQ&-U?\T7>7X+= MH3WK#90_:91K7,-Y.<4F+.WK13JK3?+"KQ6!L@T: MUB$XZ#Y2UL!9DAP$;>//EGM^EMOT&XXW(?T&HCZ@BWZU3S#3M\%7$X]VZZ]N MSK5L-K8Y+O[)NQ).=)+)><#G3H!J\KMKC`5T-S'5HK]Y.WS(!B,YT9N)L?[( M'CU']D\7:QL',FN4SS"0QT=2;#U$(7_$3P3?QW@?A%NT#6.\H=%)_H#NL!?5 M63-F8IJ,0`P82<`]LE=)50S:+9H:ADWB?BR%LL]>5E!590P@JAX6)]DF2/[_ M%ZRH8O/%.$KX6\:P\@1B05V@J"VX*5%4/EV\3=FY%1VJ%:W5;.?OVUL^#-E4 MGGJT%[P'V/3%"S3ZH/)%90Q0P.C;,@P#7/08IOX=@+_1_S1'X<6>^"I#JB;. MT`+S&[`^D/@.A^G!CVFCP9BB[Q%/2!5_^]?NHW^``5#O>LKQO\*ERV&(61.Z MYY8.\P`OI6/M.2D`#+Q)KN@X+:!MR2#(/U&?JG)O'_:C>CU9R^F3.&;72/(] MX.S\_XK<=?#,/YY\#6+:\>:6SU!AFU\]F37@M\N83MVK&\IXV+EFB\RQ[AV&KE_D!@BWH-+N=@:K"%GBB_>3#5(U;USTJ MP+U]I&O&J%S[%0Q13\(0LQ[4*44&[T$EB^=9QV^P(:FN`-B15"@XW!Z2N3CQ MGJ2:TZZ[1"I&A+N2/!L[PC`!W"#2CAI\@TBF"]TA4O5T$AB>9)M2W5U_!$(V M*JT\WRO7%XD=]BIUA>+@/4+MG<99M-D=V$$HU^RH/A)-TC0.;P\IO_>"+&@T M2)32R-"FW!>'ZDM?VW!AO-K36#1N(QU8:XZ;"5+;S=-F&KL.QZ*WFSW(0/81 MWLQ63G`E2&S6_+22H.5OX!U9[?;SUIMV6J:.?J>J952]7*Z^_.+&25'CI)CQ M)"^:%B_0PT]M-LY]0LQ*EOQXS=>0^MRE/-=5B?T,YU$58EQ]P,Z8M=JVT[!M M]#O=S!'SUPRDW^`6%N]'?^ M@0'T>G%T[FZ&JVNIPO5Y]OIL>3#&>+#\N;3_PZMH$SAR%@2*]H M-J@/,U#CMHG/P;B[CG&0'.)GGHF$NT(4$OEO))3HR3^!39M M9/7Q&0I2M"$TU7NSC4,51`+^U>N<$`A7\2^UY0?6/^''6QRKL%Z7$&&]D+") M]U`D8X95CPB3)_`R-WIV]?_>O9^_^]5^*;7KTT2>*S@?T M?G2&:%3^Q.\CO,*;#"WYIW_TB!O2,YW4<5(PHW5HD\R2$R!96XJ7FS?'T*B9 M);TXZJL/#B0SR%V`,.0:\2]!'+*1=#%RGD8I/S`Y2L@NW+(L MR2%*)TF"6Q=R]3.2_X!=C?0D43>WUC>H]6J&BH\]#.];,A3BZ>+WR(&FW%`(DEI%"0 MV=$7".H6>,9Q>34SI]+ACF>NGH-P@:6.(_&:I1./2"J^W><%DV;8')DTK><# M\UWYL8]9PPQZ/08=$@ST&WA4C/89?;3:YEFFF4LN=09**S/&W-IUSQK[[IG? M=&7.[KH%Z?R"1Y=$0R&@9:XP3A!VSD5W28-\#,:RO^#P_H%F@QG)/]ENQKI2=5N;ATG_N2[IRHFSM#%D3JYF=_I(IEE'Y(OW6;9GX*$L#[U3^_> MYSTJ^^1_/N+H*][M9E&2Q@=^K>$EF:=;X8P72#;_G32R'1FO;[)I/[D'"SH M<:>(ZMU/P-UTQQ+-][D,J@BA2_(#HG(_>#(!:AE5DOQL"5964VTCE<])DESC MF"?\671%=KL@/G[00&D7U?P',5/MPR(33];3=`?G4J89VQJO:?+>QP3Q5RU8 M-K]H#4)VU`K:4_#QD0B_@8RE_.QE>10D*,SZ@-O\EF%V]/!M&&6'@E+ARC\3 M]!!LT2W&$3^?>(>9_2#-U/%]&$5LOP1M19";'[@CZ81>TA-5]7Q@8N68'LQ= MGY(^=OJD+EZM$8<=J%#`?<)JG^QB^@1=Q^0#IY*61VQLO\TLEY\./,P_*=XE M'>!)`-_]Q(1.[LP.19!M".WLVAKLS]DY(K_C&ACL`7#=/HF@1]EWA>]P3`=U MJV"'$W8;:9@D-,FQ]ZH/]/.H^9(R6#[_80#R?4BJ-6^]E(-ZE/(19F!<_AMM MBDVF`5]3Y+73]HF=],.O@,@-H'UVF4PR<#T%1PCI$L0ZX;2J1Y8!G3@'HYW" M".RJ'PQI"53((2Z(2DE4BKY*P$E*%\N(ZUFD@'Q8K$S`_OKA[KR"NTJ&P]_8 M71(8O471Z\:>I+RPC#VKA<1UD++.A]8Q:[QYB,B.W(MWINH%\R^M$NS#&;E= MZ\6"UI64)AK-\?3;9D<'IT\8[?!]L$,Q6Z]!]W$0L7+]]IE/M]R3)QQ'CSDP MV"?D:Y0ML/'9GF+S_=DT3\#FD39L0'R7_2N; M'V+VPD>,DCW>A'=AUH!=\'7@2@2`-&*$B3H;Y3I'&NK,NH.QG3)#[Z,C@&EA M<5U!7RGBR3J`->A(JHC>V.E9-ZB-6RP8](XZ(NC\MX(@22W0&T%6>W\VAY$L M[ZXIYHK^D+K]G.#EW32A?0-M27)-=N'F>8V_I1?4]*^"1:2.%BIK2<86^LX0 M&CITLK+4K0W*"<,N)L=78;+9D>00\RT#P6;#9BO8O,6>2_.:@1MGC_<5\VB+ MDTT5X>+78;?V\@*+MS=?)+L3-SEDRV3\ M%#2V_?=KF#Z@^V.C@Z+1U1_SV&@/%LZZ,I;8H5![]M706&T2ME-#!D@@]M;6 M.CJWG3I&V9(#IUI5EY/LAKH;NHIK_>&:J M?9ANXLEZN=S!N93V M`(`'BYM1#+S)]P6`C8P+43X0'[D.,H$&ZAJZQ10"@7NX2@/NR MQ[$)];C%VS6.'Y=W?'_"#:Y.!D_N8\SG1AO`-M;+?Q@#O3Z4`[NQ/J8Q]2RE MH)FA\0W;8Y(4.PMH3N;:B';:CVR$DO#]8G'-`@H*$RB,J&)`/V%.^2>8G^C` M]PYX,9XQ!QSI@X4ZC\$FCF0V='HRK-OI8XQ=VD$Y[6UR>;3.<9WM@ZSKH*/2 M;P*RDK[',69[CE2,?%DH+=6*^?3#U+^6EFJ%$_A9GRZRF?S/%&^D"A3FBPB2.A#9V> M#.IVRB=CEW9`3LNG7/Y%E$\G@JRD?'*,V9[EDY$OB^63L5\[R#TOD?L2RJ<3 M(5=2/CE&KMWE=84SV<6\!BK%4.&KX"G< MSD-\2_N=(!*^G@@1+=;QE**]UN\4ENV?:*!W)E^UT^F.^1-T?(2^/A"4X/B) M;6/*=LG?DB#F[Q!NL.D-F2WH_\.G_#N&3T$3VS#4[(G41+R(]6S[5+9 M*XYLW9TO0O"![_=#GX``@1`Q#'5CF4^A52[O:4V[Q*BEM66`E\[H9&O)N0AJ MXM2/M\BL0DFV9&P#2WW/,="8-RH<%*>#@YUUQM1Y!5-O?PNHDIU58`-55HN` MXA#COSS0CN5Y^37"V]7A-@FW81"W[],!2N=?6BO=AQP:X]8+`I@_*4,@ZOQ, MRNAXW/=7+OJ6G4ZP14E%&&4?Y><9>#&O#04&,8]>G4$:Q2.)0`X)X@MBWY*/\XF"O&#_AZ(!9YQZ46O3C7<`WTJ?91`$U6GT^]%OO>B00DZ`U M9M)D*N7TF=JH,Y!96D;0N>@&+[9@D".E*N#):,L28F3+`?T@8W5K]S3?`YQ[ MO"01G\X5IU280#0[IAKCQNXBZ2[*6P/G'&!0"'& MX:P32:UW9!/$O%LTVDG%,#\]<#ABAQ3FD"JR\U',D]1L'5J2)&T-6U;3=7DN MZ$V6'L2)6B>6?U6Y6!\ZR*Q:3\L:1U(B*/4ZIN+*D;>Y]-`Y6(L!8A"O.C=D M&D=6J$VZ`I>=+*OST`E6-+-6CN$NGGN24JT@19)&>T'%:NJ<1455'6W7<1"R M%6AA\M0+'K?9RP7[[=N4V76PD5[C2K$U4ZG9,8V&T=OC!`([XC@W//B^>"TB MB%'LFGLQ93J5S9=JL^[@9FLSN\Y'1Z#Q[>K'8I4?*YO+>))ZJUSGJ".$^+[QM[\%"$GW@O>$D-U;"6+R%+)ZX`.)K\CA-KT[[/)C M1=BYR&6],-G^[9"D?'*L`/UNN!'HV0'PK>U>9X>PC*ATO0Y_W[)679_PMU=@E/T]2'65X%Y2M+"_=/,1[DAWR2`N=PX;E MCAAOO0B2##SQPJEXF3DZIIR<\>,B4ZQ>P:FTVN3 M`\2%_5TU!E[E6R#`1OCNVN#^/L;WM.JK7!O*KLT+DHHKP"_@&M'VC%^Q@\YP5H=@]'5CRRUZ-3=HPCS1:' M*&2%-2-G.)S>0[/LJ--2/S7>A37SV!^9Y M#LRWOW5@RMZ'=@-,JR7=1_PS#G;IPX8Z%RYYOI#XDO>SP4$2>@&-59T)8]0EYFQCY\['3\Y8:)'LTH`K'O1IZA7[+H#K[#O9N`%TJUD5!%BK' M'K+"@40X&YK245N6$'G6S!98V)6,N!C2E3)/N8;&,-ZM#MRGM_?;,OJJF40L5;U5)A'J]OR*T:?\M M*I4;^5LKCA'*ER_%*,RY`:JE%ZR4]CM`E+U0 M53ST+$'W1H;LO:FNT+`ZH!0<6:A*O5!Q^5&Q%M.QSKK]I4Z80Y,C.7]/UG8. M`E63TP0IVO,_Q7R%N7`-=VI@!\;FS?F5_)U"#GW[<'6MV>PFVCI,L M2#I+D@/>?B!QL8UB'7R;AT%V:*EHEPQ8J;I-!J#4>QE3Z\/-1AFH6_5*)LQ* M93JRW"831IL8!PE&;[8X^^M[EO*#[39D#:=I?A^$6_;1)MB'*?WWF\GU[/)[ MMKGEL.,=#6,&WR%'V9KM<^%=2,CVK;#_L';Q[@H7>VW2X!O:%6T;NO,P@R7I M#!K!PJE6O[YR"G1W&BY8W&<"]F>!!<5.$R`X7SDV5=M-7(#3QH83D"/8A.1/ M&3HCOG=PJ]YS`G9K`:3GOX-4%,L3@=3J#.9DLXFINVGVTA7;Q[QDX[7"88B3 MR^SUK`;>C?6**X#A>KUNF(2ZL5XVF7J67S%I9*CR3EW^`AT=;R?LG[?!CK\$ MESQ@G*(M&UO3HNK`W]QG6\3VP7/VOMH>QVG^?BQ?$4[8SBB^B88.W]E@^D!! MQ78.ST@ZMK(HCJ@ZT!".WN_"^>%>/I@4ZZC\\LFV_&+$[`E`:/F8[ MG,M)@C!Z(N&&-IK?+L#2RC-M[2W&4?Y.'?-"A;T9$G"TMW)IB[MI`=V=W(FCZ;'[$"!SU501><,Y5J_";^+*Z\&WLV0YXSTOPXBIX"0=O)0/_)C`KNS;9+6;;-:<[S+XWP6Q* MTF!G!['OK2'V_>^(%<7SI(A][^9XQB0_S6R!FR,BI4SK8,::C)V#\RHFK8]J M5%X`!^=OVC&@7FS>%6.Z0Q*4YI M1/3IB\:#]F1&(T#TK$JE=JU6H$HOYL`XKP'C18-!4A9V!(/5*<9+DJ3+N[:O M5O^I%CMVH3*Q?O`56W70D2H=*3"LT!NO616<3]GQ8S>S\Z($G>>!S9F]T-Y3 M@P]B$,LF2\0:%:*H3+H"GJW.5.VA$^1XEYJD[.8N0=?Z"H`B[5Q[(*5W%RLW M;;F753OJA)CS'#'DKIJ67@%2I#UO#Z0<^]_J[S.G?]$/BX_H_[&7_NDG_S]0 M2P,$%`````@`:X"N1E<4=5,V-@``FJ0#`!4`'`!V87-O+3(P,34P,S,Q7W!R M92YX;6Q55`D``XG_5%6)_U15=7@+``$$)0X```0Y`0``[7U;<^2VDN;[1NQ_ MT/9YW;[;LVO'\4[HVJ,=M:209'OGR4%501*/681,LM0J__H%>"M>D$`"!`6@ M6B]6NYA(9"8^)&Z)Q#___7F5[#V1+(]I^LN;C^\^O-DCZ8(NX_3^ES?K_&V4 M+^+XS;__G__^W_[Y/]Z^_4)2DD4%6>[=;O:.C[[L7]W%"2/-]RZO+M@_R=[G M=Y_??7CW8>^0/FZR^/ZAV/OXTT\_[KW=^_3AXX][U^O5*B[V3N(T2A=QE.Q= M9G%:,`;_<^_L[/#=WGZ2[)6E\KV,Y"1[(LMW;]_RREDM?_[,_W,;Y62/"9WF M/S_G\2]O'HKB\>?W[[]]^_;NV^=W-+M__^G#AX_O_]_7L^O%`UE%;^,T+UAM MY,T>H_\Y+W\\HXNH*#7N%'^^S9*&P>?W;5T@!?^_MPW96_[3VX^?WG[^^.XY M7[ZI1>2?$94TY,\C^EHG9L2?WI=?6U+&*):P;M5FUMO;J^R7T81KQX0TOSUDY$[,)\FRE@VWSD_< M.A__C5OG'UO.[Z>(=\^A>$.+*+$C9\EO+.NHFNE"G]LRK4SDN_Q\8KL8B M'ZSS."5YSBJY9:,H'\0FB"KC9BSB%4EXXSPR+&UNLBC-HP5G/,6D2I;&PAZ1 M.Y)E9'E%GDBZ)A-DA#@9B[:_6&1KLCQ^?B1I3CB6+HH'DIW%T2V;=!730*K! MW%B!DN-^GI-BBJ0B+L8B?:%T^2U.DD;?TY1-DN[CVV22,3%"IJQ M)F$#^@0I`493\$G7E9,KM;XB"Q(_15SK:8(B&1L+?A+%V6]1LB9?292O,U*Z MZ@GRROD9BWE&\YR-RWPXH>GU0Y1-\4X29L8"7I-[KNH5>:09'^.JT6[!?LK* MH23O_=]5G/\Y08$)EN:L,G"<9!L3O.< M#5J=*C*:LG\NJLYGMM>"XSS'KIOE[3:[F>M8F>U2F>G8EYSGS;.S/LZTR:T:1+/A[PULR9[DL^LEXS`U4]X^+N,,H?3A+Z+?\U MC=;+F'TUF^D85#.?4M<%7?SY0),ER?+CO]9QL9E7.VE]\ZFY14C975>/&7E@ M!>(GPAW.O"JCZ[:K_D&4\-"AZP?"YA)M+9?,HZ9L0"H[NS5U476]A'HS:S1E M7DT7:PX(AH%CYE^+S6EZ1[.5\:)$SJ\KYF/'TY^Q'WJ5D>>",/5;PW%9)RA2 M5MM4G-!%KZZ$!^S13*49_^4/62W[MSD;:Q?MO"SA$22_O-$IPCYS/7%%WNMK M51NPC(7)R>+=/7UZOR3Q>Z;H#_P?7.,?WG[X6$<:_H/]]$ MKW`8QR?6%.\?RY[^=O$0)RV2[C*Z MTFP4BM*P*_W/>Y@*]@JZ)V9,,S80_?+F`P^997RK=>M996Q0ZU+EI!NV]$+8 M."PGF/GD.UXJ]7XG2?*?*?V67A,V MZ*9D6>X79T+'HJ#M.1B0-ACXZ.@\Q>&`-=1`^AP&D'ZCR9I9(-N@^2D4T-PPM@!.NI\&T*@^!8<&@4;3`%`Q;+;JO-_,W6G8?@NRF]+U=?YV_LH>JR`3)(B;WX9(KK^^8\V MV.'BKDT*&1F<1AEV88M1\LHR.%!F4Z9YM0,5\:9EY:W M'353NN^FA564)V8XUJ[/XR:%34V3D]"TC@Y(8F_B$&H MA`2(F)/KX_<)SE0:`%X;8.A<=0D#3;$D(2?V&`4`D)!S$G M\^-U3V!QF9''*&YN2C;#:,\*`Y1HE*@MC"KA+X;T%49""L78_*2^&"7I=+WC M(-MID.TP^(P."S@0M[C!R7DQ2G[KS&)*4P$[2R*3@;;:\@AW5^$RHX\D*S;\ MGF.Y]_W7.G[D:^/QM`Q#VKI<&:F'V-#03041.2OS_08O_&ES47\`C>'/M:FV M/WO8Y(#,JN;=%G,=B6_>BB=Q&A?D+'XBRVVFA4K5<;?'$=?64Q%[B`,M_53H M4#$S7[9[T?T[,\1SFBZ$TRHI36U&@,9#=&"T48$"X.$ZOG[JK%HXG1;.H[UL M6:&\N/G?E(6W%Y-DK=-QJCA>[ML,PWIK21M3:$^V,CK9G=BL;YR&`CCOUBU6 M&QU?S`>#R(_\U81CI?TY_&_VZB^C#=^HEQ^\B8D&YR!#(F=N`M$P%*E;WTG` MC+NG'T.&P;N(.B_<=920O$Q(F/,'M4#$J&FWP)'1^H\?M*::,)+Q-5^)3T83 MD))$G390"A5\N3YL,.7"@)"V!0S@A*DC^//^LL_PO:OG19R3F^A9.K@AJ9L( M)!6UYUC3TU8'84K.P1_Z#Q*WRL^!Q42#D^`AD>?@0>FF@QF(8;B;"^>T(/+) MM(2BMJ"0PG-HJ+72P860VX1="Q]V'QNL,\^HG!.A:`>^!*#U'#6"`)V-1MX?TH^L.DX@M%>YBLE3['V1)@5]2EO0<=^96,/5CREI<7_JWN5>F MW"-3[HUYCR"K[DKBHPQN]GNQ2Z^]-2RT*6K7'EN5V-*[$`C3T6I[2*?>L(9I MQ_U21.M\,E4O',#C7"6=>$'FQ;$NKIW&RS+D2:^4O6!Q)CC\#7[CY)8\' MD!)V@P(`0O\AA%93$T,RO@ZWL&=TNAAGBW&R(:!F!L#(L6*P)[T+;^9WTG<+T*,#GSCC2 M_[R#P%/88&[4C:L/_/+*_G)9AJ%&R644+T_3P^@Q+J+A718%51,[`U'M(`YQ M%ID;CJ`4X4Z$KD@1Q2E9'D=9RK3.]Q>+]6I='G(4LRZ86F^]VQ;K,!O MOJM,!Q]:2LF1MSD#@[2F]E;.WH"*S.>27C@4W8O:AK>)S:YPXRNS=`CJG>,V43T`:=WHE"?W&>\\)S8[H^K:X6R?C9+?`-5>3LHT=],IZ MG.]O@A&P^0#UJK`<\NM1;IC75('0+N\18:(SK\]U9_].2-E:Z7)_Q9<&?Y>_ M@WGPX.U?*VS'^\(3V?J(SWELIH2TM6HM1\5Y/"-_39WTFCKI-4(N]`@YMKJ[ MR,K^N2P/"RY)5CXZ+`V:4Q42QM'!A79PK]O(7B\;;0<+%>Y,KJ]A]7KV_KIX MH%G\]W9[1(AIB%B(Y3'QSF-889^7Q>Y8F'!O(X@T.\WS-0JO?4()5AO"[P2G M0KNXP&@C2+BQ?"*M+M9%7D0IMQ4"I`)J"5)[U-\)7&$+NGK!JV>7&0BB:K M!GG2/#DPZ$5O5PK*`NW[%*)(^X9B!U&IML2+QMHW$ICG9G-]`O@:Y*L*\@TP M%N0UT-*_0,O6//G%W<4CRP(>+`LI^KF_Q=1V7M(8_O:1ZXYXM=?:Y)]A0O MB`(6`BH!,GI4H8`#5LT('SUVX1[Q#;25CW[R42\<*%B"P-37;WVXC*6:O8TM MAUH%`&P%%MRAD,]#FK-53SEP\"5-[2"NV:H&F%SB"[23-W4!FU-.7MMXPB34 M`B;KR2XB$>T/TZAGOU-2BD0%J9`Z3# M,=Q)::5*HZ@0#\.//3AL/P:%!D`GK!"_Y M"$IU*I'>MZ\"BQRU6";*0LPZB;D9JJ'J_]X#UE'L"2/[A7D^Z8K9@C?'`=#MB:[N$EI>& MQ4!#T;;)<*6T?L-*1U$--"G8ACL,C[16N625*_8=("J%-$`A8!7X\T&(J0UV MC$9/="0,@W_(O=5MF[\7ZE]CBF$/ZU($@1!0)7UL=%G-D:ON11]43FE?K1KX MP*083=\^GJRD=Z9[&PJ75CFN*_E&T3\RHC;X1TSDK&/@FXDB5>SW$B5_WE\@ MON%.-(FD'F-KIM%CV$(QN'>T=J.RR?,T-73 M>VNFZ#8.]8#B;Y\3/3FFD MO#@G!;@`%7YK)DO];SYC0:8&?JCN,S&_>^6%?\"\(G1)LI@NV>_\[ADY(M5? MZ'C&&L/N4_83&7IIWA,V),7W:975=K&YR:(T9])6N3_+_TNJ?K/\USHO7RX& M'OV:MQ)$,TRIQ-U&L#V@TA=J@\&V\V0%RMVSF00/=S=!8`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`I>AI[WCWM-TO'MS19/DA&;? MHFRXJVY8>ANJJEXS,D;$IW=5IB!5Z[44$]"!;Z`8[.WXA!^N^!5Y7&>+!V:) MY=$ZX_VH%+!\TTWD8S'T7?G5TH#P%9/>C`%OC\IBI@[A\D"B>:*9Y)PYB``!\"#UXOKGM[<7U"5W)P2]V@N\U\)=W@ MEJD777('$K28XE8K<8LNW,0)74QN!'HQ)_'S+/F/3Z^GR99/DTT\V>0: M5G4@>)RZ7[3J'B>/$;ZC!\HSX`X^4C8(\99#R$4XW-DH7(M.#7`"@N3:FNI< M=7HU6`Z=\ROR<-P(FN&&'0:6+[.X,!3J_B4%+2NUG8QWSZ0U3TNX\^_6[F&4 M/YPD]%ONU67=5BKU'5V0='PU5T#J\A@TUJ$ MK3$6<4)Z.MY0I.6`SCQG%>W]SCFJ<-8H1X0A:1&7V&/_3DB]Z;:_XDO#OT4A M$3I%:J/ABCCS%K/"AAI9K.]2YA"0.QB<8,&_&MY/)5_-7+^2XH$G+WPBM6$' M*-5>`MHSH<@NH7'V!(ZS58 M??@5*#O6]VA-^#3TBI3I12ZCK-P,*H-?U!T;4QC$K[QP\`#6L(U=!,LK=KBL MF`O"?-F4LMIBA,,5T((`[=$&CT=8<[OPZ]43_#U90?>JM3ADL\![!.(`>M@M M#NF#1Y[<`I:=W["NX"_&"BQ21J]6#GT_SXEHOQ!=!)Y["XH$#T6E'>RB452= MP476(`#)0_7T,0F5DL-R7&HWD*FPQ@S@'-=H<`75=WPV:[K+:%.&E6;1+Q0\.!&VF&<5WJ_0_*5DUW'S0.]KKN/6:[7F2BYF(8,L+_>CLO+! M@U;/0C/X5EG=X5Y+%7;6;*V'7KB(S+6.B@2/4:4=K+O5477FUTC]0^)E1ID] MBDVS>7L3/9-F#%%B$E,81*>\EW`+S["NU=4VXQ.E/)-I`R7-:M)VK?WR@1*.Z*`A,6='@,8JVBUVX MRJJ=<'?2U\"$_DZ&]C)*6A2[$[5;$U.T76;=DQ)-5$TN;+J^$_<"P:ZZK?[" M$:]H\>;)\QCT=9\7N$DRUZVA>40/]Z6W:98=C&9VF%FY)KA3_\CS=) M2//`ZH(RA^W:RZ)N$$]N2Y2WE(DRO:5&7B_`K$&`!:KK+I8O2QLRE7M!;:;. M3,W6?/5HN[_X:QUGI-E`NTRBM-A/E_R^T>-J'-RI7["YCZ-1T+=!PA0L=(*] M4`."IF#E_1H-@8*/8QXI>_U`L^*&9"OX%J56&0C1PFYN,/`6:O0]O(DJM`N`=K$3K,A&BF,PVN//DSYK$[UK$[Q M=JIK6+7K7%UFJI`3KF'NP$)WVG+(RD)76X2=V]X[B=,H75A>Z!HRE7M!;:;. M5P`7=T?DMGS@A`E.#FD.SOLEE(/9OI#2-[]OVOY4QR(HIZXI27=F+Y0@^-7I M-#M9[?Y6N_U.=0*K=IVKGTP5TGPHW87)S[0ATLKD1UL$\Y6?Z\G/\=T=63#S M'#\O'G@:E"MFL(N4&X6G]V%_^`;D$UOTCONVT"OJ/2HG6$(/E7H5F<<*P:.;!"]":]51@K&49E`42C7W0;\1C68O]):O1S!Q,B*G47?Z/6.[PI_BK=+["+0 MX":L/\_?K!\?D](44=*8XC2]H]FJ:G/@Y0"]4DTN16PIAT'MU=-&EU$\?,93 M]*D-2N]^!-!N%2I4:=!@<[RK,N,LSW'"I*C:VONDF@(/P:R_M<^=K6*"0 MJ38!%P.V._&XCG2H,G.3>D,5NHYP[[KSFRA,L^T)5KIL-W3*AYJ@(QO=D/[K<1M9N&"I5:[#OB^4^>/+YXSSOJ7CHETP[AN9> M++X62]D/7OQAL(OL/DKK5S&8>CS&\^*NL_/O[%7OCES;-\MJ(3LFN+BK6R1* MML^9`=[4*L_FS6X[/-V-3%&QSDBOR0=#$$C0C#4"`F?^PVX34X3Z?8]BI?[2 M]0CJM?MFS8N[FH,HC_.+NZX9^`Y%%A>L5>>3O?Y63..:9%^PGUW.J<%,[Z=$<, MH"M+*.IF%E(XZ[AG-$KS,NM>F:M<8&_U)'H2C]HJACR<.0!9.U,[)NG[`T&% MW`T85A2X>^B\U>32'31B;+8V!M^65%*V@1`22H>A'2.I(&^`(85U]:%O8QJ+ M:BDZ3#8)\J_"/F1\`^^Y7RA=?HN3I'%4IXQU>A^7SU2Z`G='IJTXU;,RRHYM M5+9&A6999YT?)2?D#LP*ZUC(!Y=A!@,ZT3Q]MZ(E`W/.?..JN)H,PC+ MQ5*?O^UR_,Q?I"?MBK^;0MMAKH9JP94N2RFC!.JU",IMK@:8TEDO'KQ;U@C7 M>W)'W;TG80,*U/;9FG[S$D59=YK$VK#-JE#!\]<=6K!G(H%Q-H M^AH*"'IG'@64#7(>^`(J[7UP"?BFI`:J]WV`LB[N"3!U!#[!KQ^,88U2;&ZR M*,V9ZDX#;CHOV/0$`L\.<.3M08**W%GGAT13>P&#D@IS^.47T&U,I]AB>'0@ MKY.[!ZVZ`O<3!^L\3DF>']+5;9R67)VY"($LD'O`D#9!K5)2=Q'`8['4'D&O M$&P`O_P`JC&IH?;][B^KJHS61581])*`1^O%59;B*B"71R>2U&G"Q&&F1 M;*H[LYVK#QE-V3\7CN,4S\DW2";>.F62M;Q\@KNEB5E;/<(Q4!8YMND_+7!T MN!62+[+XL;J')U'EG!;_18K])7TLMOAJ=T<%_$J*FKC M;O2N6Z(X2&]9*C@$>;E2QRK3[U0J:ILC.\<4*$JO@,HQ:%*TN;*G5=1SU$VP M@P[<]*J9D*[;AY?9ZS,1_LXOTYJ;1XY%-'V[-:VD]QQUNAKK0`W!>\*CKS[@ MBTW[:%8E`V9:)E&>EUVK;-WVH>G.+'`87&)8O'T[3;>XYV"<:`\=;.I792GC MN/?3\9O(:;O[?T693$W>9,L])B)6DA2I!B4;*9+.B4] M=Q7F5M":+.G4$O0QBC*YB6.WL/LI3EJH#87KI#`]V-0?U<[!B,O(46AR\3L] MBA7;:*1,,:TO:$)WU97:+XM/%S"%*T`Y,F&S&L0_[/E/. MU/>ETNZ=AKI1EA?I%8=H5DU5SVF:-?];KG?+]E+FJ;%>P="P%BL()R/.7%8U M3*-C49Q0\V?)D^XX]FV[EWJG,Z36AB_SN)097;J9W[=2(V9>IIS&4RQ]3KXF MX[%G'E1*GDG5A>H[^AEY'/N*[RDDR'\<>X#6E#]9O-!*K705(.?(.`LKP,O/@%9^8AD=:D=T@ M3Z=(8Q.?N"!G\1,9&08Y6&ES&"%3@T/(B#4UE#4D:PA@'COF11AS)S>/XS%O M]W)+;?$TM++:5RA+C'R#I(2OJ:;TU47EFT*Q#7KW7IUTRG%G_GY23_6V2P:I MB9!]'5M0M,FE*.A[3BEC(VBED=*I)6B_,,B2X]@)O.:/:F4[V.QG&;]/5P;< MZB:3PI86VT5=.L@T4YI&F9YS2EUAJ!MA@A0:CEW'=YE79G_QUSK.JRLD&3WA MP7.=&#I5@AG-T@.3H$L'DW+&S!YFN6?0=87J(13O7A^1(HJ3U^>O09Z[\OSU M>G5+LHN[4JC\-/W](5X\E)<$-A48R.@];'R))ED&IL0.O9BM;:#!'HBU)[0Q M@ECR7PZAV[AL4CGM;)2J1$TX`*J(_LWC:0'Z"1]?<'FB2; MBV\I65ZO;_-X&4<\L@0`FH)Z@#:0>O<@AS/,S+@#A0C\4O?7.*49\^W-53^N M898_Q(^7).,7XJ)[MN`]I^F"I@63FM5_7Y$,4#R93]V,$_CL#O)M&7.F/C%! MO._E7KGKE=#KQ?+FRC+_$3QR097"7RBO2CFS!B37P>:PE_/AXJZ:S^\_QT,W M/H5%;23.Z*0> MWF\B$T'*),-:`H3;4+I#,M2!](:J07H#G`Q@#U+6'>ZNF1AV;%Y-3MGZ`#6) M&%-+/7V'VMW4(,H?^"R?_3G^:QT_14FY$BH.HRS;L(EP>>-R."?0*=-,!G!E M_/*B@O:D9NHC/.6VLM(IXBK9M>ZV7;.39:/J_HHORNKG8#&]$,M$VCG53$+` MJA4#:8/7M-;`DY/JJMU].'4:K@6<#,'=X[2+"(=--3O,>U6;[ZF[]MS7;"S* MZT"Q/`G^M8< M\_6_A8`$F3K:.!@PJU'P@]W[@P&N;\%5E-VE;+<:\XF'ZTT%:\E5!:E_+"`6;@'2#,!,!G==I3['ZX1.;2CB& MN\&@F:U5>H:JS6%TGJK!P9W%FDB()@"M@8'@$!5%VUA!3NM.WTH,X;FG\%O? M-TXXN80>W:E6!MV.6]1RR:#@)RHM@I$Y%]SH]11-#+$P_(?XE&]61"T>X&N MN#2\O,)P9^N]8-UR5T8PZ903-2?-`)%'JHDC[11DH'K.(^A&RT;A&*:@:JX- M0E0.'VY7M`O%ZC:(:`/X\FX.\@NY@V?,P3'O=2Y?U"CIVGX`TGD-%:Q^>+!( M.(:[KZUP]13M+U5V;*,007;?[>P&-=Q:F=9`-;E8L\VS&]]1_PP(*=0I`NS2 MBXNX?JUWJ.CPYZ+W]JY/V^_2)J"@)O*==Q'3SNNZ04_CVXD+&!$@H1A.`;V( M#M"%A%H_,W0(^8;K'X7AG,+H0^?AEKH(0,108AM]$!@98+"8_*6:.LO^$`8Z M9?I7-U5EP@&1@0T,,8:KR=*M9H?Y"CI=@55T<\W.*(*!E@X M/15A-#_S!QUX9U17NO'^K[G$9A/M[O"1MTMFOT;]H=KC. M"[;`R?*#36N*9AM<'J4UF>,H:FL"1W?9CGH""D[18((F/Y&`P%W49[1B#=$3 M27A\IJ1KHCYA.GL!'E_(?Y`H*1X6S`T)3SE@@EI,$8$SGZFV+46HU/>)($_N M%$6\PMV&EW0XB@=NWWQCGF4@+\PK7//9=/`4X?Z@:91Q[64^,4&MX6[S]FX^ M7,7YGP<\I\KB815E?XKC-E#DVQ`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`2^M^N1T?<@8*+22Q\>`HYSO)'HW)YVQR2J[8LQ+6-%QG*K0BE;N)NF M,TT!P1:=8S(#Q6S;T`AN?TN:A#MJ3#0+M,ELFZV=&:\7&]C35*C>-+5K[3Y/ M.Z9N>(8ZY(FWTV>PL]5!L+\Y;T?:UV'1^K"(V]OU;@P<[R`'N!6OW$6D,V^I M#>X-`N+TKSO9$2/4'>N3*,Y^BY(U^4JB?)V5+[$X?_BS%>HHSA<)Y7*-'H&M MAV<,:0T..:FS24LK5I4Q<#]==EY5KUME>9%><6AFU=VT1'DLS")F MG>_0C-/YNK?YP:;]YW_$)&,N[F%S1IY((MA\UBLTM):BD'M3=!W`6%3A_K!1 MV:%A<&7=V^D_-9P"`TTU5:Y>:RKDV8&YP01S00<) ML_"VN$KTX4CA,,H?>#88]H<_P_T4)3V'L=U*&$8$Z)9K(@7PY8)V+<(S`%.C MV?QPOQ>#&#AWF)8<6.V.%NZ*-V5RVULWH_7R:-K68+?#M??FG( M];Y^1QI@.U]"T;ZI*:!P?F5N*Y7RIIR,%$SPY,6].%GC"/,Z(>_!"?B*TSGM MT+VWHS7A1XM-M&PNQHR"JGG"#:+R%2DXM5`@`5F%NU>WGR3T6Y0NR`G-CNCZ MMKA;)^.^`#@9D[*-U]$KZRNXII@`YY?T*C#8T?NI`F)*[J.BIO5@C/O>KX4C MAS_S^^"*<7"VYTP+6D3)F=-YZVGZQ+C1+/9BGMI(L]DN-(#Y*H*R;FHII;.^ MW4IU%7W[RIQ-%D<);X&+NRO6OMG3Z*5[?(&AWI("SKHTIOFH@=+]?BVIA?=O M#/=P-[!;[7ZGV9^GZ65&%R3'04Q=8H@Q68E@0(96VPQE,O;A3II;]4[B-,X? MR/(+I4L\E,P,!DK M8H:'DH_-.:K+AN>[S%7.$H5O`0F'H!`0!@,1E9)F@!%PK>'S0VB[\MP'?HN3 MI%G!G3+6Z7W,5W"NESH=T;925>66==OI'SBB;)"OQ MJ5'G)HO2/*G:9OFO=5Z446Y`@\N)!S"`B'T'!TI)+IN'$=6$IOR*:844YL3%1%73/W*C#WRD\DNZ7NEXK; M:Z9\/5R0L_B)C`PBSSR'+3C**J6PPB7)1!CB#DDU$JDY)'RVS ME1%,V&986FTA<6E[>?XOV3U$3ULK("-W%TQFV#]50 M?!`SIU09=J=0HHEYUG7EP`5(BWCDIH*Q,6H74AN@5\M$47S*::V"A1ZY6OR;W<>`0 M-:?<+XET1P\2G>H4CJBN9B>]S_YBL5ZM$WY:L+_BKZK\75H.CS\%`S4B00:[ M@5&#%,3!X$U+:S.1PG) M^;-8<9ZS=CBGZ4*<"P)+WV2%4-,[Z[XRXU-]5?M]4\"\S!2A9AIX=(,P80J( M)R2U+"5-"%C24Q.%)"7+<.?7'8UA?PG[27]A`(N/:O)>\7!#$SIJ@'Y!2C-N M\A!\`$8E71@(^GN8J3>8-\O69'G\_$C2G+191CJI\UQ/YBZC3944)5V6PD8) M-*E#4+81?1)*Y\\47Y'R"*#3!N(T.VCZP;/%$GIG?1C3=E1?Y7Z_EE32?;Q8 MPCS\.2+O[4ID*>FV\T*(SG"S0B5D%%3=J4.(<,&IIP46D*6+ M&2:P3:&>'D@="+Y*J^\'ZB3A&4">S?1#RN/=,UR9[B!3FD:=G=Q/>`<,3-XDM![&PXTVH5 MJJEU?S##5%4NQ!15N(B0`0!SFM9"\@N3&9,_3N^%8%$3MDFA8,)@0(+6U@P@ M,O;.KA\""&DDW>HB]B9*NN:*/TP7##RPNIJA0\+=HZ75]A"RU@>X;*H@VUX' M!,B"`0524S-,P,S#O=&G,:&D1K,O'5,WE_9PU81[4T]O*:.TN_)N'JH^M>%# MOXT':W<&7,;3**%<;)QY+F,N5E4OF%(!CB$+5FHT($TM8*A#O-P3[N& M&C=_%O0^C?\F0Q>+)1*K)4FEM!F*"2X!]8TAK21DDL=V904Z3GG#JL M&2SOO$G;J3.3I4:S/NR2XZQ[WP=7S\XL.8`W&J5$XD[J_@A;$U$H)8TP!'$. M/(?<0"WEK0Z03@P@+Z)NIV$(&8EK!B-!=&ZH]PTM;C=!VQ[6]YO.=N&.(3YD M0VIT.+Y!:G;Q-4)D-:$^7U['W;(V*39E@GVF-E].NH[VJ>6Z',H%OF*.(V^? M-%>1>Y"_'!+R8-/[(DUE;L!CE-57N-B`@EG#DQ!$W MH:@*8H>YT[-'FK'N\']IG!:_L;9A"R`@*DI)V09&22B=.31D>U$=3?NN2EY# M%1(EX;P+8\4$ST$UNQ0T3.B+4,8_*ZK>A<8Q',@MC@N6AO9I$H5[4`Z8:;3+ M*%_:0IN2:G)GBI^1^R@Y(:-GGT>_UZIT?O=MA2+MOR'4[A3FJ/ MUN2$V;"C+WCK%4/:[`I(28/`B8:V^M"1,P_7:YZF"[HB9S3/N7KB$6/\GKQ& MF?86$:I,$$`ST5\?<:+(VS@MN;H^A!2(!!U`8DAK),A)/=A(;`3< M7S"'G,!<432_1 M>$!O[W3Q"TF_D20Y35GO6I>3B4-Z5BR%VYLHVEH)!:VS00W?&%1/X?[HI:RF M?%Y>SC[<_315SZ;ZG4)MWGJ7$L$X7,,:#R&`Q?';C[CZH`8(_`11H!*TH8@A MA?V\#QN)`K$N,WI"LU5TFM[Q/V63RB=Y>H5A@T@+^V2BO)%4?&%&HP1LC'$) MGSP\IIW%;DAA":7KE]0,.*1QC3OEG%KUSDFQW4#2@*2P'`*8@W([!D^95>8$ MZ:!>\VUFV5[?E$7$093'B_UT>10G:WYWD8EY2;+KA_+!\B.:)%'6_C!$H4'1 M!HA:14/$HKEM)L-1J^K`;[.@YFQBWX"?W"A;I+?MKUO5ZY)&,=F>95TSWN8/ M\$H1:E^63MZ^%.-?5&E_9Q];6:B;^F4*L.H8C_E;GE0R3N])NO#@C0N9:*K< MPD9ENUGC\&4M)D7DSW!=D5[GN\](>9<-T%.G2+.1CRIB,QDHZR=1G_M,&F7:Y] M@AE=+ABPF=K"#&P:M49,TX\>M.ZO.BV%$QMSR%T?M-:\S;B M-B&M7W[^ZU\^_JW=OL<4,^1C1YEN%&UPKYHSX@(I5\:F`9=8N;JXNNA>=)6^ MM]HP,E_XRF6O]UYI*V^[E^\5:[U<$E^Y(Q11FR!7&3-"?>C@!V4X[%\HJNLJ MDHLK#'/,GK%ST6Z+A[_R:VXO\!(I/F)S[(_0$O,5LO%-:^'[J^M.YQEQ;XD= M8B/WPO:6'?'`[M75)2CDXB6F_IW'E@,\0VO7OVG]L48NF1'LM!08`7EXN7JPN/S:&3[F7GU\>A)9\=THI'E7AN0`R#Z&]6>-_]#/&I[#QL$2SO MVMW+]IX)!O5+3)[7*7-#B:XZHGF*.-X)GZ+?R@^#W^O(UATI=$1RNB:4^P`. MCM([_HXA2OR^$S2&I(0^8YX@Y=B^F'O/G:!-:'H5UY2NE]G2.#[KB.'I``5F MQ-XQ>+0$CT?;"3X'DVS1H"&*`%B;H@A[0Y1Z/O)A8LA;VYNK%:$S;WL'[HFQ MO0[Q,/%,D:-]+:2X:7&R7+EB*.6]!<.SFY:PEW9H)+^O&+X`^4(2YKDX!QS1 MW%F)J4$#R8;[!X==(&:G>DE9`W3BK3#S"5C?WI@Z)U-+3(:*:@&+O7;/6BL' MSZIJ!2R$DG-6RD73JDH!"W:_KCZBGPEHH(B+)U,_Z&ZE0`//7@L7KU)'@_7$ MW^@P1]E2&E-+(6)(\S,6/*,\:-,IMO>S?$X2AX^AYU,(7^X8)[+G'$ M%N(6N6*=L188^_R)HK5#?+$<"[2J,.2"!]!)\"P87[Q%KV^,!MK(T@;BRC*& M^D"=P(];=:B.^IIB/6C:Q%+>[)[PCP;/^GB.$8/!6&!?]%`9W#AW=`Q@,QHT M*B9(=%T=5+FMS#.QJ3T`F_Y) M4X:&U?BE+NA\;F9[WE(&VR. M*/FOE!2\]1BV!U$''J!:1)2+X(_AQIYPV_7XFF'X89CWZDC_M_33TDV/87&/ M>^\&J@14MX@3F$'CB*9B?65$[GI4V_;6,LDWAGEG0]@78%>9JP#,MVDP;U5+ MEW,.%EH+YM\>U;ZI3_2^.E34?M]X&DWTT;TRA@G;U[4&WR2^%IX+!V?BE<<$ M(G+S!)MUZL[2H]8"0I``H(S[!8B\2R,B-ZK@"\7^]1%FD_6@FEH#00*".T38)^2N\2-& M8N#D)B-`(;NI`(CW:2#N5-U4/JG#)TUYU%3KR0RV&`T4"2BV*XD(^0R(Q)F) M;4R>T=3%?(3]`),"F@)P?DR#LUU6@DC/F#S`?#&UOJ9_4F^'FO6#,M(F#5`) MH'3Z#!IZC$2`2=PK`.*G-!#ZZ!/,"L/4FU'/'O5[SW->B.N&IJ^#NG1.A.D' M$.01%.#Q(8W'O6$,/NO#861BZ+`Q&]WK8F(TZ"2C(#'B*N<0WTT)C=2^LQH*D,@(Q6^?+'VD0?`'@=^M/I*Q=X-! M*C\M7G"3(5V0_A")$$SW6:\\@@),,H)Q$8/KDR"UO$V,B"2)-FKR6)E.2R2C MW(W..:S?D0PC\RA3X6^*;EEBP8\F($UC!-?])I`_ M29KYN'1S9MHY^=9!O01SP:L'/YTNE:V\"=5H"DS'FM,$[6/BFKS?W)0^G-*4 M`B4:0ZI<'HE:3EGB/%,I4Q0I-(R:Q9;&#,I77:*X'VS-`SJSUE*(;-FB30-E MI>I-%,T\@CQ`#]1L"B$M7_YI0*U7!XJB6XHR#^82U9]"R.L5E1KXRU67HG!G MMN3!FZPI%6)9HB[5`%>C0!5%L9@L#]+\LE0AP)4+70W<)2I>47C3M_/@C-:Y M"L$KJ),U4-4OF"56U7+4!2MKB3)9$>3U"W"-,92LQ$61SV[*@SE9?RL$M$0- MKX&N0N$HENPZV)R;S\HH%Q7"6++LU$!9\ZWY`?81< MJ_D2OO)F*U]C`\V>]VWW;>G2FTWME0WMQTSGM+47SF[W:N? MW6XLH:XEQ'Z9A'^I9AH'V;^!K:3\2)E^?U!B(BM"YL9^*I1'8O9QN/G4!9)> MA0))@V:5"DD,T%R*T]=(>I5J)`VNM8HD,8#+D7[=,DFO=IFDL8!2=9(8XME- M)ZR4],I52AKLJI=*8D"6H/MJQ9)>G6))@WAQM22>VTG?/U&]I%=<+VG0JETP M2:ZP)LFD=TS)I+&'F5JYHTZ%7\'Z@8C$5$>7@>_M^G M0F0K_2=5@W&5TE@\77ZX_<3%L5[YXEB#9O7_SHJA6H(N#]W<_\HJA+GJOWG] M7^#]L9,X>SNX$3^A6YS/398BP:S0U/'PT5/7YPBM8H>N!T?+#SU;=A8_)CR3 ML8-=GX=WVONN+EZY$QYFG"M.W@GDN>(D><3%T0)DG,Y>1H8(V_:ZO>^BGB0R MI\0VE46)\H4_CA=F#3LP:F\J@Q-CW/TZ&B;\:B\JR[)CDE='RT`1L>47"RZK M"+'G"B[;^P[JB<&)75F(D$=1IZ+UA5*)XC><[D`1EB;"YC,:ZVZ*=] M^;9]^>/QA7G([LRXU.5.<*/-]Z'`*_[U<>!OER`A]Y?G`TQ)W'M.7*]3883]!KJ-@F M,@9E&?XTAF`A%X,)1P/([>L]CW@YQ2RJ>R%IH'7P4:=KQULB0D^@=/`[3^=# MRHF#WU?B]R&5#A&4*D-\;@K>XP>,7']AP_1**935 M>&X*2,=PBSB6WZ(`!QF^;JLRAN@\>AS-WI$4TY^-'RE8+\?,>R9B.02/./#6 M4W^V=B,OE>R72]7YSYK[R=&HQ_YG&1P=_"1[)C8&528,+)70><:L/4QT;L:^ MQV.[^>$I=0Z3G)LRVJN/J8.=[?"+#+'H,JU2$>&Y*1;:4\2AI-?TPS3GI@Z$ MF""7,?N\\%QW8[Q00`*D(`Y!;'&5L%]4YPY)$W?:?O[O,((\B!_?`1W[G?1G$/!7_];U["_1&5N)+>:>_/#^]P4W^Q_DGC@V9AH(`[#EZ5^+ M^QR'80R2!AOM?;R86GSRB,YMZ0G?MY+.9K\3'7G43F6U2M">2S:K(,P0]F@# M/@/BKGWL;/\+1P::.AW`5@BQW8V$&9=GVT(-.*]"HN]JN_>8OF#7U6'(F/2\ M@.'0=S)R"+ETW]."Y>L/0?8>?OT/4$L!`AX#%`````@`:X"N1JOI"[A*DP`` MQ%<*`!$`&````````0```*2!`````'9A&UL550%``.) M_U15=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`:X"N1KNS8&E%$```@.$` M`!4`&````````0```*2!E9,``'9A`Q0````(`&N`KD;<'KO^%1D``(1Z M`0`5`!@```````$```"D@2FD``!V87-O+3(P,34P,S,Q7V1E9BYX;6Q55`4` M`XG_5%5U>`L``00E#@``!#D!``!02P$"'@,4````"`!K@*Y&XJ'L=7YM``#< M"08`%0`8```````!````I(&-O0``=F%S;RTR,#$U,#,S,5]L86(N>&UL550% M``.)_U15=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`:X"N1E<4=5,V-@`` MFJ0#`!4`&````````0```*2!6BL!`'9A`Q0````(`&N`KD9NTM.';`P` M`,9_```1`!@```````$```"D@=]A`0!V87-O+3(P,34P,S,Q+GAS9%54!0`# IB?]4575X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``"6;@$````` ` end XML 60 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
LOSS PER COMMON SHARE
 3 Months Ended
Mar. 31, 2015
LOSS PER COMMON SHARE [Abstract]  
LOSS PER COMMON SHARE
NOTE D – LOSS PER COMMON SHARE

 Basic loss per common share is computed as earnings applicable to common stockholders divided by the weighted-average number of common shares outstanding for the period.  Diluted loss per common share reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted to common stock.

The following table represents common stock equivalents that were excluded from the computation of diluted earnings per share for the three months ended March 31, 2015 and 2014, because the effect of their inclusion would be anti-dilutive.
 
 
(in thousands)
For the three months ended
 
 
March 31,
2015
(unaudited)
 
March 31,
2014
(unaudited)
 
Stock options
  
952
   
1,754
 
Common stock grants
  
390
   
875
 
   
1,342
   
2,629
 
XML 61 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
ACCOUNTS AND OTHER RECEIVABLES, NET (Tables)
 3 Months Ended
Mar. 31, 2015
ACCOUNTS AND OTHER RECEIVABLES, NET [Abstract]  
Accounts and Other Receivables
The following table presents information regarding the Company’s accounts and other receivables as of March 31, 2015 and December 31, 2014:
 
 (in thousands)
  
March 31,
2015
  
December 31,
2014
 
  (unaudited)   
Trade receivables
 
$
9,270
  
$
19,734
 
Due from employees
  
116
   
110
 
Allowance for doubtful accounts and
        
commission adjustments
  
(4,361
)
  
(4,571
)
Accounts and other receivables, net
 
$
5,025
  
$
15,273
 
XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 92 187 1 false 31 0 false 8 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://vasomedical.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://vasomedical.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) false false R3.htm 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://vasomedical.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) false false R4.htm 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Sheet http://vasomedical.com/role/CondensedConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) false false R5.htm 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Sheet http://vasomedical.com/role/CondensedConsolidatedStatementsOfStockholdersEquityUnaudited CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) false false R6.htm 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://vasomedical.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) false false R7.htm 060100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS Sheet http://vasomedical.com/role/OrganizationAndPlanOfOperations ORGANIZATION AND PLAN OF OPERATIONS false false R8.htm 060200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES Sheet http://vasomedical.com/role/BasisOfPresentationAndCriticalAccountingPolicies BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES false false R9.htm 060300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS Sheet http://vasomedical.com/role/SegmentReportingAndConcentrations SEGMENT REPORTING AND CONCENTRATIONS false false R10.htm 060400 - Disclosure - LOSS PER COMMON SHARE Sheet http://vasomedical.com/role/LossPerCommonShare LOSS PER COMMON SHARE false false R11.htm 060500 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://vasomedical.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS false false R12.htm 060600 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET Sheet http://vasomedical.com/role/AccountsAndOtherReceivablesNet ACCOUNTS AND OTHER RECEIVABLES, NET false false R13.htm 060700 - Disclosure - INVENTORIES, NET Sheet http://vasomedical.com/role/InventoriesNet INVENTORIES, NET false false R14.htm 060800 - Disclosure - GOODWILL AND OTHER INTANGIBLES Sheet http://vasomedical.com/role/GoodwillAndOtherIntangibles GOODWILL AND OTHER INTANGIBLES false false R15.htm 060900 - Disclosure - OTHER ASSETS Sheet http://vasomedical.com/role/OtherAssets OTHER ASSETS false false R16.htm 061000 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES Sheet http://vasomedical.com/role/AccruedExpensesAndOtherLiabilities ACCRUED EXPENSES AND OTHER LIABILITIES false false R17.htm 061100 - Disclosure - DEFERRED REVENUE Sheet http://vasomedical.com/role/DeferredRevenue DEFERRED REVENUE false false R18.htm 061200 - Disclosure - RELATED-PARTY TRANSACTIONS Sheet http://vasomedical.com/role/RelatedpartyTransactions RELATED-PARTY TRANSACTIONS false false R19.htm 061300 - Disclosure - BUSINESS COMBINATION Sheet http://vasomedical.com/role/BusinessCombination BUSINESS COMBINATION false false R20.htm 061400 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vasomedical.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R21.htm 061500 - Disclosure - RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Sheet http://vasomedical.com/role/RecentlyIssuedAccountingPronouncements RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS false false R22.htm 070200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies) Sheet http://vasomedical.com/role/BasisOfPresentationAndCriticalAccountingPoliciesPolicies BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Policies) false false R23.htm 080200 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Tables) Sheet http://vasomedical.com/role/BasisOfPresentationAndCriticalAccountingPoliciesTables BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Tables) false false R24.htm 080300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Tables) Sheet http://vasomedical.com/role/SegmentReportingAndConcentrationsTables SEGMENT REPORTING AND CONCENTRATIONS (Tables) false false R25.htm 080400 - Disclosure - LOSS PER COMMON SHARE (Tables) Sheet http://vasomedical.com/role/LossPerCommonShareTables LOSS PER COMMON SHARE (Tables) false false R26.htm 080500 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://vasomedical.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) false false R27.htm 080600 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Tables) Sheet http://vasomedical.com/role/AccountsAndOtherReceivablesNetTables ACCOUNTS AND OTHER RECEIVABLES, NET (Tables) false false R28.htm 080700 - Disclosure - INVENTORIES, NET (Tables) Sheet http://vasomedical.com/role/InventoriesNetTables INVENTORIES, NET (Tables) false false R29.htm 080800 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Tables) Sheet http://vasomedical.com/role/GoodwillAndOtherIntangiblesTables GOODWILL AND OTHER INTANGIBLES (Tables) false false R30.htm 080900 - Disclosure - OTHER ASSETS (Tables) Sheet http://vasomedical.com/role/OtherAssetsTables OTHER ASSETS (Tables) false false R31.htm 081000 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) Sheet http://vasomedical.com/role/AccruedExpensesAndOtherLiabilitiesTables ACCRUED EXPENSES AND OTHER LIABILITIES (Tables) false false R32.htm 081100 - Disclosure - DEFERRED REVENUE (Tables) Sheet http://vasomedical.com/role/DeferredRevenueTables DEFERRED REVENUE (Tables) false false R33.htm 081300 - Disclosure - BUSINESS COMBINATION (Tables) Sheet http://vasomedical.com/role/BusinessCombinationTables BUSINESS COMBINATION (Tables) false false R34.htm 090100 - Disclosure - ORGANIZATION AND PLAN OF OPERATIONS (Details) Sheet http://vasomedical.com/role/OrganizationAndPlanOfOperationsDetails ORGANIZATION AND PLAN OF OPERATIONS (Details) false false R35.htm 090202 - Disclosure - BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Details) Sheet http://vasomedical.com/role/BasisOfPresentationAndCriticalAccountingPoliciesDetails BASIS OF PRESENTATION AND CRITICAL ACCOUNTING POLICIES (Details) false false R36.htm 090300 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS (Details) Sheet http://vasomedical.com/role/SegmentReportingAndConcentrationsDetails SEGMENT REPORTING AND CONCENTRATIONS (Details) false false R37.htm 090302 - Disclosure - SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) Sheet http://vasomedical.com/role/SegmentReportingAndConcentrationsConcentrationRiskDetails SEGMENT REPORTING AND CONCENTRATIONS, Concentration Risk (Details) false false R38.htm 090400 - Disclosure - LOSS PER COMMON SHARE (Details) Sheet http://vasomedical.com/role/LossPerCommonShareDetails LOSS PER COMMON SHARE (Details) false false R39.htm 090500 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://vasomedical.com/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) false false R40.htm 090600 - Disclosure - ACCOUNTS AND OTHER RECEIVABLES, NET (Details) Sheet http://vasomedical.com/role/AccountsAndOtherReceivablesNetDetails ACCOUNTS AND OTHER RECEIVABLES, NET (Details) false false R41.htm 090700 - Disclosure - INVENTORIES, NET (Details) Sheet http://vasomedical.com/role/InventoriesNetDetails INVENTORIES, NET (Details) false false R42.htm 090800 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details) Sheet http://vasomedical.com/role/GoodwillAndOtherIntangiblesDetails GOODWILL AND OTHER INTANGIBLES (Details) false false R43.htm 090900 - Disclosure - OTHER ASSETS (Details) Sheet http://vasomedical.com/role/OtherAssetsDetails OTHER ASSETS (Details) false false R44.htm 091000 - Disclosure - ACCRUED EXPENSES AND OTHER LIABILITIES (Details) Sheet http://vasomedical.com/role/AccruedExpensesAndOtherLiabilitiesDetails ACCRUED EXPENSES AND OTHER LIABILITIES (Details) false false R45.htm 091100 - Disclosure - DEFERRED REVENUE (Details) Sheet http://vasomedical.com/role/DeferredRevenueDetails DEFERRED REVENUE (Details) false false R46.htm 091200 - Disclosure - RELATED-PARTY TRANSACTIONS (Details) Sheet http://vasomedical.com/role/RelatedpartyTransactionsDetails RELATED-PARTY TRANSACTIONS (Details) false false R47.htm 091300 - Disclosure - BUSINESS COMBINATION (Details) Sheet http://vasomedical.com/role/BusinessCombinationDetails BUSINESS COMBINATION (Details) false false R48.htm 091400 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://vasomedical.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) false false All Reports Book All Reports Element us-gaap_IncomeLossFromEquityMethodInvestments had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '090700 - Disclosure - INVENTORIES, NET (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '090800 - Disclosure - GOODWILL AND OTHER INTANGIBLES (Details)' had a mix of different decimal attribute values. Process Flow-Through: 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Process Flow-Through: Removing column 'Mar. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Process Flow-Through: 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2014' Process Flow-Through: 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2014' vaso-20150331.xml vaso-20150331.xsd vaso-20150331_cal.xml vaso-20150331_def.xml vaso-20150331_lab.xml vaso-20150331_pre.xml true true XML 63 R38.htm IDEA: XBRL DOCUMENT v2.4.1.9
LOSS PER COMMON SHARE (Details)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,342us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 2,629us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 952us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_EmployeeStockOptionMember		 1,754us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_EmployeeStockOptionMember
Common Stock Grants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 390us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_CommonStockMember		 875us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
/ us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis
= us-gaap_CommonStockMember
XML 64 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
COMMITMENTS AND CONTINGENCIES
 3 Months Ended
Mar. 31, 2015
COMMITMENTS AND CONTINGENCIES [Abstract]  
COMMITMENTS AND CONTINGENCIES
NOTE N – COMMITMENTS AND CONTINGENCIES

Sales representation agreement

In June 2012, the Company concluded an amendment of the GEHC Agreement with GEHC, originally signed on May 19, 2010.  The amendment, effective July 1, 2012, extended the initial term of three years commencing July 1, 2010 to five years through June 30, 2015.  In December 2014, the Company concluded an additional amendment, effective January 1, 2015, extending the term through December 31, 2018, subject to earlier termination under certain circumstances and termination without cause on or after July 1, 2017.  These circumstances include not materially achieving certain sales goals, not maintaining a minimum number of sales representatives, and various legal and GEHC policy requirements.  Under the terms of the agreement, the Company is required to lease dedicated computer equipment from GEHC for connectivity to their network.